"analysisId","targetId","outcomeId","comparatorId","targetName","comparatorName","nestingId","nestingName","outcomeName","type","targetEffectSize","oldOutcomeId","trueEffectSize","trueEffectSizeFirstExposure","mdrrTarget","mdrrComparator","stratum","logRr","seLogRr","ci95Lb","ci95Ub","method","comparative","nesting","firstExposureOnly","database","calLogRr","calSeLogRr","calCi95Lb","calCi95Ub","calP"
1,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",1.14216270719561,0.132328935895127,2.40154260822194,4.03429345070723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.903651843477759,NA,0.555110954621253,NA,0.252885023793645
1,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",3.05721231879574,0.0736317961567515,18.4251039627594,24.5901367572567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.66644806261642,NA,1.90157100044795,NA,0.000813234360406007
1,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.189509123260189,0.152528864556497,0.615567076089365,1.11928579759511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.322104594639327,NA,0.219634813063757,NA,0.711247544864558
1,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",3.58564511761476,0.0676266512719955,31.6411385518455,41.2458181145365,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.15283848321139,NA,2.61005149120387,NA,7.609794556968e-05
1,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",0.172583404853043,0.143150469915354,0.902119360343171,1.5811162606538,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0112098452844479,NA,0.284593175698924,NA,0.967864678027038
1,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",4.69560241041654,0.0613125235022585,97.2424574401177,123.661512696937,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",4.17453804676953,NA,4.92753774094866,NA,1.67160939620441e-07
1,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.498337759101573,0.136736285819661,1.26678595385108,2.1651276899257,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.311053763419328,NA,0.357703354860981,NA,0.681342753975579
1,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",1.2642627521916,0.127604292816219,2.77793643463882,4.58095732292139,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01609281742269,NA,0.602907366994581,NA,0.199389541535892
1,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.20258203770928,0.0728147672083756,2.89045091289412,3.84525975683028,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.959282644439959,NA,0.583603028660033,NA,0.22178531533428
1,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",0.129418531224681,0.116518732205753,0.901585283073973,1.42353668413627,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0285396746789351,NA,0.278000009762541,NA,0.993008178633812
1,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",0.456879930350383,0.320109272200471,0.799910754716419,2.80541134454289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.272884746525137,NA,0.322186166730205,NA,0.729872072862475
1,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",1.57456991373958,0.0761722876940017,4.15905240018495,5.60622249627553,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30171929420434,NA,0.745932805113928,NA,0.099390800695106
1,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",3.26877781895181,0.0586894761311804,23.4541980001519,29.5211813346725,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.86118600488199,NA,2.16278100527819,NA,0.000323754651916827
1,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",0.0234481322488757,0.197184532135655,0.684163558834304,1.48199757970767,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.126092529896441,NA,0.251522991570266,NA,0.89851120307005
1,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",0.401662078301298,0.169524871104128,1.06101071349005,2.06214610864393,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.222064060182108,NA,0.331417838952,NA,0.765089640821789
1,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",0.738252604189633,0.149378557074794,1.55160443109492,2.78665707450941,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.531885632421396,NA,0.42053373811344,NA,0.495390034850922
1,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",1.307960737762,0.124129669390253,2.89492020400988,4.70928885344442,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05631494971938,NA,0.621122785188301,NA,0.182269413768242
1,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",0.626786652467684,0.194357002118024,1.26565002030552,2.71136253460406,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.429282744726169,NA,0.384279002895574,NA,0.582382671724828
1,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",1.00577066929734,0.170746737086819,1.9440925341894,3.79661627134582,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.778128637998695,NA,0.501643596769817,NA,0.326668552724982
1,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",1.2254789281808,0.158479983457888,2.48510445887487,4.62531656045358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.980365041865344,NA,0.583475044804586,NA,0.217910544962133
1,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",1.98222894303094,0.127608527646562,5.65128813116901,9.31941392937024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67694280203092,NA,0.964850245034166,NA,0.0356665563546907
1,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",-2.02320753559681,0.572489770479001,0.0490935156118322,0.463054901337773,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.00999497551812,0.832735590765066,0.0376260253598612,0.984328327813856,0.0378994179003841
1,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",-1.61511619537224,0.55038945279465,0.0779796594915282,0.674475280824335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.63435473402999,0.895356648016786,0.0541176442921651,1.80965924069538,0.0884899502416037
1,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",-1.17319981443956,0.535050277382181,0.126092037931134,1.02697272048216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.22757472001111,1.01034310257007,0.0786692423342874,4.12872715480444,0.199159246637686
1,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",-2.47245858927075,0.596103996772524,0.0295967012923475,0.306233426156788,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.42351877308444,0.786698122152027,0.0250139583490426,0.546335893014964,0.0132753912179829
1,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",1.8443619764288,0.222792557255416,4.18993119665824,10.0343588561745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55003843730945,NA,0.862847081788778,NA,0.0570348783664648
1,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",1.88220998576025,0.369823362974959,2.9494869588749,12.5699894980722,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58487513219966,NA,0.834316578927003,NA,0.0646343695158786
1,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",-1.14342552265625,0.536903873400893,0.129289781178792,1.06069619667772,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.20016799756584,1.02279801026868,0.0803853925985051,4.42987658064636,0.209994769608868
1,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",2.37138956018577,0.29391744682161,5.75817806145611,18.2243085274318,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.03516640762311,NA,1.18459421350138,NA,0.0148702901969658
1,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",0.571594426640035,0.805988664656274,0.483923854688624,11.3997314679697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.378475706156341,NA,0.225864807377359,NA,0.713929072823226
1,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",2.11280631738153,0.332294024369819,4.06271264523228,14.945638674432,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.79710728106833,NA,0.987653903576444,NA,0.0337083374928529
1,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",0.87791569270764,0.790811806826323,0.685887505121375,15.2241604383049,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.660439326662377,NA,0.290781966136456,NA,0.528372903294568
1,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",2.72076904618057,0.253307235824748,8.96676671388654,24.2028712795483,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.35675989282874,NA,1.4966975775216,NA,0.00431307418749161
1,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",1.32251898775386,0.772568176868582,1.12610256910506,23.2702151170338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06968775552782,NA,0.413908895380555,NA,0.307979677454503
1,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",1.56196954220354,0.763788125154236,1.46663761439013,29.2818209458496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29009766305481,NA,0.497799670181472,NA,0.218113761367696
1,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",2.09965810260107,0.220743634454463,5.43189356454962,12.9046400772549,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.78503224024607,NA,1.01874794328444,NA,0.0286075797766862
1,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",2.32401821070254,0.218992385630689,6.82435155593313,16.1018102552967,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.99155124683133,NA,1.17664147014454,NA,0.0146770326510862
1,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",3.0293552105704,0.215286546614746,13.9262945199295,32.3847133301764,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.64080349316211,NA,1.82930520988155,NA,0.00123559110718997
1,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",-0.0598446466543192,0.355253328248273,0.452056321468206,1.81960411030123,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.202753316042764,NA,0.21727465463426,NA,0.833839681016501
1,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",0.103634867778783,0.33401089280439,0.560006181734075,2.07402504239662,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0522715837621581,NA,0.248153842517035,NA,0.971324141891166
1,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",0.590867457115961,0.28501029365461,1.0226517539664,3.12557677491928,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.396217987457725,NA,0.360768686365325,NA,0.619783558277919
1,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",1.29326756768008,0.238348615469228,2.29682937494219,5.84647574772841,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04277264466554,NA,0.595885375572494,NA,0.199476000236323
1,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",0.0787926363854026,0.163096162567539,0.787519888170557,1.49250893895556,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0751445353704837,NA,0.264806101730193,NA,0.947420301172495
1,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",0.43574282264744,0.151568464211849,1.15361512901829,2.08973667281568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.253436018298925,NA,0.341181398779375,NA,0.734953836822427
1,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",0.0100171427678724,0.14644251840001,0.760444476494252,1.35011793052383,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.138470514167691,NA,0.253550296416364,NA,0.885337336441185
1,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",0.76762465850983,0.143826477691142,1.63462157991034,2.87255179112345,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.558921885457183,NA,0.429668618331903,NA,0.474101569167603
1,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",0.390885556953374,0.136471052663991,1.13665987993306,1.94070387256899,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.212148646240507,NA,0.332055377416536,NA,0.77296424678817
1,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.46078140414161,0.133209958688754,3.34416464317962,5.6372162571438,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19697562953312,NA,0.686111658171689,NA,0.132168159232348
1,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",0.699507125003401,0.130723598946671,1.56650947270247,2.61503366220671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.496222648561616,NA,0.411392548614316,NA,0.522189358786003
1,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",0.256522696516527,0.423994766832973,0.624594394173774,3.29160779209313,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0884303492026781,NA,0.260327711964825,NA,0.901707529433441
1,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",1.34890191835463,0.122339169286193,3.05216089007539,4.93035286087888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09399918063485,NA,0.638461627264455,NA,0.167329962368859
1,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",0.797572328276766,0.420417488627694,1.08242532532702,5.62494104611854,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.586474023879086,NA,0.385049701449345,NA,0.493872501324627
1,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",1.2001040223286,0.418935342415399,1.6250686960978,8.39592488486519,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.957008495065146,NA,0.511082598178663,NA,0.270518426901868
1,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",-0.141380946371112,0.138446977785102,0.655274001356375,1.12749727136514,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.277803532429413,NA,0.228278262656492,NA,0.751648374794137
1,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",1.98800755588781,0.417051542951422,3.58946519886289,18.4085499795633,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.68223158408518,NA,0.873488177061226,NA,0.0548317583906918
1,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.223580514944653,0.117382147816548,0.987293683252281,1.56414888391149,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0581557270674752,NA,0.296877817834165,NA,0.92144188438928
1,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.447735386438956,0.106688879748317,1.26316197157884,1.91905101799533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.264480642639332,NA,0.34773435193905,NA,0.722746665532227
1,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.10251790766764,0.0817521546330343,2.5609399242908,3.52837317052843,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.867182657887978,NA,0.545251584868211,NA,0.268706547233578
1,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.17185148298656,0.0977476596927227,0.694459154043597,1.01871482070376,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.305850335032308,NA,0.22566193291798,NA,0.723868846793302
1,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.212206572827857,0.0881377724099839,1.04020615863475,1.46948594472644,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0476936405382632,NA,0.296270341253994,NA,0.931479299003726
1,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.553190900803308,0.0814239208683815,1.48324512588024,2.04093542578089,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.361550297927344,NA,0.375588511560338,NA,0.633563968644287
1,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",-0.0924379792569764,0.135102531683548,0.698094730420838,1.18553212466776,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.232752568891639,NA,0.236582345428701,NA,0.794090755663736
1,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",2.24333337465596,0.0672312131365684,8.26728138694002,10.7601256893392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.91730950701463,NA,1.14852570323098,NA,0.0156715961167316
1,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",0.279552141352942,0.122026398175981,1.04110463718685,1.67970299952088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.109673852443461,NA,0.308379819479567,NA,0.871047034571756
1,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",-1.96622902222005,0.56780471993475,0.0526289191008245,0.487367941301264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.95754085120043,0.838896981627411,0.0396872368082321,1.06363268186335,0.0427451535234776
1,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",-1.50885219943088,0.193913785747273,0.148847850962618,0.318318585381313,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.53653396914466,0.737413915823122,0.0817731091309389,1.47226584433788,0.0645185707516577
1,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",0.579447486251642,0.113772596758564,1.42984608509061,2.2334493626932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.385714129397975,NA,0.380255108618492,NA,0.613761406713495
1,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",1.13212880005324,0.1023428188333,2.54498713589191,3.80114399715988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.89446428146351,NA,0.55448887405093,NA,0.255477667628211
1,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",-0.552845419445994,0.165191177648087,0.416567553103363,0.795989630132796,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.656547366220023,NA,0.16834079201099,NA,0.435406303648477
1,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",-0.127674216234951,0.151376254661461,0.656544214684037,1.1884129672836,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.265186877680749,NA,0.229617138455184,NA,0.764051343050802
1,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",0.134880646337573,0.145163371572477,0.864915497617734,1.5279187158182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0235109959621467,NA,0.276994986516944,NA,0.99798841722312
1,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",0.799766326823913,0.133567260395004,1.72393915951614,2.91009556569942,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.588507620147473,NA,0.440270649072955,NA,0.451032444976963
1,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",-1.00598949534481,0.158030107622475,0.265977703341308,0.494169769976654,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.07366385208997,0.892070689796397,0.121128276102072,3.99861353775999,0.195609811045529
1,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",-0.786578096341231,0.144930254214836,0.340600795074034,0.60113964359796,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.871690205385828,1.00585297472179,0.143028088002778,7.3754503147149,0.294443964523405
1,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.40318804957217,0.105862034382972,3.31686536802712,5.0228209600608,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14396929491579,NA,0.663722802335604,NA,0.148113429981413
1,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",-0.0510985979662599,0.110454308958227,0.763611238556336,1.17736214484123,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.194700425659448,NA,0.245139519702292,NA,0.829892940221628
1,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",0.200205622016207,0.111016855442394,0.988472284000596,1.52742513817101,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0366417911786691,NA,0.292477832124178,NA,0.942578268674905
1,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",0.555946272387463,0.108851157655805,1.41716062128614,2.17133894953869,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.36408293218191,NA,0.374526852517942,NA,0.632480703980664
1,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",0.807951248556978,0.107552743524689,1.82839736892753,2.78720370221078,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.596042545303707,NA,0.445113952502509,NA,0.443605623088932
1,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",-1.67941025834869,0.559366836982521,0.071491617640406,0.640505633193872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.69351301496909,0.887532192777987,0.0507834295241616,1.64687095709679,0.0788044000581191
1,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",-2.16031716166609,0.57316540408445,0.0427582124285711,0.404369222998531,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.13619500608619,0.811822159157016,0.0335435122930361,0.808457295368587,0.0273205375761379
1,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",-0.0145168278347263,0.142285516911528,0.74404295085812,1.29964670372793,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.161002985898197,NA,0.249505749062731,NA,0.863296760214572
1,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.399984244930897,0.127385388576791,1.16248310555272,1.91534904135517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.220524901741805,NA,0.334908622429333,NA,0.764705779964515
1,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.674630494902017,0.11944411249134,1.55581600666111,2.48485047922912,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.473325406724264,NA,0.40544622495739,NA,0.540017158295908
1,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",1.56302057042561,0.198489499781846,3.21949240940315,7.00965337119304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29107422874139,NA,0.722483955949129,NA,0.10967713413134
1,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",2.6967258838619,0.15333336829712,11.0403571479517,20.1380920745972,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.33463701333258,NA,1.50894200838692,NA,0.00372424445974661
1,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",3.36898097618915,0.141169982142849,22.1944779690828,38.5987417659387,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.95341175560506,NA,2.27765902059878,NA,0.000241709632787118
1,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",1.45863734710818,0.105542393138676,3.51922215153325,5.32258221470996,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19500674864451,NA,0.688509762505702,NA,0.131137174572717
1,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",0.404280567787606,0.164963715602715,1.07580475110465,2.05384751333398,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.224474748742957,NA,0.332493077261708,NA,0.762609807236382
1,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",0.861027358313075,0.141649777537816,1.78632420542803,3.11247091372887,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.644896308918947,NA,0.458156047978192,NA,0.410969177711266
1,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",0.135043380979735,0.18253151074975,0.790940681114338,1.61765580597183,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0233608732601841,NA,0.273712505069549,NA,0.998150321136531
1,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",1.19197551269442,0.266393645755525,2.01635721954619,5.72897384203868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.949524885169531,NA,0.550488663058721,NA,0.245818640734907
1,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",1.37488798259937,0.122500016635027,3.11014475303586,5.02718663688445,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11791772843255,NA,0.649540043190871,NA,0.158418964625776
1,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",2.1306500626164,0.253419756993602,5.30701517348518,14.3308815299526,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.81357532707281,NA,1.02902383529628,NA,0.027644353274598
1,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",4.34306614754999,0.132322090191096,59.9174843226235,100.651234436961,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.85004899671964,NA,4.02193667094199,NA,1.71188289825241e-06
1,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",1.44954718444032,0.262368952823823,2.63268212717322,7.36302271304968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18662129162658,NA,0.655786684903365,NA,0.148231165203986
1,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",0.892075783157957,0.274387321230549,1.4676383201327,4.30265837645305,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.673484225641365,NA,0.446942585807347,NA,0.407413974195432
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",-1.24129284657214,0.471395025663563,0.101547682619569,0.644427943049088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.14108760040805,0.703888027831538,0.0842306505758162,1.32975400238622,0.124171023018636
1,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",-0.552190865066454,0.339641909099215,0.27959743039,1.05862125640993,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.399242822804733,0.624385186162772,0.207445534504715,2.39805620985641,0.535801506073496
1,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",-0.21132208244754,0.292663173348415,0.439207968466052,1.38325070562139,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0322798346859842,0.604241859370425,0.312069197941546,3.33360478711683,0.947028178191524
1,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",0.411548719899622,0.227468323924795,0.950453802673769,2.31832217500537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.638265821072068,0.587021477080275,0.63347959313448,6.32528070476216,0.29680465299725
1,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",0.632077533806418,0.622869393616541,0.607582566650164,6.98200382346493,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.87567631784713,0.862321174042412,0.468995328480009,13.7780179128636,0.318216667974543
1,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",-0.381459698893833,0.406629478835948,0.318805173031076,1.56954090831959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.215444704386254,0.673040768281139,0.226848328590986,3.17338134933334,0.748674676450144
1,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",1.13976187886948,0.762993641804776,0.963322361223806,19.1731898340182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42222181980012,0.993528703861468,0.62852886234186,30.8824365209607,0.153144184764599
1,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",1.52583717765428,0.75758914846709,1.43912913293608,28.0428319538693,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.83784711800601,0.995588116146521,0.951099880789625,47.1105754343235,0.0631741460623394
1,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",1.76393355690046,0.755063191093166,1.83879437907024,35.4776687512929,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.0941757616075,0.997737830914993,1.22590227925809,61.2361411315749,0.0337246056193401
1,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",2.40650902964003,0.750578059786544,3.54051354150233,67.1201108971991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.78592842266105,1.00616989865109,2.41981452733182,124.936351922273,0.00451674608151858
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",1.01222656149159,0.497347686345108,1.07294000043892,7.53809615325888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28494671174429,0.769611676164266,0.848900750707184,17.3398849055298,0.0967740224362818
1,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",-1.10037370850736,NA,NA,60.3011096375841,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",1.12335724351915,0.483064183116087,1.24382191047213,8.26281747088243,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4045755960965,0.761424697221395,0.972974126330666,19.2465568190631,0.065467658028745
1,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",1.53876233623167,0.452957534340646,2.03123141288195,11.9915606612215,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.85175948759861,0.749324547147892,1.56261071815669,29.4783533727977,0.012241925143641
1,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",-3.33700491963637,1.21618289244465,0.00585779875177685,0.688918673853097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.39718895380316,1.3814503323975,0.0023167848856625,0.520800054347889,0.0164415491885509
1,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",-1.00379506641366,NA,NA,1537.34939533181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",1.87884575102706,0.428962364044032,3.03036752048256,16.2840397967213,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.21786985782599,0.741122664312593,2.29553525266434,41.9346939512334,0.00211526153553079
1,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",-0.569324337398098,0.545461079127898,0.168292867473849,1.42777684628887,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.417682699069641,0.775607842870815,0.151411732167017,3.16633391999735,0.595244617309015
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",-1.26386567428717,NA,NA,2.01559614144948,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",-1.04261994052408,NA,NA,8.48460996895846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",-0.925945648648129,0.550618820825364,0.154837570802609,1.34045280923847,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.801590151756172,0.773445691547005,0.103378122854206,2.14360605163825,0.315743556061838
1,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",-0.676856124335909,0.890252535480501,0.0724328411381595,2.37412829829325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.533447011425411,1.08405057182089,0.0736489942714693,5.1600969325672,0.6229985303198
1,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",0.0739910176518326,0.286445108358318,0.59689093998592,1.83459423092293,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.274893048698687,0.607836229518728,0.421992699023276,4.57179986411855,0.674393587863745
1,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",0.192848454344325,0.273690623325074,0.692400820904853,2.02436740499664,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.402852249516107,0.603969044193149,0.483587471192945,5.16028639488617,0.528988602243546
1,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",0.808546996588748,0.22016833127375,1.44735353887848,3.43075633564692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06563813051904,0.594638462584108,0.95928044474425,9.86869996225176,0.078054919311767
1,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",1.31045308637095,0.191353503693272,2.54775052994664,5.39408388341284,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60597123171908,0.597335185719283,1.64345174632256,17.0868584232888,0.006600482819608
1,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",-0.747795639767524,0.392560671643882,0.229206152136461,1.06788077842438,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.609796798999186,0.655363238699568,0.157986489491993,2.0621124738984,0.371814586471503
1,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",0.331021106252579,0.607239267855024,0.40833591334592,4.41350458217433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.551577860442631,0.843530936386252,0.351228210394225,9.58559466325741,0.526105673672986
1,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",-0.335242388681897,0.370414798080745,0.363379408158133,1.55222834140888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.165685628886972,0.649264650921732,0.249852984013583,3.18415856223836,0.796180079896317
1,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",-0.132300695123692,0.170586986709712,0.626051023718564,1.22184901405826,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0528166112292737,0.549150305799383,0.378685769133424,3.25952382886741,0.940997202640853
1,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",0.326792246464226,0.152845294738368,1.02969713283882,1.87462241223488,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.54701082279656,0.555745786215627,0.614458406045249,5.42745000519706,0.34967224095646
1,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",0.488450154916739,0.147936708166145,1.22318264358307,2.18443546375324,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.721049716694673,0.558776402122674,0.727661908549641,6.504176422784,0.21444319942458
1,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",1.26733800000474,0.131518167496574,2.76022674491601,4.62212508072875,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55954039556604,0.576870017115984,1.63261029985856,15.6656287288979,0.00638598664201726
1,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",0.735358013349872,0.219286955278004,1.36881196525713,3.23339365944457,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.98686217050622,0.592230291904253,0.890372041575028,9.07373708255431,0.102762334114323
1,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",1.01857937758858,0.20915868137723,1.85851976541873,4.21929187127105,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29175055881281,0.59590392519268,1.2013258834846,12.4202264991953,0.0310866490682985
1,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",1.20818891003921,0.203637387222931,2.27436649696777,5.0528146298983,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49587808008531,0.599098212442127,1.46603012400608,15.3479204742629,0.0121192976616572
1,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",2.04088547032827,0.188008618202153,5.41270772887078,11.3104798126208,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.3923018839558,0.617976530842209,3.48292708891794,39.2635475519681,4.83943085058018e-05
1,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",-0.205392770843005,0.358165856797157,0.425643724171967,1.73296142043558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.02589662555118,0.644166746743226,0.290440158763984,3.62817413809183,0.957573162113956
1,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",0.236082461752654,0.344032013042886,0.683076019082713,2.63117782018194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.449362954449943,0.645560149773268,0.467102417277165,5.86699483975752,0.507588666906873
1,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",-0.195224568538663,0.389848834496376,0.399348374414857,1.84090670711171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0149501363129378,0.665481085681144,0.281644569082758,3.82488546991381,0.971414266616496
1,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",0.596478374228495,0.289202116449327,1.07922213799586,3.35312250926731,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.83735009651643,0.622634971347167,0.721747598495807,8.28630747659449,0.190610210748853
1,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",0.0329878726937826,0.373565748837524,0.520847339905302,2.25252663118359,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.230722780015961,0.659708918102532,0.364662070039536,4.84151287692595,0.745888897785944
1,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",1.26055716790652,0.286027963235097,2.11160913743925,6.47960333166202,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55223961590034,0.638583257209514,1.43607313187782,17.5510322762676,0.0144467768207472
1,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",0.631023452484997,0.352851183114052,0.992729909054573,3.95845807629613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.874541151372254,0.660636001008061,0.69550496679325,9.26763674643098,0.19596355497313
1,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",-0.832344846823092,0.23767024548684,0.267958713737583,0.680265496587219,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.700840849137479,0.559870853241881,0.173845727435913,1.56059384658576,0.241576645614576
1,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",-0.544207857753088,0.214262586511154,0.376207437620407,0.871342035502279,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.390647632798754,0.55604111010508,0.23923163462746,2.11555689590668,0.502096947846888
1,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",-0.0533241667905985,0.179622768414518,0.661869456827471,1.33832840485729,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.137787624959164,0.554611098339422,0.408081779330924,3.58854874410441,0.826355182329768
1,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",0.362997311330305,0.151626061336921,1.06516279678028,1.92994380706385,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.585988874557989,0.556376398057195,0.638233979268425,5.65141004707613,0.315504841432937
1,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",-0.495960762319565,0.430508384120906,0.236873473659247,1.28060511077641,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.338702541482962,0.687731173077758,0.194725632994529,2.88548483360836,0.62805623121128
1,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",0.0141764159662558,0.338568952616935,0.493492135310154,1.86063448408916,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.210462783556733,0.636871317121973,0.373661037618114,4.53617197760787,0.761163236598232
1,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",-0.55385983258489,1.24602052815849,0.0849979652676577,11.2366724759424,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.401036425064795,1.43669066150417,0.0421627841059348,11.7694426497092,0.776876361401897
1,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",0.601665319321307,0.261934215094912,1.06223650925212,2.96577937299249,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.842936070585775,0.608540758119904,0.746134636194398,8.10585565193299,0.177888897173299
1,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",1.37348183512412,0.195158169806724,2.67048799195288,5.73889792319343,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67382638178373,0.600609587632586,1.74834258687204,18.4122198598689,0.00473000237085172
1,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",-0.468578462925331,0.537582955628152,0.253101579085153,2.08198567755806,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.30922650911441,0.771059055078175,0.170367647949504,3.49977756545841,0.689491572747782
1,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",-0.0821346729269379,0.529646054985539,0.380244381480432,3.03203272474022,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.106823196201254,0.772021497919242,0.258344212761575,5.32709593598949,0.902630141961517
1,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",0.702211392283655,0.520928850609938,0.852181733029776,6.56694083801616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.951163315465706,0.780999430849193,0.593404209701464,12.6743724306433,0.230891496973703
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",0.414754755522806,0.444478685131154,0.576812728387713,3.29394786212952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.641719069258891,0.717391389252662,0.492378609287393,8.19574604085074,0.386232725117398
1,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",-0.0128369212677411,0.297001777085828,0.576653627425057,1.84727592515881,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.181418667007878,0.611566100636,0.381340432285101,4.19222778292693,0.787514732738528
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",0.375370358246168,0.292063305348714,0.859560095952751,2.70075829192492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.599308195215343,0.618524739528746,0.572676868156647,6.46975845533818,0.352337408491004
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",-0.85157509355004,0.892569514827846,0.091865031621365,3.03852858097568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.749964353411998,1.24516339984049,0.0593211842055442,7.81591498945646,0.555535749250187
1,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",0.771537889392826,0.332625986421515,1.16067731362963,4.27538276133873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.822987365295953,1.14155262910597,0.430235823074779,37.7649824911814,0.334038126010077
1,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",1.14749465813761,0.316759850245035,1.75496485925162,6.0746515524248,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18733122858157,1.20255862807572,0.590123776397586,65.7934459055543,0.167103668206836
1,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",0.404277110426947,0.178817677548358,1.06483960188472,2.14636689143073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.467080723988454,1.04310292560215,0.343356184784017,20.4892713768402,0.550888041206073
1,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",1.36928418522521,0.310567711113095,2.22281042273525,7.50954898347382,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40226686718354,1.24299674719584,0.708752716185316,92.5925905897532,0.103736404089207
1,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",0.81899844039516,0.172910475458585,1.63187508986193,3.21403232374511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.868970452630471,1.1100747146043,0.482036398536749,37.4002455310293,0.284928847592632
1,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",1.91363068788396,0.298018924415396,3.94547375776525,12.6895872413745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.92979019082405,1.35608761081251,1.10504598132662,224.899289619826,0.0256334473201853
1,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",1.10648915600133,0.167150117004161,2.20188097632046,4.23985216964113,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14759738891193,1.16053395402674,0.609174519192622,57.6020996877998,0.162010659479322
1,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",1.85597126065957,0.158895696516296,4.74145144343819,8.83925843308103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.87389414369815,1.31430446837361,1.11220445660691,192.158948871464,0.0240384080750915
1,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",0.34518923623823,0.108293320487729,1.14326067146604,1.74784995191089,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.409821009683555,1.02333569066405,0.333879429461033,18.4382415836341,0.591735045512779
1,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",1.30958181389979,0.391831644184208,1.87830964524374,8.72614829110637,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34442902418778,1.25747537047376,0.643037556435318,88.9132101275581,0.130738420416903
1,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.686370944776723,0.100928599086738,1.63269220837722,2.42507669901003,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.74045688658664,1.07759724486157,0.441167840614867,30.1376040062288,0.352216323500896
1,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",25.9332861148642,NA,0.117787669950164,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",0.955891054151928,0.0964346539028358,2.15799629776722,3.14935304206361,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00166441780635,1.1239321521352,0.548939177698534,44.9686440254726,0.214301956240346
1,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.57116634794517,0.0893399720671527,4.05183764037276,5.75101736290032,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59791197595215,1.24328061692153,0.899847518553925,117.688406600659,0.050766582572059
1,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",24.9833291906613,NA,0.17869344811912,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",25.7183936470444,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",1.72602432068483,0.389137889370379,2.86706882906079,13.1797648874561,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.74797521981531,1.34135620198935,0.903163483050316,173.49833366039,0.0507497410654964
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",24.8912310768305,NA,0.396349603494037,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",1.98813809957332,0.387999570875296,3.73684478668239,17.1015992974616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.00199745395333,1.4005689324781,1.11638167878048,270.486487326925,0.0256134047501152
1,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",2.6164570668317,0.386066953034569,7.03783783339399,31.965450389314,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.61092992950653,1.56951715459856,1.84594060740659,867.298453141796,0.00373669793416184
1,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",-0.618999539467214,1.09621259244623,0.062830197434562,4.61704518888719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.524557980633459,1.42480230597414,0.0540017114746115,14.3878323062282,0.720601850784794
1,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",-0.183771921750777,0.460728576078144,0.326067041668502,1.98450708232347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.10279759514201,1.05179352560441,0.176699232155025,10.9096597631084,0.94826342063544
1,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.574534404084524,0.143983737660655,1.33164210364843,2.3415631646102,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.632076453569197,1.06447151694377,0.398803934840456,25.8773041608395,0.426161369546293
1,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",1.05532888517565,0.157524980712976,2.12760701132814,3.94514006073581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09801954120544,1.14957999154898,0.586243983390714,53.1039620010649,0.179349950676845
1,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",0.62345994700598,0.369778328205364,0.912188692561019,3.88683810457865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.679481479673022,1.13002953049697,0.371938683212588,31.2059285412718,0.427439955021002
1,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",0.83073935301779,0.131546226355424,1.76652487488261,2.95845153410665,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.88034480176938,1.10583224334494,0.49246642790625,37.5793144881209,0.274999914585727
1,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",0.918312724778895,0.347675393072371,1.29031880285697,5.04174281685322,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.965230783156704,1.17133668342215,0.480688419501268,47.4188311417491,0.263446062856568
1,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.53433947622415,0.107061709451751,3.7594245000238,5.7198356729872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56222319790518,1.23714367323806,0.871158745329138,111.228097378355,0.0565854374042744
1,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",1.47650210774248,0.315311100521912,2.43160441724044,8.36911459194131,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50617236397507,1.26575322660896,0.770932179984568,110.1129439206,0.0816791553695675
1,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",1.37431850781087,0.152525609683207,2.9578229786323,5.37814178260705,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40714773781686,1.20988738916622,0.758653050072787,87.0480874795805,0.0874884383029515
1,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",-0.580831843463241,0.896945636136586,0.11776482797049,3.96258527463666,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.487610046153455,1.27455121759058,0.0749904712841835,11.0867948037769,0.711181641014694
1,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",1.65169192590975,0.149635279430434,3.92687537732223,7.05970705672604,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67594797100629,1.26724322309034,0.947626533244451,136.143210107241,0.0426565959007142
1,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",2.30709834610919,0.142887496654218,7.67186065014873,13.432375413199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.31110586823716,1.42519269970166,1.59520565383425,425.666165241539,0.00542988433704588
1,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",31.9603616875246,NA,0.0701384440094829,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",-1.22074307935797,0.143251270668878,0.222971819249019,0.390950148687955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.10773303236438,0.821396062812337,0.0907368181744113,2.27054826700736,0.207590191339046
1,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",-0.807445008072409,0.131980522917251,0.345283247580547,0.579241350421825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.707195394192015,0.868013099856609,0.128535346955908,3.86127518902127,0.430415626574771
1,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",-0.505316739438474,0.125132659521894,0.473951298685191,0.774033831770116,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.41440532686131,0.904971141045809,0.165438614596402,5.74463643310884,0.658298038351358
1,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",0.249537893488905,0.114900774273162,1.03015992842785,1.61626320181836,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.317126520817326,1.00943890052296,0.308363180410298,16.1262881658495,0.670310727032784
1,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",29.7796467824237,NA,0.140606716180172,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",0.412543825727179,0.132888273397966,1.15832280680902,1.95010957307191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.475092759482531,1.03695935952312,0.350623684625898,20.4250939802005,0.540861703909285
1,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",0.667039129101895,0.1216024011268,1.53045363685351,2.46511100619099,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.721722431204335,1.07669874642797,0.432384037674718,29.4337042518969,0.365337069804214
1,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",33.0297234845688,NA,9.23206104688142,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",32.7979928735099,NA,13.5646779044897,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",-0.965127754106576,1.12999993767707,0.0213489376404894,1.79098376986559,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.86000811380862,1.42174970215719,0.0374576379119807,9.86123862862377,0.552152285435332
1,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",32.5134006630232,NA,17.9610292744652,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",32.519284117561,NA,34.8984425422109,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",0.88001060532618,0.976485299728917,0.317126173718286,14.5748359683166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.928112566704961,1.51113435067821,0.242762480572119,90.7280024396088,0.442299388039708
1,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",-1.07052183711628,0.435427291685724,0.132420882647851,0.729842658180372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.962153104925749,0.93640231615194,0.0851474135205313,3.34430326864404,0.324884331757877
1,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",29.9951150527949,NA,0.208316635261832,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",29.8299506393382,NA,0.276403642239272,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",29.6155008676313,NA,0.484412110022072,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",-1.05797193819221,NA,NA,36.1646856597015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",0.151990200479083,0.168373533061165,0.828021035085355,1.60206817075729,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.222591750647632,1.00289122253071,0.280359460978346,14.2902665287627,0.756284370942089
1,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",1.55894364717167,0.183502709471659,3.35937276992149,6.89689757852575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58606589889872,1.25262525971448,0.871482798428175,118.231153735155,0.0565284626911514
1,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",-0.379562697461601,0.43001731798759,0.266233758319051,1.43656715376927,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.292539284354858,1.01318957444993,0.153854718863382,8.16521979336786,0.787762739694349
1,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",1.32678046930145,0.151072369140865,2.8289228132783,5.11454690059825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36107926843488,1.20023863916213,0.730565169818972,80.7140104774782,0.097939126886689
1,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",0.0952536354245986,0.226418008000154,0.70684263277281,1.71702829297103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.167606954230696,1.00677061486984,0.261431302132675,13.529663277036,0.808672068909544
1,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",0.513449992842254,0.209191907990623,1.11561879193359,2.53305588197837,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.572879411609993,1.06637969947225,0.371044085428982,24.256805442969,0.474540885028529
1,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",-1.87487914858279,0.323136764237208,0.0812211440576757,0.288255848332465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.7416631717462,0.80608096783926,0.047113527451204,1.11024889399429,0.0564957164303175
1,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",0.760721910664282,0.201017620815648,1.45471452705313,3.1988273008285,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.812487212737215,1.10533928427921,0.455241712515266,34.6716937153229,0.319145442066817
1,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.0527554610231768,0.152456880691811,0.775276422758074,1.40928763315325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.126425432015968,0.985636765196155,0.259827303969531,12.3775833111949,0.843085815553008
1,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",-2.9757084362014,0.485293565081767,0.0186593178990586,0.125043472839107,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.80846419292309,0.797816271405921,0.015404228380451,0.351434854497442,0.00387470542571091
1,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",-2.87513161599068,0.45353492074921,0.0224248507677136,0.132687133057221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.71099848566476,0.786350212767628,0.0174567820619101,0.380758159837335,0.00465550553144878
1,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",-2.36690073352011,0.383461752389856,0.0433092056835195,0.194709297281282,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.21846426254782,0.789051569929202,0.0292599116117046,0.644995727543423,0.0171831018337742
1,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",0.676859427471751,0.162891474284974,1.43980290539806,2.72652820186007,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.731239102292609,1.08428706583932,0.430935199202351,30.2207763312542,0.363086627932629
1,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.07381657278884,0.106954812674083,2.37056587401228,3.60522381596456,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11594046567432,1.14646512701635,0.602412784660364,53.9063529855506,0.168843914001046
1,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",0.0854982833840716,0.180562520363631,0.767053228090452,1.55673859952389,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.158154566747279,0.995418959945266,0.26432730464605,13.0841747896781,0.815020390847935
1,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",0.393368980560419,0.170471585389092,1.0667157495245,2.08094240568161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.456509846109167,1.0398896232703,0.341296865060172,20.1114601762832,0.558458277299361
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",-0.681998916329183,0.303331565132593,0.270678316177986,0.888885985228001,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.563660916813253,0.549791617203279,0.282184133220948,2.43500320072289,0.282301441864518
1,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",0.86219442300557,0.488791365807781,0.810967052666169,5.50963894953153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.460921474499965,NA,0.580240207203368,NA,0.349212417632316
1,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",-0.0680829408214898,0.328446325695848,0.496826684794584,1.8003334576344,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.156319265597455,NA,0.389164387577364,NA,0.823392318800078
1,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",0.379042130997035,0.302833455672078,0.825237770160444,2.70472868222037,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.140333371143042,NA,0.500616037574143,NA,0.695327103182494
1,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",0.847222175739914,0.285023958647675,1.37380758569966,4.19905513378917,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.450976813907318,NA,0.642946902312741,NA,0.293925221606936
1,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",1.55932026228855,0.26872049991112,2.90750828551523,8.33665001299352,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.923482205306197,NA,0.922654947809078,NA,0.0391676230005085
1,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",0.723605101591369,0.193336015453624,1.42078966917148,3.03155617413031,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.368976268352804,NA,0.62393635369894,NA,0.359144570606229
1,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",0.481694028449654,0.771640586223371,0.486906914427854,10.0251125598003,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.20846504938099,NA,0.372656024465846,NA,0.703331331755881
1,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",1.00299912500604,0.184725461703437,1.91502676649988,3.95049980473212,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.554357530178522,NA,0.719492155906803,NA,0.183611201759715
1,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",1.27919926714671,0.177941416685142,2.56227304899503,5.14699119733879,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.737646469363916,NA,0.825932143095388,NA,0.0820066624794297
1,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",0.75055915999315,0.7653446935247,0.648538636753263,13.0274982280121,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.386859200079857,NA,0.437580771911932,NA,0.516188736218095
1,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",1.04143696013065,0.760191398263694,0.880012744256851,17.3237195449159,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.579861151396176,NA,0.518289259755688,NA,0.346551033858844
1,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",1.65633757095967,0.752814280586324,1.66145137453024,31.7746657063735,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.987875775427873,NA,0.731519225467424,NA,0.118277383130667
1,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",0.192162967901357,0.633716374239331,0.342408607898461,4.10568272565755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0163507799508642,NA,0.358162354515518,NA,0.915914278134423
1,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",0.888410395639499,0.333827494443291,1.29876349753128,4.80661160764469,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.478317856411521,NA,0.642532200618971,NA,0.281999805828419
1,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",1.10693512053708,0.321631193615847,1.66095909639597,5.86009793566958,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.623313018845153,NA,0.722206489454618,NA,0.166765964912281
1,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",-1.16097588961348,NA,NA,6.15720600192703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",1.45547723726461,0.306542661692458,2.43409834816685,8.09463545707753,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.85458014240787,NA,0.864975628352932,NA,0.060657668443403
1,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",1.9679156047537,0.29203240335749,4.1980040784131,13.1886311070656,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19459214086036,NA,1.11521850909941,NA,0.00919730606439344
1,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",0.368251401377163,0.543836625846754,0.481288306449157,4.05727514416072,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.133191000548566,NA,0.42633759926481,NA,0.749338066545316
1,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",0.203294116698689,0.327446560054201,0.613812876053412,2.21555241506463,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0237303132028649,NA,0.4504444854202,NA,0.883549071146467
1,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",-1.00254573530609,NA,NA,77.0943491613475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",0.168664804428211,0.180400166960287,0.832712821787999,1.68891989982074,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.000766991353760648,NA,0.471369447749315,NA,0.91480680683526
1,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",0.247515015939607,0.51580531493944,0.456401584388525,3.44711445466586,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0530788042328882,NA,0.407449645977901,NA,0.855842906108677
1,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",0.119160461888481,0.766343253908898,0.182958730402493,3.68959127529066,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0320774476153484,NA,0.30302384973332,NA,0.981536738515497
1,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",-0.974058724950139,0.531233341775793,0.114429168280864,0.918142354143877,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.757439102131525,0.59466749140427,0.199434178573274,2.05193387638011,0.205321761273608
1,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",2.45306328202734,1.12463634160543,2.51362920901283,206.483614244051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51649291989658,NA,0.819503196184167,NA,0.0702973908861339
1,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",2.44548971132406,1.17020946212705,2.16592712584245,212.72182020461,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51146705428399,NA,0.781739118593945,NA,0.0799460806027802
1,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",2.77510571771009,1.12035844383291,3.51482951883297,283.926505840299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.73017213402939,NA,0.982402043513609,NA,0.0391017317381075
1,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",3.035927574536,1.1178761962436,4.59680723982077,367.732639797941,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.9032307562405,NA,1.13340768507341,NA,0.0233480567650661
1,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",3.66149017857026,1.11354124048515,8.70846183154067,684.916292855964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.31828878190467,NA,1.57710031059529,NA,0.00581332946902954
1,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",2.51166827772588,0.249864757980905,7.49284140690775,19.9534076635976,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55537861179748,NA,1.45605239776503,NA,0.000585946697407467
1,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",3.01792584775258,0.221041715445539,13.242583806154,31.497408912425,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.89127545599875,NA,1.84130929258994,NA,2.47729617991188e-05
1,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",4.09633379223507,0.177341727924045,42.7992599023075,85.7715708754851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.60682514120524,NA,2.93981458494008,NA,4.08601737212175e-09
1,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",1.94316872937708,1.1221748447193,0.393709978619162,32.0309884860994,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17817204753013,NA,0.615677541120986,NA,0.155377145605947
1,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",29.5676612816176,NA,0.109246154374704,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",28.8598155400172,NA,0.173947669928396,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",29.9034032033645,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",30.3018232695606,NA,0.530662110566622,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",1.80838492425582,0.168952433684198,4.43551058497421,8.60139247319512,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.0887438018018,NA,1.06796391298823,NA,0.0115570606481475
1,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",-0.62843391533187,1.17752799091964,0.0981730663463088,9.92246651761995,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.528147651291615,NA,0.120820700569268,NA,0.5911644986101
1,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",-1.53832086132005,0.622674960004875,0.0694527950737232,0.797505160593264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.13183794723992,0.572098079771264,0.129390048632323,1.21854735923073,0.0709772597689085
1,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",0.0808708360809904,0.87346485795711,0.156758553563727,4.81083561685156,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0574861555723993,NA,0.26540520206677,NA,0.989097741027719
1,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",-1.01597509024338,NA,NA,48.2482578494751,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",-1.80858017777143,1.1458247633543,0.00906407285758157,0.80905677947222,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.31116031029535,0.886713278977286,0.0588769622161251,1.903219230262,0.14931668606415
1,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",-1.02305425865231,0.256783676251394,0.213160610416432,0.583252055795242,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.789958200535639,0.467587672005332,0.239939164372473,1.50011252796436,0.112595531317332
1,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",-0.701395863453317,0.229179051692906,0.313003493117894,0.768606953652868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.576537380805175,0.521716959421488,0.290799401227945,2.24784349243247,0.251770426741004
1,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",-0.635199402988283,0.224186317829793,0.338234892260769,0.814467739222333,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.532615708099066,0.536114266052394,0.302209513703603,2.47167129126306,0.292175115070606
1,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
1,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",2.00866551688932,0.322639339975785,4.17030596740626,14.771688052689,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.75132105441906,0.567697270497536,1.86650759043247,17.277438105899,0.00295233598294444
1,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",0.523315057369042,0.100531535698902,1.38842836211023,2.05905844188325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.111820111212221,0.469650627609043,0.438575826156034,2.76426304723478,0.830827332211248
1,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",0.115269899131056,0.0931458611049901,0.93561567967077,1.34793606344156,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.338561263545921,0.471706687707697,0.278340933654166,1.76852824680281,0.464900276419122
1,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",0.524622894708311,0.121368885582815,1.33603071909879,2.14998390778348,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.113263603263619,0.475601550574786,0.434116677848155,2.80073499847774,0.830516292222087
1,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",-0.0435533028982293,0.107169725042812,0.776473569882101,1.18187827111751,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.513873480851163,0.476846962694822,0.231215794589648,1.49900554346172,0.27547725088626
1,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",0.597043194004718,0.046705082512809,1.6585936767211,1.99182363749412,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.193201122363129,0.458531878631101,0.486265893629664,2.9341336689971,0.694947979161822
1,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",0.420712175473029,0.0536641231947966,1.37168537755599,1.69282661292462,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00145354755559616,0.461181055267977,0.398149206056948,2.42751490929091,0.981174459175699
1,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",1.21257062408176,0.0428498175750157,3.09341410674189,3.65919642854304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.872576890221227,0.452134796361003,0.971755364642604,5.71837483567211,0.0649873319327402
1,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",-0.0923017048697261,0.0974250855993698,0.753661555897179,1.10416284480435,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.567681477853167,0.474762729118681,0.219992875127854,1.41464070710493,0.226658621800479
1,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",0.0463636899039697,0.0541819731298377,0.942064503388605,1.16498463731466,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.414616059136558,0.464904664664517,0.261406579818801,1.61722948592882,0.365747577186668
1,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",0.449505985009562,0.0842767748116753,1.3306584087058,1.85156782027266,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0303508067916,0.46645032324095,0.406790132248128,2.53196022731275,0.965174877942734
1,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",0.536856106049297,0.143819568731886,1.29541777278667,2.27640079633191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.126771120959639,0.483058652805725,0.433637486027885,2.88062920505151,0.811671331047728
1,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",0.262786275765357,0.0574642586102814,1.16251673540749,1.45621850258838,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.175720828722917,0.463281821934826,0.333042180521525,2.04734788834364,0.692986124546076
1,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",1.44923477845224,0.152904791885224,3.18788934756265,5.8050882740984,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13383678749193,0.478156192312334,1.1992897311155,7.81517473582632,0.0231173162405053
1,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",0.905888854980274,0.0849300452254558,2.09922226229876,2.92848898298293,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.534105254720918,0.462222747537073,0.679005734962109,4.15683584528449,0.269133374988112
1,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",0.511925071486355,0.142433394223643,1.26776558111432,2.21573596348445,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0992508723772166,0.482788497252014,0.422083421859457,2.80090850654673,0.855210499816412
1,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",1.16116949563865,0.34759148327477,1.68366358435379,6.57651981027485,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.815871188182904,0.591532272810713,0.698627700959456,7.10022593599536,0.181237457227005
1,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",0.895126719257251,0.127801757595176,1.91483592336917,3.16010616436981,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.522222358000381,0.474197094584201,0.655415116609562,4.20524256071696,0.291727934933656
1,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",-0.31205559968432,0.111471815007525,0.587858644930229,0.910003098665085,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.810245558238864,0.480629678480889,0.170610080393289,1.12261317730961,0.0884427076075167
1,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.592362277617688,0.0339718909129315,1.69218620061592,1.93322321233839,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.188034478733703,0.457209830674971,0.485013664810612,2.9114504383412,0.702309581766244
1,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",0.241138698977048,0.198993894438383,0.867121209161091,1.89167981146265,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.199641124087065,0.508982854993265,0.297314828677304,2.18630402142372,0.684181295832457
1,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",-0.0669639182709415,0.133799404247616,0.719950122510628,1.21641825401073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.539715765359845,0.485201894063498,0.221654006288938,1.48485753567279,0.260405694888818
1,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",0.116966302336203,0.231062546788351,0.7181144950823,1.77645939773857,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.336724989856401,0.526309759701281,0.250550774773385,1.9719100906457,0.51390949463638
1,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",-0.361729044702953,0.399420921806886,0.318090626177888,1.52239125688834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.86509068897415,0.640945200442848,0.117954410361764,1.45499423123288,0.172349376495461
1,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",0.0566968955166809,0.0522123552175808,0.955541000447242,1.17256196114244,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.403209683068469,0.464528226398328,0.264602367335714,1.63458689136442,0.378499920087504
1,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",1.0799414851664,0.118953272050112,2.34339738958156,3.73553112429895,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.726222015419245,0.469660613446663,0.811011327085445,5.11185584055798,0.138259505058719
1,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",1.78407078391794,0.12430751499166,4.70083841175153,7.65238514626084,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50342142580062,0.464878126946225,1.78166253792585,11.0213655371374,0.00207291958504817
1,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",0.932387991329052,0.0942373565193279,2.11800863837229,3.06448636708458,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.563354330726484,0.464165795169134,0.696513846185519,4.29662089965184,0.245453479973828
1,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",1.16847625877108,0.0916225105438947,2.69690023128819,3.86227617634976,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.823952825178328,0.461294358036256,0.909111899571582,5.54531576735592,0.0872094343447154
1,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",1.87426836500503,0.0863508076656703,5.52142309956586,7.74559721834371,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60298524407131,0.453434616205191,2.01295045658481,11.9058820609872,0.000793591697833246
1,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",0.973250577875375,0.113433491746096,2.12757613352944,3.31890358596372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.608456714830623,0.468989569401341,0.721810240283317,4.5376639473105,0.213918506838504
1,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",1.27687426337866,0.109646622675761,2.90520227532367,4.46518157985135,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.943600411342773,0.465058685414445,1.01718788067471,6.29677997917238,0.0520454398724368
1,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.348107826179657,0.0487754617837729,1.2877188691094,1.5590374808502,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0815970896907151,0.46123049680523,0.367429688001939,2.24065228204893,0.845598411375706
1,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",0.894711360085084,0.134756325097648,1.88922706014333,3.20400910286818,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.52176344828299,0.476542061154277,0.652109801364541,4.22267253499477,0.294420799430308
1,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",0.0639066216269907,0.100738836524035,0.875572756690456,1.29954207858299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.395257808882566,0.474099382099969,0.261759366768409,1.67884454056305,0.397301329230464
1,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",0.388098141747892,0.0941042449180559,1.22765354716131,1.77533035990185,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0374071086858717,0.469322352876281,0.377980904041159,2.37928069855592,0.921351518753325
1,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.81563052959529,0.0502436350683746,2.05007610933931,2.49634671556761,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.434479659871986,0.456868939469288,0.621066462434896,3.72317260681774,0.364556253795225
1,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",1.048221253293,0.0488120917246812,2.59461749531477,3.14174691848407,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.691220172716374,0.454435038600004,0.80682075211093,4.79080696640282,0.145608203769465
1,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",1.72535842658481,0.0457992677806717,5.13747752704791,6.1477861183419,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43861988440912,0.447583000490794,1.72738958428153,9.98520482818266,0.00226228908902905
1,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",0.377194382878516,0.098187190056995,1.20493174801069,1.77058435681534,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0494442188226571,0.470444881784222,0.372635310485101,2.35597579630009,0.901538269881409
1,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",0.683103041271443,0.0932097017545269,1.65307476882408,2.38217126237724,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.288192831873084,0.466281010167674,0.526692072774597,3.27608387934894,0.558817593092835
1,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",1.38599938402894,0.0856937014701635,3.39007596140244,4.74345354215494,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06403437654695,0.457859264996503,1.16378534632869,7.00380281406253,0.0263594636602506
1,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",0.86122832200936,0.0326571936756865,2.21999300879077,2.52317465796495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.484812747540225,0.45447667530837,0.656216031609731,3.89716982212604,0.308552929128024
1,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",1.09743455801408,0.0314514988664948,2.8183184320974,3.18810920861388,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.745546733000209,0.452101698600966,0.855771155698296,5.03520284906851,0.114722631706702
1,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",0.855233767518618,0.122683072660919,1.85719021881053,3.00408646979781,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.478188955018209,0.472918442274119,0.628739198466817,4.01391667623533,0.333560535826527
1,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",0.457389331952771,0.215407926940762,1.04502314924966,2.43129149390331,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0390524224861177,0.515176875377145,0.372967126076979,2.81001900242032,0.955101510280701
1,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.379567542855011,0.0503952976636618,1.32472134768636,1.6140524569217,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0468704438423831,0.461132049194037,0.380497480495198,2.319446764838,0.904053818971565
1,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",0.608663742017043,0.209961513011015,1.23031452326314,2.80191707893308,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.206030729219571,0.511106958543758,0.444320390505612,3.29462741420417,0.705551364402722
1,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",0.593800469955785,0.0484872942198315,1.64753493133925,1.99241384392855,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.189621785109463,0.458788882992517,0.484283440382112,2.925116916375,0.700740119561037
1,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",1.16106948601974,0.194274166768295,2.21289037602636,4.73906691741398,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.815760865884764,0.498634082878002,0.838057049078693,5.91765694747431,0.115585747105706
1,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",1.22121701825379,0.0445548657735677,3.11041095180009,3.70397556858744,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.882120846849472,0.452252702589721,0.980852950976528,5.77457863583023,0.0621843242966746
1,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",1.77696791732198,0.149058863262165,4.46136297930954,8.00250267576751,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49557779558922,0.47372747469187,1.73732706413155,11.1264520383289,0.00260283488970174
1,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",1.17779341556997,0.123446224070699,2.56367265195081,4.15927660645855,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.834230917861452,0.470165962274179,0.902676354323948,5.70090824979778,0.0889610243476139
1,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",2.0519402049881,0.146734480073492,5.90222599373325,10.4910043280566,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.79908676302841,0.470392102498118,2.36926051433468,14.9764811337787,0.000280788403827166
1,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",1.15710437879232,0.130798054063511,2.47690948975443,4.13600588466194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.811393080125685,0.472771970465059,0.877785220519091,5.60062798255733,0.0997957953586372
1,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",1.87384255670737,0.123389659962204,5.1511723431044,8.35535714495913,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60251135059819,0.46376373244329,1.97166980651267,12.1435871892277,0.00101694533900189
1,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",1.31242152746833,0.116079879471551,2.97457674495245,4.68856480762544,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.982836424733434,0.466628637595035,1.0546659339024,6.56908605595111,0.0437298637920025
1,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",1.25703090710801,0.0811284131543383,3.00575685527181,4.13111331069374,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.921704623771199,0.458061305859897,1.00888247128958,6.07638883913616,0.054228928883075
1,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",0.934532591924125,0.051298606012941,2.3044393610236,2.81770932857247,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.565726464420155,0.455863842261613,0.709622416561038,4.23732073465912,0.235436424243826
1,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",1.86604142678715,0.110826244933678,5.23216015171858,8.07889512274192,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59390160745243,0.459952253728431,1.96941820317996,11.949839826271,0.000990365164451952
1,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",1.52406905565173,0.0791961311735619,3.94133386265321,5.37609535090817,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21643426293269,0.455123737547646,1.36276775371395,8.11382999852489,0.0107950845953048
1,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",1.55471335831502,0.333101614250789,2.58372027198782,9.53495634296605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25027487049879,0.578343200812998,1.1072062262572,10.685670281611,0.0364260219547126
1,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",0.624884922498272,0.116029766454081,1.4928222231983,2.35254275052347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.223931602947554,0.473029469461862,0.48740203561857,3.11296449571526,0.656981845941563
1,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",2.15040829470881,0.0759047574695384,7.42326334326011,9.99574943327104,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.90779674928794,0.448582143171482,2.7568290175246,15.9984333526059,5.93848281416892e-05
1,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",1.75863497537963,0.327530935639078,3.21059132499546,11.5924359126414,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47534225972256,0.572951233799416,1.40161382596791,13.2440960481324,0.0128599284396299
1,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",1.23020780387859,0.107188860847991,2.78559316133716,4.24029757106133,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.89208977773179,0.464789499017338,0.966609626552029,5.97737074483799,0.0660338426707854
1,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",0.859642211799023,0.0788953595867616,2.02759831944029,2.76244491244498,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.483058219297267,0.461358785263665,0.646288189898298,3.94316399654611,0.317222367824626
1,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",2.48132034953735,0.315919130238893,6.79621696118345,23.4470892813777,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.27305185430494,0.559564242143659,3.19632355003557,28.6585773410762,9.90733835030274e-05
1,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",1.16927182392167,0.0758677310220218,2.78072798966834,3.7438286873794,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.824834653394812,0.457786121262431,0.916192649639823,5.51217895914197,0.084631795515101
1,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",0.588371016881029,0.187615094247665,1.25786395587638,2.62440096085145,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.183632672994494,0.500579635147219,0.443531002222282,3.15582053427547,0.732607879312193
1,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",0.710051576728899,0.0832174328492972,1.73109856380186,2.39878547575177,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.317938913320848,0.463712708479568,0.545342401618224,3.35811227724522,0.515623197614786
1,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",1.90690262861087,0.0715835710006632,5.86631574496123,7.76657475318205,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.63900945074239,0.449982315465493,2.10099869312927,12.2596215802948,0.000555034336616363
1,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",1.37549232400763,0.076741901511556,3.41255940154164,4.6102647900155,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05243685784584,0.456019157476341,1.15451594527182,6.89808206212679,0.027445010893543
1,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",0.649364834093975,0.0535261682460298,1.72483648766317,2.12750723085274,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.250953672288839,0.458932329392245,0.514789445078002,3.11112490778058,0.606869324455313
1,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",0.108246695776061,0.358060806101114,0.560560290529503,2.2813197011976,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.346324766147438,0.606869624591165,0.211909079433963,2.28710596621675,0.559822307965435
1,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",0.220956771344249,0.350351151332276,0.638787789014156,2.52229272341657,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.221917612834424,0.600507634290427,0.243012934043283,2.55820556300513,0.701909544765175
1,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",0.749778454982249,0.321432162050587,1.15895232402209,4.08575833600871,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.36176990911767,0.576352589788491,0.456927359270994,4.37553931746104,0.547260334258026
1,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",2.05378335707242,0.115352594248405,6.26178819156651,9.84181020852623,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.80113154127243,0.459592508883905,2.424901736698,14.6928434128181,0.000203991613924169
1,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",1.68612297154391,0.0298323450116376,5.09394233416062,5.72585967501682,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3953118804037,0.446309175310498,1.65827054328833,9.53791622966432,0.00296925630551203
1,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",0.478952229027589,0.0863890220363805,1.36490371374952,1.91500959003865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0628530922838691,0.466638545784226,0.420082417796848,2.61662451208237,0.910779601142807
1,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",0.295607823397434,0.0895358153622338,1.12897707440963,1.60365584465036,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.13949938084578,0.469113518053251,0.34141993680005,2.14738135835969,0.753829675573474
1,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",0.615263118022919,0.0847774237945462,1.56960456831032,2.18834404724304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.213311624080358,0.464964357702352,0.489933905811215,3.03175605366219,0.667792067754973
1,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.37996065743035,0.0772449902414687,3.42460569985634,4.63567184400391,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.0573689342992,0.456080481864683,1.16008811840861,6.93304148325155,0.0267537832625539
1,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",1.67473689885126,0.314803750669221,3.01217931906707,10.3467438884845,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3827263908007,0.564806266725943,1.29816866383869,11.8811657142422,0.0180485052237931
1,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",0.311919938759441,0.122824298376765,1.07627995704282,1.74189397654038,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.12150143447655,0.478057709493831,0.341583333335461,2.22506955993056,0.786671705127394
1,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",1.11649188068338,0.1318313150566,2.37307341116554,3.97870015639327,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.76656474929746,0.473495711893666,0.838093017458711,5.36256764692372,0.12048506096951
1,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",0.867278740556662,0.136295656107084,1.83234140786262,3.12634240744349,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.49148338355931,0.477326515728173,0.631673856499216,4.10293877568992,0.32441184725544
1,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",0.882030710990617,0.17980346092368,1.71598288354055,3.47224945481251,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.507747309197277,0.494443056334496,0.620858584087121,4.312549324143,0.324717781921368
1,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",1.55928827382757,0.168396539602042,3.46175952662438,6.69847105091464,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2553200326267,0.483483691912422,1.34022923441433,8.91791269415909,0.0129062574394392
1,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",2.61327524741995,0.143492144928422,10.41821373522,18.2841482261794,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.41866325193756,0.464201249761107,4.45782577039544,27.5030419236602,9.50071530291404e-07
1,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",1.91580160146627,0.309721283795602,3.87969960502122,13.0637713369738,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64881966818558,0.559556069899176,1.71166406363508,15.3464706515985,0.00452309794240299
1,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",1.46237134262536,0.120050111656192,3.4325997310801,5.49536881311602,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14833252021502,0.46646568510918,1.24501347977789,7.74973184920812,0.0185783462374063
1,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",1.43169808879115,0.337098106234509,2.26317702008245,8.48389688164229,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11447910755997,0.582078190587964,0.959520025951259,9.39692480137709,0.0636567126283298
1,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",1.50049877765059,0.334921478346489,2.43689865961947,9.05751011122435,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19042636346401,0.580037423670665,1.03942525908752,10.0983580877333,0.0469173490641659
1,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",1.00886769427134,0.0851194742570426,2.32655758278499,3.24804069240517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.647774820320867,0.461286087048101,0.762195003069626,4.64901508679361,0.178805501279356
1,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",1.97783002878682,0.10378684531866,5.92829493451497,8.90464986751671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.717295417223,0.456916343101185,2.24151639997964,13.439951869615,0.00036532185535843
1,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",1.18033476062975,0.345769156583951,1.72413926979186,6.68668435823019,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.837025422885217,0.590087607594856,0.715596295701647,7.23161085853759,0.169147798006214
1,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",1.30318732033579,0.324512975554793,2.0310502992589,7.24723877179354,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.972627491777076,0.574256010795612,0.845415742579225,8.02944515102804,0.100988187243728
1,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",1.58251458575106,0.0479053553858889,4.43560472584503,5.35188856797966,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28094710609571,0.449209019560137,1.47058577451763,8.55510180403849,0.00662657389108873
1,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",2.63829365224354,0.30050405323101,8.16316436261201,26.5116995077711,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.44629265825464,0.547954794198568,3.88888201866698,33.3169088402447,2.00344319023328e-05
1,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.189594257630834,0.0400094578580814,0.764710401744249,0.89455947932198,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.363582947423207,0.287716187114234,0.388849658492319,1.20113174952335,0.187917131604868
1,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",0.260380756385371,0.0452234217136944,1.18720184872896,1.41746732652076,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0988915010318332,0.28147681236097,0.625613528244547,1.88578911862372,0.762846342898385
1,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",0.139619753544325,0.0828268502916863,0.97709555337775,1.35189114208601,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0252262482200902,0.292205465913867,0.54098186619167,1.7007253878751,0.898381155041189
1,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.290640337584527,0.0578994895438428,0.667277177668597,0.837287371573689,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.467434915816313,0.292514307127897,0.347142233453184,1.09265916430302,0.0965789909889523
1,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",0.231509166624174,0.0665392366691445,1.1062410352112,1.4359071767692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0692159024939465,0.286360527463245,0.601496233979949,1.84813613421901,0.845261248136451
1,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",0.541360215712498,0.0202098625188694,1.65164656492395,1.78781448146443,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.387670834589031,0.274023551005702,0.847786902663695,2.48190550260986,0.185480037024395
1,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",0.429138857999673,0.385054635076622,0.722921403938871,3.27046331914151,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.272332951844317,0.482182450603602,0.50224545028227,3.32494835056027,0.593080022192373
1,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",0.196527105348898,0.0321180558188341,1.14284699213184,1.29618194277094,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0332620876503188,0.280561410114289,0.586857885206934,1.76263161222646,0.94173887328728
1,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",0.400816506573083,0.0587541788990076,1.33077489634778,1.67543620215501,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.243235936890542,0.28196558247294,0.722245993137693,2.18124384601324,0.42458106471806
1,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",0.0619652465819831,0.0789628337501124,0.91130419521199,1.24190947774375,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.105037272428198,0.292252308526439,0.499363453218521,1.57017474077895,0.689428732903783
1,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",1.72284943692926,0.0142216748206727,5.44688045567024,5.7591563227628,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60197046014885,0.256012191357153,2.96371994374707,8.08487123407466,1.94446077927402e-08
1,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",0.491268635697932,0.183566724514156,1.14306487064861,2.34733695638899,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.336192150715593,0.332770310463399,0.717617353224882,2.64485663360112,0.340747844868635
1,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",0.0739103654007303,0.0376554635174099,1.00000080145893,1.15905788391228,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0927612341341904,0.283211044563867,0.514570879013655,1.56165307620087,0.712203985061535
1,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",0.12391367788141,0.0298469029426781,1.06753973476261,1.20003940928243,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0413697865754527,0.281434454921391,0.54365076509788,1.63845639673373,0.849794593558529
1,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.029813787946461,0.0579279209364407,0.919295664735143,1.15364419060734,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.13808181617635,0.287492268384511,0.487636146381902,1.5049553512694,0.602181656532061
1,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",0.393970630001731,0.0504068452585002,1.34338338490104,1.6368645438559,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.236202521480324,0.280355287027498,0.719440338193746,2.15909867302187,0.43618476199739
1,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.48295001689165,0.0266183967711985,4.18265205073071,4.64266105575586,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35540267775216,0.260523447586348,2.29482930470111,6.37186122226292,2.24715009722777e-06
1,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",0.715082329153404,0.164702813547155,1.48421369030679,2.83065545945427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.566238177986205,0.319231828125096,0.927852992667157,3.24295126632687,0.0927734989077666
1,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",0.914588018296343,0.158666359316541,1.83518066144477,3.41816422075478,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.77124838217213,0.313387575095557,1.15253669887437,3.93701199621657,0.0200412424648807
1,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.599915951260272,0.0613019929115498,1.61596574263257,2.05491021825991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.447826737860966,0.279536701327024,0.890791046977458,2.66477157160619,0.132664571405937
1,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",1.51321115760548,0.14407470907316,3.44357355879202,6.05734896075209,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38651158401873,0.298082931593025,2.19942025176859,7.07563664308887,1.65756475876528e-05
1,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",0.877834074083113,0.058122479934611,2.14754894972831,2.69706219085842,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.733488764891614,0.274675494154887,1.19722974789183,3.51387176512861,0.0125550882171474
1,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.584636977137057,0.0410680883675803,1.65573821125429,1.94493956907552,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.432148228572346,0.275820923877431,0.883297644168414,2.60414681063778,0.141904619857716
1,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",0.962766402136396,0.0878396936031741,2.20803386880748,3.11561865975155,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.820760998141155,0.281690144331394,1.28877696924014,3.88801505271743,0.00643920068609764
1,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.70850979015078,0.0802777206930822,4.72738235362384,6.47568580846844,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58725770787891,0.268797341251321,2.84801374346923,8.16852239556971,8.84722885050095e-08
1,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.642289611455931,0.0410136127607097,1.75407704227716,2.06001491799477,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.49140312021509,0.274936710095443,0.938939255052119,2.7586118675199,0.0937088529967708
1,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",-0.115171374280283,0.0964734482473644,0.736730304223015,1.07533858740026,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.287063381577322,0.300426300876514,0.409488658681318,1.32950060645386,0.317211925721649
1,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.79160540076408,0.0545072042474384,1.98403303458377,2.45664346634216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.64486549117162,0.275171682424391,1.09446017828165,3.21849683159115,0.0281635148247686
1,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.71927107524303,0.0473575360755991,5.08956753259938,6.12777057563986,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59829310571717,0.260244885693079,2.92841986573089,8.12222546626758,3.20320749969914e-08
1,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.482035534146035,0.0280457391926964,1.53278458787609,1.71090650644174,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.326686006407761,0.275664890163628,0.794994295013497,2.34237687552847,0.26865938663952
1,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.586205084525354,0.029253988654193,1.69707437819221,1.9032811976514,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.433761073185125,0.274198725269967,0.887541934005298,2.60007357604659,0.138243680991431
1,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.761287518033506,0.0265498148974602,2.03259398059242,2.25553266982074,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.613705392576482,0.271239610925433,1.06903577348436,3.09564669653701,0.0342085040339085
1,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.862284867708307,0.0275482118084103,2.24426571459931,2.50018667167564,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.717507302785907,0.269818420580647,1.18949909131184,3.42534110769681,0.0130528046349278
1,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.59425813394921,0.0245543173891916,4.69403201073368,5.16829616548559,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46980842174271,0.258692989771405,2.5826638844861,7.11979736918528,2.80212991960248e-07
1,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",1.22325724642144,0.0179660323791921,3.28087014398087,3.52025780797182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.08850908078362,0.26355762973491,1.74610374665168,4.90626911961067,0.000145044539007022
1,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",1.93501776587489,0.016453042102629,6.70504349353203,7.15173327461703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.8200302214746,0.253112986631708,3.70801944324332,10.0009747867471,1.7189608508443e-10
1,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.4856685972868,0.0524439932956421,3.98923067555196,4.89970537273666,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35822986189534,0.264597804443605,2.28295734127539,6.4409498159369,2.90384476931775e-06
1,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.525826417580255,0.0331745305128995,1.58538413205401,1.80555586458256,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.371699569338856,0.275594636739468,0.83177143922462,2.45006250459744,0.206949728554548
1,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",1.34230405247272,0.0636030565900092,3.38236703615289,4.34009037398775,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21086403338559,0.269216778049742,1.9519760614062,5.607767006922,3.60615500550655e-05
1,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.18057779598675,0.0290237222907182,3.0766443271357,3.44736578784016,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04464094057679,0.265229016353211,1.6655845430335,4.71078602376317,0.000281107339850953
1,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",0.036199019118189,0.0533584669959095,0.933793733950571,1.15103511833727,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.131519352232567,0.286439984462073,0.491853468023152,1.51172241128828,0.616965048194177
1,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.771336111495162,0.0464016951010041,1.97507443298748,2.36906979767656,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.62403325991689,0.273898639878735,1.0745360563275,3.14417624972474,0.0328568191077599
1,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",1.08055016051404,0.0440921044515594,2.70322120298525,3.21324706789675,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.941833908633155,0.268888711682281,1.49185673883871,4.28039741442038,0.00116611673047169
1,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.77239494419468,0.0397266876119134,5.44682447469025,6.36464545101803,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6528921444552,0.258134216388502,3.10584404303786,8.54334866728025,9.19672973034823e-09
1,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.464046604076301,0.0161730370901724,1.54093236442176,1.64178621578626,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.308204091468308,0.274933681916842,0.781525017665833,2.29610018508285,0.296176525784584
1,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.136310584815688,0.091026872919841,0.958096820509276,1.36890663453886,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0286272618030293,0.29482496751714,0.536378012361538,1.70365597703963,0.890207452680804
1,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",0.942207263060061,0.0743532040948671,2.21921923394911,2.97015649078754,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.799649727028272,0.277849928776998,1.27132333292383,3.77805776734577,0.00717005902478056
1,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.560341023810051,0.074919451266809,1.51235370332891,2.02860027114682,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.407197222746471,0.283612388649657,0.848421634348526,2.57889903749068,0.177804326266304
1,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",0.185648302317484,0.0449795208030903,1.10231131629559,1.31485402733904,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0220808418314048,0.282594235240488,0.578013586511328,1.74995687033513,0.973218382503811
1,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.839055132691415,0.0705040261031007,2.01647692372988,2.65839510147059,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.69363039328999,0.27829340202047,1.1422407645707,3.40036237329293,0.0195566206239675
1,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.126781204169795,0.0353413156130344,1.05909163399721,1.21646243502129,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0384223914879685,0.282062089003678,0.5445879201489,1.64532377995532,0.858255370879498
1,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.51854379868796,0.0624971501787656,4.04317249326121,5.16556238972381,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3920139250011,0.26643147153044,2.35306389633014,6.68663288482683,1.93612210681116e-06
1,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",0.834642300839209,0.100860202927007,1.89314949824347,2.81118632445225,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.689116097949525,0.288074841361138,1.11546826834186,3.45045779414605,0.0245900134315042
1,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",0.361193012382252,0.0966931219262502,1.18799614675377,1.73550432868709,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.202502508833996,0.293402783391119,0.678020337922641,2.1415712364518,0.525854353525536
1,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.68962665906219,0.0881778592080982,4.56866647462743,6.45511099291295,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56784239329947,0.271660873405652,2.77755790063884,8.05637049574433,1.59978279380114e-07
1,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",0.389725340911776,0.108631523961695,1.19387297769528,1.82764887774256,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.231826798191031,0.297378106970046,0.692808772022292,2.2226484910276,0.470358889675727
1,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",0.776238554036701,0.332323986235971,1.14301927267719,4.20535761333834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.629066770373656,0.435383838720607,0.786947244827187,4.33655051824693,0.164255142767617
1,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",0.301078521209269,0.373639180606741,0.646265220202477,2.79573033367923,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.140716454404054,0.473753954327701,0.447539360288379,2.86649659884735,0.787944047978345
1,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",0.991653877469252,0.319612810695128,1.45944778615074,5.10855881133514,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.850453946858918,0.423124557726899,1.00622562359943,5.28474364872531,0.0531282696103594
1,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",1.94199978651648,0.27787079407583,4.14470964051133,12.3180569809457,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.82718524456741,0.381319968544382,2.90495689109446,12.9509009933997,6.28008148270281e-06
1,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",0.716000822897972,0.364679220422812,1.01049428420603,4.22050959270036,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.567159117591967,0.46251175129916,0.701329831491063,4.29836949258867,0.237333452507534
1,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",1.03114213293711,0.344375067560871,1.45148035687761,5.59856004914584,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.891042369250298,0.442847502004086,1.00823344075755,5.72092233650249,0.0524028396677452
1,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",1.94077893208694,0.299711624822059,3.9923625343501,12.92587543922,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.82593746181436,0.39845123405876,2.80547380463204,13.376140707922,1.43710770340599e-05
1,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",0.662450507923138,0.0493446426917075,1.76087528419035,2.13664843827891,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.512123927251518,0.276077471101705,0.956490849210643,2.82277302364717,0.0818215736914794
1,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",1.33708274495911,0.0428449692920847,3.50248798584138,4.14301076942625,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20550338256937,0.264915359531558,1.95795027348091,5.53088187819466,3.03098782945967e-05
1,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.795812248207072,0.0154562863156329,2.15022135805521,2.28452545193994,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.649188634315797,0.269804805859644,1.11084216666648,3.19866597809278,0.0244833055720409
1,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",1.05334357625583,0.0151441314627431,2.78351568434899,2.95375921084905,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.913870716586328,0.265901084057677,1.45918751762656,4.13791849513926,0.00144878489441103
1,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.320732488840023,0.0355262076241445,1.28542177780345,1.47749350026677,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.160926379676137,0.27906414324986,0.668876521287882,1.99721863934106,0.602401002781995
1,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",1.0597799672585,0.0304386948927371,2.7190295001907,3.06360555013828,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.920486488537737,0.267188694165602,1.46518572323693,4.1759523632863,0.00140569839905592
1,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.493913962906811,0.0272297969330544,1.55358587684011,1.72858744723769,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.338898806255754,0.275395350717393,0.805201605790777,2.36994641903395,0.250362248644709
1,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.764407628298896,0.025877426495539,2.04163084710074,2.2595972088315,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.616912134662724,0.271123553304403,1.07271959085183,3.10490120626612,0.0332218715051121
1,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.45934256461623,0.0230120515655724,4.11387294815385,4.50221947796432,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33113682637491,0.260504026376244,2.23982050672508,6.21864943650792,3.32216586151526e-06
1,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.520255735126167,0.0319826542828474,1.58025331702551,1.79132373350114,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.365974134074417,0.275530976575365,0.827117822422566,2.43574693015983,0.214047218121602
1,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",0.788734434743559,0.0301191197089904,2.07461087382379,2.33459489872755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.641914528701926,0.271218576773486,1.09972170076678,3.18424251967196,0.0268268692234771
1,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.883614908732369,0.0389014589203439,2.24242469930034,2.61182354165791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.739429875136109,0.270973651319987,1.21315603466783,3.50932057976382,0.0108665593311892
1,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.712451945532976,0.0909481821827514,1.70815362186969,2.43981778184225,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.563532765828283,0.286320835375971,0.987001597877927,3.03215452167491,0.0641378144737954
1,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",0.967961141496479,0.0383428871716236,2.44233377988466,2.83844226992054,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.826118289813529,0.269628672055112,1.32663788881483,3.81741240193564,0.0043516576808602
1,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.63046860650858,0.0340259647858122,4.77831548154942,5.46010164407022,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50702451007136,0.259304082615499,2.67753715411058,7.39904342973994,1.53437096710801e-07
1,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",0.808415760184089,0.173362244855649,1.60438466810071,3.16548983907977,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.662162819154414,0.322859361804823,1.01419521516754,3.59549203736483,0.0518204685546838
1,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",1.0474448644731,0.166290201532215,2.06904520032447,3.97066210135821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.907794982231853,0.315856780487249,1.31508389794862,4.53595793308632,0.00670911438405693
1,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",1.7297915220288,0.153591471347099,4.20426842389112,7.67653140344609,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6091313851211,0.300389345132036,2.73630071302051,8.88275271191069,8.12504696369196e-07
1,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.872392449933249,0.0430465539219458,2.19966220449723,2.60398560385119,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.72789584710122,0.271803631627304,1.19726747507248,3.47464568913405,0.0123826134493969
1,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",1.12010582739201,0.0413942506160351,2.8272192188436,3.32528738231953,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.982487886739793,0.267851075553349,1.55703830003095,4.44928057142693,0.000688471508122865
1,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",1.02989247844468,0.0523878529670107,2.52865357756136,3.10509275704375,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.889769711415458,0.271203740143408,1.40961210531228,4.08129234805201,0.00229266819731874
1,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.81477606135894,0.037847008259718,5.7035016811825,6.61564873115779,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.69645013694938,0.257232591224534,3.25008396548582,8.90857290122746,3.56869796459648e-09
1,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.4340553657947,0.0236575308413949,4.00609826965257,4.39537822029559,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3051392259246,0.260934356073245,2.18043071348854,6.06397977299005,5.18198926518714e-06
1,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",0.93532859291039,0.0186913714016067,2.4565295946207,2.64327439449621,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.792579043958472,0.267912174540094,1.28714569616739,3.67893590633036,0.00588653689041618
1,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",1.02848383323293,0.0440035205351396,2.56665080259007,3.04985024754104,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.888321762067458,0.269643561848906,1.41189254551056,4.06297057598384,0.00221165016634616
1,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.388129602782215,0.0738239409184819,1.27613365150217,1.70441075504421,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.230191366075531,0.285879299482906,0.70742441271446,2.16951094134297,0.456854451557605
1,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.214651520855941,0.0358441610069569,1.15526161252392,1.32954044431583,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0518904154070636,0.280755872870747,0.597684303261371,1.79651775953163,0.889984044279094
1,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.559933331346832,0.0712574092748159,1.5232368970289,2.01407799456711,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.406780678937854,0.282618109094235,0.849719907456338,2.57279826583892,0.176832021183888
1,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.400793559104134,0.0523899846860591,1.34719278576064,1.65431657144377,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.243214895402599,0.280635529935809,0.724114150464185,2.17551372113265,0.422545467818282
1,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",0.372561505418133,0.0495735571175555,1.317187924778,1.5997124225877,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.214196666140264,0.280525931128657,0.703520346103049,2.11273425045888,0.482402470804249
1,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.357789926494436,0.0425162018729811,0.643098097872889,0.759725910573435,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.536449323443419,0.290782542718412,0.325051051363789,1.01620346938959,0.0549208748405487
1,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.61140338993646,0.112928591610677,0.43344170318733,0.674808706248714,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.797104228319457,0.313914131141777,0.239247390432459,0.818946620703137,0.00805242592366778
1,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.532918661526193,0.0456409652958519,1.55834063249122,1.86363867653388,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.378974861165584,0.277366479261938,0.834962620075627,2.47660407756543,0.200743410931701
1,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",0.114681693032995,0.0307140161205141,1.0559285924712,1.19102858754948,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0508580729786781,0.281678212987449,0.538250333591525,1.62373131626586,0.823782906634935
1,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",0.403372146912697,0.176552675414458,1.05957838678797,2.11688326952707,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.245853603212154,0.329869182945264,0.659267041774292,2.40232455342911,0.487112839499422
1,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",1.01663821679434,0.0963589510422084,2.29223112864105,3.34426113403934,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.876120718856581,0.283861852246699,1.35648353755427,4.12725992779112,0.00392496737908335
1,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.56344987972405,0.0348139438783225,4.46181859608164,5.1142184509363,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43814468510377,0.260379542953026,2.49379040045013,6.92039504345348,5.59387577843094e-07
1,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.1906960169312,0.00812635916648095,3.23746622272151,3.34225502520166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24697950991132,0.210504688711265,2.22645334626089,5.0813303570546,4.83549791021996e-06
1,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.38813514169773,0.0222815115920065,1.41137285217482,1.54018849025319,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.430597034627796,0.249788989563818,0.89900345894182,2.39333179009638,0.116676395062897
1,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",2.45749063991595,0.127734886528343,9.17211674048191,15.1330281089601,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.53559439156627,0.207836368632235,8.23239371132333,18.5929117377141,4.45056000393347e-17
1,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.272854175760874,0.00948618121251677,1.28952845954992,1.33838245727909,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.313330858337203,0.255019901443785,0.789517595456969,2.14540100932833,0.253153237997214
1,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.554818887207244,0.00896551462327504,1.71131965746946,1.77253189554459,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.600149814035498,0.240369042665549,1.08845252325789,2.79263701837538,0.0280874516524994
1,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.23452041123311,0.00833684057924159,3.38111074020918,3.49343010423379,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29155851319308,0.208605637500588,2.33806469725372,5.29648084052475,2.18616595153385e-06
1,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.403406610064673,0.009515448716761,1.46928542429461,1.52512450636385,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.446131000440848,0.24813554429076,0.916319194874501,2.42367007483025,0.1030263444989
1,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.677929980940761,0.00906637031960885,1.935140517789,2.0051511840888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.725380146202925,0.234275919069099,1.25126023309597,3.13458239398991,0.00790963240162853
1,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.35035758967849,0.00847986207871744,3.79529496418921,3.92357246066027,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40939014988745,0.203655766598473,2.66025626962359,5.91054708005234,2.36542297923197e-07
1,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.159185887200915,0.0113219864925784,1.14684182318814,1.19888660310871,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.197690027884284,0.261257842511623,0.693075864688467,1.92995388929389,0.472781945666403
1,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.463301908230496,0.0109406001406905,1.55563857442991,1.62380552608517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.507057503708952,0.245105548654325,0.98082763143362,2.56366417551601,0.0637823525997647
1,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.16623327942534,0.00994436326317629,3.14803349438726,3.2731707325243,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22208712504037,0.211658915426371,2.16607517635873,4.96594969882482,7.48580230124592e-06
1,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.197611273544345,0.00916260596485488,1.1968172490853,1.24058432219046,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.236792383215521,0.259068110920104,0.724407078880841,1.99995874517088,0.38884509625146
1,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.492364649567518,0.00884407155204223,1.60809421382955,1.66482145453327,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.536620449826501,0.243527893100889,1.01395327741258,2.63390787140627,0.0496696129350619
1,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.678884126758739,0.0213451216305199,1.89112621096368,2.05616761629645,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.726351866582881,0.235065810312987,1.25054901917552,3.14251587961394,0.00798825349144376
1,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.32242687832719,0.0199069185238373,3.60948793139328,3.90243064662092,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3809788570975,0.205667438084211,2.5746094647703,5.76554336302458,4.3653651114391e-07
1,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.367489365087526,0.0115127459539023,1.41191849001057,1.47709680885385,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.409595461850869,0.250098518757674,0.879424442371629,2.34405081551801,0.134716124026562
1,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.660829745935585,0.0110325049340303,1.89503524579729,1.97878706267807,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.707985735066422,0.235201205471772,1.22708218893515,3.08518286406051,0.00956105544176104
1,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.38741117367368,0.0102278960966028,3.92515419170231,4.08572115861191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44708175213137,0.202179265751808,2.77179975327164,6.12283361421511,1.12509716737447e-07
1,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",1.60660716858994,0.133165159527445,3.87231579287551,6.52636781137527,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67005518298211,0.23618358193033,3.24945139156361,8.20143228683289,4.10165724408107e-08
1,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",1.78315112280067,0.13156679861269,4.63484014524294,7.76273005462077,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.84964013063902,0.229559917831112,3.94746620557474,9.70782487667194,1.11799805119912e-09
1,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.132792885711067,0.019380475457515,1.09948957963187,1.1862725988186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.170884845892932,0.263207729501817,0.671750998909645,1.88492455474398,0.536352766142282
1,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",0.0951503976544966,0.0171883254955284,1.06342366342825,1.13754288508361,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.132585180877774,0.265130972114689,0.643541555725678,1.81943431473016,0.63244977137831
1,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.415331699005814,0.0183962867017287,1.46133719374191,1.57060990971272,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.458261738860782,0.24804385422151,0.92788653524825,2.45338381345757,0.0945224837908533
1,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",-0.286848493910427,0.0165591929871019,0.726649057960116,0.77538096661011,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.256013141604734,0.287269291280196,0.413915065505643,1.27631937508677,0.343814126385469
1,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.14709088995683,0.0166656880008895,3.04811746799057,3.25389413013331,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20259668347043,0.212943054319682,2.11838497048923,4.88112353739412,1.07059204758823e-05
1,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.0979780053094308,0.011894638041594,1.07753955135535,1.12897074583284,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.135465672946925,0.264666453639762,0.646024591107241,1.82313167860282,0.624592156829402
1,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.403109081397246,0.0112249429727703,1.46394397167341,1.52979709964966,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.445828416424895,0.248226316763063,0.91587360460278,2.42335361379435,0.103346565461064
1,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.13884635079172,0.010308147755669,3.06083538372305,3.18704793661576,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19421665270322,0.212884465808998,2.10068537960632,4.83922911571402,1.20394538706413e-05
1,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",0.0236406784544317,0.00999663266145361,1.00406519703205,1.04419164060271,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0598308449436028,0.268754958826787,0.593185415805005,1.70106040676513,0.832224413144844
1,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.422827221212391,0.034821256838764,1.42590740897765,1.634448122957,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.465886778876308,0.249510039359267,0.932439962459428,2.47963375266059,0.0910812339429628
1,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",-0.075496039413924,0.0125708936801487,0.904723215736868,0.950421961224112,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0410229176309925,0.274540245104026,0.528990177891028,1.55176434521887,0.874177028103713
1,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.69523283293175,0.0332962191921181,1.87815091470755,2.14000147375148,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.742982928677871,0.235735191662147,1.27020024716416,3.20028393022997,0.00690770955288674
1,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",1.28468646983771,0.136668347527211,2.7852767580566,4.75918921584038,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34258939059331,0.2492518425131,2.27351458532982,6.03983188794747,1.15391328791878e-05
1,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.38292200323559,0.0308032010788183,3.75449264019982,4.23633915621583,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44251590802529,0.204542136032795,2.74625595363615,6.12285782573578,1.45922053084336e-07
1,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",-0.128005281936885,0.0101468977296212,0.862526840879162,0.897525360233621,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0944363176152462,0.277490829112831,0.497942722385885,1.47768080984578,0.722941653891744
1,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.559918619235207,0.113151221852465,1.40689978807989,2.1922604732136,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.605340942316694,0.266567243662358,1.03937800027825,2.95514243677658,0.0412194616268306
1,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",-0.27224121517494,0.0340123260937777,0.712533286097261,0.814156409436832,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.24115298303352,0.288027591399812,0.419654966131315,1.29787069782916,0.375221114785506
1,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.877306754256048,0.108649741495,1.9508584919259,2.98669877399451,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.928196741155984,0.250646678686713,1.48910147266031,3.97764456281528,0.00161831958578474
1,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",1.42382838272539,0.103030734258461,3.40906886293571,5.10546865317393,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48413848473609,0.226443837755016,2.74403878414176,6.66636262081381,3.7445248841197e-07
1,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.475567579187805,0.01517938388476,1.56183954332918,1.65759277181853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.519534555595042,0.244715913683711,0.994134535722035,2.59447976564281,0.057691006507055
1,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.75041192261998,0.0145481782389286,2.05846625863034,2.17926787149418,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.799110382277342,0.231040753556131,1.35723536690723,3.35721890428887,0.00345551287319233
1,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.43194563429247,0.0135686633178053,4.07712482938231,4.29985036888757,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49238311876008,0.200528722396485,2.9113269072526,6.38957085092755,4.53703962812588e-08
1,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",0.0847618797606114,0.0163134982071385,1.05423358632876,1.12385167651581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.122015586457713,0.265650975820285,0.635978992867569,1.80172212541161,0.660209695180808
1,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.417450258240565,0.0336545158762457,1.42148269408528,1.62194128467432,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.460417202823014,0.249617258632899,0.927061593042629,2.46636745330076,0.0947789605225564
1,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",0.0177114905058924,0.0240032578464536,0.971137693705932,1.06694991064703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0537971379026057,0.270025436041984,0.588069657866348,1.69480957055047,0.850032120304951
1,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.700193457624025,0.0322359815818312,1.89141130424249,2.14617244626851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.748028903044658,0.235339846393463,1.27772915372269,3.21426800253471,0.0065092583842814
1,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",-0.0528172434692145,0.0603734951970946,0.842875724002133,1.06793192669167,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0179493108757,0.279913080927117,0.535950277926582,1.60564449028468,0.942635555279851
1,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.40549330939845,0.0296731383528699,3.8486390974756,4.32337423197859,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46547587434979,0.203431533774325,2.81698794332602,6.25327400849459,9.09387798670657e-08
1,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",-0.27087484768844,0.0125141501258034,0.744230812679767,0.781648996269495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.239764898416348,0.286099823844101,0.421831870555637,1.29478187684614,0.374651232097262
1,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.436302852885231,0.0120775199992037,1.51083218540086,1.58407972508644,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.479593693025486,0.246550153065632,0.951061998240285,2.49998020765032,0.0796788158469181
1,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.719416468634218,0.0116372723324987,2.00700330554208,2.10067765623299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.767581042200814,0.232378236424523,1.31100880023934,3.25992068634572,0.00495679414669401
1,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.38406308867025,0.0108369954031599,3.90738604035999,4.07694877729118,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44367604922349,0.202352890515358,2.76131541476149,6.10382681315238,1.20796446254231e-07
1,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.519368620340144,0.0246257616266176,1.60199325164628,1.76434558443745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.564090187682404,0.243302070426191,1.04318390494951,2.70744144942746,0.0397720998834703
1,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.805229273290779,0.0236176023906095,2.13637360803939,2.34360212662771,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.854872447136753,0.229215720913094,1.44153453643023,3.54032068435838,0.00180190687956878
1,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.50371042458747,0.0220877041690298,4.30864492444782,4.69832311657163,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56538396786112,0.198377076374639,3.14789394931126,6.85074559145164,1.03837040364314e-08
1,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.471681689157544,0.0243463984677486,1.52821088883673,1.68124371450303,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.515582173768997,0.245692846821655,0.988244418146554,2.58900345954941,0.0602711753382284
1,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.72556102104713,0.0233583512814312,1.97374391622213,2.1629980787529,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.773832551319509,0.233006025667962,1.31773682343584,3.28472381688125,0.00473239988610395
1,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.38666272700181,0.021777850962456,3.8350069185537,4.17677261219946,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44632084157357,0.203166558080285,2.7643066079984,6.12995924969443,1.23087041643465e-07
1,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.309016913732652,0.0177243787618901,1.31565266704006,1.41031228034491,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.350116406624535,0.253559390033755,0.822064263492209,2.22108949111895,0.2020244155228
1,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.586196066938634,0.0169465798698909,1.73855449489892,1.85796794963685,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.632067733911334,0.239251403991083,1.12687111263111,2.87856853874312,0.0208914834603992
1,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.27513893104171,0.0157800121749392,3.47049129915693,3.6919422691805,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33287656701002,0.207307900867495,2.44426135765492,5.5089553464694,1.05529980460192e-06
1,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",0.000203020345159693,0.0567935566502909,0.895071398045184,1.11826106883912,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0359849380765206,0.276147623003395,0.570563026284589,1.68429512147013,0.903146912590666
1,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.30056318343809,0.0535226334403807,1.21670240591742,1.5007261951024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.341539738438701,0.259252197741544,0.805832254780571,2.22636511478449,0.221413072398069
1,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",1.03208938509117,0.0483488160739962,2.55545439480895,3.08871124028899,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.08564286870932,0.222981908150894,1.84468042859253,4.42105816558079,8.94124974468438e-05
1,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.258605283464503,0.011686360979334,1.26582406286461,1.32515977416408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.298836661976012,0.25587972074778,0.776614738704285,2.11746409422203,0.276088745004435
1,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.541527193961677,0.0111942835641808,1.68138215184859,1.75680523090249,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.586629465516188,0.241137423252052,1.07195169805001,2.75859732135285,0.0318937356574408
1,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",0.0251517375268851,0.0363621378265115,0.955032401606699,1.10133926226505,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0613649868645296,0.271065673755089,0.59143033254681,1.71145952955474,0.82925086604007
1,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.24817341520382,0.0103242400780709,3.4143182675963,3.55533083823809,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30544663648757,0.208108436655456,2.37352159338969,5.36633316441475,1.70840917604169e-06
1,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.15846869288741,0.0308076771343552,1.10318224213262,1.24478500211468,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.196998774989669,0.262951960957835,0.690261480235376,1.93492380794811,0.476946238564283
1,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.436872820554411,0.0292379065833359,1.46189674483884,1.63942442626621,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.480174105966849,0.248031981238629,0.948863003842197,2.50873000565377,0.0807982563982503
1,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.14945165124145,0.0265556783957594,2.99714941988762,3.32595878874762,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20504709444274,0.213889943972119,2.1196111858801,4.90211057836795,1.09179134478244e-05
1,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.3162058102197,0.0560657226886362,1.22978841735226,1.53206382342318,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.357450705844834,0.259006078182462,0.81941198159851,2.26170030658273,0.201348476683013
1,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",0.551234676636854,0.0538894650995225,1.5625411068988,1.93006992374458,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.596500111287377,0.246657580993856,1.07111436184146,2.8167381095577,0.0322816760101468
1,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.19905099205046,0.0497337181591553,3.01169807038922,3.65997623966292,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25548737114319,0.216071386218622,2.22137134486551,5.18157465869082,5.96624034959402e-06
1,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.398389147985062,0.0338446891539189,1.39412929424648,1.59191676408961,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.441027868480532,0.250625660875111,0.907123641450977,2.42288267384288,0.109624263999633
1,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.652324197066597,0.0324876160829249,1.80205690055024,2.04680051579982,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.699335420437813,0.237685959552091,1.21042525082497,3.07309004755134,0.0109890562992817
1,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.32824128581227,0.0300229186575704,3.5600432766311,4.00466679460163,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38689018490604,0.206705808763519,2.58481543716028,5.81200722565699,4.27566106874066e-07
1,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.36749203449853,0.0268758490407053,1.37016696362331,1.52239384802426,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.40959858711254,0.251338916055295,0.877290383287576,2.34976004666531,0.136314224186663
1,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.687364155042174,0.0255035841578326,1.89181576303346,2.09072166766226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.734978233205976,0.235089999722129,1.26150631456592,3.1703511665634,0.00735039279434349
1,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.365764660083,0.0235526296785647,3.74277303806817,4.10477693885053,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42506297095097,0.204247997164712,2.69969014427372,6.01210202371456,1.90789450548382e-07
1,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.170540075915747,0.0150459855932795,1.15151759553255,1.2214759229181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.209239315760206,0.260834510994292,0.701883088439894,1.95123804392919,0.447350985616669
1,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.484723715132912,0.0140830385027128,1.57958678370554,1.66923891003128,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.528848267613363,0.244177290881422,1.00467652988829,2.61646199301075,0.0532809678526583
1,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.20893458385649,0.0127983568139011,3.2670730534736,3.43515871631036,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26553218461858,0.209952770205884,2.27118273041005,5.17221204406163,3.53887369793472e-06
1,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.479737733284762,0.0158834237465535,1.56621039989485,1.66682533545929,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.523776540181825,0.24455007065351,0.998764725070516,2.60486961800989,0.0557085939109855
1,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.75006345517146,0.0152353414234871,2.05498840695362,2.1814540448525,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.798755991632989,0.231103831104869,1.35657778564132,3.35642213441232,0.00347462089211292
1,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.42153140255691,0.0141972243284733,4.03010501150191,4.2607471396275,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48178961232368,0.201006949511353,2.87756372895201,6.32732003981571,5.66620125310767e-08
1,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",0.230658971457998,0.11910769182644,0.999322054251666,1.59395029427209,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.270409731869485,0.284757764989291,0.712845966447756,2.17654772603053,0.367835971629961
1,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",-0.348282072091785,0.0132173175426102,0.687844429997656,0.724421659794945,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.318504506812851,0.290857702012104,0.385481779273195,1.20548248448344,0.239338163186561
1,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",0.0301345952360416,0.0375691013998279,0.95753505990847,1.10946201742203,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0664338670237661,0.270960618166257,0.594626563735449,1.72000020707918,0.815005712977014
1,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",-0.163935734822047,0.012861240472722,0.827670490724191,0.870467351773492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.130984964282172,0.279722006407522,0.477547480143759,1.42960535024847,0.625187036630082
1,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",-0.0448106443991775,0.0291579031936974,0.903104600197647,1.0124569335169,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00980725742600802,0.274111462479601,0.546623205194331,1.60079700882163,0.965236075334056
1,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.218994174228436,0.00996450299045668,0.78779093543351,0.819171020475635,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.186991440192653,0.282868033799447,0.448131306793733,1.35819053278419,0.487445263418513
1,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.119008603968433,0.026455118605513,1.06954729716192,1.18641675171645,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.156853978114933,0.264616993173613,0.660367195793581,1.86324634141434,0.571611355110778
1,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.116060355861424,0.0257953943538295,1.06777655898134,1.18139340322577,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.153854759606855,0.264710804256293,0.658225463426518,1.85788645768348,0.578999612500083
1,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",-0.299493713815727,0.0213456856301667,0.710816175310308,0.772851871868314,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.268875630176344,0.288371046871942,0.407601879118768,1.26229231373786,0.320916902173687
1,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",0.0547332992832161,0.0129969500478844,1.0297064685824,1.08352637886408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0914641870880219,0.267138278770095,0.614630416041654,1.75142312058174,0.743047294140346
1,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",-0.363308200713901,0.0617298009722183,0.616063593327996,0.784719687075555,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.333787007821505,0.298324889217593,0.373949046786739,1.20415291872528,0.229113914806658
1,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",-0.000579386902895375,0.0365959889860281,0.930334841355701,1.07384206007643,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.03518943838921,0.272546375832251,0.574136022922166,1.67108518119315,0.904203214003739
1,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",-0.0867295453911355,0.0191665172926367,0.883136772208779,0.952044188997134,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0524490100901088,0.275593507599742,0.521758156335406,1.53688186070569,0.84147833901988
1,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.834656572345086,0.0783101981945563,1.98344863325069,2.69610300730858,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.677138036304261,0.653479773267741,0.486133352409423,6.29856188687574,0.325889940498331
1,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",-0.276723874478908,0.156856007818883,0.56554749258811,1.04592666011485,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.498129174303031,0.727572539708517,0.12688829051532,2.1980789318488,0.471118912969192
1,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",1.13399930350148,0.0781454106911232,2.67692328980402,3.63639384940259,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.993643785825745,0.638392697011491,0.690916223972496,8.43775845035885,0.148338025305823
1,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",-0.0338921286185381,0.15598201468529,0.722307389910757,1.3312705395719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.241336202379545,0.714138749098451,0.169312006348771,2.78252943195031,0.723905596204149
1,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.81965082459123,0.0779576872227433,5.31565899700457,7.21560116859159,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.7187370716836,0.605226837213201,1.54009399623669,16.5153302879005,0.0122119714441473
1,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.402587135509617,0.0954807485209465,1.24736906392266,1.81360076312737,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.220216968135399,0.678442111285531,0.290708500607702,4.15374350667601,0.75421772698483
1,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",0.645499482746413,0.0956477195997817,1.59006250654568,2.31337037735959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.477096847467933,0.665790399172414,0.38712443179278,5.26373735814829,0.49182726015837
1,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.787725544430668,0.0330700354765864,2.0617878829214,2.34715901664417,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.627458313846354,0.651486610520013,0.463999829627923,5.96500260414998,0.359993869699732
1,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.44649658011823,0.0328864770607975,3.98577515183452,4.53418081895781,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32412439088066,0.618454991898905,1.00523783633663,11.3534673077679,0.0523262248234259
1,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",0.690751618401452,0.122723673747915,1.58313957142244,2.56120514411486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.524947532652432,0.668511296362118,0.404284938310141,5.55601303765572,0.452123213756411
1,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.33503510686273,0.122124098465917,3.01916621444597,4.87294450049868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20624923719017,0.636391530255462,0.860934050794933,10.4319330268246,0.0821862829067822
1,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.417529825610889,0.0317134913849681,1.42753726223694,1.61650331228355,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.236021617324104,0.670800900976688,0.29989243083983,4.15852224222709,0.734311775706224
1,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.707981264161604,0.0315590278898878,1.90932606478283,2.1607587868857,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.543185260067388,0.655540692627019,0.422476047100717,5.51818923234383,0.428716571609163
1,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.41060081437153,0.0313635781613605,3.8565034124864,4.36101090095333,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28616392289113,0.620118611538945,0.96405944113345,10.9596238883308,0.0594555676754804
1,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.700433021965608,0.095048652315918,1.68158827440455,2.44079210268768,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.535189780544157,0.662862413062202,0.413073192681664,5.55246755180922,0.440017139922447
1,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",2.59051920738134,0.0892631855271608,11.2533580783711,15.9677623652355,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.53389208302895,0.572068813787774,3.75654475693172,35.3736831805061,0.000224333902074974
1,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.36887502314302,0.0946154322400824,3.28414133799701,4.75877797896692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24203519157807,0.629397305923274,0.90515915978363,10.6711903503244,0.0714562266529075
1,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",0.121698004002569,0.758779786722122,0.352157841181978,6.89424025186826,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0768036778418188,1.06157860602408,0.101234108414389,6.49473682638803,0.937657376383016
1,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",3.07730977981286,0.0892836782202168,18.3098736579558,25.9825730486982,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.04864709107838,0.551161019408988,6.59160657964004,57.1859709268718,8.94996596540476e-06
1,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",1.37968250443809,0.194242782233314,2.77980655641111,5.95242712247734,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25347549634543,0.654352414662755,0.871995952344658,11.3366839509034,0.0783992963461743
1,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",1.78678517311108,0.305460188649579,3.47778541883147,11.5164638910234,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.68396915686579,0.683509450874224,1.27506261441742,18.5840391174268,0.0255382726780262
1,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",1.70257250750694,0.183925458420016,3.90917597845491,8.038971509267,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59490673123284,0.636022258921749,1.27858438600274,15.4701901986902,0.0243635169321232
1,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",1.64991938761668,0.193982563686825,3.644844316579,7.79678391405057,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5392274321023,0.641795640920778,1.19469557542573,14.7860488009181,0.0305193757444997
1,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",2.28653981099284,0.193616511599424,6.89475252927265,14.7276016782855,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.21244100698862,0.613488544880712,2.50042225790662,27.6960700191376,0.00185044958983402
1,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.525565705499948,0.0331001244145731,1.58624455434024,1.80600894961626,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.350272152014687,0.665161408798336,0.340649923605046,4.62041655420276,0.61183213888586
1,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",0.269238561669847,0.0960775281941397,1.09029639882746,1.58893912215799,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0792030551804753,0.685610388020943,0.248280976213973,3.64862042486955,0.914339413391472
1,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.58552058461823,0.0950319667266634,4.07563036279694,5.91530990611578,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47113711277422,0.619043716245147,1.16576964839069,13.196983604624,0.032654872220256
1,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.422969010294716,0.12300934356022,1.21046298706406,1.96048263767289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.24176966536331,0.682408563144743,0.294855742364054,4.27901722041904,0.732306778176195
1,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",0.020567689168549,0.0959599882964893,0.850322979797984,1.23864397984593,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.183789164013721,0.698982041321573,0.184977896969965,2.86463320783269,0.78284630687677
1,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.491547211942776,0.0608856041529882,1.45391695273142,1.84582889779159,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.314294261801533,0.669180457317593,0.325814919492653,4.48937458114333,0.65047827445124
1,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.772445065603246,0.0607601308010495,1.9262150653368,2.44423528594229,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.611351902971669,0.654543062361636,0.453707365697968,5.90298880289502,0.374105437526273
1,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.522690643272913,0.0440889910574765,1.54874935209805,1.84093465034758,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.347230587553548,0.666037910873781,0.339012928448641,4.61403894342253,0.615336431877904
1,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.572046876194538,0.0440778628684114,1.62708814676597,1.93396838844256,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.399426294163497,0.663445147623938,0.359342376127593,4.84127220808691,0.562461084072235
1,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.8303724808642,0.0439417691291288,2.10738748864231,2.50351962834049,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.672556900779493,0.650025060890181,0.487184233344343,6.22727284829238,0.32672044528087
1,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",-0.210141706370482,0.0551371326286474,0.728748901844318,0.904572828071808,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.427700848234643,0.706705694214974,0.142043613045468,2.26735574451649,0.524914012467055
1,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.475761647744172,0.0545991919994681,1.44864266675882,1.7943663045679,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.297601286114671,0.669395027269054,0.320187563744367,4.41554810108591,0.667931977579131
1,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.53153358269314,0.0438358892443595,4.2497695635531,5.04651693470769,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41405213730885,0.615097950333913,1.10865909500922,12.3578429946048,0.0383912093890433
1,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",0.0911393587255746,0.0626201105674469,0.971138660742159,1.24132617484238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.109142103970676,0.690797189527327,0.20283890994371,3.04205131383844,0.866643100172994
1,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.16769471447166,0.0542568862527328,2.8958686395611,3.58216798729474,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02929104831665,0.633886550140329,0.722769565208303,8.67221979007702,0.132777594328805
1,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.463185023939716,0.0414483303677294,1.46665847265442,1.72540384287341,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.284302235215581,0.66898507264469,0.316133947788025,4.35264639746188,0.681741238052198
1,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",0.213375361645568,0.0527687035287554,1.11812869800683,1.37507187084569,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0201292374703717,0.683237941477402,0.234864863835222,3.41951435176418,0.982723334265459
1,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.740876240049801,0.0413933131303884,1.93642766162569,2.27755766652999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.577971284930943,0.654459821732616,0.438630984832142,5.70497476052751,0.399872598247683
1,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",1.41101304714848,0.184122070238492,2.91896901846191,6.00730200981583,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28661400017088,0.64955272005011,0.910385038842027,11.6151725901892,0.0695985835495856
1,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.473177018387109,0.0621831078755071,1.42429969320117,1.81744842534368,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.294867456535606,0.670284060504107,0.318740741981662,4.41094083645263,0.671184680323422
1,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.41429336889788,0.0411246477049817,3.7982306623922,4.46264214534619,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29006816732267,0.620585712486057,0.967004504765145,11.0132508058541,0.0589001244865213
1,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",2.20447752452848,0.0893381960396704,7.6490705883545,10.8567113037523,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.1256558585358,0.589303621918187,2.40106361854479,24.1900057763348,0.00197395134866815
1,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.2289301839272,0.0565597677765889,3.06524807347462,3.82607211404235,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09404618502932,0.631073191877918,0.77622069697651,9.21141116481308,0.110084039903313
1,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.142183093405159,0.0574787053349397,0.776553601012437,0.972799555095453,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.355892686276013,0.703129684018617,0.153930148939885,2.42289076068845,0.596024217020276
1,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.41850486799087,0.0617803548130224,3.66854697557413,4.67378952920073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29452038094814,0.622322580911699,0.968084368571137,11.1008718781773,0.0586731050074399
1,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",-0.692882435770754,0.158979597631488,0.371289821803868,0.692405329042077,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.938208942979693,0.751385979753076,0.0772440983180755,1.46901800581565,0.17718270150281
1,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",-0.161931692217972,0.101488870383269,0.70131010614273,1.04396289600822,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.376727872126928,0.709880444789213,0.148702493190505,2.40337151906404,0.578137069263424
1,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",0.614352212809989,0.154607058644615,1.38547091437308,2.5398083505002,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.444152958983152,0.679875756910061,0.364148988523684,5.23240913170124,0.529682643421395
1,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",2.41364605981922,0.0893877127980462,9.4276814971379,13.3837809546157,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.34684881452575,0.579907559951398,3.0605056062813,29.7186857218275,0.000633455796430112
1,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",1.12633105866625,0.306435356108606,1.79243601498815,5.95826969930309,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.985580034456102,0.712622826099895,0.5923837978471,9.67775158904358,0.192494054942864
1,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",0.00357370228662597,0.0318540794361148,0.943417081033647,1.0688880413639,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.201735870365287,0.693198415126611,0.183692001513179,2.78095119829472,0.760535721981462
1,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",0.567176750440469,0.307954671610741,1.02109453564471,3.41451429709438,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.394268404220559,0.739099982651373,0.308142901218603,5.58467955758138,0.605448620708365
1,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",0.207559282388379,0.0485968749037216,1.12021187451876,1.35528815228826,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.01397890385063,0.683199154510291,0.233414856857323,3.39788631797302,0.98992299903658
1,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.746904233707515,0.0757156227261357,1.82589936627906,2.45683136411025,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.584337903690696,0.657627373141289,0.43874296066765,5.77772718529785,0.396930734967359
1,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",1.9254195173092,0.183791880444736,4.88631583096967,10.043137278364,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.83055996085092,0.625921715100239,1.65656529708963,19.2654704587147,0.00973051116960575
1,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.405282089723527,0.0747908789867674,1.29968641401543,1.74245994056133,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.223067615803244,0.675333003696076,0.293339782548522,4.14056832577266,0.750051478480483
1,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",1.04824893795072,0.0754780427463848,2.46894159693973,3.3189817907481,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.902960283983045,0.642295835442266,0.62527217578645,7.75381644749347,0.189032293403418
1,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",2.4941466164256,0.183559253912294,8.63566508175255,17.7332211876413,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.43194613378066,0.601082617242638,3.20058955338008,33.7687423248619,0.000587207965367935
1,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.77016500683723,0.0752947347735804,5.08415671051541,6.82968883425859,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66640528307434,0.607173837844467,1.45485856517713,15.7208270807305,0.0150735399806915
1,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.616355161980452,0.0484027569879085,1.68686623434025,2.03930248298861,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.446283233137458,0.661471450700218,0.378363583110031,5.05825091603154,0.517147305990143
1,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.914876642289743,0.0953613333351965,2.08257400504826,3.02652225219629,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.761967872438325,0.651990298953038,0.531504267210225,6.84631776933974,0.270203279517351
1,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.858575651346208,0.052356615171489,2.13335596059392,2.61936119239281,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.702380628711205,0.649294857925716,0.502919371521805,6.41002811377043,0.306034312783103
1,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",0.0588903141954942,0.123800692803303,0.839588954380362,1.36403463506748,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.143210439279451,0.70188782736021,0.191687533299699,3.00254740163779,0.829764495101324
1,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.904913047632728,0.0482137171505498,2.25208455883346,2.72059486360606,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.751386576771338,0.646562613385287,0.531467937162256,6.70173510497902,0.273041058633269
1,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",1.05011887847878,0.194595158143949,1.99772374470538,4.28365838700097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.904957724835991,0.670084129943998,0.593279930640332,8.20376003191964,0.204656682761372
1,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.60035429234265,0.0480237438187528,4.51527424484144,5.45054466616802,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4868315713219,0.612135082698653,1.20066251268589,13.2288351729317,0.02950904849005
1,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.544806314025947,0.0568515392168216,1.54550279389199,1.93131907692046,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.370617113231342,0.66597687761996,0.347225109936755,4.72467800615708,0.591949297729916
1,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.83557750862835,0.0740770106007792,5.43996540008554,7.27285734235262,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.73558125287282,0.603925087213365,1.57065206501841,16.7572952668202,0.0113291024103717
1,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",0.114054934996436,0.0611626808390298,0.996430648282497,1.26639915993125,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0849066737201327,0.689400454885794,0.208484372943712,3.10964612810213,0.894653740073223
1,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.202718058556988,0.0442611853902935,1.12433679998014,1.33735530298786,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0088594557471024,0.683124818424905,0.23223389077386,3.37970969531516,0.995921907045373
1,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.4387452460106,0.0604345605799115,3.75301083368145,4.75624043285794,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3159248484254,0.621187501411067,0.991570640681745,11.3197068244461,0.054554758581067
1,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.16292320106773,0.033328844463157,1.10326563011101,1.25724297189065,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0332224649393663,0.684575104892376,0.221849191668065,3.24698754038314,0.954702652609023
1,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.190377152852197,0.0546855347995142,1.08859794663758,1.34885210498048,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00419077667754926,0.684652799470429,0.228478191032328,3.34502825503378,0.988787322136235
1,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.828805961763971,0.0744296539477916,1.98642182014516,2.65938215207902,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.670951939569512,0.653262188724822,0.483288940974063,6.25636998307015,0.330022541588302
1,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",0.427727146438277,0.0787378960090952,1.31940704434399,1.79648020279513,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.246803045362169,0.674657747476565,0.300917539207486,4.23630219966286,0.724050394616855
1,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.738256343636968,0.0917362500911564,0.401048681193335,0.574604691851408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.986190464943101,0.741085368190108,0.0750489755329303,1.37078955422805,0.148104621383582
1,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.50912424167446,0.0436896658003383,4.15571466914703,4.93200085494546,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39035364070681,0.616171134058239,1.08001702414139,12.0893302520621,0.04176530404747
1,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",1.12306652099876,0.0741892774577483,2.66746329345806,3.56778361607034,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.982083972420361,0.638400099736278,0.682832934435368,8.33928391835367,0.152846578160227
1,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.747272256853394,0.0620887235992976,1.87370441183046,2.39001768244762,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.584730307227897,0.655988305493359,0.440336756788454,5.76157812734955,0.395549194264445
1,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.255491162925635,0.0570934890794337,1.15673025372839,1.44686571772902,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0646656536671852,0.68136529149543,0.246677541323071,3.56523356309339,0.930669445275497
1,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",0.443714142869007,0.755049299847179,0.491119366191879,9.47513307860694,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.263704142797995,1.04708618962395,0.147377288590437,8.93291750240281,0.805289506618645
1,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.840902880498418,0.0438909933759931,2.1298781736969,2.52973439537552,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.683693444841976,0.649485656823023,0.493262021400394,6.29164290103495,0.318708713466346
1,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.593391896648353,0.0526030764748833,1.63554506838612,2.01008376370014,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.421998191192143,0.66303569173618,0.367991726199773,4.94985027335613,0.540696983886642
1,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",-0.548715620351271,0.102622564253878,0.475244560921213,0.710594963942313,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.785754858168243,0.731808609651346,0.0938048881789375,1.65218511753474,0.249722457535268
1,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",0.807695305036026,0.0999557151605746,1.85489236100603,2.74462889156246,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.648620240556729,0.658201426614164,0.467878015847031,6.17528178415366,0.349058464764316
1,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",0.896251790382692,0.306953686927387,1.42242022485127,4.7379101748149,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.742267126845827,0.72330024411777,0.452936028027661,7.71587947673484,0.327365609988124
1,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.53637151344726,0.0522103215211633,4.202874253177,5.15738329157278,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41916721340989,0.615606056020588,1.11332364212058,12.4345788744099,0.0378794334920736
1,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",1.41536984982751,0.748942784166008,1.3202308522585,24.8686600021889,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2911985907038,1.01015360449736,0.450729826063652,23.637683405863,0.217656648847592
1,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-1.31846084270657,0.0945194271911832,0.223239442267794,0.323356126227792,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.59972791384707,0.776116912522596,0.0373859749216403,0.783380104584502,0.0192988962646696
1,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.077368574260752,0.0416615208447072,0.99675629671341,1.17358267480011,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.123695793224059,0.689742815172329,0.200263260487816,2.99103558550456,0.849483559317251
1,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-0.961686093932611,0.0926528115065922,0.320174847228279,0.460383386559588,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.22248801260619,0.754348926897315,0.0574201544416242,1.10476599397069,0.0733719226390569
1,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",0.745932137415699,0.752467865815528,0.669288711326601,12.7825387267725,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.583281667804031,1.03462758709873,0.209118380933448,12.0710599098546,0.580556880935623
1,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",-0.103660344633849,0.0900768893786399,0.759217275464005,1.08072016777597,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.315101521336573,0.704900011462566,0.15990862615956,2.53452072728573,0.64003854054825
1,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.127388155812482,0.100910332386573,0.937674852515093,1.39265111156679,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.070824855605108,0.693989631401878,0.209606200701443,3.18312883329173,0.911709941126819
1,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",0.311496496682729,0.0761002238006011,1.18017167830283,1.59037098626525,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.123890152500659,0.680484866841115,0.262477643639721,3.78052275257634,0.862344557248187
1,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",0.0930097022920346,0.044372181995038,1.00701461003931,1.19832635528812,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.107155313176452,0.689080974231245,0.20393449900111,3.03797557352202,0.868619399363369
2,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",0.0674249726477415,0.454996149529703,0.438525762736352,2.60964818031318,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.137542461150048,0.421898973669505,0.50203167726458,2.62405682798208,0.765130139180366
2,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",0.967411718410715,0.310639605499304,1.49958161533134,5.0676187057847,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.971780189648416,NA,1.50291958573706,NA,0.000853646985752159
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",-0.466832241551232,0.528198969706964,0.213154422489499,1.6900591475241,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.357688493241961,0.489622830133736,0.267852647960617,1.82570817967153,0.450775740154201
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",0.046973885088783,0.339837134061437,0.557721566448836,2.11328088308922,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.118583810982753,0.315043955844733,0.607241395133938,2.08782057034531,0.734001072868376
2,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",0.605070833705835,0.536790722523936,0.698031577216248,5.72412688755746,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.635915766685374,NA,0.712252059906606,NA,0.209543718973615
2,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",1.99843023716058,0.360254230342438,3.87410938940976,15.9026607007602,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.92746550558947,NA,3.5466531713074,NA,9.61209404978749e-09
2,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",0.0123367360301949,0.612700432256405,0.316898938252644,3.49932187023185,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0864786457591343,NA,0.358196797203233,NA,0.895028424590198
2,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",0.205336085872891,0.329183282684523,0.669807227263217,2.43417874414984,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.265378343975676,0.30522490430335,0.717000531148953,2.37211257901012,0.40547570214335
2,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",1.08310134837188,0.506548646003321,1.21404548496973,8.84270092185193,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.07902824380966,NA,1.17203207710262,NA,0.0229998184184769
2,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",-0.542603483939028,0.366482713811915,0.290034229975255,1.21997395662181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.427924774702499,0.339711947089289,0.334958282209914,1.26857862043894,0.195788710952967
2,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",0.316099825992757,0.578627621507405,0.468364225539714,4.52523527908412,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.368052984137079,NA,0.505000850542127,NA,0.506251729095887
2,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",-0.00504007012025055,0.73570262705099,0.235277237834852,4.20767643641165,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0703712552443037,NA,0.281886689963445,NA,0.931255674194764
2,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",-0.622539955906661,1.29132863659592,0.0265474693455758,4.19164973304158,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.502022408187939,NA,0.0579541619883347,NA,0.667892555057214
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",-0.29256937537981,0.800087111249553,0.147040913799391,3.3846125512473,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.196154966408965,0.742417305917915,0.19209794553819,3.52708749511416,0.779439690673433
2,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",-0.00426942035793507,0.735702817684634,0.2354585358187,4.21092189953999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0710856119468864,NA,0.282088031830692,NA,0.930423048586932
2,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",1.20044453258914,0.584129839823465,1.18868258987082,11.7351959049225,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18779984873314,NA,1.1349112142692,NA,0.0298272710033937
2,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",0.627925254291766,0.399831499839939,0.88092351266968,4.22291734661417,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.657100491244533,NA,0.933035869915057,NA,0.0815416189609094
2,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",0.277677126010049,0.434265721465026,0.563583630933956,3.09210102877349,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.332436509647082,NA,0.633474720026433,NA,0.42535362584815
2,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",0.992010356147883,0.373490829452828,1.33649646456279,5.77829559745091,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.994597828191964,NA,1.37168677719541,NA,0.00451886602500704
2,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",1.42585450075313,0.358750851218729,2.1615652542983,8.82077830790317,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39674488843675,NA,2.10610597484696,NA,3.10735203604241e-05
2,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",0.0793590156596761,0.458660146231897,0.434905854685175,2.62554642999664,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.148604793833919,0.425314509067126,0.504248291004187,2.671167782219,0.747162059633637
2,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",1.0431852740143,0.394346293782474,1.37192127862394,6.43673366814534,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04203564453539,NA,1.3848531548198,NA,0.00481627007327215
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",0.753227691825605,0.718519660209365,0.589856467368638,9.86180549627221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.773250418692304,NA,0.587338956762996,NA,0.252769867035591
2,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",1.44210164561418,0.660115550683795,1.37962027081013,18.3460392253866,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41180544700595,NA,1.23677644787559,NA,0.0221143549052756
2,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",-1.85771276595745,NA,NA,7.85726397423843,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",0.46063445913468,0.434195704660251,0.694463173890827,3.80912591126855,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.502029636044333,NA,0.750650527425099,NA,0.222970651897512
2,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",0.753227691825605,0.718519660209365,0.589856467368638,9.86180549627221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.773250418692304,NA,0.587338956762996,NA,0.252769867035591
2,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",1.59260298950371,0.343981768282223,2.61494805768801,10.0706775496675,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55130593164673,NA,2.52397549037282,NA,1.37179940313593e-06
2,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",0.227941232956595,0.960705536622938,0.161034574562034,6.95708326115395,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.286334202833409,NA,0.232451990692078,NA,0.757647173456905
2,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",-2,NA,NA,6.74973718641998,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",1.72630728192321,0.640788374064283,1.93262888329853,23.8247620369253,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67522988049053,NA,1.66705192547007,NA,0.00509532722583345
2,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",0.872647376615024,0.404214055680926,1.12924359861907,5.50709912091054,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.88394687456061,NA,1.16133639200816,NA,0.0198933989180848
2,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.473055069481489,0.188411212591067,1.11656430987349,2.33687547985979,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.5311345056558,NA,1.18456018182226,NA,0.00475463989537277
2,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",0.5309064256545,0.325950755026609,0.906887986833194,3.25426728591728,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.586647891489979,NA,0.97198536771839,NA,0.0672306782277199
2,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",0.521122191890119,0.487296648483754,0.697929430577029,4.71397017678668,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.577262275015158,NA,0.711972868059159,NA,0.22675160145567
2,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",1.17820669211011,0.454567417298679,1.45760257611054,8.65956549725197,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20783440767664,NA,1.41427656418212,NA,0.00622599372018777
2,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",0.652644419306214,0.313524754137723,1.05350281299031,3.60065249316465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.703479562757788,NA,1.11652789813107,NA,0.0221929295383826
2,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",0.0401295682883902,0.205595662142372,0.697235241128093,1.56093931708872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.115650439991472,0.204631869436285,0.76166434892891,1.69875033053757,0.599388918459175
2,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",-0.147010045184736,0.552751317095195,0.304974469127896,2.66237380884008,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0639471596567324,NA,0.331648540214465,NA,0.889057679612996
2,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.766429505004679,0.179437061225876,1.52710964274185,3.08563410670822,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.812688073580808,NA,1.57143312067396,NA,5.17789005231622e-06
2,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.50766016163347,0.165266667574091,3.30512232535479,6.31739485953781,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52403773314037,NA,2.77878636028663,NA,1.42237311482587e-20
2,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",-0.0329453857885024,0.229689097156697,0.616076617511742,1.51585672174542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0455236328064099,0.226230656335252,0.678962932076181,1.64809344572591,0.874515485212691
2,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",0.204684986428488,0.21655512391299,0.804677662259551,1.88055507470842,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.273574007116346,0.223083724578881,0.873118553941655,2.09339719744697,0.212098442992575
2,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",0.304516182667892,0.236859607359381,0.858394584394314,2.17228846275759,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.369386939871906,0.254309205348799,0.924638271249821,2.50558212001643,0.118812112192896
2,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",0.674437470325337,0.197511947278087,1.34278104400884,2.91239415215186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.724399670137534,NA,1.40384045765549,NA,0.00021651117039799
2,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.707989673658958,0.220112099758638,1.33433744824469,3.1621698437954,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.756596666523234,NA,1.39193507478096,NA,0.000499416324682568
2,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",0.206788684705729,0.193820278062613,0.844469486178072,1.80527846324785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.275593661508731,0.200443702010027,0.912528726402743,2.00208504638665,0.161626184298513
2,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",-0.352504973150659,0.44040235476926,0.289996802601384,1.6298045938095,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.261160804422754,0.426819069211238,0.336360258817119,1.79234982901523,0.52236714414975
2,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.271010925480464,0.146939950888771,0.570592482979846,1.01502577786972,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.182978461830366,0.143039197911988,0.631222211450441,1.10584088972586,0.184933999939768
2,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.508104021243918,0.182673654323082,1.16969138532469,2.39362153959043,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.56477491965156,NA,1.23637898622075,NA,0.00196149939395505
2,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",0.0909463603479413,0.389921030342301,0.511851838886686,2.36019036654965,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.164443953672713,0.396197894136555,0.565976069655874,2.6747708819811,0.681749640639348
2,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.190578506418805,0.130591514444813,0.937492239807134,1.56418126115343,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.260036110356729,0.138137121246472,1.00882693931491,1.73373107123632,0.0557666042216264
2,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",1.38025885934716,0.163066534378079,2.92003025523776,5.53340327424832,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4017703034411,NA,2.57296216289995,NA,4.84464717703396e-18
2,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.456921515806435,0.123473913651756,1.24223447425883,2.01560742365421,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.515648743638212,0.162712675427556,1.30633568135824,2.4720505670101,4.61756047763583e-05
2,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",0.822821461750475,0.241024924896237,1.44065810364098,3.70580448433599,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.866794870360221,NA,1.49062226670181,NA,0.000254850561765987
2,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",0.198456568323015,0.456903469194308,0.500083204895963,2.99830732205752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.267604497022528,NA,0.553232908979731,NA,0.558618476578331
2,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.46710094724311,0.223164535677021,2.85662903394733,6.85125039693656,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48514060766385,NA,2.57455263523539,NA,1.14084696274349e-11
2,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",0.0878749705000096,0.353128668425132,0.545224178622771,2.17641866584806,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.161463287479254,0.355948624006925,0.604696187989829,2.44064866700761,0.657271704187284
2,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",-0.383548353689366,0.356756847180606,0.332295307278035,1.34545186771631,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.290954182859186,0.344775447737593,0.382109731063646,1.47616493292102,0.381758332461501
2,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",-0.046179445579942,0.324133568948443,0.503288878463221,1.7931776688166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0328198028438004,0.319088593658589,0.561529904150388,1.96150895941047,0.942505137670903
2,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",1.12423846000574,0.289700839102458,1.78474202533565,5.55601043493995,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15608553790713,NA,1.79750418576635,NA,4.39089781538876e-05
2,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",0.280376378355699,0.29832566467029,0.741275194585396,2.38698670338145,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.346214969150787,NA,0.805779807081847,NA,0.244422120306213
2,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",1.11615378202341,0.184538606847805,2.14899800639067,4.42991207542443,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14831133966247,NA,2.08670111540223,NA,3.12586731244043e-10
2,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",0.853488923828548,0.267016419859798,1.41383595166631,4.02687916796289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.89624623131368,NA,1.46510345173835,NA,0.000620351933182331
2,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",1.19071841718657,0.384654199012324,1.59304110146934,7.19554140589361,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21987776579515,NA,1.62217510091484,NA,0.00111128068542214
2,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",0.37686616326548,0.505400390321642,0.577509196664444,4.18749295119434,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.438819582752591,NA,0.599287077987632,NA,0.378260412885888
2,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",1.51892054882562,0.346847199857652,2.39093704012486,9.31197676503512,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53484208501399,NA,2.29143404598356,NA,5.29797159663241e-06
2,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",2.95604145375687,0.304703915774072,10.9127485489076,36.0298981941199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.9140466829852,NA,4.87144806873969,NA,6.66351129482202e-23
2,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",0.7414705431801,0.340944436699554,1.10408170931785,4.20171002190753,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.788745545862115,NA,1.1545572723056,NA,0.0180588622537457
2,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.09018177866809,0.111055331542713,2.40208380433567,3.71235153470608,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.12338418242241,NA,2.21708010751087,NA,5.34090855198434e-23
2,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",0.269038235578221,0.267465962152718,0.779638407719775,2.22447795069644,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.335334646095158,0.28284603709798,0.844400873735962,2.55897852066166,0.209919666550869
2,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",0.477103763918419,0.255876286026586,0.985826348591344,2.68784982730647,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.535015560450882,NA,1.05160835542142,NA,0.0345516920460149
2,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",-2.22136632899481,1.22091726247848,0.00560014232139983,0.670953434285817,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.05470224818334,1.17210441012684,0.0128911434576384,1.27551510745172,0.0781611865837355
2,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",-0.0849197486285328,0.565237100662271,0.311034703073685,2.85147935764181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00435403787469089,NA,0.343840506142763,NA,0.978593814315416
2,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",0.192612707394719,0.530500136329866,0.449013470665852,3.59239794866346,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.261990591759728,NA,0.479054388249679,NA,0.621858633085693
2,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",1.69309699976888,0.446559860513694,2.48417447559409,14.3023361130582,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70199925903022,NA,2.27347341654713,NA,8.38417656486941e-05
2,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.947325308750508,0.212952899860286,1.72268408173885,3.96951378691372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.986297561598568,NA,1.74415497828066,NA,2.59288574890499e-06
2,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.145850718769271,0.2109747938963,0.571393050496854,1.3064689551701,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0628355179940508,0.205987716732124,0.63114392735929,1.41515018564302,0.722537044998109
2,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.59790899365755,0.199109567998291,3.40512620409883,7.43186746080562,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6106487223459,NA,2.85828865076903,NA,1.95134158568212e-16
2,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",-0.606185746183743,0.47753753763156,0.20490709717046,1.33204341169588,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.504618235509127,0.460164600739546,0.245890775882393,1.49323401344664,0.262791966583397
2,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.0192905805803479,0.0530364108832242,0.883684989762387,1.08789461673846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0304577416203316,0.122166657639518,0.773026660831153,1.24787581434522,0.789798590377664
2,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",0.689514387126949,0.484383991906957,0.788666250750745,5.26635412986236,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.68430359527338,0.508761097379764,0.745574485852577,5.4778167559854,0.172531360610445
2,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",0.014232579902104,0.11534230402973,0.807608601028868,1.26928757828755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0033471978182133,0.16090519992859,0.74134991779556,1.39299241843696,0.992104094994863
2,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",0.0910789318783243,0.0780905046303314,0.939350870080771,1.27576110704316,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0808277380548898,0.138006660311503,0.838292116139554,1.43991994128227,0.555204343364001
2,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",-0.0120897303266616,0.0587194836360848,0.8800976466029,1.10788603952157,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0231963718636639,0.124994739926857,0.774401672315736,1.264030965572,0.839838359263757
2,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.12780901861128,0.0781045469813874,0.974102162140198,1.32303072241806,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.117866608680467,0.1389609580446,0.86853269544293,1.49745484642509,0.386323236369334
2,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",-0.0136771018732148,0.0424761681431017,0.90737445735635,1.07176139449226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0247971163227823,0.118030929191361,0.7837816286434,1.24489091577965,0.81972806257796
2,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",-0.0173127806119197,0.238299937054792,0.61222477958979,1.55809327067134,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0284666772692092,0.264954697550971,0.585587816825356,1.65444268900793,0.908689915832231
2,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.0792224914709078,0.0479471713828689,0.98509214545195,1.18878213206295,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0689022706336387,0.122769444970535,0.853364029798367,1.38082110063238,0.571914105282127
2,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",0.0522656001413009,0.0398588062757995,0.974284865629093,1.13904717472817,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0417003104829889,0.118983349116223,0.836495656367951,1.33358686998026,0.729913108349502
2,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",0.0530144759203227,0.0409708123887406,0.972884394509811,1.14237864130314,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.042455371933497,0.119391051713742,0.836463637277317,1.3356687373572,0.725907093461523
2,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.30137520503918,0.0738978076995302,0.639423498767366,0.85426467570407,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.314913288167431,0.126109624468614,0.576146882045801,0.944544948807198,0.016088826416402
2,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",1.42160153942311,0.188155624122105,2.89012341782166,6.04272881133845,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42254307074522,0.251499008825542,2.6048769888702,6.98135798669217,7.96581384117011e-11
2,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",-0.00175491146284514,0.0251775426439268,0.950115469076223,1.04866968919783,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0127748125547416,0.113199509918281,0.800866867940018,1.24816362605159,0.896069512732986
2,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",0.110455639931515,0.0675317605774887,0.977930567404186,1.27430767501864,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.100376272678631,0.132696270325272,0.863894636690891,1.45332691958257,0.44126178821764
2,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.50054113418555,0.0586253410719855,4.00098192394638,5.03466468004226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50217523354718,0.177339750243546,3.26554860081889,6.5442501235002,5.86736142992872e-34
2,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",0.400255029412893,0.215426276596795,0.978118209677779,2.2757979529316,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.392583422429418,0.250548543569319,0.9206942725564,2.4583858943776,0.107455194950615
2,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",0.7035042570443,0.215116745852598,1.32918270647687,3.08887329703127,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.698415468074658,0.255880329242882,1.24060484080128,3.38255552015783,0.00407215848736108
2,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",0.709495407684814,0.0212037454654008,1.95027842953496,2.11930732469181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.704453282932288,0.135860231963563,1.5789928854854,2.68948453537325,2.04951800839243e-10
2,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.428835845424887,0.0371980158455668,1.42748299531569,1.65156990472226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.421434818762222,0.12975118200796,1.20091672180249,1.99710870550019,0.000254776567567231
2,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.665953964327536,0.0443520127910962,1.78442416339413,2.12325961281183,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.66052749197133,0.13996750355992,1.49837067835263,2.59358434322511,1.95249466776687e-08
2,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.30826987511641,0.0389094334892202,3.42922939976204,3.99425767222044,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30826061229024,0.163197424406497,2.75749026706036,5.2280747356602,9.38726014643718e-30
2,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",1.57715149820066,0.0179138080820621,4.67449765331016,5.01454425274235,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57940500888907,0.171608107839611,3.57207837823735,6.99950216199093,1.05219558538382e-46
2,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",0.24334808907144,0.0510762138021292,1.15383469795076,1.40960002535394,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.234364642763267,0.128800462499399,0.996354793011454,1.65076145351146,0.0526633500409264
2,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",0.637642649109407,0.202909275410404,1.27482345791123,2.8241217985723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.632007027777639,0.244077931947767,1.18725497192286,3.09074390620528,0.00649884520525009
2,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.405977270612462,0.038009536009994,1.39296912029845,1.61677297213747,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.398384134840587,0.129246778849595,1.17447683393485,1.94928154077192,0.000563914266984897
2,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",0.321495834735823,0.476503743111322,0.538634812958628,3.48735261497968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.313192602858907,0.497339630578762,0.524205914304637,3.68276865944726,0.527253001762275
2,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",0.548701896310544,0.1073837879908,1.40338023685708,2.13789242447779,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.542307573917786,0.168239017853208,1.25813476322999,2.43297578032778,0.000419974078998561
2,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.31118978962316,0.0945593780274611,3.08951611410618,4.47577907675859,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31120194262243,0.185295442635812,2.64860087467463,5.47600771818669,1.21106920408179e-19
2,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.413469975238286,0.0517626850774299,1.36599347429261,1.67328369606384,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.405923225574666,0.134289254629966,1.17180582404866,1.98367305302328,0.000784134338021382
2,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",0.865359395705078,0.019616582323269,2.28639572138345,2.46914576468558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.861645979318151,0.141451429852414,1.83062679965181,3.18718422153972,6.15656321944733e-15
2,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.44250994643091,0.0418117483628941,3.899022057994,4.59341983698353,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44362766052869,0.169769566576133,3.12308834529206,6.07575850862484,2.86144054295057e-35
2,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",1.19900353313833,0.0418510643603765,3.05664747033423,3.60157725229365,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19807593654246,0.15937840655524,2.48456749159094,4.64063156570615,8.58927733874537e-25
2,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.446780354814509,0.0360321404020054,1.4566679946134,1.67765171519082,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.439530172415687,0.130004125501906,1.22243239554364,2.03490563806799,0.000129317498286649
2,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",0.473161921836468,0.226509464544711,1.02944570529235,2.50157689871581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.466149061463319,0.261601909180136,0.970352384625721,2.70571079945943,0.0662795303447882
2,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",0.640930761038656,0.0735957316817736,1.64364387859672,2.19329640814377,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.635311165462645,0.151292649945911,1.42864260358126,2.58514359371552,1.42581966832435e-06
2,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",1.45951280031219,0.0188555067929128,4.14805316265246,4.46625984734487,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46078134891322,0.16624452415705,3.19992865821177,6.13981784756093,4.36535922565703e-40
2,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.430241321583626,0.0525506099214893,1.38712805467256,1.70442884717492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.422837568444218,0.135129694428614,1.19000766909858,2.02113335391192,0.000485171045669907
2,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",1.16041772432464,0.0777831031912417,2.74370620835505,3.72182373288431,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15915584707364,0.171255720282172,2.33359245181511,4.56637189160259,5.23874615414825e-18
2,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.266366832480115,0.114347558618075,1.04286248583487,1.63264845575992,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.257601478074704,0.165823703332475,0.948581581566588,1.81707758946419,0.106047333151919
2,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",0.0400364550637302,0.0671053897403908,0.912227143517978,1.18670675161486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0293651474816423,0.130602271764953,0.807574406887318,1.34747357677789,0.829077574313354
2,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",1.4292114737186,0.0582505965530426,3.72784505164299,4.68407508262743,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43023826395164,0.174113874544465,3.05474073343601,6.04486148211361,5.04404677560778e-31
2,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.575293701153559,0.0205370679900251,1.70759792786248,1.85075097589593,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.569125319244634,0.130935277626897,1.39066696584437,2.32342019139719,2.76016415594187e-07
2,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",0.768070403444361,0.0475089742411646,1.96416527957484,2.36623271302152,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.763513045281095,0.144598066588515,1.64763185220262,2.90418564242245,1.31399162502491e-10
2,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",0.0717558058339538,0.125041272905419,0.83925215854469,1.37013422818571,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0613312195534796,0.169342323975567,0.773057755027602,1.50141529662426,0.720152628942821
2,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.404239439215019,0.145893927103507,0.498837827830006,0.883750456688502,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.418618902387292,0.177525524089053,0.4693297572994,0.941235049885935,0.0214311767823949
2,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.45218275552512,0.0484856037471464,1.42925554274305,1.72843052101866,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.444955029067199,0.134265022221925,1.21892159672109,2.06323625284781,0.000194592371697312
2,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",1.05716994574494,0.0984048078123857,2.37684317933832,3.49562774004184,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05504784601368,0.1782699707314,2.07142908507883,4.16636599842051,7.74055799378715e-13
2,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.206473911294347,0.0620577947826826,1.08807550234873,1.38773459112993,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.197198604492202,0.132607288340715,0.952578784619483,1.60196108458275,0.118535955002082
2,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",1.35460213542682,0.180686283472415,2.7401029759055,5.56375209756624,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35498111605102,0.243739744338647,2.46950154163087,6.42025968509953,1.74673746479991e-10
2,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",0.763596539918688,0.066519534322924,1.88437105199102,2.44573548336558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.75900756661711,0.15195226949972,1.6166943378083,2.93299910099669,2.87272548617959e-09
2,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.64601353893825,0.04796254376059,4.7242945912918,5.701492448894,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64885589922146,0.1806632492474,3.76604971342179,7.64623641165422,9.39451244789849e-44
2,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.50737917377614,0.110606911521733,3.64739770517647,5.62704862553625,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50904099867882,0.201610005303051,3.13585624760402,6.91158480280795,3.34998900401406e-22
2,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",0.113963801250298,0.145503623185723,0.841059302164692,1.48775848460328,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.103918733245999,0.186140687201676,0.780796447742235,1.61966168747225,0.575584760098709
2,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.705929962683002,0.0349693931678271,1.89168564987864,2.16960649449801,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.70087812340619,0.138625465963231,1.56476729230804,2.69430142479535,8.7427727902322e-10
2,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",1.19443258554084,0.445295804551083,1.4382539455084,8.23964548063922,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19346780482919,0.477395274171437,1.32719278600533,8.62289704148693,0.00988798630565642
2,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.678742986564783,0.0355200366001781,1.83894751803671,2.11367764884403,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.67345875489616,0.137800667457152,1.52449239267508,2.61648074545909,4.06635273750288e-09
2,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",1.19580533962618,0.441343749249536,1.45459039886794,8.20513399125177,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1948522803153,0.473617786196369,1.33891063829567,8.5711673220118,0.00919935725855945
2,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.41339461240062,0.0310023941293281,3.86850998030147,4.3683989402605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41427011597935,0.166049197061705,3.05351045943017,5.85439575900652,6.10159072409062e-36
2,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",0.428075334899553,0.0226250667613987,1.46775378938653,1.60387380269451,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.420671069064317,0.126228344489076,1.20829452171011,1.98182056042823,0.000156694445610104
2,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.387801363327913,0.0780020477167445,1.2646023414333,1.71689963524618,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.380054668356331,0.14598146967511,1.11576812991642,1.97739420414244,0.00474584881093539
2,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",0.55119138612396,0.452001427404293,0.719969158397689,4.23450371161894,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.544818284785901,0.475624418582644,0.690968977311049,4.45823572137939,0.246431381504807
2,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",1.02726164933914,0.412319880550848,1.27778052642133,6.43266451939127,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02489730408487,0.443240801700924,1.1961157631893,6.79747662282013,0.0172638201393455
2,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.2581479154767,0.0652610426369454,3.09912047994209,4.00257114716517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25768799113792,0.169625015914529,2.58692824590231,5.02984420537912,4.10603553981505e-23
2,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",0.774629122595191,0.0661251429990009,1.90651257595636,2.47065054413154,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.770132878622013,0.152148859088245,1.63434098627971,2.96729933642979,1.58133271797712e-09
2,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.460358681678566,0.102165614039848,1.29688323577646,1.93565490777174,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.453221741188272,0.162459032010126,1.16307617534014,2.1987655160416,0.00254280074148958
2,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.533245355193977,0.0606151244271078,1.5136464700893,1.91962248081833,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.526717435102629,0.141771622978234,1.30441426965458,2.27388234471481,2.47400670753395e-05
2,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",0.319033546098816,0.0627558645109116,1.21651409114421,1.55579696969827,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.31070509279528,0.136190896303367,1.06056373573713,1.80879177810688,0.0138705401625234
2,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",0.832917028646624,0.0570068826855927,2.05752565289591,2.5727284651944,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.828910030605884,0.150356962383418,1.74046497121384,3.1378591391124,1.59141107528900e-11
2,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.708878879858603,0.0339538427776958,1.90105369239015,2.17168839093004,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.703848125142831,0.138470460253105,1.56994754363395,2.70157905471751,6.66597653553011e-10
2,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.47697168428241,0.0833818876165849,3.72606937775142,5.16654860985254,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47837511957427,0.186329195722774,3.13200526264999,6.50174423130203,5.25782631962984e-27
2,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",0.926241348759641,0.0554837544787224,2.26589255185575,2.81640448171289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.923019495872078,0.153144989613835,1.90379631510181,3.47004402568629,4.35688259325582e-14
2,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.527128024951107,0.0701880963774291,1.47646272755447,1.94406561917191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.520551495888563,0.146044366120291,1.28551578843163,2.27878732180396,6.16919355270559e-05
2,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",-0.0602388820858171,0.0993800292829748,0.774176211708165,1.14294331311309,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.071749300645318,0.147946979680279,0.70503407067121,1.25914428763167,0.618524445353905
2,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.183090078493507,0.0219922429844647,1.15025890143781,1.25382020796056,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.173631866887163,0.118154833639995,0.956934388318389,1.52065017093355,0.120509616256243
2,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.349667886220206,0.117083277588982,1.12681147179396,1.78309381230392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.341630104554187,0.16975031141114,1.02448830075083,1.99292271572766,0.0340194247728092
2,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",0.0340890578960928,0.0583979840972051,0.922421957637629,1.15970235976817,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0233606231493367,0.126081716683175,0.809849660390752,1.32753600293059,0.861062902878838
2,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.747417737391586,0.0954269272349545,1.75238719966709,2.54732974971572,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.742693084403934,0.166532408185437,1.54547922027227,2.96871465128182,3.21232188633006e-07
2,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.619143406641925,0.0565463634858684,1.66279485474775,2.07540747072777,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.613336236637041,0.142842538551816,1.42061747811593,2.48686798872403,5.98446037478271e-07
2,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",0.895169985303849,0.0534483386832564,2.20460010829773,2.71844431419687,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.891686547494577,0.15125859949326,1.85124096556611,3.34939261728369,1.99774374798175e-13
2,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.4121409029271,0.0299297045352739,3.87174636020013,4.35370822308744,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41300628874977,0.165789765316742,3.05114474581392,5.84391404043083,4.64989104361129e-36
2,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.494343681721495,0.0428561521413941,1.50731350092042,1.78304389508012,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.487513953268759,0.13365713949693,1.27388038642294,2.15113158850255,3.1691314778626e-05
2,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",1.71367245133596,0.370394203441098,2.80688786555175,11.9890645413166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.71706865920914,0.416469202172344,2.54498642956109,13.0221869560268,1.0322884204688e-05
2,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",-0.128516262861853,0.126989629036384,0.684145555400571,1.12547550215309,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.140599270318413,0.166879690176086,0.633865326437843,1.2192520524968,0.396175904815215
2,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",0.790379494086681,0.0399699987566253,2.03838441928513,2.38413663003311,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.78600331923628,0.143034701429778,1.69072487450582,2.96193592564005,1.20988252425077e-11
2,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.47976356708805,0.0353309752266638,4.09934353055685,4.70827559065784,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48119503282355,0.169911528702824,3.243591638294,6.31370204729544,2.0269913881876e-38
2,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.4016597313881,0.030790671821334,3.82495030939175,4.31562730553315,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40243685751801,0.165486399755189,3.02038102326156,5.7781164563593,2.09615214990178e-35
2,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",2.01230362733995,0.402104439072662,3.61789978963786,17.4984818559643,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.01820870946015,0.452869940345245,3.2225906100995,19.0183274886976,1.55455438982397e-06
2,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.732050102943087,0.0493367117857249,1.88803717002881,2.29087562041526,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.727189832203752,0.14395688086272,1.59025743632473,2.79601871097325,1.19930917722101e-09
2,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",-0.0592015515255177,0.0880957894900544,0.792143904862249,1.11886742228459,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0707040932645442,0.140459947383423,0.716205970375698,1.24210235433849,0.605136216183863
2,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.57789540561153,0.0502424020658743,4.39360424806053,5.3499996771253,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58016033381021,0.178157373481082,3.52923197307884,7.0953833993382,1.03996096766978e-39
2,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.20573007041984,0.0579593809814403,0.72619909127583,0.911435479111906,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.218464116954672,0.119625254511101,0.642960186290615,1.02762457984282,0.0738014304867399
2,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",0.174808555977385,0.246656652389414,0.730326913251575,1.92055324265414,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.165302529908297,0.275207452699464,0.697612610247657,2.05176841181818,0.546799748884876
2,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",0.588427891288158,0.131201725753939,1.39366309504584,2.33085910759888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.582371359320143,0.185751486321424,1.26588527792024,2.62191285415869,0.000688806158467991
2,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.395894648667704,0.0471767933831466,1.35438237688134,1.62950318172809,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.38818638959046,0.13198901406827,1.15623185602831,1.93973961597062,0.00110056580189034
2,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.49452134099007,0.0706199008055693,1.42761761514092,1.8829354635656,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.487670793408146,0.145260318977186,1.24547429390671,2.20103213691079,0.000180087955388352
2,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.41928314476067,0.0436148869332515,3.79730001133156,4.50531362628789,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42020557214629,0.169213368084169,3.05302099154413,5.92651175935851,8.12718144805986e-34
2,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",0.834845494661036,0.12354112873479,1.81204916498852,2.94094414075268,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.830838133436353,0.187017492378453,1.62305612834186,3.37841265368663,5.17301954931668e-07
2,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.240480103453302,0.0921616327464903,1.06157168607333,1.5235109313378,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.231494093353411,0.150336225925084,0.952412249143518,1.71695070863486,0.107717316862782
2,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.374973013118101,0.0895363429882426,1.22101892852123,1.73440031279624,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.367116699359338,0.152267524058106,1.08783018668853,1.97597665340793,0.00962111151861
2,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",-0.609620009526019,0.419295510539003,0.234925900297384,1.21546055991712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.64692444019862,0.495031569599783,0.198765252185424,1.38383316916015,0.183592352307413
2,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",0.206569100890952,0.49560444750336,0.482625224432587,3.36766247465967,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.194678991710718,0.565652697652506,0.401574392280145,3.68752445472347,0.736351442328697
2,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",0.447161816078741,0.74724617255025,0.404033463922788,7.56016940953112,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.442806628059358,0.807938524023562,0.320096285051617,7.59832159360855,0.58704582843427
2,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",-0.476486764687155,0.171957097106281,0.442548833864822,0.868363366276662,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.509665024593038,0.299404294130709,0.334566948725458,1.08190674906523,0.0777671772382469
2,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",0.0771490380863242,0.0982063206734428,0.891550900329856,1.3101857944666,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0612493100413253,0.262531247420825,0.636522249317894,1.78134317715791,0.826464445919381
2,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",0.709220614715472,0.62373491346762,0.655236505312092,7.55520629331312,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.713045693176793,0.687691386105899,0.530880703610217,7.86547360811773,0.300965484575915
2,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",0.676808101214364,0.232628080936561,1.26428279202148,3.14681339265234,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.679642532469532,0.341652159387015,1.01166283582294,3.86069494349939,0.0435484707314919
2,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",-0.756653738491163,0.281008417345853,0.267440628131125,0.804668463087979,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.79857589022022,0.376742372530595,0.215366742889328,0.943074534273627,0.0303270194796945
2,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",0.150014294268599,0.239513807203188,0.730775925534817,1.86867285219401,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.136388773176892,0.346021586763217,0.582618840524547,2.26179240742218,0.699886449199987
2,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",0.0981360697322276,0.230386730963668,0.704712345599564,1.73869322429723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0828915362122176,0.339298866260231,0.55958996344838,2.11589130420718,0.816280371567162
2,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",-0.096128756329406,0.111330473368151,0.730526609502641,1.13022622786364,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.117437417899717,0.26776868749643,0.526922902982365,1.50521076572571,0.634552493487069
2,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.146760156268663,0.070537369287104,1.00895924576831,1.33032165196156,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.133032969062052,0.253014700173499,0.696770449360576,1.87854987550263,0.600827511087007
2,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",0.577640433447767,0.243653686830038,1.12131602611288,2.91423666377911,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.577360689890636,0.34960873603,0.899185150938619,3.5401700013888,0.0947619556567596
2,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",0.0758706427100219,0.234419539362025,0.685097780967477,1.71723253524933,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0599312191587784,0.342195317998524,0.543791140815684,2.07963200989056,0.871488754978201
2,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",-0.401419454774458,0.199507800139102,0.451560680687834,0.98709468566257,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.432254992345012,0.317157099023193,0.34913413209411,1.21037942530257,0.158069329715655
2,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",0.0431791034300271,0.0930647604909942,0.870387092937013,1.2535630364536,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.026219207979077,0.260476290194965,0.617087967853544,1.71310001495598,0.934931518489115
2,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",0.521975131719701,0.0840372833593157,1.43136770390888,1.98983261267246,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.519931802256661,0.2579845389213,1.01603922621979,2.7932136158026,0.0380212225695398
2,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",0.210786755286608,0.133249171219629,0.952950132733169,1.60662298265467,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.199086453808953,0.278678686699785,0.707823860279101,2.11032165125691,0.473654330922082
2,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",0.14292117469495,0.152802318715708,0.856687926040097,1.55938655382107,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.129075022095911,0.289052863366363,0.646699492948434,2.0081077265338,0.660231450519355
2,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",0.0214423093857707,0.16775952534591,0.736630080258531,1.42181726330265,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00380500073445125,0.297568488618447,0.561110881186826,1.8014831492644,0.994765372659828
2,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",-0.124959317158673,0.185825497287622,0.613758094626126,1.27159008533694,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.147180427334335,0.308570370662253,0.472189901805707,1.58280657794376,0.611644013822625
2,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",0.185549181424818,0.195025071500844,0.825017300060099,1.77204333863098,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.173032861885854,0.314962387504898,0.642294210799326,2.20763336020461,0.585982169340576
2,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",-0.583027902071291,0.194094884729623,0.380318499824977,0.813907746794709,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.619531219334985,0.313327871985075,0.29168261698155,0.996141157434786,0.0414149835213459
2,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",0.131367364675859,0.0823194444494992,0.971024816254468,1.34082224184856,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.117159765791327,0.256746365619953,0.680800844204521,1.86254121120447,0.652165475962744
2,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",0.683722368933655,0.0740881451844546,1.71576940698037,2.29396510301587,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.686740469996715,0.254993431544561,1.20752571692458,3.28093777393866,0.00534116873600923
2,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",1.30212859611404,0.0683909623847348,3.22174403230058,4.21230702336825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32445967159836,0.254344918786075,2.28773151053919,6.20015617210196,5.52601921204065e-08
2,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",1.47265447133323,0.13435274322326,3.37697663033364,5.71808464485614,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50029448869573,0.281180428220751,2.58784770972365,7.79150124017057,3.25913382805892e-08
2,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",0.681766556254726,0.310830093338075,1.10390751636472,3.73328203698342,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.684717019653772,0.40240107203541,0.90270842537151,4.37115616979034,0.0862521612239125
2,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",0.612158689679321,0.180327489710413,1.30502720378074,2.64612063702144,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.612956267802541,0.306109885513524,1.01469569399252,3.36866815663662,0.0412402108291666
2,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",1.15017545768297,0.0765934609473907,2.72418169152802,3.67814642396344,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16776419485521,0.256563074995665,1.94741802826639,5.32393760363828,2.16579175325202e-06
2,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",0.464432772849163,0.224548890103139,1.03488419558853,2.49553967115597,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.460619929733651,0.335587996117071,0.822394014706336,3.06468597782221,0.16539778023846
2,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",-0.0672092388614728,0.181761110817331,0.655716906412055,1.33704818043871,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0876193861764551,0.306065203575568,0.503631565653656,1.67170364492281,0.754516826245802
2,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",0.181208214556897,0.172463721896714,0.857625346662113,1.68616620357705,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.168556613796188,0.300645453558396,0.657636621570446,2.13700598101965,0.577706297904282
2,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.440212131089224,0.0771860724922704,1.336419558594,1.80860876402545,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.43566453532324,0.25556106231313,0.938328347385281,2.55518752242291,0.0798942448759019
2,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",0.685815894318214,0.716184361336061,0.558367891692673,9.25028053600718,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.688911016714218,0.777582069123658,0.434512436628824,9.15714994758109,0.377516016640711
2,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",0.90329167234481,0.0613400448494438,2.19066932568753,2.78613598066183,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.913174108793147,0.251741463727933,1.5240666417228,4.08855083875855,0.000163121274044156
2,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",1.29604343620068,0.189429038725037,2.55665696962822,5.37226023808557,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31818479365854,0.312840904333786,2.02717320534708,6.90990661834224,1.52555097146188e-05
2,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",0.855946495241251,0.699916838147469,0.691016730872221,10.7406149668752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.864352233669291,0.761762687266977,0.534150085812646,10.5801165631656,0.257433473025257
2,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",0.454728620513901,0.152861407527162,1.1730647308512,2.1357662015923,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.450613091138985,0.289549144692202,0.891093893898317,2.7723804350601,0.11294151565263
2,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",0.604434304883671,0.0877074000291881,1.54381105105276,2.17724596279838,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.604973827183633,0.259416537082385,1.1031170419336,3.049671824646,0.0161907035358584
2,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.01078323716313,0.128797943458705,2.14678339012163,3.55675739315654,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02402873239126,0.277681907334082,1.61828644507237,4.80597970540441,0.000141049538747812
2,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",0.629634243325583,0.138967998882469,1.43587627238727,2.47569174834501,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.630970888431921,0.282269041559674,1.08259713871537,3.27342626301223,0.0219468342406168
2,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",1.1680758894612,0.0811528556475149,2.7495012134594,3.77927754962574,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18622327879432,0.25807940519654,1.97781805559667,5.43928122084654,1.73335827130236e-06
2,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",1.04836505618852,0.229033691987033,1.85486552647326,4.55218699645964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06277658506302,0.339538300407393,1.49020620047121,5.63997808746552,0.00141621863373005
2,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",0.850924088126411,0.1741242737555,1.67947187160431,3.3235516746556,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.859158949765756,0.30260551907042,1.30692819529808,4.27965043576695,0.00364502024378736
2,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",1.92690696572739,0.205346136489684,4.68908648560718,10.4874557037582,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.96873639567527,0.324194185002142,3.799825349133,13.5416884165355,4.20903534556862e-10
2,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",0.418266765068487,0.21878769110494,0.998869034946985,2.35490499440512,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.413013135688466,0.331459116589065,0.790527085571693,2.89863664098776,0.208404196456965
2,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",-0.105089290198744,0.155922004629915,0.663974686289856,1.22347084404068,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.126690202017765,0.290456539575806,0.499383540711148,1.5592233636444,0.63931153372532
2,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",0.368310980055714,0.100694131662013,1.18840276374801,1.76354137667113,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.361523212840389,0.264001744503562,0.856974816202732,2.41215629419724,0.161932120341482
2,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",0.846425128780074,0.211771933405039,1.5598204442384,3.57763311109797,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.854523369326944,0.327132462590533,1.2398221933482,4.46962121909205,0.00775156881313842
2,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",1.49512114095753,0.197229789407195,3.08078230111957,6.6746056670077,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52347542074941,0.318201497409029,2.4631133672822,8.57416057134034,8.80750416722722e-07
2,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",0.901250059501794,0.152303109867836,1.8400045121278,3.34272132767626,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.911062847172433,0.289894218115021,1.41127140405427,4.39670526387104,0.0012408144738969
2,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",0.283371645286463,0.493679757369135,0.523593388593722,3.62606927355997,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.273883641628027,0.563933401287089,0.43612915878292,3.97792954312474,0.631714134897776
2,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",0.306605905540085,0.214607349480571,0.898504222879328,2.08385903229555,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.297867482600733,0.328386527151448,0.708810338526387,2.56788920033399,0.362428257160977
2,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",0.920422773958076,0.445508833947968,1.11571851516259,6.39720479545907,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.930840709306253,0.52005091245346,0.916826637379427,7.0408242083114,0.0723091969595679
2,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",1.77065985683164,0.412094709203531,2.83442299229148,14.2566000789917,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.80761021785866,0.490627504366161,2.33408790648466,15.9721355096703,0.000198554212127712
2,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",1.55793095675343,0.0572811184902556,4.25141824628764,5.32168770458465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58821744894777,0.251850148080372,2.99291140506618,8.03238156317766,3.99952201018449e-11
2,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",0.810245110391156,0.119572548527107,1.78587523742186,2.85372283982382,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.817222595088417,0.272927748219601,1.3282962398838,3.87193434207977,0.00202641658514834
2,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",0.671035548451673,0.457176351655752,0.845111655472734,5.07238866613385,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.673664179967395,0.530508456706903,0.69453302611576,5.55689430055882,0.20372600042905
2,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",0.673663523935062,0.1473790954215,1.47741331270634,2.63269552342578,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.676380631547884,0.286834210225188,1.12276505416675,3.45617983211897,0.0156721085919736
2,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.384522275176406,0.091670557776295,1.22898765077522,1.76038540591792,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.378237187447588,0.260508788027335,0.877408267674669,2.43608639954063,0.137369664457584
2,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",1.0247138147005,0.434901118502538,1.27199920031734,6.99622623528529,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.03838692978174,0.510501059042109,1.04021678305234,7.69489033908677,0.0408779062557837
2,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",1.39516900678153,0.145555232540696,3.0604230587828,5.41470926314238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42040409740727,0.286933161475768,2.36228680567214,7.27459004490459,3.11922334373857e-07
2,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",0.196163469792309,0.160806676041708,0.890598380242058,1.67278329395626,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.183978709754396,0.293714797831978,0.676989996026147,2.14093375473631,0.532148645359312
2,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",1.95027949271396,0.406535894987929,3.43894965915314,16.9244194743396,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.99283889425112,0.485832846875645,2.83559408914418,19.0426506644868,3.37846419113131e-05
2,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",0.983969193493351,0.140579673755261,2.04451766011944,3.54743246914777,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.996370685525387,0.28365332029566,1.55583714505327,4.72994862756962,0.000296162399926356
2,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",0.568805023600377,0.0646054784750015,1.55752201782949,2.00640573590692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.568222101554237,0.252040771993859,1.07880511451322,2.89746357417961,0.0198915050499927
2,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.349835240131446,0.0868760075081016,1.19804611687794,1.68411412803355,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.342459783437496,0.258698383718818,0.849585997778118,2.3421584536779,0.176109753599204
2,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",0.737486408392981,0.208639281875125,1.40545114231065,3.18422619131873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.74222211500965,0.324840738219624,1.11306626844717,3.97677387390231,0.0199975901317791
2,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",1.48317491384103,0.110869897735825,3.56447813045214,5.50479576316776,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51113758050283,0.27008525008692,2.67357225990008,7.70700942027193,6.03244228894534e-09
2,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",-0.124351589923691,0.172459020098211,0.630359302779689,1.23931850538892,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.146555534855955,0.300205737813259,0.480295903600625,1.5580452161553,0.602730990752355
2,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",0.0129866845722949,0.356375866964089,0.508279013269231,2.05493246766199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00491555612392113,0.44007852951034,0.420684372191055,2.36127965831984,0.980511445155201
2,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",1.29694799033602,0.194228300772378,2.53772214695462,5.43374093323913,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3191175575023,0.315956072567309,2.01671545301769,6.95871771149418,1.84596651419122e-05
2,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",1.03890947517974,0.221279781914628,1.86249770825792,4.43407598047892,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05302595620496,0.334011302324525,1.4918133099113,5.52505174249797,0.00129634350756644
2,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",1.30554836479558,0.222944041166279,2.4317778378273,5.8272616655631,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32798625140578,0.335520843318612,1.95814259951239,7.29518038266305,5.2025525096831e-05
2,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",0.924303925151055,0.194171550742069,1.74313283948432,3.73154541907673,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.934840774164158,0.315412120878955,1.37472067501316,4.73339810242792,0.00244476049650934
2,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",0.591516617424783,0.20718133571717,1.21551551212464,2.73820936179353,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.5916699556861,0.323653877388655,0.95974801249363,3.41308089039184,0.0633250127996748
2,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",1.38385528497555,0.566093323903355,1.49915364612394,13.7900286090792,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4087265337322,0.632911979135866,1.18513294069119,14.1657109624499,0.0255353692965828
2,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",0.23732089242561,0.145186543195572,0.956628346737526,1.69008779287506,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.226420716502558,0.284993200659499,0.718521092280963,2.1959013506811,0.424412344357187
2,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",0.60572359116597,0.437568574029969,0.811870962125892,4.51237411647545,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.606309531862692,0.51256792743063,0.672529780001896,5.01543656180661,0.236601552240865
2,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",1.63634210760564,0.12354604888585,4.06035054228118,6.59004991503973,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6690967779975,0.276115721710755,3.094307943267,9.13321726660991,3.39286205885605e-10
2,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",1.48423897224985,0.657738471788274,1.45000694842271,19.1031984727577,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51224939747402,0.721065489130576,1.10583551541061,18.6738836261656,0.0356048946325523
2,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",0.711169613690313,0.0946785963244856,1.6954953898263,2.45741071642461,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.715049238419145,0.262184450132312,1.22480838599125,3.423038378023,0.00486650502568471
2,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",0.401719338313961,0.215430964179504,0.987235210087706,2.2970527818524,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.395949287636827,0.329092094146989,0.780764184122318,2.83639871262042,0.22464315180789
2,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",0.385142928048718,0.166172529781218,1.06649812397476,2.04575077050335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.378855704290262,0.297134020898945,0.817167618159622,2.61910568240251,0.196040777042838
2,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",0.977447151546829,0.412740149227562,1.25182105588605,6.31236867720351,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.989645086453416,0.490504566343433,1.03032935268644,7.04713449500665,0.0424237546807299
2,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",0.54139657433765,0.124716275969546,1.35021938251678,2.20151531583283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.539973094113852,0.274961475871678,1.00267565487449,2.94615597518148,0.0441570894922437
2,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",0.888110607888608,0.603629966625511,0.827126394411705,8.81441305075345,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.897520173186226,0.668455133195262,0.662964088840709,9.10898708360102,0.17948946995499
2,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",1.56604075436464,0.161309255200955,3.52996476003391,6.64329814687372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59660840182098,0.296001855440021,2.76786091220019,8.83199338054692,2.55983573879934e-08
2,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",-0.233825302677361,0.376340085350239,0.379122653648635,1.65753328545437,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.259437689224685,0.457179675771052,0.315398654957698,1.89305803402304,0.557716835864067
2,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",0.651524748004597,0.159643069025594,1.41165616173813,2.63940345931347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.653550917826496,0.293698770306339,1.08275618571294,3.42392597388637,0.0228574258869926
2,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",1.38439443640402,0.0874522651096366,3.37345320372159,4.75284549004226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40931480888045,0.260617827926068,2.4598607381943,6.83261760172832,1.76140076137403e-08
2,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",1.22890794336415,0.401767800567512,1.65287658465225,7.98382797963043,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24896203956402,0.480940310863245,1.3606300191888,8.96384458312848,0.00885483671445872
2,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",1.05522522270614,0.591884045165679,1.00790235843575,10.2575510423611,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06982868715522,0.657300591222138,0.805063335362521,10.5881626336721,0.103204289973015
2,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",-0.32092699438098,0.247354267013202,0.446149031668748,1.17645852827818,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.349231327622024,0.351273553492077,0.354814802381524,1.40608285054114,0.303490476556594
2,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",1.85251257811693,0.382336710897658,3.23225658644026,14.4676177523954,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.89201945280185,0.464377534067726,2.67374614457013,16.5073712481986,3.75021216068636e-05
2,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",1.26646453277167,0.215808995476101,2.36714661805384,5.51593396612161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28768268100976,0.33047436346424,1.89947056262202,6.93798160010297,6.73049664092078e-05
2,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",-0.0469145265391529,0.537076227033295,0.336180231531764,2.75989397576246,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0666863921415534,0.604397471892235,0.286585780175266,3.06325223699129,0.904056957428681
2,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",1.97749880500978,0.212924650347864,4.86842461209185,11.2168789022151,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.02090816469623,0.329420033890406,3.96254419450095,14.4138434683793,2.87482009389165e-10
2,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",1.0298035168954,0.131349390031923,2.17751278283281,3.64393247167291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04364702381683,0.278979353525001,1.64615251260488,4.91366316198342,0.000113088026388799
2,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.389677464512671,0.0615817402355437,1.30939809824709,1.66689656053182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.394762966568599,0.216153276399516,1.0786232445406,2.51680622856544,0.00157670050160915
2,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.29033348485208,0.0645529779194601,3.20735784056657,4.13088024734643,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26235277968353,NA,2.17678704794684,NA,6.64371049586258e-24
2,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",-0.743980203408215,1.38134868060284,0.0220855596350498,4.96273020544701,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.6972986084607,1.39189229426548,0.0366805600681842,8.59008964198126,0.598802675706084
2,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.318143772571993,0.0805705062511995,1.17489046638274,1.61124231244944,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.325860918997272,0.212252736900128,1.00401819220855,2.30717903368088,0.0159376453806578
2,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.39407058581916,0.0697214866702549,3.52342026514465,4.63082662892404,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36226346726204,NA,2.34598693071429,NA,1.489700885828e-26
2,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",-0.032049177383501,0.140083258027541,0.736253374326575,1.27498615565452,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0115006054183551,0.206369778132501,0.698951931188325,1.56953807792986,0.923556749378026
2,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.306212917441952,0.159499917985514,0.996874236133791,1.86283129191498,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.314359060062863,0.253731643121132,0.915592940859213,2.4754603128696,0.0997213101072209
2,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",0.0502815912424941,0.073372431049915,0.9110328281003,1.21462853495184,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0678229313618342,0.176617013154449,0.806895252277338,1.61246578624459,0.627234766888197
2,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.821508186435862,0.0499727517656113,2.06321708637391,2.50968198115255,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.810734929032404,0.308191774469838,1.53101296157728,5.12442918000557,9.86413426082139e-12
2,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",0.152209533002019,0.244222015859592,0.725107428001879,1.88871603581718,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.166009081762915,0.30209721433306,0.706542956836268,2.30903120191962,0.53427787396454
2,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.102921104560509,0.081473821691147,0.769072307379657,1.05844539837596,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0797566756204681,0.165401688203581,0.703058167603216,1.34453342249212,0.525249345353968
2,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",-0.332664550260935,0.242561309839307,0.443795333820192,1.14847052621572,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.301053630235722,0.269542463699167,0.454152358973233,1.30638593648076,0.234342440418011
2,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",-0.165293062395812,0.0898090246763091,0.710793322461229,1.01072847228625,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.139839166320055,0.164359402822495,0.66067007403413,1.25831852380244,0.295149984387461
2,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",-0.743980203408215,1.38134868060284,0.0220855596350498,4.96273020544701,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.6972986084607,1.39189229426548,0.0366805600681842,8.59008964198126,0.598802675706084
2,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",2.36081975852999,0.094858748196966,8.84517937751357,12.8290491917583,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.29354893135699,NA,4.55145808753535,NA,8.48142721184455e-59
2,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",-0.0754299395725862,0.0446120929272924,0.849725326655571,1.01210676467703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0532746531685607,0.15346317516767,0.740276484228845,1.35098378587703,0.615762282972154
2,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",0.732176959697045,0.219330453835497,1.36958181892409,3.23576388690926,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.72467002733795,0.369413145457485,1.22148158534885,5.19729063039152,0.00242895405743222
2,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",-0.0326593824707271,0.0671736484192455,0.848590962913044,1.10421852496338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0120740041191639,0.165573129731702,0.755889607803796,1.44654044736857,0.891541838857766
2,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.307345560684549,0.0982898381679492,1.12301446623168,1.65087531824901,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.315441173705898,0.218540974584376,0.980344593625096,2.30899816507425,0.0307943773873175
2,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",1.15831108259084,0.207556064444538,2.15297128390565,4.85715901779996,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13517804601768,NA,1.76569657614952,NA,6.62565275822673e-07
2,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.140549174992116,0.100483785564234,0.945964681134547,1.4026161282696,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.154771583471504,0.199166246087254,0.849889797974075,1.85534145368734,0.302296118860375
2,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",-0.284490858944606,0.149903483025886,0.560091399126391,1.00798728948392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.254661401279366,0.195422594786908,0.550654776476082,1.18458830103874,0.149832372625756
2,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.488081679329524,0.0527173903414902,1.47001540502945,1.80745766550795,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.489538488425511,0.230148139725951,1.17378759426806,2.89330633912838,4.98372083228932e-05
2,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.732346339522878,0.0581980773126404,1.85728960984717,2.33322282132362,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.724845715382,0.284194272222183,1.42271325297066,4.33441592454818,3.40357271281571e-09
2,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.43199546140159,0.105167663995673,3.42257625232645,5.16881381066676,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.398824338336,NA,2.37380264664006,NA,5.07334840933459e-21
2,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",0.0743131060426063,0.263078730099423,0.645582874376794,1.81058135285615,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0909453097242748,0.311701735273476,0.638386600865981,2.16633571235847,0.75529435350333
2,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",0.278246886759788,0.414348241009817,0.599132862050944,3.04026097824525,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.287420310732217,0.467887383344222,0.594243615037672,3.7196103678659,0.494784319457943
2,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",-0.179457140535185,0.0882074824226133,0.702975139968457,0.993355400486955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.153483334951186,0.162344631122622,0.653688975567243,1.23522809705157,0.248735415960708
2,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",-0.0940328927395929,0.174678443128236,0.646359732396528,1.28188012247877,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0711932058402812,0.226752235051945,0.630068780522158,1.53253946127896,0.702829640088509
2,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",0.791534968284971,0.0937857324310531,1.84071201683735,2.65856307136465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.781858752549029,0.312108758785246,1.46082586896408,4.96516133993345,3.51200147280833e-08
2,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.45138962735998,0.0870900431782961,3.61084662562044,5.08008992529915,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41751581912086,NA,2.4296052603465,NA,5.58761334829459e-25
2,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.284891062349306,0.0746307130736861,1.14950786998924,1.54015172018464,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.293820770888709,0.20531172186591,0.981115947551347,2.19403546825082,0.0261477712277333
2,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.573384967148281,0.0708744399694581,1.54543612074342,2.04036527631409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.571721083865631,0.251465951410326,1.24501624106851,3.33634865215113,9.33924151158115e-06
2,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.43808940799172,0.0843012508271991,3.581807143687,4.98444614403636,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4047066196642,NA,2.40893468901425,NA,4.09810227037431e-25
2,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.784009429313721,0.0401795550637462,2.02507854281645,2.37052025530236,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.774606419658254,0.294764073186036,1.49186001103838,4.73734856989648,2.05257918011346e-11
2,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",-0.165330048258151,0.136254084588015,0.648781847613795,1.1067717472702,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.139873815288399,0.193395451718128,0.624443903993001,1.3326940052045,0.393855664789381
2,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-0.350555202731448,0.140915262124576,0.533461811739899,0.926825368971863,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.318295187900594,0.184806950520582,0.525674394995714,1.08475771226585,0.0623563582226961
2,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.172316676055176,0.133850789188058,0.647263726802215,1.09382857874082,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.146603693678315,0.191222008632782,0.6225974063858,1.31748064836922,0.367232360537433
2,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",0.36619978212682,0.118549943601999,1.14557439907288,1.82323684816607,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.372143036861247,0.236954006780072,1.01003570201464,2.55698368897849,0.0195845701777449
2,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.467907111455787,0.0675727833794279,1.3997441552222,1.8242517759178,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.470119571104125,0.230868334996531,1.14552530222813,2.83162444147907,0.000228405335790204
2,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.364873762726252,0.0406238290101141,1.33043236923645,1.56009460336094,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.370892151194368,0.206861479834415,1.06805215967735,2.40300173441042,0.00146429210149967
2,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.53251557488129,0.0595655321972458,4.12568485261155,5.21075431030838,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4956281041268,NA,2.60384700776299,NA,3.98653257978329e-34
2,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.486382001754389,0.0557283874098667,1.45901335545366,1.81522910394424,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.487903626252094,0.230627048427506,1.17044712813738,2.890493515526,6.3232343461744e-05
2,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",0.0333179107146142,0.220246321607032,0.672855948785457,1.59540193362937,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0514818894965237,0.272434606034419,0.659038803028699,1.91736369580928,0.84557137189515
2,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",0.834720100919648,0.189082756798044,1.6068585152759,3.37188463512293,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.823466961535616,0.377599543049314,1.38274847936317,6.0753292183767,0.000111631689318102
2,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.276131644824195,0.122999453217193,1.03764880037081,1.68052523045601,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.285381704309196,0.227385770204486,0.931593007935582,2.27158220194259,0.0805421090408736
2,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.310034516583797,0.129759942836991,1.05963221690844,1.76221494965078,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.318040416626736,0.2356026492115,0.951740900608152,2.39667646116363,0.0582671151901
2,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.821647692786206,0.0641334520379482,2.00785643431676,2.58174677603419,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.810872276361848,0.311652902138617,1.52199915033287,5.16384588755375,9.67823518750565e-11
2,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.3515735631252,0.105428045431023,3.1565785700244,4.77196921970706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32135508789131,NA,2.23539063616833,NA,7.02823216361134e-19
2,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",0.802752190045768,0.228768110826553,1.44599312592032,3.54504511376245,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.792663631326812,0.396469676261887,1.28112760822269,6.06099032637352,0.00133373393923112
2,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",2.03849951756662,0.204179026191982,5.25588657851258,11.7014852359223,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.98304123952976,NA,3.46023561135727,NA,1.21598878547805e-18
2,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",-0.163077074928073,0.109053145875551,0.685999225397097,1.05190383255731,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.137704523544516,0.175672935476714,0.647797649917073,1.28974993809277,0.343414874767754
2,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",0.513126555085611,0.118327906872182,1.32833186852402,2.11226491771554,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.513676180009836,0.259984693007474,1.1421050344485,3.16449773911418,0.00120581765703328
2,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.745922502568907,0.113892492647859,1.69204956668124,2.64425912705815,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.737926605630573,0.307812562803404,1.38713354316545,4.63595627072056,1.95424601731797e-06
2,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",0.140252626364543,0.127464244874102,0.897379261306997,1.47901150570337,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.15448627514281,0.21439630150262,0.825071678651982,1.91196793773277,0.361138610966266
2,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",0.630021119069719,0.150107597229804,1.40617494406207,2.53269557744956,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.626281658276069,0.299619115470666,1.2184884446131,3.94360966118323,0.00058007207588766
2,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.112638618030397,0.056654718512845,1.0018401671363,1.25097205334377,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.127896152396146,0.177300670905828,0.860616622168864,1.72443543815232,0.310577263482925
2,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.671558539909141,0.074254591625734,1.69443830012109,2.26692423489228,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.666292328177978,0.273718432279203,1.34430819043411,3.93077285796058,3.37708002337977e-07
2,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.3485867001941,0.136744931586061,2.96876672228792,5.07424072810631,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31847213039381,NA,2.18597129199297,NA,1.28220470769768e-14
2,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.0660015868248601,0.0604865049537174,0.949034653167603,1.20296913134917,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0829686628604546,0.173332518061232,0.825584774752745,1.62870897260442,0.526040136036216
2,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.34339464946304,0.0684500063766735,3.35718055112549,4.39040112129449,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31345394808617,NA,2.26093915946139,NA,4.9873438418136e-25
2,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.110513254876116,0.0451667124960733,1.02234872417782,1.22036855887321,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.125865034904709,0.173650021336881,0.864752282941958,1.70810297660912,0.300111695785377
2,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.380863877152105,0.0707948236625423,1.27492236496784,1.68269368934135,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.386271099524791,0.217809689344682,1.06471195363986,2.50052970070288,0.00286072582704094
2,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.32053414749758,0.0622383447671939,3.32067906729485,4.23820202566068,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29144764794502,NA,2.22798408374489,NA,2.3109652974389e-25
2,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.581640160684244,0.0924132702027623,1.49527062290685,2.14805025318292,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.579659229988619,0.260926225454222,1.23521600461637,3.43514063404539,4.07579167253519e-05
2,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",0.775196419284445,0.089656090760607,1.82507813956143,2.59365536899081,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.766127733029555,0.305782853521545,1.44598834205049,4.79435805551554,3.79031698596847e-08
2,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.600129163781932,0.0766670656546728,1.57020218392301,2.1206735820571,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.597488896650845,0.258809894502623,1.2675994977877,3.49607565071111,6.04051674125866e-06
2,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",-0.0497882114418175,0.225112086577341,0.612469628615901,1.48018523781013,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0286009702660528,0.270425361068768,0.606429064082067,1.75046316651036,0.889453788666548
2,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.818165090739912,0.0528390462297292,2.04497274611819,2.51559590916633,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.807515220633998,0.307747847177888,1.52533616968847,5.09655192777261,1.86792339201371e-11
2,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",0.0829741779234539,0.10685701611092,0.881845403479255,1.34062146768679,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0993130254859691,0.196436513989426,0.80379775307221,1.73604474900601,0.527930399666167
2,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.46484373256996,0.0493085996503933,3.93225140944496,4.77072506436441,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43046102799643,NA,2.48638408473968,NA,1.48173137480519e-33
2,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",0.0905565884883999,0.0599797312988237,0.97358193393715,1.23163546542692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.106622637562425,0.17589278029825,0.843047962048505,1.67993583785669,0.407533085620421
2,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",1.04336301717954,0.365818174935792,1.44965634641673,6.08184084918953,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02446124996698,NA,1.29317123799269,NA,0.00568383069903983
2,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",1.89132349648845,0.340039951627015,3.6005190651271,13.653694397097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.84128607459865,NA,2.72112694990445,NA,1.01900610296185e-07
2,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",1.11617006660534,0.219913836033147,2.01774243592263,4.77801733555844,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.0945850795967,NA,1.68262963240022,NA,4.62745582174966e-06
2,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",0.556648176884648,0.922626971476997,0.339115092570718,12.6191505801073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.555602375269407,NA,0.30385186990298,NA,0.538641368295846
2,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.45922236109393,0.0373549710713614,4.001080241117,4.63202056869894,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42504608403885,NA,2.4829246381172,NA,1.1775926553135e-35
2,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-0.587171904861392,0.151314672039537,0.41176920074746,0.745164958803755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.546227011173094,0.18114702573623,0.417350380227048,0.84895773421102,0.00237986985451859
2,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",0.0420987495904569,0.0759551050381318,0.898999542304488,1.21078121923442,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0599402971999343,0.17686019949501,0.799618234007203,1.59944768041928,0.674407638982803
2,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.685604948090723,0.0385768740552619,1.84108397970395,2.14164255809974,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.679805909875689,0.268212226021715,1.3816973933096,3.95383243374245,3.57162209384342e-09
2,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.40212600661623,0.0355093988705695,3.79244960907635,4.35884202267826,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37004559582922,NA,2.38277226868942,NA,2.2175850560245e-33
2,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.571628273436836,0.0970574985352814,1.46723259354793,2.14649534532779,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.570020333983085,0.260877049362053,1.22080863310254,3.39441928221167,7.72390633898801e-05
2,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",0.703336001589954,0.0917452857243575,1.69155986102573,2.42367748707658,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.696891327853924,0.28753318526888,1.3633883935261,4.20839963825745,7.24277827735448e-07
2,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.42417542939306,0.0537279561984802,3.74430957996187,4.62208989195363,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39128550990515,NA,2.41096352133516,NA,6.09963979295327e-31
2,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.303252211108059,0.0789847112944139,1.16104411539513,1.5823863863495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.311508069064149,0.209536826651967,0.992916408002916,2.25750555636897,0.0204515095400058
2,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.5370586156141,0.0824616170913161,3.96841039707233,5.4827632137852,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49999990823359,NA,2.59156313574579,NA,7.63591288503811e-29
2,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",-0.320889272774045,1.10486876994686,0.0826601120616414,6.28388160350911,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.289731358736008,1.13130334640669,0.0928645892092134,7.83040906720266,0.782859266924714
2,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.657001197167294,0.0538942237060205,1.7367769340329,2.14532816991173,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.652262339808726,0.264606532648855,1.34294966775289,3.78901839738352,6.78062372560235e-08
2,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",1.50515373284526,0.0996644294997084,3.72135193560467,5.50008975133966,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46927554808393,NA,2.51247990766338,NA,4.16606273630451e-24
2,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",1.90915068336003,0.194924466562533,4.69130278864911,10.0724119086504,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.85845879858676,NA,3.17483282529583,NA,1.18692558733463e-17
2,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",0.26282960012036,0.118829468118864,1.03201233386102,1.64429804705894,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.272567604283979,0.223377612804698,0.925267307193068,2.2209866845227,0.0893490910429099
2,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.493069802194959,0.0419669007917158,1.50853429042353,1.77827846002871,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.494332162726857,0.228593651646789,1.18398725775052,2.90071837842291,2.24118680053982e-05
2,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.430808744941034,0.0559192778054505,1.37952493246091,1.71761848415292,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.434386513265456,0.221135249123776,1.11884524612253,2.66214282332256,0.000378784676719788
2,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",0.401632209549244,0.404211567619594,0.694942955452635,3.38906717553087,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.406276490355476,0.472422811541363,0.678465575223005,4.32296649221792,0.320829355479571
2,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.32815087634318,0.0496046356139987,3.42834617132,4.16420165444951,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2987857510058,NA,2.24946568859981,NA,6.92376013351795e-28
2,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",1.01849987622055,0.104817532182716,2.26288775604854,3.41275178810501,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.0005078366604,0.419104151431246,1.73365705336832,8.96287607678609,1.70300833828702e-11
2,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",0.955614877213518,0.116731120247322,2.07745445959749,3.28287942201015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.939923899599595,0.38496129730597,1.63619499340192,7.39936345208815,2.05548369318966e-09
2,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.50516405303705,0.0464964089351208,4.11629263709217,4.93925982381629,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4693013249311,NA,2.56180901393732,NA,6.27092906022085e-36
2,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.596330239292632,0.116035433839675,1.45028380387146,2.28555711035607,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.5938252381821,0.274405122447078,1.22584159340777,3.59403647610237,0.000152992343280121
2,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.629672654411329,0.0677753347733351,1.64522617928039,2.14588552672689,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.625942202311821,0.262229844745128,1.30495767974162,3.64768497766303,8.81634318670072e-07
2,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.33679403242379,0.0193624469020412,3.66551084572465,3.95455115861899,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36316220041947,0.0510931642609,3.53949483249323,4.32436599069872,3.8152275579804e-160
2,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.647965977642623,0.0369801137464998,1.77841574956675,2.05583547362496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.659937302079655,0.0576134172245863,1.72951016253764,2.16772595474173,5.96780275476531e-28
2,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.38053758204351,0.0126080418011221,3.8801808327144,4.07676741693699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40783484691096,0.049073573130227,3.7159330154972,4.50412960823945,3.95591736702152e-187
2,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.33171646430614,0.0366502818358062,3.5267369548219,4.07161421108562,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35798738061413,0.060144021366642,3.45930846764984,4.37903743168425,2.81256837715458e-114
2,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.422707452488453,0.0385371606077165,1.41530183822901,1.64609483380134,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.429974329959809,0.0578460189610998,1.37352861102115,1.72311773171157,2.69410707346675e-12
2,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.505108237109061,0.0660060126065238,1.45692730528941,1.88715130781543,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.514098962974646,0.0798358030000955,1.4310651519258,1.95691572788918,4.77954455671135e-10
2,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.706013638230599,0.0175851994362159,1.95738041733491,2.09706714853496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.719199829746612,0.0473451992604152,1.87243004113278,2.25427146481188,7.38652938773232e-47
2,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",0.263508810069312,0.0694202793333615,1.13625850784762,1.49162085180963,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.267452267706732,0.0821967726604438,1.11304751025105,1.53619285911123,0.00193370933585866
2,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.359539845828589,0.0114091839458442,1.40100302316054,1.46508257265148,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.365484098979184,0.0436780665598684,1.32399057464889,1.57124015216693,4.44635943431696e-14
2,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.350611698713889,0.02017590667833,1.36492737608276,1.47726044793608,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.356364051628542,0.0468244722293599,1.3038958080995,1.56659600662613,4.17298492664826e-12
2,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",1.15012870711234,0.0596298173333562,2.81328869921859,3.55408889955621,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17259734279453,0.0763656441676277,2.78385915540912,3.75536684272785,1.34176021842667e-52
2,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.34566521512098,0.00992153396534198,3.76688885630616,3.91627568642712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37223000615014,0.0482361607432996,3.59179949174274,4.3393978910919,8.70916449611705e-183
2,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",0.000399282155579046,0.0158062157157152,0.969875215319387,1.0318686350188,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00116181396445648,0.0434982969405592,0.917868832825573,1.08850958634135,0.900874821822085
2,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.649278346148056,0.0134821581293748,1.86429772766479,1.96547415680469,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.661269527551755,0.0456498230450365,1.77290360515133,2.12031078690216,5.25560837865769e-42
2,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.38096574342445,0.0289119343958757,3.7607188787125,4.21202205527298,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40825561368132,0.0558020189533271,3.66877636049097,4.56581981289245,6.0689113634746e-144
2,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.359261434233767,0.0284639434566529,1.35464690510544,1.51454860156326,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.36519241022366,0.0511499939433604,1.30435496699354,1.59394636586586,4.47624071844906e-11
2,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.51978166604455,0.0645927342993103,4.03411337478912,5.19650045561044,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54999317672799,0.0816349110452824,4.0188563341646,5.53449508194675,6.42201815639975e-82
2,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",-0.0576101796829211,0.0211439457715668,0.905674450832767,0.983937776791674,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0603902180266057,0.045554745348339,0.861585537636498,1.03003252731613,0.201161446194291
2,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",-0.0209971531229053,0.0467786321518738,0.893366844658863,1.07316356203042,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0230172080069741,0.0624823758843859,0.865220657124877,1.10534301008208,0.674385683042586
2,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",-0.0214489731916367,0.0311444876521793,0.920786109738028,1.04034942421876,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0234728158211458,0.0513205847596156,0.883946938146292,1.08092240218871,0.613065225315522
2,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.806944723920266,0.0395811798604438,2.07449487659911,2.42267684964567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.822243837907533,0.0599767142881106,2.02495684904173,2.56165309685061,2.48680475392797e-40
2,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.36798000927586,0.0125035666063928,3.83255171005743,4.02507645064743,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39501120730937,0.0489787296401486,3.66926397660726,4.44590826789379,5.60953902750601e-184
2,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",-0.0281832233313431,0.0161899100974232,0.941833789842867,1.00354307944978,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0303479108445482,0.0435072877433471,0.891426125565773,1.05718818046634,0.473098645530383
2,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.50775937016478,0.0361769670053897,4.20954266675871,4.85090417966655,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53771218131343,0.0606071391442923,4.13681272100641,5.24618547871365,1.45807650740983e-147
2,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",0.29147586503807,0.184920976167832,0.933330002355785,1.92683828662494,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.295995729513204,0.193363509545529,0.921049039361045,1.96546533875314,0.134324226202664
2,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.396347420489323,0.0153739978714519,1.44229509200173,1.53188748124326,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.403043274747624,0.0450937644463677,1.37085694919128,1.63591186279641,3.99185650482492e-16
2,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.617040295023346,0.0191788530208937,1.78516329158649,1.92454507146671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.628365917568421,0.0475779187836019,1.70903727537508,2.05943614572308,2.78598110945742e-35
2,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",1.57997110994442,0.15121989281977,3.64248931618919,6.58924262066072,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.61143522556623,0.161822911793745,3.65203859886956,6.88689058940021,2.12922344780768e-23
2,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.101453073431284,0.034162575482044,1.03509997880351,1.18342509283971,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.102029198141911,0.0537220393805226,0.997405143364781,1.23119875903743,0.0941938763130421
2,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",0.940782956636146,0.069198993462415,2.23960793706847,2.93749122537321,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.958872360683762,0.0837796166762839,2.21570266125342,3.07707553529506,1.44463973671719e-29
2,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.688377864423786,0.010972547366737,1.94817319255272,2.03379540379936,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.701180351588044,0.0451360693458834,1.84696437419276,2.20444009878801,2.5193103180624e-48
2,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",-0.175819564630983,0.208245650039872,0.555586769015731,1.25681088119429,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.181073629744866,0.216273309229465,0.546462901108078,1.27568965163883,0.392614314441106
2,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.494417191205647,0.0312380956630608,1.54236247446183,1.74327652032128,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.50317894903876,0.0533387917869858,1.49097382176009,1.83769799721499,8.11828861474179e-19
2,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.649475524622161,0.0226523856784685,1.83155261847963,2.00162580479265,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.661481048129615,0.0492870602905926,1.76068268952943,2.13593256896795,7.70837987931017e-37
2,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",0.00625529586639405,0.020329789528381,0.966953091401443,1.04716448046825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00480333362331142,0.0454299534960469,0.919867564653368,1.09917134652947,0.997922664491077
2,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.756821669115327,0.029849771336097,2.01071596171556,2.26030511777472,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.771071829627078,0.0535781986089397,1.94819339069441,2.40349795158954,2.04861087996893e-43
2,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.351462107691013,0.0117689899425672,1.38875536756209,1.45432448281955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.357241875289567,0.0437406662431958,1.31295618530405,1.55852753210943,1.83097912250766e-13
2,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.0286515335661886,0.033648879050176,0.963369734019393,1.09920059197727,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0276968580358027,0.0531214541535245,0.927066406380392,1.14168152059993,0.693477619569854
2,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.644647502823608,0.0403453239738393,1.76095289504621,2.06267945524015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.656568055596417,0.059915210978891,1.71588427968065,2.17014041752952,7.66574589635187e-26
2,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.629301014672911,0.0111610866891415,1.83574172002132,1.91783944393935,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.640862278023708,0.0448819349583471,1.73975263734962,2.07441024255159,1.56351227364451e-40
2,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",0.0118938304919322,0.0260154273867546,0.961640995000412,1.06488255640335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0105414697492306,0.04837619990658,0.919843877893754,1.11191071214468,0.916123011786208
2,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",-0.0421462631934276,0.0376356304330521,0.890494306961215,1.03205338050216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0445771687136465,0.0556021300338926,0.858232762005976,1.06724057207091,0.410410591733636
2,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.29581813792161,0.0102008675024276,3.58176929660664,3.72789436587719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32134059727596,0.0480330179836485,3.41490969643644,4.12240619211438,3.78367465890357e-169
2,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",-0.0131727647634435,0.0168812523059076,0.954785179691667,1.02010379970068,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.015023542893652,0.0438459754529461,0.904596319429382,1.07423263076703,0.686267528683469
2,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.371611665898752,0.0340369352787112,1.35663920783026,1.55027572969098,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.377806105975795,0.0546350821684714,1.31190953413271,1.6252299641789,1.20758213066122e-10
2,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.692361023252547,0.0320070491902881,1.87729969358087,2.12824934592834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.705263333629191,0.0545992003443104,1.82044409376129,2.254899515942,4.70824873839188e-35
2,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.406392662681833,0.011488169407869,1.46798235755268,1.53560080547639,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.413325461102856,0.0439213826278561,1.38821458251992,1.64902978305411,1.28559267037798e-17
2,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",-0.0455987690990732,0.022198423774596,0.914727379696042,0.997889249208971,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0481276228157673,0.0461235465262745,0.871246530312568,1.04390728779351,0.303483534699947
2,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",0.00397992890056763,0.0126129625127283,0.979468372992255,1.02911228713323,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00248806690454914,0.0424052113117015,0.923192825701651,1.09014227961194,0.959279906103716
2,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",0.0482716466319065,0.0420698152338164,0.966361610325432,1.13961839869641,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0477059808074976,0.059110645184367,0.934789672046186,1.17853924853706,0.498473131890938
2,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.40287098810612,0.0158091660820169,3.94305732155834,4.19514198097388,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43060795347344,0.0501446951980009,3.79355460558355,4.61756293843788,1.15237887910467e-185
2,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.776572798384068,0.128447020231804,1.69612327974949,2.80624780524054,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.791209966213168,0.138382868841679,1.68347137432006,2.89593732919387,1.5705256142869e-08
2,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",-0.0695959734733871,0.0752658294503269,0.804636883318819,1.08076859496186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0726407371476089,0.0866637538552366,0.785226275888692,1.10288813850304,0.387304573147901
2,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",1.32430635785125,0.119304730668881,2.99055665833063,4.77371818050424,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35042450238032,0.130581361935882,2.99052809020729,4.98941926633483,5.43338296837752e-25
2,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",0.123256637557469,0.045557728289581,1.03456803037849,1.23684896850773,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.124258872045173,0.061979285316225,1.00351551304762,1.27949271387352,0.0691384571644634
2,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.748620430821105,0.0713669199482607,1.83969925611753,2.43356021960207,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.762700092928117,0.0851265536897827,1.81608773446016,2.53545865496943,1.69013707293877e-18
2,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.344600493013543,0.0192332938064436,1.35925151106274,1.46569174961283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.350225542692594,0.0463828653538033,1.29703712645673,1.55566019927871,6.78898701350572e-12
2,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.695331038275969,0.0267018608585735,1.90241282530119,2.1123315972224,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.708293241522681,0.0515534722487681,1.8369018802234,2.24828182131062,4.03491353854363e-39
2,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",0.0557094523503369,0.0242894356638,1.00813009264356,1.10883516087391,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0553190317774907,0.0476183796401791,0.963383968713935,1.16108787968483,0.337920464358006
2,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.31569498900226,0.0174383573442052,3.60243556333411,3.85729926675622,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34161315916925,0.0502593798968823,3.46968746889797,4.2252467956254,9.30905468223045e-160
2,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.32716333023507,0.0166300355809067,3.6497232706974,3.89556953250845,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35331719250826,0.0500319395796959,3.51210955090934,4.27309533699877,2.00408210127061e-164
2,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.509936865634952,0.0418290034242812,1.53445208166279,1.80785317056606,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.518999763101013,0.0604875734898489,1.4937282125542,1.89341500950617,3.37867821619873e-16
2,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",0.436628109955478,0.0756926873388922,1.33495814499604,1.79608594348025,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.444185547113048,0.0881814756382979,1.31276507187887,1.85484417035007,1.08777183569445e-06
2,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",-0.00355059011665898,0.0155059650386248,0.966619437807311,1.02719507127918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0052001512447192,0.0433675201274986,0.914407219538216,1.08384866349339,0.83587372304395
2,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.32319291718716,0.0333945646326771,3.51880774832365,4.01094354759346,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34928295958844,0.0580968279376491,3.44310904719224,4.32369446385186,8.41282153050884e-121
2,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.696163154284695,0.0144918022930217,1.94994048973427,2.0639170857007,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.709139505932191,0.046193788831331,1.85787140929271,2.22667124190687,1.63250740292719e-47
2,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.37267053537069,0.0132284452027065,3.84512687655603,4.04977430560543,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39981023025658,0.0492035608565622,3.68527150585178,4.46924109123508,1.05320790336307e-183
2,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.385859371527612,0.0425656843078989,1.35338397909493,1.59913446526227,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.392352943098363,0.0605851130554868,1.31570023672995,1.66838868687166,1.06735889852579e-09
2,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.32954027884353,0.0205806392113362,3.63040170640204,3.9354212504114,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35575980609993,0.0515508896884089,3.51023460844634,4.29631917188288,2.32107147187499e-155
2,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.45027833550197,0.0271269547762311,4.04418147788244,4.49791917703649,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47902961183155,0.0551866337459977,3.94265293224998,4.89483936312252,3.21398764970657e-164
2,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.360428459419931,0.0148100897119703,1.39294188785942,1.47620183521604,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.366367848311984,0.0447325190501173,1.32241854341918,1.5758747934947,1.20075374846691e-13
2,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.414008627085223,0.0307784414936191,1.42443426300661,1.60708824821765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.421088055036503,0.0527421819328889,1.37505451071492,1.69086279559719,1.0547253426688e-13
2,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.694626839598274,0.0291407165786167,1.89206072652097,2.12101781850565,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.707575748550214,0.0529092042767478,1.83071322430626,2.25264684559545,2.69000032930731e-37
2,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.376219956187365,0.0142569013043905,1.41664678179811,1.4980716044221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.382486651027379,0.0446176517292526,1.34421341782943,1.60112579460897,7.54545683188479e-15
2,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",-0.0313317261655057,0.0127372393293714,0.94535438998779,0.993753247362172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0335623228704454,0.0422878447869737,0.89070394241508,1.05129435408989,0.423597924580675
2,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.687604013930795,0.0211137857147099,1.9084755727583,2.07315025573963,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.700406653491367,0.0487416731282943,1.83254077767059,2.21835793830922,3.4786187017333e-42
2,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.46020917626647,0.0372519022321687,4.00568634809101,4.6354798079953,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48916778809397,0.0610763966072909,3.93712429934721,5.00213918967274,2.30324969283769e-135
2,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.386689780455168,0.0146629100654015,1.43042056653187,1.51504638366846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.393178973523134,0.0448023102365994,1.35817417176523,1.61892622592173,1.53086725795975e-15
2,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.419845271089451,0.0223601738440868,1.45655601086411,1.58998570132919,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.42704787545715,0.0481437393256418,1.39579896482336,1.68571022966508,3.014570312822e-16
2,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.72688277740799,0.0412435848191365,1.9086297616144,2.2435455828865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.740513700688714,0.0608369336052679,1.86286390313596,2.36455876070966,7.11494481820668e-32
2,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",0.788522141607013,0.167336893712444,1.59436025941842,3.07228361749395,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.803427040502398,0.176483286584678,1.58151839077109,3.1587840635839,6.44964230107382e-06
2,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.38593511340664,0.0100681622761757,3.92055624619928,4.07838066655426,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41334193200771,0.0484822735149223,3.74077151875257,4.52373915499344,1.47666906909077e-193
2,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.632829083946117,0.0140154788646777,1.83195246056973,1.9354154069709,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.644476969238569,0.045738363339096,1.74307277957929,2.0853581409327,1.00783764940517e-39
2,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.471226006593382,0.0431735052477559,1.47232412323465,1.74382193577319,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.47948290936472,0.0613325016024338,1.43346284428393,1.82305210058083,1.16026135400823e-13
2,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.381747817237679,0.0238308912170662,1.39806782918495,1.53496340194651,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.388154289964424,0.0487126082309932,1.34104830169457,1.62320329304383,2.4225515219002e-13
2,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.3223581533661,0.0123409905892321,3.66279776028375,3.84434433727621,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34843537151067,0.0486934781405412,3.50418884714617,4.24114802509431,2.66024698140956e-172
2,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.409972067071658,0.0186442551856259,1.45276017002002,1.5629099712985,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.41696403814585,0.046421301429168,1.38646495663036,1.66317008150865,1.93232652414835e-16
2,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.461141028442129,0.135801651569719,1.21812152308016,2.074339166929,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.469208856745206,0.145054296038608,1.20407163897883,2.12614660994727,0.00149299799374778
2,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.656522203441563,0.0108283667359336,1.88762124873198,1.96946878764186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.6686540700443,0.044929354542015,1.78862434919987,2.1330793456682,3.87388355750747e-44
2,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",0.176455451131227,0.144185047417001,0.900212961088773,1.58418658477909,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.178570144874011,0.152873589760787,0.886635500716662,1.6143495888221,0.260538491844066
2,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.403659214973139,0.0145265923941007,1.4552952968927,1.54056930863649,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.41050345152052,0.0448340936622642,1.38182692024638,1.64732522470606,7.58459939970776e-17
2,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.66938387001965,0.0137023302135519,1.90134517175486,2.00626296112461,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.68179726352934,0.0458140341519954,1.80909794982436,2.16499069740806,1.89439307773887e-44
2,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",0.0406863088407247,0.0474646295926621,0.948970258673797,1.14302711657711,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0399618892302328,0.0632036341268162,0.920166110950564,1.17886560372365,0.601427794423737
2,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.0408937855713641,0.0125319827118408,0.936634219158532,0.983794763021078,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0433244108541245,0.0421816967794226,0.882233240674761,1.04086323265169,0.315264441885757
2,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.3912701094753,0.0263445976906169,3.81870223835323,4.2341371386312,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41878704773871,0.0545083862874363,3.71703854019224,4.60248423058407,1.6799542461232e-153
2,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.672253884290217,0.0138377781256851,1.90630404943803,2.01256375292319,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.684727789444044,0.0458700923349868,1.81420899789143,2.171584350915,9.51546606319917e-45
2,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.35398086643015,0.0243248428029697,3.69326652755351,4.0627615857719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38071682024733,0.05334082924229,3.58635751832758,4.4203959654324,5.44378968036236e-151
2,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",-0.0120529889329836,0.0161418392508747,0.957241378378831,1.01976800141341,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0138803514655809,0.0435580731507927,0.906139613320485,1.07485161876791,0.701870107351423
2,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.31822505496123,0.0127437219399157,3.64480867317268,3.83150756531893,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34421582339935,0.0487810859838457,3.48883963571572,4.22402109991695,1.82764990232025e-170
2,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.618362626510379,0.0182568434150761,1.79075016595073,1.92360326991503,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.629715151475199,0.0472044938020996,1.71259811864067,2.06070838641658,6.50136290402605e-36
2,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.47601249929395,0.273747201248366,0.945339291595135,2.76449487637072,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.214769007443921,0.682886125704256,0.253344802592116,3.6834895930199,0.781273017755434
2,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",0.0625034503176833,0.303745233460316,0.583188273955266,1.91825176318654,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.283759165840414,0.764148400762859,0.123365083555946,2.46649848577031,0.643574266357113
2,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",0.819004398751792,0.255078911386177,1.38999502760799,3.77798624758225,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.628291992668313,0.62633522455288,0.445705294309394,5.19185807800666,0.358711710266832
2,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",37.2496928874711,NA,0.613889167145681,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",-0.646854189882295,0.499409140684847,0.184934369663109,1.30982505587494,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.13897601110326,1.04401362417293,0.0256515802688154,1.53619427086226,0.159374573477124
2,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.271286709559407,0.221430051556361,0.852434792061849,2.03059994599746,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0320486154283686,0.68223983052206,0.192894364054773,2.79747833528053,0.920522873087785
2,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",-0.102558718594132,0.422559636118347,0.387027487671332,2.02819001140057,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.482765834763334,0.878201743578625,0.0781304012090053,2.44271845322676,0.502940584159508
2,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",0.898569961310042,0.195646082569409,1.68995183889308,3.63867127962314,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.724214404119531,0.581612279837227,0.54039668712987,5.28264246602166,0.263617725496495
2,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.30950544445872,0.184939700721934,2.60960476489165,5.38786436256198,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21964758224583,0.528197735535642,1.02204999678675,8.10359254845313,0.0533811310075799
2,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",1.94877659257837,0.761902253766044,1.49750467914316,29.677884235187,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.99035107641309,1.02468507955596,0.863663218811672,47.9481070822167,0.0703937365593786
2,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",0.622673485599439,0.205445485432601,1.25527491171368,2.80859990919788,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.391586534790239,0.62270760206881,0.346844121159093,3.98321438350712,0.563826716283748
2,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",0.548311068252541,0.887834221625656,0.372337571238053,12.0889499807689,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.301932504143724,1.26499222607599,0.0866577815587852,12.3405420688775,0.823483572904505
2,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",1.16766918285365,0.347150235674684,1.60889914607355,6.27362353019101,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04864401740166,0.655916775044615,0.661254704085367,8.64974923179826,0.151757310622413
2,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",-0.133565668306929,0.236580292885867,0.546999561335156,1.38274468833737,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.520150297387071,0.758347543032569,0.0953173614473383,1.86288141351283,0.389434099647922
2,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",1.81310829349843,0.295856710080377,3.43706478468105,10.9611240938546,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.82680261902699,0.556716034345813,1.83602935412761,16.2792621004982,0.00783571197661612
2,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",2.27530087846718,0.259024507807665,5.91035526750643,16.3146480132801,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.3840283099055,0.492263633901128,3.73223720632757,25.7039795897709,0.000313926327087912
2,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.357793388397486,0.207373752773644,0.95443394752505,2.15168947140523,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0722410842713972,0.661748182242825,0.225681544714063,3.02035640842848,0.947512014233115
2,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",0.649097962295664,0.19487409515698,1.31296472945143,2.81843044002425,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.423444817664911,0.613660655559421,0.365662590915655,4.05301607457485,0.526616863955699
2,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.26060939111371,0.176237678774716,2.52118672038546,5.03074818557604,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16069463845831,0.528955543000633,0.958362302928553,7.62123356429976,0.0647192778265473
2,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.56557061521988,0.22894105752976,3.1113391891659,7.63303620203514,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52836410883801,0.528777561733278,1.4165779113994,11.2572683454961,0.0186366920142543
2,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",-2,NA,NA,6.74973718640703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",0.828664261282899,0.337074041910404,1.20532924867092,4.5179517097137,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.639938378786151,0.683681062773059,0.402775068631201,5.874397518243,0.386323294556709
2,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",1.60745418844668,0.301292179375004,2.76938394545063,9.02202250911291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5788600746875,0.578221022293159,1.3552121261793,13.0729178466767,0.0225980318491141
2,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",-0.117058119497621,0.42103377687873,0.382425843073435,1.99212430452396,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.500246638614869,0.879367230348209,0.076395079366789,2.39940120967718,0.487830522692708
2,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",31.7304809355109,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",-0.0629733368608734,0.423331799352822,0.407540813990719,2.1421627857069,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0456470055940121,0.467933800249118,0.458737421791613,2.87194497777842,0.923993490514849
2,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",32.7979395526756,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",31.7102266930873,NA,1.83303085611444,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",30.5511168960875,NA,0.45861380260742,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",-0.0116239239659126,1.64780672728851,0.0391143542522085,24.9785614507762,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0952738571986367,NA,0.048485833405264,NA,0.955602855448266
2,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",0.233765395580479,0.315802920975869,0.68135731972646,2.34962629188884,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.33244867840235,0.399503968434949,0.726729014326255,3.47927926163389,0.285736598945579
2,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",-0.233544294198586,0.864306203872622,0.145439988796213,4.30607293513269,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.119213723198423,0.903828635745468,0.172084679083418,5.94871092870788,0.880274260466684
2,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",0.340887464214295,0.387175528572935,0.667303381395887,3.04405251429745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.43597074012231,0.481688341525698,0.711414207391761,4.70056706558679,0.251212953499275
2,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",0.804717413417677,0.355547467418272,1.14550356633018,4.61616742031797,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.884260199614771,NA,1.13734676275903,NA,0.0106484852897043
2,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",1.5760576176849,0.323442306334117,2.67414800510043,9.50199113527619,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.62974050910013,NA,2.27127525579687,NA,2.07684223749842e-07
2,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",-0.629089051651707,0.407776786612265,0.230409292140041,1.1394635830447,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.501492944999073,0.421961662041738,0.276196041217772,1.44399698104538,0.197309954907533
2,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",1.59001568868213,0.64557910554612,1.38671264270048,17.4189646122517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64323116530937,NA,1.43036940832803,NA,0.00871503479547066
2,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",-0.0567442865247497,0.339389562487789,0.481930718404145,1.82289833357754,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0516818981736451,0.389756367247863,0.53492107726895,2.46497292339491,0.890750270296927
2,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",0.898628843416498,0.256174458705662,1.51175897290342,4.12662252250855,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.975010935479669,NA,1.41936305495857,NA,9.1780404887299e-05
2,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",-2,NA,NA,1.75273352936767,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",-0.355174747751067,0.521248157546753,0.246921126846942,1.90516556153317,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.236762021242414,0.543503613127973,0.290897271012167,2.44907381816661,0.629026707313965
2,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",-0.339246735483767,0.671450045079622,0.180903154351615,2.51492344017358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.221353078615633,0.693980214732603,0.223305114847763,3.39103857589249,0.725357536732005
2,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",0.995856271056115,0.271957744376919,1.61641251847259,4.69390081690747,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06898389162429,NA,1.50866340228204,NA,5.3027943139832e-05
2,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",-1.22566480136352,1.25348999648505,0.0148986599272723,2.02811438772419,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.07807570648277,1.24261324004372,0.0316568937922109,4.12949471159284,0.370603712803148
2,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",1.59001568868213,0.64557910554612,1.38671264270048,17.4189646122517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64323116530937,NA,1.43036940832803,NA,0.00871503479547066
2,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",-0.0793897555314824,0.311489178344843,0.500162625115194,1.69586537970905,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0297942646917829,0.362639593272017,0.5494619838398,2.27665074993417,0.93865751497906
2,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",2.29763773888353,0.566277055862297,3.37057581935113,31.0267230049877,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.32713390907737,NA,2.96145228100025,NA,2.23548650320956e-05
2,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",2.36155254898637,0.512932307659042,4.1071561272645,30.673176658863,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.38890749472697,NA,3.3411420468872,NA,1.54340021401411e-06
2,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",0.146792662353949,0.294498613998828,0.652535617303155,2.06994864646702,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.248404374930298,0.369821470263296,0.695257951819958,2.96299676345741,0.395646555170923
2,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",0.142195654632432,0.294476074371623,0.649571667609771,2.06036446917477,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.243961589900122,0.369264985100834,0.692388161560357,2.94433677964481,0.40435077446602
2,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",0.0563362348533797,0.414619735487699,0.469440233184525,2.38468063657044,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.160957492230154,0.47042504752268,0.521033000829698,3.2939597194803,0.700114648702523
2,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
2,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",-0.0504350981821005,0.476921156684777,0.343541133030196,2.22787485985955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.148284616949458,0.411606012465118,0.517732422306869,2.59911029195954,0.715523891511369
3,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",1.25276296849537,0.847943204841861,0.845802191258419,23.486047505497,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27279771270884,NA,0.851064793037362,NA,0.0815303810100351
3,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",1.0723989612851,0.74711842348488,0.772511082876191,14.4477902774017,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11716332403636,NA,0.863826669300693,NA,0.0826468954338952
3,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",-0.693147180559945,1.3810397825492,0.0232506762115225,5.21821509199614,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.40630262567252,NA,0.064444321289252,NA,0.734213265834101
3,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",0,1.08161097084541,0.120041405708988,8.33045892868214,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.191804709483494,NA,0.194476414853801,NA,0.835754017886216
3,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",-0.693147180559944,1.3810397825492,0.0232506762115225,5.21821509199613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.40630262567252,NA,0.0644443212892521,NA,0.734213265834101
3,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",2.0164565242711,0.663678157128752,2.45070985060827,33.0475782452982,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.93177073176305,NA,2.2463538987039,NA,0.000734968400539843
3,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",0.918146757382616,0.392016670849772,1.15740008265684,5.38088734174354,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.98407616211757,NA,1.37862564405728,NA,0.00356660949322932
3,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",0.928665398539816,0.767960151381141,0.633736605995,12.8613490706586,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.993139245191154,NA,0.736639259885367,NA,0.133286527092269
3,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",-0.835006046967413,0.679859447492496,0.0971209296215521,1.39542870495039,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.528710725969966,0.586642460100265,0.186652436199109,1.86095382555657,0.368993892101244
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",-0.213074944299674,0.557515366350059,0.250500811744771,2.22805043740687,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00794501683903728,0.481135410889424,0.392609610699924,2.5884950271958,0.984011092906321
3,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",0.789889137809766,0.354199524211544,1.06914290859374,4.28574298494553,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.873389268528119,NA,1.31568523738441,NA,0.00419412518056062
3,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",0.845521552700794,0.754510231695602,0.553334780011184,10.6529163287542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.921413829146395,NA,0.701416217581722,NA,0.156239584850728
3,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",-0.486394193458122,0.569522913616137,0.175995263867711,1.64081095433116,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.22789826283859,0.491438265629229,0.303889694326088,2.08613299697152,0.645307225284335
3,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",0.845521552700794,0.754510231695602,0.553334780011184,10.6529163287542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.921413829146395,NA,0.701416217581722,NA,0.156239584850728
3,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",-0.258066251377762,0.559471070808797,0.238935217329526,2.14153631862623,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0308771637448651,0.482801190363146,0.376412580535135,2.49796510166036,0.951799496004443
3,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",1.32273173840547,0.66373287541889,1.1148472713498,15.0368293456698,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33317463474057,NA,1.2344795074747,NA,0.0197678071131799
3,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",1.35858052949544,0.291919882043735,2.17680691216642,6.83573496632182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36410571346686,NA,2.38743639311041,NA,5.88922212876035e-08
3,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",-0.110006190528951,0.837541097944437,0.132469163065832,3.53140349601433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0968818266838182,NA,0.267244900401681,NA,0.891504116187046
3,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",-19.1237365199681,16.2072641114524,8.16226740256465e-28,3.1849840694104,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-16.3098094325506,NA,1.02958236056113e-19,NA,0.243569077216241
3,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",2.0328460402798,0.366707320639374,3.81803186151473,16.0739725648999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.9459077015674,NA,3.67896234312738,NA,7.50642909637849e-10
3,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",-0.726040372801467,0.591125590183718,0.135110266952822,1.3709524160565,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.434685716191188,0.510074726563335,0.238255187474475,1.75952383391265,0.395950079350944
3,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",-0.726040372801467,0.591125590183719,0.135110266952822,1.3709524160565,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.434685716191188,0.510074726563335,0.238255187474475,1.75952383391265,0.395950079350945
3,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",0.489738599358109,0.416402796546462,0.70797649468411,3.62163138494979,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.614393285893064,NA,0.914079357905489,NA,0.0864088261490281
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",0.27507148494577,0.899010825544536,0.230922997254975,7.83332219298649,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.429160175642175,NA,0.335789530624211,NA,0.578614489088338
3,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",1.00981432557539,0.476346807761773,1.06677106304876,6.90248549000701,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.0631599263859,NA,1.29378316000917,NA,0.00957865337574408
3,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",0.206615860769763,0.593407847428721,0.360526486550695,3.69110608422862,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.370090654409211,NA,0.53073295098451,NA,0.467787562542519
3,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",0.956615683825067,0.346244121853733,1.32803429724105,5.16007902521584,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01725550571125,NA,1.5398077544005,NA,0.000648453427175509
3,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",-1.75021950913576,NA,NA,4.47912619018111,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",1.53405651573929,0.637662106144893,1.46020775677644,17.7816717430346,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51552382005395,NA,1.54819507562394,NA,0.00582588903279459
3,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",0.60484157162764,0.510133746369277,0.659959396928431,4.87495354271566,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.71371426600488,NA,0.861536937885418,NA,0.104111597571178
3,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",0.141189438824405,0.143204452335413,0.868781238939645,1.52300782798945,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.128215922863564,0.238007918136288,0.738646179414409,1.87768125300689,0.617796227398601
3,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",-0.170420502522129,0.0764486121568487,0.725410909576953,0.978882210469092,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.216836007063039,0.179930757542771,0.582193012731719,1.17864132990588,0.219768118680124
3,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",0.452519414231745,0.130621870101205,1.21880472186351,2.03378576328892,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.472955400696151,0.244415342237103,1.03823394622592,2.70637926551746,0.0376083136384914
3,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",0.870468961652478,0.665025603860245,0.696362527812091,9.44010953868432,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.935755739408426,0.783501458384486,0.58609236286983,12.6415801722184,0.221830763133645
3,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.463239724706309,0.0216816469565648,1.52313555561489,1.65824791144541,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.484841120455493,0.197826482472565,1.15122069385601,2.49999420531716,0.00525429607304977
3,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",1.42320256754029,0.24523182527437,2.60867423036627,6.82186725452734,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54781829020779,0.390873605832929,2.38234579162975,11.0262854527181,1.49631743381407e-06
3,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",0.630003177840439,0.094538829892456,1.56132941528777,2.26171426729475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.669486490633413,0.233443776526225,1.29828698417966,3.2417991855667,0.000881225422800006
3,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.32790975020095,0.0570447201857906,1.24112209445591,1.55212829004574,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.33497494953293,0.198079084242095,0.986744515691801,2.14494008589177,0.0719161828764356
3,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.478750396072517,0.0840479798342719,0.524673312042178,0.729411345651006,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.558255335283669,0.170802677373765,0.419031937486276,0.818506495277463,0.00283087330823017
3,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.463566310378063,0.0443759473839366,1.45743498783921,1.73434279701991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.485190785821579,0.202567525449286,1.14100563935768,2.52429072423277,0.00678188522029378
3,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",1.21193412235091,0.0189843521806999,3.23751732530063,3.48763575147325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31385783686217,0.255255277907797,2.42717911097641,6.60159988502491,1.20550943716629e-14
3,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.669081265270338,0.0423884728009509,1.79710367542449,2.12195123627571,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.712756513077776,0.215998713580467,1.40457867097452,3.27538945034346,5.65430107442257e-05
3,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",0.140933260279351,0.0602625004232141,1.02278918794861,1.2953203696448,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.127932492027801,0.188427816642408,0.813662855343914,1.70303897449952,0.524091995351227
3,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.51365215060992,0.0719378911460934,1.45213947725403,1.92519896731828,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.540632269165685,0.215454309288209,1.17782129857031,2.74075038968146,0.00441353527509646
3,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.51250984038997,0.0462712015946548,4.14708641093362,4.97181913021877,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64669498060458,0.287746962106961,3.23205741213433,9.98482328772903,9.84045652235312e-21
3,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",0.37921738174398,0.286020971924906,0.837610667277715,2.570189736496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.391781458890908,0.373164279996051,0.742788336897442,3.20731117857517,0.290521923698378
3,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",0.0973736796590075,0.0790834204459107,0.94394413872724,1.28699883322928,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.079680088749909,0.19463206358249,0.765206263880785,1.64104595208722,0.724720316887078
3,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",0.69001763487816,0.027413947345841,1.88967325821195,2.10405120975645,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.735935111343206,0.214422267457807,1.44299496332073,3.34424391203683,2.12349358325484e-05
3,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",0.11508968361968,0.0497673883450674,1.01756473520709,1.23676220002037,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0993170708565183,0.18308465136503,0.798532051402996,1.63672692957998,0.624889535668
3,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.34302900204752,0.0378106046539794,3.55835373569686,4.12684358989494,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45901098744024,0.269796514791944,2.74684295892776,7.90926724982444,5.05880553717497e-17
3,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",0.852199445670487,0.0515356072666165,2.1202412540734,2.59489421181888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.915529749426449,0.231781687880816,1.67917574468906,4.16564266860332,3.29662615721279e-07
3,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",0.94450616499789,0.0886079077759652,2.16479968745195,3.06382596407864,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01774308011644,0.25232436597941,1.79338357424171,4.82204175973125,2.21624860031475e-07
3,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.570010339701822,0.0765543749438413,1.52265891362449,2.05555467715445,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.603047017216518,0.221044667045358,1.24222178679879,2.95465151311012,0.00165771651299437
3,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",0.0316252328616384,0.0720420804873329,0.895865918710646,1.18819487626965,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00691674555856206,0.187721580107674,0.720113315390964,1.50306803427149,0.972805851109546
3,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.11329220914839,0.116944114296691,2.42875066682186,3.84121798812135,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20463507902614,0.279021367175597,2.06750841735908,6.17240085876079,1.77709297235241e-08
3,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",0.798414373687346,0.0732681480062455,1.92622337648549,2.567075077782,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.855970322243881,0.235207835429206,1.56832466100337,3.94325185714136,5.80417093774626e-06
3,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",1.43159136560275,0.0249201920736834,3.98663478506238,4.39572650753268,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55707131895867,0.276318184954773,3.00670157318302,8.88168273836049,8.45136128777929e-20
3,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.667515880796311,0.0616646184885671,1.72817727366995,2.20072778443539,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.711005257417072,0.221676536226723,1.38661266967751,3.30626746541068,0.000112223977927462
3,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",0.10915979007382,0.0485346854057794,1.01399457949048,1.2264821491102,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0927511916160597,0.182335220804151,0.794360555005108,1.62340064145308,0.650741357933965
3,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",0.100033906252403,0.168616796519403,0.793105187572121,1.53597640871663,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0826434616734488,0.256306620208324,0.680289646939717,1.8579372539874,0.781793007732096
3,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.675112477675026,0.0436389409590353,1.80356304420559,2.14004248693445,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.71943539584735,0.216740421333095,1.4122342183329,3.30283054567074,4.9839063831084e-05
3,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",0.976132786724278,0.119803462105572,2.10302547632825,3.36355332650436,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05275724070129,0.270452187852799,1.79509031131081,5.18208989140884,1.11906540225348e-06
3,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.172309904717305,0.0724820462183992,1.03065440939603,1.36932559148757,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.162704232274043,0.195467177182789,0.831537975164482,1.78914695383371,0.420446808953447
3,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.19850502257949,0.0484422981369729,3.01615536521536,3.64688464725659,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29900758355255,0.259026215382227,2.37222715875493,6.548220607166,2.47908932394176e-13
3,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",0.0866778895837029,0.0709459015738182,0.94871967273401,1.25290005427624,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.067874321513037,0.190103553562299,0.762755100487867,1.60700784449202,0.767457781316384
3,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",1.18354453098059,0.225863670204861,2.12415228307707,5.14868897964498,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28241032934863,0.358842782195324,1.9192597038123,7.83481606283358,2.4605971317628e-05
3,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.191448892397206,0.060361710429563,1.07570467764476,1.36286556735972,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.18386931876193,0.19131595828326,0.856660964922905,1.81345112783087,0.343407324304237
3,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.494714074184689,0.0673119402420946,1.43783632608751,1.87198130152807,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.519650939090741,0.212353704466454,1.15971722913623,2.66602189097665,0.0056783049702241
3,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.450033481171571,0.0647944831757986,1.38157225598872,1.78106566509628,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.470224046611671,0.208521583524467,1.11059297817318,2.51502734100435,0.0120412763993121
3,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",0.090571875861177,0.150007203773556,0.814092137663934,1.46570404743711,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0721706024588814,0.240998704096755,0.693495953050695,1.78369612461486,0.802510642497855
3,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.58254461433999,0.0609338819158059,4.32418911794083,5.49083898051159,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.72425171100378,0.298263251268546,3.43736697130084,11.0659875984109,2.38080665279998e-21
3,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.435043964475042,0.0458622289403759,1.41231348490811,1.69046859083355,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.453607425852103,0.201140429065242,1.10769905100833,2.43693458151462,0.0117557244899083
3,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.74100232725483,0.0458277984465449,1.91829890869728,2.29579795791475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.792397860205936,0.222026772601816,1.5069858859543,3.59822442944715,8.2794698005882e-06
3,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.32631316210001,0.0387264514363364,3.49313777001715,4.06577878193042,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44050117085833,0.268418759252282,2.7012168578543,7.73599847788725,1.38494696473624e-16
3,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",0.602311299756647,0.274763981505101,1.07433729570403,3.15427608116218,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.638840534343765,0.371102335126479,0.961369906468495,4.11771499672146,0.0715611134265649
3,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",1.29525265514424,0.628873544934583,1.17224826545874,13.7916384226393,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40613277988092,0.760562403136546,1.00263398353534,19.7663373494349,0.0517798117682148
3,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",-0.142229895240394,0.149446883770083,0.645974702182418,1.16047114589002,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.185607957302352,0.231154179238564,0.54364651685707,1.34534663878138,0.398090328439936
3,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",0.227713703363086,0.266863828521434,0.745114483589984,2.12096162427596,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.224025720470474,0.349499747200359,0.655108166959041,2.57811604647264,0.534696004268806
3,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",0.82781438457539,0.0873011539110133,1.92998333621096,2.7175360444184,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.888527443908292,0.243271701642535,1.59668143929913,4.14347547440555,5.87356014466207e-06
3,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",1.48454116288561,0.0775859376228049,3.79616051096523,5.14549436409614,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.61574619231366,0.293665443175498,3.09223386604003,9.77708270834058,1.5627773647089e-17
3,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",0.0486240750906875,0.0950525781499038,0.870921416253358,1.2641446544412,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0257131884123413,0.200949672262409,0.715306891263842,1.57249673118664,0.949542262206986
3,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",0.618949913648552,0.0624367805043705,1.64364520772481,2.09942635925785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.657222120065746,0.218638056494902,1.31969524902439,3.10945127199782,0.00037304964614974
3,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",0.856448033012611,0.0674684506411742,2.06456151118485,2.68959151066677,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.920233185644859,0.237236826316183,1.66948483577283,4.23111845400324,7.37198291673484e-07
3,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.245535048415908,0.0676093134098402,0.684632045837517,0.892391710201431,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.300013092613545,0.171884985225898,0.543471566038751,1.06609119500149,0.0874077180658977
3,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.446624410810675,0.0487203633461153,1.42083691779618,1.71983162169775,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.466430239466853,0.202727394978736,1.11889338846847,2.47692268419348,0.00991434926021591
3,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.229460263057701,0.101065859700093,1.03133252762787,1.53268725778328,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.225957877131012,0.213731295321371,0.855955623157853,1.97837249822195,0.290445740747236
3,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",0.681712423805697,0.243105608593518,1.23760439457961,3.20956060862645,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.726760904273656,0.345694786082126,1.1060664501548,4.28837830305867,0.0243589977201869
3,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",0.964793000016356,0.0491038624001699,2.38423082160043,2.8902996135797,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04021940611611,0.239805004019532,1.88111045662981,4.81569614532315,5.24417526696314e-09
3,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",0.171607397235374,0.0838411646664358,1.00713941313575,1.39901074273051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.161887651119424,0.201029581552668,0.821866637934119,1.80731865583634,0.437013365755659
3,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.384383724319476,0.087281537101372,1.23813246381401,1.74323312214744,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.397503201152637,0.214717792175462,1.01835529062469,2.36284675618227,0.0466625411763812
3,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",0.782730138345452,0.064115774299387,1.93026111722961,2.48180099580697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.838599047640318,0.23066354534063,1.55414720808808,3.83861436405531,5.56022964532662e-06
3,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",0.0522861746417743,0.311790083373333,0.569347223522247,1.93272296636348,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0297715643315915,0.388294580996277,0.497955004209823,2.28151849818573,0.965566899107149
3,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.40516030390381,0.0581960487046097,3.6402228561828,4.57299898631142,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52783481689756,0.280199487276299,2.89354172978682,8.67845112501139,2.91510864146022e-17
3,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.534316949366493,0.0551740949682091,1.531607895101,1.90141162995927,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.563533148188697,0.210487883478701,1.21763726388303,2.77877352870141,0.00199847716318839
3,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.389093457936401,0.174620513865766,0.477989475394501,0.947747911281698,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.458976107515219,0.244130032289093,0.401461185248748,1.04532486953826,0.0647632412220549
3,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",0.994890810656456,0.67442819083328,0.79888980919925,11.2366153622945,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.07353826865056,0.797841132483453,0.658103387173825,15.0155530431785,0.165903805775275
3,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",0.465422949483279,0.0284893010158853,1.50631671103666,1.68428882876656,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.48722509946731,0.199058185986034,1.15129774267882,2.51226196536792,0.00535321598982765
3,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",2.14766102728223,0.582797384694297,3.14374246062088,30.8747199734414,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.34998807015689,0.764811862685623,2.74693382325899,55.0638118357563,0.000456236758658736
3,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.388554215548477,0.0994167534647025,1.21389227795762,1.79236946515467,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.402125399343331,0.221487418854102,1.00973249129075,2.40584252301369,0.0521055278011408
3,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.22995779251896,0.0845652101841728,2.90369545421135,4.04496845893398,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33382881732587,0.273295052755451,2.39267261725218,6.98460130382408,5.60622994858741e-12
3,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.33091836828012,0.13256637782741,2.93178395797596,4.92961922780331,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44562217729088,0.304901972599675,2.52929150526759,8.35727984116892,1.22185271848185e-10
3,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.565854036183571,0.0554449875749053,1.57977806368315,1.96329606901966,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.598455411313346,0.212669858664492,1.25678219728497,2.89274295075316,0.0010210332740162
3,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.193224345278381,0.137093399288379,0.92753418638111,1.5875161479959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.185833855813822,0.235853284789575,0.786767026023262,1.98318628342883,0.444730200217171
3,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",0.0727104397973327,0.0536845110545416,0.967841582671082,1.19452970667844,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0523889925726817,0.182114248479622,0.76263918351235,1.55722358868291,0.825324966664821
3,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",0.657278807214104,0.0208587365973432,1.85232442366576,2.01014335542718,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.699676554235531,0.211124715045738,1.39906090957202,3.20078121002201,4.79040345466305e-05
3,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.204871716519018,0.0230166872885063,1.17321722473341,1.28399138547043,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.198702901092935,0.181647881549229,0.886401084550489,1.80662573742376,0.272856716024219
3,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",-0.0345813988638188,0.281850969665441,0.553718981715295,1.67152690814579,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0663908439978883,0.356033334062133,0.480807859332617,1.941260442216,0.822071793918629
3,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.163617009217701,0.146321801814392,0.882635622704439,1.56631871967118,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.153050312951803,0.241360455969717,0.752693083376669,1.93870044697701,0.548170936235783
3,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.41590026464575,0.0736499084142814,3.57173293523471,4.76717187126767,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53972636729829,0.285854851053245,2.89789311759939,8.88633219163418,2.33879640378644e-16
3,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.0368351358999907,0.0653591514505601,0.847481123553363,1.09495848875538,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0689143219587577,0.181070339786028,0.675297264700178,1.3732502789787,0.652265333445778
3,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.202020434166241,0.103184502967373,0.999703060677408,1.4980718317878,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.195573590488123,0.213568466736422,0.830036506750704,1.91724145538998,0.367968102976076
3,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",-0.0152201721089825,0.109651111090922,0.793735504992387,1.21996170247331,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0449795124907142,0.20706952690108,0.65763984750944,1.48082562702304,0.778298339906139
3,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",0.0578825599495876,0.0310446754821562,0.997023882353012,1.12604594951197,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0359899160269133,0.174562794293179,0.76114988212765,1.50885124043596,0.893975162293633
3,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",0.870468961652478,0.665025603860243,0.696362527812092,9.44010953868426,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.935755739408426,0.783501458384484,0.586092362869833,12.6415801722183,0.221830763133644
3,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.54585312065832,0.0651958563602631,4.13437925279944,5.33826267234444,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.68362261296989,0.295753683574044,3.3087482604498,10.5476499865231,4.76676232133264e-20
3,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.560351352005788,0.129546986515859,1.3598155893649,2.25954609513586,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.592359866352262,0.249714856114852,1.16165957991694,3.0916777471515,0.00858106708455263
3,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.74377037563918,0.123685548767427,1.6535446360752,2.68521202135105,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.795464411549509,0.257079334909454,1.41165501134502,3.86706282199239,0.000296317921134941
3,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.50084906051418,0.107604384674489,3.64473484060655,5.55714814901963,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6337847703226,0.307175776669766,3.0698614125933,10.2342438393271,2.99081848589137e-15
3,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",0.437776931095359,0.156323101778565,1.14159925194586,2.10687420735389,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.456602662492715,0.261977273055438,0.986519248288134,2.75484064244589,0.0654518824487903
3,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.319201953378895,0.0587897512527376,1.22613762394527,1.54391388469568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.325332558426524,0.198194060764321,0.976828358788052,2.12434202222029,0.082036547184687
3,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",1.29024987731713,0.640583249444917,1.167524810287,14.3812626891303,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4005929094801,0.772889803373616,0.973377773107371,20.1396264838528,0.0569499881170075
3,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",1.73855488807485,0.619950846321505,1.9157217082059,21.7639968678818,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.89702695793501,0.774125498940903,1.64734661088651,34.2498461857314,0.00767299348196512
3,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",2.32253464420582,0.587620789768099,3.66218625833579,36.6528605749752,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.54367016728518,0.785689278791851,3.27506857968866,71.249242547037,0.000165578635840033
3,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.267028059739439,0.101097143455166,1.07146164077055,1.59251934499477,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.267557405569088,0.215745922643969,0.889654603972348,2.07256402332182,0.20632693931872
3,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.3327103189058,0.0551097822260227,3.40579236280598,4.22704849805533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4476107852039,0.272662936879353,2.69894450452223,7.85916089776976,7.86473690531634e-16
3,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.574810047139298,0.092637459272484,1.48228675470441,2.13127025847409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.608369404104151,0.228975217224209,1.22981908348016,3.01751435186268,0.00241934875577623
3,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",0.681159308426734,0.148039768852849,1.48202711658841,2.64776544098276,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.726133903288103,0.269192612485731,1.28345251815876,3.68683872718765,0.00233376973290582
3,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",-0.0845390665115938,0.110522075197931,0.739198751205089,1.1400249244568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.121737621988939,0.204525562094114,0.61121003300372,1.36262208230739,0.514967600520101
3,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",0.663985938376977,0.0828698164340941,1.65213173609857,2.28624361183804,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.707114131903643,0.230018080519801,1.35867789104968,3.3473413209494,0.000275621128196567
3,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.43016381409475,0.0411402086719539,3.85746420937021,4.5325136791019,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55550485215574,0.278664197970316,2.98806366520051,8.9081728900563,5.74753697715333e-19
3,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.607813877839829,0.0273299209148916,1.74081969726936,1.93767231307202,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.648584561658996,0.0518794926992317,1.73873293429257,2.13084906792688,1.5601860478589e-50
3,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.50578469191702,0.0592498989353289,1.47691828160382,1.86304642489618,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.536548831719226,0.075622823942587,1.48208201489834,1.99348405378595,1.93267689482042e-13
3,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.570096212487397,0.0549010962428081,1.58861070188348,1.97006828496024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.607169754003041,0.0729521877492221,1.60001567121165,2.12969919100698,7.67462614476943e-19
3,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.355627799631607,0.0287572856297309,1.34892369163294,1.50988501249692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.371660999987411,0.0455011318780243,1.33137162077671,1.59133114502481,1.29685632740788e-16
3,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",-0.0421398178855711,0.0541794279036057,0.861972110285824,1.06592939641001,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0651024762038944,0.0634636236605022,0.828760402308406,1.06284433323174,0.275304606713922
3,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",-0.000422429657459389,0.0946227425625098,0.829890819328297,1.20256070645244,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0193210837116438,0.106549371967549,0.797476388264358,1.21089870013813,0.801906033811588
3,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",0.0211751131038457,0.0417970531753493,0.940973390830216,1.10849254020967,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00439571026252847,0.0515327967512909,0.90964908655491,1.11327762350265,0.950009388722045
3,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",0.152402291406157,0.064167056437197,1.02691932987567,1.32060982399478,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.148502167244111,0.0754584570697268,1.00311653223272,1.34837936681452,0.0671242926896509
3,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.678943637963361,0.0517067211649662,1.78229290751308,2.18275383818079,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.726693514067191,0.0729822403964138,1.80564922443298,2.40369066583796,7.57329767666974e-29
3,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",0.0102258535650933,0.0221103638698581,0.967401389051455,1.05498785077244,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00763474975978235,0.0334861172797126,0.931095029563374,1.06169770282331,0.691841261331108
3,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.474935560038741,0.172968030238647,1.14934600858909,2.26418599880695,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.502671180762937,0.194328564720814,1.13534855325372,2.43195065790389,0.0101109775931282
3,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",0.0654730919579953,0.0299067483328785,1.00683261301827,1.1320630495998,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0530687506202248,0.0409340752764946,0.975192586022062,1.14492407320981,0.314087845019228
3,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.43707017601123,0.0503940750229213,3.81572561168174,4.64909227312887,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55919234934029,0.116080129678235,3.92505280831399,6.18672305085237,6.48693730695138e-133
3,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.758412177211647,0.055951849082221,1.91403081971221,2.383425201296,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.813957073210746,0.0791126319812352,1.94928458856746,2.65801139253563,7.55694140058453e-32
3,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",0.000644929331887543,0.0233731330486601,0.955808754515213,1.04751800838425,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0181220315749967,0.0343596005532473,0.9197415861094,1.05234880827094,0.514985805863149
3,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.36231579130158,0.0511567046878033,3.53636674640514,4.32162053079189,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4771016164478,0.109498017869776,3.6430464364352,5.59595831390252,9.59171782531784e-117
3,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",0.0452635686107312,0.035717953643726,0.975486606493646,1.12208993132496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0308490597825711,0.0459660630086754,0.94436975442786,1.13082353068288,0.643921459303124
3,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.23874780416933,0.0491968537921074,3.13617056141978,3.80322964516065,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34141190337034,0.098327759425672,3.2282190230266,4.746314078848,2.43791986748584e-102
3,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",0.00355069048352201,0.0664733459495646,0.880766102300981,1.14294418150991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0149586731718229,0.0766117656154561,0.849376153116846,1.14689634820389,0.773180902597026
3,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.111600598088446,0.046538446997205,1.02054214140121,1.22478014851964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.103663165915665,0.0572085534081646,0.993879046600183,1.24372840353115,0.107614874862637
3,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.623567477851121,0.0577952257110825,1.66651007678575,2.09025232251911,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.665884697220312,0.0769069673045813,1.68480875099589,2.27759902437346,9.66768857475163e-21
3,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.349701853324603,0.049006296497454,1.28886465619314,1.56183727971267,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.365172123894777,0.0629900624609517,1.27813943772489,1.63611080289735,7.84385782309551e-09
3,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.605757440197291,0.0312197697878323,1.72406072318497,1.94850350120281,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.646326507168394,0.0544193465173194,1.72616697141418,2.13661594949467,6.82337001563299e-44
3,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.735921723582615,0.0256330352284117,1.98531754999105,2.1951678829793,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.78926014670336,0.0558461792080935,1.98958745278098,2.47648522495354,8.28820721584263e-79
3,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.434855370820597,0.0844330454789652,1.30975569642965,1.82359911678839,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.458658734568462,0.099589875370799,1.30726738066158,1.9315525845824,3.8881088379824e-06
3,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.666765125040755,0.0457465551689178,1.78138685502583,2.13126434766846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.713332419915702,0.0675624608057336,1.80035347390877,2.34626100598106,3.82879625886222e-33
3,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",0.0729141796835504,0.03216338194593,1.00987796391836,1.14557607897054,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0612217269233617,0.0430508589455958,0.979148221105994,1.15914656982558,0.253526440843791
3,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.27475599074808,0.0244922402001158,3.41080200281383,3.7545005703511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3809554219147,0.0889463344065312,3.42666576091708,4.85617422312503,4.69529048304333e-249
3,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.346006736691,0.0410653429418833,3.54684284432842,4.16631126050027,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4591940731447,0.102441626563186,3.62409333963787,5.4149732528355,2.83338707654074e-156
3,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.433626738834311,0.0439743957877356,1.41541762337708,1.68169311373999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.457301710522089,0.059986170684411,1.41079556403709,1.78478015165918,3.7721532425536e-15
3,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",0.47201968615608,0.0972309833595513,1.32555841064245,1.9405516023771,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.499497168274726,0.113358724126281,1.32599419103471,2.06787300291431,9.58707361639163e-06
3,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.33356617217389,0.0819960495863677,3.23722707784488,4.46440403814481,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4455518796644,0.12914356899245,3.39143165720324,5.62648907848347,1.23082065481876e-51
3,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",-0.00475453623131487,0.0238635383962263,0.949747583268885,1.04287812638304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0240743251625867,0.0346894453572658,0.913706537227335,1.04679623266431,0.427983527159754
3,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.18577809767572,0.0138723702495832,3.18557282734952,3.36359659474704,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28325126840436,0.0784431372748313,3.15867506768437,4.29582708035749,9.5701736570541e-305
3,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",0.854044509179506,0.0892989828636755,1.97426312147354,2.80174042999251,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.918971498373556,0.112930531662233,2.03029230545521,3.16090799068305,7.33267225451683e-19
3,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",-0.226600480457587,0.313448131584431,0.427015451242066,1.45901130362218,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.267687761590094,0.3450874611669,0.389623174601743,1.50703292114205,0.425226475417288
3,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.455358129194927,0.0272319329579088,1.49486181534498,1.66326242016152,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.481172709980387,0.0469747606900978,1.48244168388452,1.78216370917302,1.89290761436869e-28
3,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",0.0116243084582054,0.0178635370286943,0.97686529856338,1.04772093755061,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00612098190227594,0.0302884787514613,0.938388604603165,1.05668593054002,0.701192751441322
3,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.31471418302567,0.0138475160896846,3.62413100364417,3.82629052318874,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4248364762783,0.0896733467887552,3.58320700005582,5.09251222468886,0
3,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.349779878497075,0.0386269001337117,1.31540162160375,1.5304421810333,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.36523761676648,0.053522535645512,1.30219026369552,1.60616949640169,8.29984208134876e-12
3,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",0.931204203132025,0.0765499711552233,2.18658098140002,2.9517833146519,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00371812621265,0.103399524933833,2.25547520116199,3.38271747363649,8.72993491262526e-29
3,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.646878029547633,0.0362933164874373,1.778769090193,2.05071556659226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.691497206981496,0.0594698824155966,1.78908690188173,2.25877591138988,3.68936384926563e-42
3,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.36997565186895,0.0180533014046562,3.79879878752857,4.07737153554094,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48551756162263,0.0959807476216614,3.77361934123622,5.49738319052847,0
3,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.480119715217931,0.0537545086602016,1.45492324571048,1.79618855258367,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.508371672757238,0.0699130350289656,1.45673260998832,1.91601987150283,5.15403533203756e-14
3,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",1.07483809861567,0.155559768522479,2.17418554418237,4.00057147418772,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16143262235054,0.18651295501784,2.25539630543814,4.68536139609099,2.98467864131131e-11
3,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",-0.01988777748156,0.0315498497190173,0.921468593429467,1.04277617312166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.040695500428954,0.0412563589841374,0.887084705002773,1.04279765081654,0.293553653047051
3,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.33115351722576,0.0158534111705542,1.34998458917238,1.43653994584655,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.344782003574283,0.0363212266535181,1.31936026911771,1.52123661522385,1.05851269275811e-21
3,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.570284765898843,0.0150282876020074,1.71747918731427,1.82169508300647,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.607369432369462,0.0438657017766529,1.69414645292433,2.01200037311244,1.21041893411039e-66
3,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",0.0389785128873687,0.0220352884629479,0.995773403533021,1.08560907591461,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0239749539609468,0.033904149080062,0.960289678928667,1.09678319915715,0.679964280377152
3,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.616490587130753,0.0191414224762224,1.78428415169978,1.9233150710117,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.658112096791276,0.0475314216830163,1.77058717413738,2.13321659187039,1.06185828106601e-68
3,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.44397321331917,0.0231406718649285,4.05028580291712,4.43486517075486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56677327325092,0.105103611282205,4.04234194402425,6.10325843753905,0
3,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.323750151164251,0.0274850236149975,1.30984956352618,1.45885459874555,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.336657724279485,0.0437707982373833,1.28965194679447,1.53104536855995,2.00322501545582e-14
3,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",0.277286690141276,0.180791664590944,0.927307608349281,1.88366691956517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.285632688387253,0.201404736487661,0.899744770134003,1.9814876778787,0.166706479341593
3,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",-0.0358786257468141,0.0300981820402247,0.909433818931918,1.02331735161671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0582546902221857,0.0397282696901161,0.874220168786956,1.02153758633727,0.142157365842949
3,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",0.000565422864395173,0.0628001046445321,0.884495346675104,1.13137517324678,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0182375086200815,0.0727452554889355,0.853028485227316,1.13450204039274,0.729479792450948
3,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.638734347481126,0.0191539058705385,1.82438383700867,1.96663554552483,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.682538002466849,0.0484188384629066,1.81174987346542,2.19041608358632,8.71860106897386e-74
3,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",0.271099654051727,0.276746866326752,0.764868334263162,2.26319200779808,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.278838211613379,0.306331521112253,0.727784029663934,2.41825585698495,0.374963498697685
3,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.719235307137967,0.0916450434320911,1.71655821305736,2.45852903077655,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.770943807843652,0.111858598672903,1.75017760318898,2.71337953771295,4.02468719126559e-13
3,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.388972913245605,0.0163619736875255,1.42892039149782,1.52357103789156,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.408273696428377,0.0382830472120324,1.40107125326479,1.62792127972021,1.55623132305597e-29
3,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.0602112040269096,0.048337740567579,0.965949819628557,1.16746772838639,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.047280720105424,0.0584228275991947,0.936909672842412,1.1780315577908,0.520091427912984
3,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.31633128291132,0.0185738050431458,3.59673392154109,3.86837362793424,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42661049965935,0.0909017863071202,3.5813173286764,5.11439522185829,0
3,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.672192143824069,0.0155129227885344,1.8999467770179,2.01906677806445,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.719275395129619,0.0482177014963275,1.88116891270565,2.27255162118755,9.4766332338446e-92
3,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.358784710223502,0.0575812545025916,1.27902801415667,1.60290049192739,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.375134341657362,0.0714034380766914,1.26995353913461,1.68013920558222,1.70891789613526e-07
3,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.2282618238626,0.0280021217734423,3.2336908204164,3.6088546627857,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32987179166955,0.0863686625131213,3.26495537276354,4.58048565218568,5.27781048343209e-204
3,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.35673784701986,0.0375251828386291,3.60978109730194,4.18180573132201,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47097562496062,0.101685675240998,3.67489261722834,5.47462858402985,9.44500572478149e-179
3,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.352071430553979,0.0210699010443632,1.36450271748967,1.48198521010559,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.36775227208986,0.039960728302979,1.34063793497828,1.56798091154728,6.46792468655547e-21
3,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.36033918607624,0.020169635957919,1.37826358609768,1.49165755708129,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.376830052620531,0.0396210835796072,1.35385280425412,1.58132997690203,1.53706342243653e-22
3,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",0.156534950363976,0.0582904460844484,1.04306682095864,1.31082877522842,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.153051031753187,0.0694840740152297,1.01956719161107,1.33876932854925,0.0407215199550068
3,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.28268679136801,0.0462187746378143,3.29562335889273,3.95021339196631,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38965691232361,0.0998857796166307,3.38515607803303,5.00754149582573,2.99931201013795e-120
3,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.0219778694057294,0.0179414475605373,0.944459511650513,1.01327404989287,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0429852333503946,0.0297632389042129,0.905215849320502,1.01723472971428,0.162366515089389
3,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.641339125312573,0.0204521135416048,1.82450559347343,1.97680094659648,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.68539857590183,0.0491662702173365,1.81434626089491,2.19999140548626,2.82466631220017e-71
3,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.614528440585934,0.0282845930260141,1.74926819643392,1.95437626072264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.655957888019753,0.0527350959869418,1.74881741012724,2.15040795698066,5.55423850804283e-50
3,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.33714672666402,0.0140517253399316,3.70487245073902,3.91466823204023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44946959344944,0.0918623767155005,3.66177151859432,5.24901768553601,0
3,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.18015174655116,0.0255470246692178,3.09646729120316,3.42261327477047,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27708628076196,0.0816068562099272,3.11910242175187,4.29494295326912,2.60975455313157e-205
3,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.457868777661281,0.0429780812642135,1.45323295367328,1.7198923136787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.483929788612153,0.059655309644904,1.4500776703964,1.83209777886341,2.57641795674558e-17
3,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.684533030931925,0.0407563836250036,1.83106566681975,2.14826430704589,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.732830957837608,0.0641233279605453,1.84871325891344,2.37702258097869,8.76044155094059e-41
3,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",0.00137923200463927,0.0171158901384914,0.968327736867645,1.03552482822486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0173626688910759,0.0295805012896476,0.929137025899447,1.04336845846404,0.482884043147571
3,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.37377982666213,0.0297815457343985,1.37087574729849,1.54062978066086,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.391592953378741,0.046714454924299,1.35517522081522,1.62750482317432,1.04889876151753e-17
3,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.27852178141823,0.0173657250316499,3.47142958754777,3.71596679510093,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38509223439135,0.0871328950740125,3.45378458470086,4.85993606900155,0
3,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",0.243662132677448,0.088783339560226,1.07216441214061,1.51847070970769,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.248709100322957,0.102013945532196,1.05317293654712,1.57097236786128,0.0184170845325028
3,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.685851576362034,0.165670263779236,1.44175536650097,2.76012750562673,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.73427819464641,0.188814958728185,1.45074115035287,3.04108877728288,8.22564180322757e-05
3,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.613961336790789,0.0198952268182718,1.77715112582208,1.92129501776679,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.655334898141987,0.0478097346067094,1.76465701538894,2.12839263166646,1.8186399007516e-66
3,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",0.738314191575,0.248240545769425,1.30145717006122,3.4437796207763,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.791917610947325,0.279025567948106,1.28989632441623,3.85095809953694,0.00425982217103084
3,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.40269621154969,0.0212259101496084,1.43493713993403,1.55943734854409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.423343142035048,0.0414712283054598,1.41365713280163,1.66320137699374,3.36390099638333e-27
3,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.68042263590437,0.0416042451617541,1.82052348255803,2.14300646171511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.728341753863079,0.0646478006324619,1.83837651663128,2.36859647731687,3.17194888318828e-39
3,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.26802936496295,0.0179542338991281,3.43125814468971,3.68144855416144,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37357029287824,0.0863528505258493,3.41753976970309,4.79425286426621,0
3,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",1.49120046428792,0.223836906475086,2.91748432742408,7.01567031453023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.61866089187693,0.277695638332148,3.06678069484345,9.10820155484696,7.86644254335762e-11
3,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.643960097959097,0.0153964738888941,1.84747069063136,1.96240463918631,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.688273362575237,0.0469709997032805,1.82747527205726,2.19692425665115,2.20914086383779e-84
3,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.352394982376022,0.016181864680451,1.37808075214018,1.46832679204006,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.368107463573321,0.0371041084995078,1.34863851178481,1.55977410524809,2.39518304209009e-24
3,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.371788940990841,0.0216266344902578,1.39017026004994,1.51316136021207,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.389404347124295,0.0408543506716596,1.36779250743164,1.60535392083854,6.78377747365348e-23
3,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.666914560331367,0.0199202711940838,1.87372015491326,2.0258955921491,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.713482915998945,0.0499388397040686,1.86386772177249,2.26689352605568,1.58661158798486e-78
3,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.400149138560416,0.0199417162539811,1.43492576611086,1.55159464955256,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.420544430411118,0.0406148752847118,1.41204547405616,1.6557378322376,5.42832738766324e-28
3,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.30430611218498,0.0173909890125878,3.5619378977608,3.81322838047252,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41340603408612,0.0894838826139266,3.54169695079004,5.02978053102785,0
3,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.2667284525705,0.023298693391009,3.39133449984745,3.71564655318071,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37214050721335,0.0878441298744445,3.40246617507133,4.80109096234028,1.95994817523566e-256
3,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.597349687106126,0.025956746728794,1.72729516494533,1.91229726142952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.637093678851489,0.0506396746733703,1.72282033730426,2.10111163783505,3.57841263329621e-51
3,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.407234531344972,0.0600615304428077,1.33609765276145,1.69078013180593,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.428332632222894,0.0746101360892825,1.33147720624078,1.78381685030169,7.32685452859788e-09
3,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",0.0193634395014153,0.0230513422548282,0.974481221863784,1.06663578750095,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00242006836512206,0.0343896946344277,0.938851966537918,1.07434122902381,0.890883674724971
3,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.359210776174757,0.0330488097731026,1.34242880806313,1.52810662702404,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.375609029346768,0.0489793123976981,1.32758560653467,1.60858890097616,9.40391271042612e-15
3,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.35174919457026,0.0369299553807197,3.59597428767211,4.1561024802546,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46549703971572,0.10094428501898,3.65893543601712,5.43503829633693,4.61796343169934e-181
3,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.26878715819683,0.0327064743021879,3.33678638680725,3.79321979121323,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3743907087729,0.0917196801614907,3.38491101184172,4.84943477359121,1.8880314787154e-184
3,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",0.0325465475812687,0.268303885788225,0.602719636554012,1.72534799792738,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.146902542448033,0.329894356141278,0.591409874506383,2.15527028638764,0.63860133489261
3,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",0.914065178137956,0.322861694702187,1.32045366947232,4.68127240203149,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15834442077123,0.377071896721745,1.50785497250356,6.61131627015786,0.00187641197542183
3,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",-0.294255368034012,0.27008499967349,0.433036186334039,1.24829642401629,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.228063139621391,0.343059859944736,0.390762455015265,1.49947418679424,0.461946343036751
3,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",-0.528036046648643,0.496148382891532,0.208010483097148,1.4545537053669,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.496298651626237,0.607778180678699,0.17345986576701,1.87880824172494,0.382902473308158
3,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",0.471973355859863,0.481233536293776,0.616512195769251,4.06625986257178,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.651091611152703,0.562608535987008,0.625880920920554,5.6790830662909,0.240276898182028
3,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.176206082697005,0.234889849292493,0.750390459584125,1.88436273995031,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.311733675939142,0.289468657390837,0.758428092397925,2.35888488075332,0.253516621927877
3,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",0.563911580180338,0.29954848630543,0.962042766064115,3.11276723153892,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.756578548726191,0.354361279713341,1.05008370044706,4.21201252203971,0.0288275653285647
3,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.455029860364608,0.219719688201503,1.02596920869478,2.42764848314843,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.631643776086955,0.266864799271845,1.09864213891602,3.12728679115587,0.0132865810797358
3,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.15152229809508,0.187882096014319,2.20641855331946,4.60828108066906,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43079157095559,0.222567429699619,2.68748639717895,6.43051497593148,5.99372207613282e-11
3,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",1.13620235362841,0.417496847590515,1.397725554264,7.1807503365418,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41322696060218,0.483623337598779,1.58151247845858,10.5291784330949,0.00328896196080635
3,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",-0.100007742477182,0.429716002740775,0.37566074797418,2.0246300023992,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00519411315931933,0.514964482638622,0.350456611084726,2.63822226779642,0.989405605911754
3,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",-0.0512342682349448,0.429344309367556,0.394349036297846,2.12225644550485,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0507759917647123,0.513198526708815,0.372704133408549,2.78634548838638,0.920328246072857
3,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",0.481839112028352,0.32965677447571,0.851232672309314,3.09925274723402,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.662410997051592,0.389537614765125,0.890495435629513,4.09997997369791,0.0818389013860836
3,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",0.999189046886799,0.294602201078067,1.54559654042192,4.90487375121621,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25602897973762,0.344265231055412,1.7747639635515,6.84256282721594,0.000222773684682318
3,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",0.360714940038927,0.511974547386866,0.533952757783223,3.97273762546729,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.523436065020583,0.5994993207649,0.510826869318713,5.35627944748332,0.375011914511312
3,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",0.31462204851459,0.246497626155829,0.838973825828599,2.20488900378335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.470548437731956,0.299122148182021,0.875186015080369,2.82700669876413,0.0997348103369244
3,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",2.13720909067504,0.63839238488455,2.93477801046362,35.8406950086031,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.56174845265912,0.733836319671075,3.06790568367288,54.4662179460875,0.000480401821343399
3,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.543373715467129,0.18659418989544,1.18312817520328,2.45861383779844,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.733044439820677,0.228986362159875,1.31179865172639,3.21880205472577,0.000746332403036425
3,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",2.3094229413008,0.389193717385583,5.03924149069775,23.1701986281238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.75934820411706,0.447634676588767,6.55629756149626,37.9064672056067,7.41477558947388e-10
3,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.438348878945131,0.266715700047306,0.377151633118718,1.07293552131661,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.393392943800651,0.346118440075891,0.326550921134577,1.26818909321464,0.200010958768791
3,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",-0.17158256009976,0.575589385465359,0.255301683859177,2.4374674541195,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0873114826180256,0.685055560146092,0.229205751736435,3.36098219423285,0.893324933896749
3,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.157826149194261,0.223228884536121,0.755013078806753,1.81125674943037,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.290644767480276,0.277237106427062,0.760326595618281,2.25408084115892,0.263205249161813
3,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",0.95776326223499,0.187133106412647,1.81854305335931,3.78703714768786,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20847669097043,0.223626893482347,2.14378916737703,5.15092451820229,2.89501688394344e-08
3,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",-21.0257808475093,NA,NA,0.896947602987581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",1.26051733375125,0.430142773885033,1.60522817847451,8.66588977336612,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55586981625661,0.497448324163292,1.77689201455449,12.4887392462091,0.00167993428529298
3,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",0.131101351532476,0.346157309090636,0.561047172631928,2.17920782405298,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.259982256781181,0.414406688427403,0.562229928129369,2.85365315023912,0.516618570862236
3,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",0.727784218197359,0.225885669870482,1.32746566007332,3.21789416896351,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.944590611837616,0.269504917482475,1.50089594741201,4.31674692476999,0.000310804322155779
3,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",0.997533445460466,0.205376385768979,1.81711922649467,4.06459067612282,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25410816457094,0.243553559173369,2.15863449754796,5.60796693290222,1.45874354539376e-07
3,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.26437920496683,0.177598179127521,0.538657544863684,1.08057878202116,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.193793988436326,0.245080061629224,0.491532833280492,1.28462859933602,0.345313378694549
3,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",0.131101351532476,0.346157309090643,0.561047172631918,2.179207824053,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.259982256781181,0.414406688427411,0.56222992812936,2.85365315023917,0.516618570862244
3,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",0.693147180559946,0.736773956468232,0.527675128603743,9.47660725267383,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.904845083443663,0.854470519800303,0.455301274545524,12.9703625645459,0.285596376511183
3,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",1.00810804422516,0.270007900465732,1.60204512137484,4.61675711195236,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26621219982956,0.316293555639474,1.89441155331001,6.54535880792965,4.97815474390408e-05
3,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",-0.0150086979963819,0.54101454308247,0.326147492197546,2.71918572377814,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0923410161341875,0.640491480165502,0.302161785287892,3.72061052663462,0.883683758566162
3,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.110859811850716,0.158076824221531,0.817560521051225,1.51925398866242,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.236751921982285,0.209868744224396,0.821501381525521,1.87020621563202,0.202687860090151
3,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.36300440198063,0.275546471028597,2.3192406592761,6.83025595939212,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67344182769562,0.320277101400288,2.8319143329563,9.93849989562582,1.47092237204298e-07
3,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",-0.299083642723762,0.427234465021441,0.310761085614779,1.65863911069725,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.233607295826082,0.518615380564869,0.274104774982923,2.09319180454651,0.632565394672989
3,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",0.0135839065346637,0.38992765103162,0.464757709630727,2.14309113291982,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.125160031110819,0.466681241816086,0.441344014630341,2.74951964899424,0.782709992147483
3,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",0.157119075461919,0.217013386309881,0.752542502500832,1.76187580614466,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.289833279070833,0.270524485837913,0.769800778355175,2.22290071493549,0.251362886037723
3,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",0.697503524829788,0.313149019375617,1.09638291074705,3.74169268335043,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.909859133450984,0.368130256929744,1.1937776311869,5.05393349245841,0.0118561347078811
3,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.356067452152131,0.148302803713698,1.06668004512647,1.90767909854437,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.518103595930802,0.192419117356613,1.13305102726633,2.40893104243614,0.00294340266400707
3,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",0.228993572566065,0.869979465044672,0.228742970510386,6.92474018006973,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.372306786269901,1.01763582639867,0.190269672272846,10.2753338657835,0.710366156864887
3,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.22999181519609,0.143134854787995,2.57736536854691,4.51699081314738,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52082393535269,0.172147601788829,3.24818898827673,6.37831404212536,1.48384052765231e-19
3,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",0.291979178648157,0.360632624595655,0.658587982973104,2.70742163605306,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.444570027668242,0.427633690230828,0.661680018505518,3.53714557531321,0.285875053954265
3,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",-0.21209526406338,0.246832465154863,0.49465973882093,1.30171201767177,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.133794675324833,0.314644172019704,0.456017561620553,1.56542684673992,0.635767435602467
3,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",0.589224129148599,0.337076018409658,0.936246079396374,3.50937086457394,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.785622230822718,0.396531936506573,0.995376778670592,4.7102580163751,0.043446111305275
3,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.743711690403783,0.172590777362967,1.48920733702426,2.92937006553776,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.962878400291143,0.210377530998482,1.71711375447322,3.91693554528194,1.75064507018014e-06
3,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.00259716841988,0.127791568561554,2.12566067098299,3.50789590990518,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25991737552015,0.158117348497602,2.5675633558734,4.77200215287775,7.08548292078728e-17
3,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",0.953533071443084,0.450130229629804,1.1256611295529,6.5721998604411,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20362569792284,0.522179609142024,1.18669754255436,9.18967645571235,0.0202107211162374
3,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",0.83168927340726,0.28625379282812,1.30667185115843,4.01315446465536,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.52430689755742,NA,0.948492122096301,NA,0.0417871705580692
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.642124173342575,0.309780497840146,1.02456474689703,3.45072765394858,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.329289527107289,0.319532899592304,0.744282149573895,2.60442225477381,0.204405057086903
3,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",0.155767131116597,0.364078895405598,0.555557863304117,2.31493251074856,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.17105993206783,0.374552985050778,0.404477182414863,1.75603911245194,0.797929433919785
3,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.43183804408723,0.18591225809308,2.91770307657075,6.04698227097355,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14170339436292,NA,2.15181813930517,NA,1.9856768408677e-10
3,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",1.14729354967122,0.203551366721173,2.11475265900955,4.69662682913159,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.848984089153393,NA,1.55042217452542,NA,1.01855856873135e-05
3,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",1.49637703319029,0.488928223800228,1.80115208900505,12.243435660955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20809507699525,NA,1.24889714873004,NA,0.0107326307583184
3,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",0.721119333998767,0.220290321952112,1.33281035024392,3.16075825373231,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.410548543242857,0.226960453306016,0.966931573780015,2.35382362744773,0.0320928011096867
3,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",1.98373595908946,0.447976520325894,3.23165240740282,18.7094600164507,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70947750052276,NA,2.23856118373479,NA,0.000107758814396912
3,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.307293181259409,0.248550494541252,0.828242388946121,2.19427261323856,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0151768680530582,0.255700335327896,0.596703751581884,1.62578760586978,0.814513568126959
3,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",0.236462739154615,1.27204593730345,0.0627158356947427,9.18146839086829,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0880439867702309,NA,0.0704468137522574,NA,0.992147843324365
3,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",35.2167649746003,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",-0.920210601884822,1.17270394376448,0.021280647812363,2.11056949929884,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.27797659805173,NA,0.0261861533736595,NA,0.318761948112678
3,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.41144618524163,0.241280981470781,2.57388995054483,6.62746528854127,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.12072552815114,NA,1.88540606603314,NA,1.45086035474539e-06
3,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",-1.125,NA,NA,48.8235642999872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",2.73194563655853,0.418932461960704,7.30739687345543,37.7532732397634,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.47919259953393,NA,3.86114125974975,NA,3.08736757200043e-09
3,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.733539712594198,0.230288786330584,1.3195099317882,3.25429563793611,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.423326060401723,0.2373981759452,0.959819392561217,2.43409154485746,0.0353668447258903
3,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",0.931087310757932,0.221106850495066,1.64041269617524,3.90270843103413,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.626553992212205,NA,1.198105501288,NA,0.00203579455652644
3,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",0.0660529917313228,0.27901729805368,0.606994526913278,1.81211053228413,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.263353726937288,0.287040484207702,0.437822264313065,1.34882761539621,0.512070732425357
3,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",-0.291831317576556,0.557372484556122,0.231244030370938,2.05562157926002,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.631528734323141,0.573406027083568,0.172843150910712,1.63613963390562,0.331902153288268
3,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",0.104301801187643,0.472106515126296,0.424546137063863,2.70172089786104,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.224005109720291,0.485713393195215,0.308533910231771,2.07101327632445,0.75925788715602
3,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.6784998171111,0.183479738419782,3.75421383266007,7.70682466328538,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39544013592482,NA,2.75744391128741,NA,6.64020087831664e-15
3,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",-0.601680276659796,1.29146059546325,0.0264000347799827,4.17052762971477,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.950287171536125,NA,0.0286017709015799,NA,0.510100068701789
3,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",0.615637249440144,0.408140921837545,0.822619627111461,4.07398506234242,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.302014883184982,NA,0.593979882548899,NA,0.368995827917509
3,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",2.02363168970727,0.446286319039521,3.37513528616803,19.4111109699668,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.75051358693266,NA,2.33970744276678,NA,6.99418262811063e-05
3,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",0.153479305653834,0.493415556564953,0.421763681915036,2.91783914441224,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.17341354415648,0.507701351302853,0.310895688768229,2.2747152914541,0.846525815496629
3,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",1.00087130902266,0.116059234844891,2.16891197921106,3.41838935216392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.923979905649268,0.336231087777597,1.38687832923064,5.18130554527089,0.00162696839921597
3,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",1.03430194200815,0.325665909216949,1.49144637541565,5.34591798906428,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.956707172754576,0.452367164720952,1.14248209578659,6.72915698708931,0.0229534082228173
3,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",0.0567191450633275,0.427814620102459,0.441432694771002,2.36144277513186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.000221591413335673,0.501297134023138,0.392152918810023,2.7981129406908,0.979695091774539
3,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",1.73756657964201,0.101972676087124,4.6621916311286,6.95326400100716,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64475900382163,0.370743088451407,2.71037758487768,11.5926833934044,9.15588171560779e-09
3,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",0.471378442113415,0.579805497856235,0.497155357194727,4.8256385879638,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.405928012377909,0.641452190085038,0.450264267608157,5.56516021185429,0.530393223799872
3,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",-0.127127869496762,0.174095493044823,0.622606647883851,1.23195390428931,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.17965447751517,0.314045856919309,0.471378870071334,1.61436876849489,0.542159404295003
3,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",0.611667565510267,0.0795864535598158,1.57651265219583,2.1537023636187,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.543175933316453,0.306831746605942,0.996488671466295,3.31759737131911,0.0556267622999284
3,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",-0.253002986426678,0.164879510091024,0.558811316834937,1.06648948908787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.302811025429037,0.304647647595134,0.423773876290501,1.3988375326422,0.310171774434725
3,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",0.733517345638842,0.133784953122241,1.60134571475081,2.70545938790272,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.662391283806431,0.330152312270295,1.07487939853799,3.92113734521032,0.0284138832595739
3,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",-0.089434217315639,0.109619722009922,0.735819791224187,1.13080681684295,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.142777285951822,0.285868007209755,0.517101520202192,1.58576340863807,0.587326607685037
3,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",0.854675137929235,0.540231100044828,0.805037621840169,6.69125019174936,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.780941974348153,0.616546916695853,0.692685011607066,7.76510199067012,0.194236351906819
3,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",-0.889323202087446,0.296930076841879,0.2225578215744,0.712750517008119,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.925385982115055,0.373386450598954,0.197231766017623,0.852375796643112,0.017209123893906
3,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",-0.0654126862672586,0.183914603363795,0.648685165532407,1.33392298124706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.119272267202488,0.321628638569193,0.493767376128238,1.74206349065802,0.680732352475929
3,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",-0.059136770021877,0.175689421301993,0.663360542493516,1.32082064541562,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.113131923999079,0.317360082543618,0.501021940732512,1.73832721279195,0.690747101067627
3,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",0.157178950006703,0.0917961751351123,0.976128984156977,1.3988827033577,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0984998134432911,0.289966210853929,0.655303176054209,2.04212181718604,0.760203156098557
3,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",0.78146774994384,0.133825433974855,1.67963498990017,2.83817875639809,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.709308198292808,0.332355082533976,1.12266094414015,4.13095945737884,0.0187900873176475
3,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",0.29558675392845,0.229887409778702,0.852054572399703,2.09811093523895,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.233923730743435,0.361640776631065,0.653502284143712,2.69715238545509,0.525574569631422
3,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",0.862234549950434,0.514962327422212,0.85819937025422,6.46043330137611,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.788338175798815,0.595269330245007,0.727574743138113,7.50353581357043,0.173448118448908
3,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",0.712253270602657,0.0709933336992025,1.77424544529019,2.34354323166126,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.641589411660233,0.309561545588947,1.09563157261377,3.68691452560926,0.0221585215604423
3,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",0.534221467434878,0.260422305335136,1.02226257444426,2.83730613893966,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.467396109479711,0.389676503864095,0.784410738320046,3.61351625987542,0.217106149674829
3,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",-0.0331413821043351,0.257907982353703,0.577812421480584,1.58799897948933,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0876975202972042,0.368707047959006,0.464948836783925,1.9728459833346,0.783887047317782
3,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",0.11535092893012,0.162418823457032,0.813602506916868,1.53785215101994,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0575760085149305,0.317018068329441,0.596206736896045,2.06580544149154,0.885158014240705
3,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",0.795122928607427,0.553601624719938,0.751607153285971,6.58330565515924,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.722676339439812,0.626467825794325,0.640189355365811,7.46120905970892,0.239441695972834
3,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",1.07416507132897,0.131234665945579,2.26549727206015,3.78946450878808,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.995690566148757,0.345192283311125,1.46624231735622,5.67364499455667,0.00087384336026385
3,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",0.443491903306617,0.215482806730849,1.01909855224456,2.37167283850168,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.378639530050708,0.358460084824744,0.761820000014125,3.10524538314051,0.281077443399699
3,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.173564665185567,0.0650505775235199,1.04631727744864,1.35022361896281,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.114568693394613,0.283554350216774,0.67448158891528,2.04971698713133,0.709942031418872
3,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",1.5164386786336,0.0451629245163098,4.17054314357033,4.97826625354405,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42842346104337,0.346849387761239,2.27504666041638,8.86069477343955,1.5114353789062e-07
3,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",0.292294525316424,0.235619549140809,0.836572519181134,2.10679870090712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.230703876514904,0.365103067449622,0.646975924267236,2.70670364994696,0.535887374610293
3,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",0.320159277172758,0.389805694673588,0.629129452760019,2.89965570882654,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.257971380880115,0.477348746434721,0.533977730401469,3.46867111938028,0.598038956321396
3,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",-0.0651969622285296,0.463531416983111,0.355348651638656,2.18661330721753,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.119061119163724,0.528463901501349,0.329441346217167,2.614789190589,0.801895298110951
3,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",0.0877355721929254,0.166708125942208,0.785142931936683,1.50922209118523,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0305590703671308,0.318120900629509,0.57882304188221,2.01426132612398,0.954690090126419
3,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",1.15351172713514,0.232248998794674,2.01915575030053,5.01823774279388,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.07332158906018,0.397199412222957,1.43367403682878,6.80211430576976,0.00243112731246647
3,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",1.5026784079765,0.217312451521749,2.95267359083344,6.92099965931545,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41494598278485,0.405054383006163,2.00237983665737,9.79743284179301,3.82037878098695e-05
3,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",0.862072466748055,0.0529520952001153,2.1343686497775,2.62672884678367,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.788174080107894,0.313366490554736,1.2627487850864,4.3131348846308,0.00421240461934094
3,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",0.470196490890999,0.224394242451555,1.02871600132426,2.47916222602524,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.40476234298599,0.364749375684881,0.772773958951255,3.22851598985239,0.255736446090664
3,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",0.118913004485067,0.0814867582992189,0.959500280263899,1.32059124807963,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0610524994585258,0.285307419900422,0.636648691348879,1.9480858100078,0.862082948402468
3,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",0.764797696985562,0.21119733623471,1.42145411129962,3.25293841320176,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.693005344553975,0.368769269619503,1.02820912288899,4.36390608523104,0.0434189923653758
3,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",1.18005410296964,0.0660882601251812,2.85958907948873,3.7052071025172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09930035515651,0.331972003615976,1.67262898969723,6.14539472347215,7.19151521531621e-05
3,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",0.535136165147327,0.215739653328805,1.1138728714372,2.59484534390958,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.468304353592642,0.362142357948234,0.828591563085259,3.42651608451973,0.179757606199345
3,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",1.46247927606915,0.18279052867699,3.0293696072656,6.20205229941664,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37560769709305,0.385971734482787,1.99650078037189,9.06460651010409,2.11474753014873e-05
3,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",0.339903070794636,0.133356493565533,1.08044321391689,1.82233599020536,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.277316215010315,0.312780951960628,0.751509229478806,2.56102357696387,0.371984299157416
3,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.451022171880482,0.0757415189832546,1.35327165236068,1.82107394278934,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.385994100910696,0.298457268228065,0.863223512036432,2.7811078794939,0.176452505714769
3,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",0.322390045932445,0.161333762682129,1.00289444640422,1.8876015353448,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.260145270336896,0.324645604775348,0.721576599679802,2.57608459417518,0.423871376150099
3,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",0.242429600327374,0.151577573706484,0.944259646610411,1.71055703576279,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.181904554626543,0.316797587624084,0.676749555979563,2.34285370329923,0.578694808158874
3,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",0.410673033405618,0.0942392787907966,1.25229103086545,1.81191787392167,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.346523423180868,0.301741592658021,0.823935162349088,2.68892603353822,0.235792667978844
3,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",1.60219722595572,0.431435318362285,2.22866651383433,12.0926617544299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51228766020137,0.551697925593142,1.66104644621738,14.4408922548846,0.0026507949948808
3,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",0.541428034575183,0.0581593838297157,1.53278258346983,1.92526835063175,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.474439760952841,0.298798099772989,0.943876921616004,3.045020177045,0.0896097071149754
3,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",-0.392643108766334,0.196721880773077,0.454056214080668,0.981769555723664,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.439437040935073,0.317849237786494,0.359568937540179,1.24994150778249,0.168279905504602
3,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",1.28702665023341,0.47128220532052,1.45200399788088,9.21043396201853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20395435947729,0.571983249887643,1.16416459255448,10.9587352825216,0.0252397768629324
3,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",0.837516114299096,0.169841431044542,1.65816522416895,3.22675787834699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.76415229706415,0.350499152298109,1.14577949667075,4.52680602345294,0.0165777958457536
3,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",1.14806300199948,0.0702137817531756,2.74707813330502,3.61745527797077,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.068004376756,0.331133441380884,1.62264714980583,5.94219204892814,0.000122180662008442
3,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",0.951148217486912,0.161152916403139,1.89156288212243,3.55768920157431,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.875330446814822,0.351637252897711,1.28050327235819,5.08170017029631,0.00527376895622632
3,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",0.355819351226785,0.188425237619225,0.984675824025464,2.06095723978803,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.292859089574623,0.339854286736335,0.72409787976372,2.74388725529536,0.386831685870097
3,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",0.729480051808401,0.197788066908302,1.40863785136957,3.05854144392165,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.65845030225735,0.359962954778582,1.00988748921197,4.14071211747598,0.0496436160227364
3,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",0.114715418950695,0.087900674104951,0.942736834207775,1.3305550721875,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0569503761559277,0.28697031137377,0.631943832186048,1.94633513818523,0.874560472235989
3,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",0.735723883943465,0.146415275365744,1.56391291980205,2.776325513576,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.66455445823927,0.335434847270268,1.06617276972536,3.97075330132286,0.0309589802029301
3,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",-0.620012047130238,0.187678326200741,0.36857837273131,0.76919067410384,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.661899418506622,0.305162842649578,0.294275253609127,0.973338512979372,0.0368063433790725
3,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",0.185422184376421,0.144383638591199,0.905035962769582,1.59391437998127,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.126119499004189,0.311210832557415,0.646503130488188,2.18966115529892,0.706716858399239
3,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",1.00192385618528,0.19319553608272,1.86319519211047,3.9733336176662,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.925009730374219,0.369316110201581,1.30128128281136,5.53472527650421,0.00517683515191726
3,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.04303209628439,0.116671766917191,2.25974572217887,3.57011288944428,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.965230056974414,0.338498590172624,1.44011637780954,5.42823491472813,0.000998316559638747
3,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",-0.416868896667173,0.248741432003755,0.398369663839442,1.05619581105328,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.463134760683848,0.350705726681333,0.329166437666286,1.30154161601026,0.18669825592983
3,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",0.347243837866437,0.204427545870523,0.943298659235329,2.10216742586093,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.284469952883826,0.348401204680984,0.706019502613129,2.76653382222305,0.414319205101685
3,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",1.77599557424223,0.106214468711003,4.80512480671376,7.28659299131918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.68235899446685,0.374099137847406,2.79857590968722,12.1284309018153,4.99050846745001e-09
3,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",2.46239293699675,0.415585121368143,5.45591632779772,27.8202542453209,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.35393278381851,0.576837387242225,3.76135013691009,36.0872269913966,1.44587065120346e-06
3,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",1.78149343508279,0.4303611252057,2.68404520385536,14.5023350216742,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.68774928053903,0.557812071484561,1.96505608501334,17.4983033956263,0.000770475629268274
3,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",0.961287363121388,0.524098635447485,0.953097257964192,7.43642761040208,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.885251087223342,0.605747413851053,0.786908705271159,8.45572045284364,0.130961884596805
3,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",1.03230900947115,0.512667237674312,1.05141524865632,7.84405371547829,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.954724643868805,0.598156003199398,0.857388499386682,8.94293923416721,0.0971022469559604
3,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",1.40159474234564,0.495144927667198,1.5868788919864,11.0529966008311,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31602644785695,0.59511528168915,1.24795176402991,12.862455688035,0.0183660499458559
3,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",1.75878492724173,0.264882132609422,3.4663662252831,9.79062923842748,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.665522470675,0.443939106599027,2.39950580602983,13.673670502013,8.55575757031951e-06
3,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",0.11562774605709,0.162912401628556,0.811979454026632,1.53775665614067,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0578471245511861,0.317274806942857,0.596071036484355,2.06741484435844,0.884559498826247
3,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",0.541026170007575,0.0775317588034998,1.47486809053212,1.99868100494995,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.474057722195397,0.303035004176502,0.935707054714451,3.06921724875699,0.0953402097831853
3,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",0.395815355005753,0.551298447064401,0.498894326755688,4.33052692489588,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.332000615687718,0.614725461313273,0.440049521911023,4.89792438512396,0.595629405624427
3,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",1.40769840748131,0.0638685606389982,3.60811996694181,4.63458662317651,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32204287799807,0.343724222231412,2.0527404410057,7.89752874379132,1.64681749482199e-06
3,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",0.844743504305659,0.173469249307354,1.65698520451371,3.27064355533854,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.771223766013146,0.352549054461008,1.14945120721153,4.57795099221087,0.0162185218460269
3,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",0.658472207638684,0.123815120401408,1.51573625844813,2.46267375884411,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.588955455597912,0.322906180400678,1.01169046585012,3.58727057648915,0.0486571593581154
3,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",0.489986141461244,0.150639195226133,1.21459174250487,2.19219385030646,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.42411956846539,0.32658228076717,0.849282420726186,3.05510975897739,0.176136121749663
3,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",0.837463924312553,0.145509103063543,1.73823748023623,3.07485227764766,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.76409923396342,0.339654432360521,1.1703056966747,4.43126857506379,0.0127524939850798
3,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",0.980563109478145,0.333230731761609,1.37101686790493,5.0621594926157,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.90411082472417,0.455749907429036,1.07564313885561,6.42004778247889,0.0341428455110769
3,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",0.527193147601319,0.368733429461269,0.81522168666206,3.45946270253187,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.460513311837408,0.466941463333019,0.669639536673836,4.17603063158935,0.317846156610179
3,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",1.39897777422087,0.121023988095561,3.19826451504748,5.13979728258953,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31348238429099,0.358021075495182,1.97878420273847,8.05183039979233,7.89270210905482e-06
3,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",-0.107201187249316,0.602120378451582,0.263902574131098,2.79572993774264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.160158014565451,0.649386683737235,0.24942153011639,3.18018096536202,0.788963382624248
3,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",0.670309816791621,0.0875574908957144,1.64580038515336,2.31971858714374,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.600554601018731,0.311691583670321,1.04642819212724,3.55086487271307,0.0354123009670143
3,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",1.37663371435648,0.0734508399332036,3.43162270906398,4.57659487315596,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29159593600434,0.343911625892662,1.98914453164943,7.65847948920661,3.44615581350199e-06
3,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",-0.648574033603211,0.208810239713744,0.342637990015763,0.776809825826904,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.689839891167532,0.317322004817505,0.27933957773995,0.969041625490282,0.0361350523138833
3,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",0.353858750020543,0.393414569020361,0.638605194933167,2.98526317470969,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.290942934337991,0.481166484279276,0.548069853893213,3.61389244097541,0.552224949615009
3,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",1.62629901387363,0.121798992553332,4.01511047330591,6.47214859833577,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53589578745306,0.370429001270026,2.42546111334468,10.3612890916122,1.72688186059746e-07
3,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",2.62406924130889,0.407051254338801,6.56768262996597,32.3875032768213,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.5121191453673,0.578847564480322,4.4131513152817,42.6757044586448,1.79903253497713e-07
3,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",1.50766892534348,0.174823417839679,3.22108122474691,6.39177682115865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41981887134956,0.384618260940123,2.09451849360919,9.45931120828904,8.59236356158133e-06
3,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",0.600236384903583,0.213540365847227,1.19719716627662,2.76501478635372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.531998426679442,0.363432935644301,0.881858172348409,3.66528791812098,0.124750957484808
3,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",1.16049260702369,0.121192116802578,2.51864841724968,4.05028311480577,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.08015433177655,0.345866776780722,1.59623434742066,6.19300342097955,0.000246697306842313
3,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",1.81433187907107,0.163859441619126,4.46987672058739,8.49670156627815,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.71986425885667,0.396115847155139,2.78588515408118,13.1617018869871,3.85402524290313e-08
3,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",2.31599019658654,0.190336450549076,7.04098614467204,14.8478253547995,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.21072084802211,0.435778406462498,4.27296488240948,23.5830421776655,1.2883802333523e-11
3,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",1.76089095055448,0.144504637444777,4.39864380533472,7.75039676341417,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66756744966819,0.38567345992025,2.69475907827359,12.2205747601723,3.92279103763693e-08
3,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.422614908319391,0.0846064016804337,1.29168368653271,1.79965962721802,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.358204042528198,0.299483784894387,0.83747731538963,2.70903846763653,0.214954434078054
3,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",1.68936439995675,0.165409757358163,3.92545293511206,7.50730146985842,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59759189515573,0.390005843616067,2.48686274875949,11.470938963241,3.56612982744921e-07
3,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",1.11435453891915,0.183835159746159,2.13133745937085,4.38140864991156,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.03499627009589,0.369754286477922,1.45470276800014,6.19790769064984,0.00145299563232867
3,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",0.734943530725877,0.201241834535964,1.40648658800116,3.09549648644086,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.663795851259816,0.362052100049694,1.01126107357663,4.18043911713133,0.0491469903246976
3,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.394262025040802,0.0809521018596124,1.26473039970138,1.73704498484613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.330461105408443,0.297223511813531,0.817796461021979,2.62204083321309,0.252318609160712
3,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",1.00913494664676,0.46769300713685,1.1314257900828,7.07665613008194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.932085019290479,0.560263980395088,0.902200357147007,8.11144306399927,0.0824158333188816
3,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",1.0237582562522,0.459260612247479,1.16663029106022,7.05959736408291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.946345528646846,0.553869394618266,0.926972815057794,8.12785532922284,0.0737900847836796
3,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",0.67529024479575,0.209070972069727,1.30320629504324,2.95757820565382,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.733515934401004,NA,0.884035268724446,NA,0.00792529021971398
3,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",0.322264168829485,0.379882076527494,0.63443116297861,2.81252846631493,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.249631526720431,0.763230765881603,0.415420992352792,8.27589268262066,0.594686844516039
3,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",1.4493627344707,0.891622447050141,0.926405437350104,30.5282494128862,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.79453049043377,NA,0.518141119582957,NA,0.13601805536022
3,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",0.693147180559945,1.64774137711557,0.0791534762044054,50.5347357034633,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.757967177792017,NA,0.025436671288012,NA,0.728027509398431
3,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",1.22755547918902,0.527698218264451,1.32735306671653,10.5036812274501,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49050108459867,NA,0.929410654358838,NA,0.035855548668377
3,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",1.64828417156486,0.50551801071121,2.13917552618494,15.5182178005364,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.06718519167909,NA,1.61693649383008,NA,0.00250359265550947
3,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",1.4493627344707,0.891622447050141,0.926405437350104,30.5282494128862,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.79453049043377,NA,0.518141119582957,NA,0.13601805536022
3,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",0.196595791963686,0.444685093957738,0.486566632915562,2.78083742500755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0773774391929271,0.808484911989071,0.3040139234782,7.23203773874094,0.863498339864753
3,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",1.05063156703337,0.335077512804544,1.48463147653642,5.52148194061452,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24798845185463,NA,1.10870877759682,NA,0.00548790164223519
3,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",-16.0702946060441,18.7726792728201,4.8698119734991e-30,442.771162550006,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-22.2194608412068,NA,2.80236848065032e-32,NA,0.388441657424329
3,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",0.448852223549699,0.40870105009351,0.682070691562031,3.38534798808743,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.423141062865208,0.868485241922176,0.457054635317201,13.7556169675418,0.421240781045053
3,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",-19.4568168861685,16.1516086354596,4.85414291036715e-28,1.52286340318694,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-26.8613273005584,NA,3.08798528769809e-31,NA,0.22548367938173
3,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",2.78085111635996,1.69493800793238,0.877327167387955,673.952477231653,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.61961117450068,NA,0.383800019273249,NA,0.116462676574403
3,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",2.78085111635997,1.69493800793237,0.877327167387959,673.952477231631,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.61961117450069,NA,0.383800019273264,NA,0.116462676574399
3,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",-0.184343677144607,0.277851016124208,0.472756239890654,1.40492033055416,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.444773610947467,0.516128222848014,0.273775914008278,2.07039646326571,0.273143807269785
3,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",0.949781334804177,0.549580606897453,0.950541720802829,8.19556511030841,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.10976776825599,NA,0.624477921039928,NA,0.131151286832502
3,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",-1.40671593180214,NA,NA,1.42029081851693,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",1.87396019463865,0.836456041513556,1.64618927429557,43.6983576116586,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.37652095092385,NA,1.02726346120896,NA,0.0360184242861504
3,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",-0.130857792945919,0.584200362144606,0.245517403688791,2.42452564669855,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.371460400694122,0.930106173751652,0.139211415921769,5.33446010631242,0.667451172460827
3,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",-0.267167514304972,0.529830728593391,0.247041280697649,1.97131033025717,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.558294231274478,0.831760632394854,0.133380368076791,3.47603210771518,0.464774856488565
3,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",-0.421176912526691,0.527537178679778,0.211846154818855,1.6753344028994,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.769386756922712,0.809854296971301,0.109169426344592,2.61095557802104,0.304832936274557
3,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",3.61643561956754,1.4213659654342,3.20574453480494,842.687820520696,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",4.7649098071373,NA,2.29770349996915,NA,0.0139010689428147
3,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",1.97378167578723,1.31145030233554,0.321423018458715,54.9153830910619,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.51336621192361,NA,0.353928043047625,NA,0.157530811416443
3,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",2.53852207299118,0.793716036351162,3.58807658905821,80.5538560721408,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.28742481402626,NA,2.5587868078955,NA,0.00231213976595256
3,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",-15.9144524884286,NA,NA,442.771164092597,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",-0.105285756891769,0.268492864139348,0.522733739881293,1.49748890433278,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.336409966073401,0.518564037218225,0.308809864707991,2.35774147147984,0.401133187532932
3,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",0.0269945372231654,0.256442560038689,0.613185326086169,1.6755614467892,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.155084126934493,0.530931081616419,0.37376789617377,2.99544057363156,0.716432298940798
3,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",0.773709385202614,0.566607131653021,0.762784903632976,7.03065551370042,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.868419126891658,NA,0.478830062277684,NA,0.248718282978962
3,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.480424487762238,0.100867220630122,1.32861153000117,1.97294366532317,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.505669360216226,0.218252145257108,1.21210296562263,2.85162648412004,0.000226737647182824
3,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",-0.0349019348262074,0.0664471129701179,0.847705687152348,1.0999295432114,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0520483289830846,0.122798566324351,0.771643920659958,1.24873302421604,0.555722110583494
3,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.39346910668204,0.106592336257439,3.2835529762115,4.98663004917624,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49384860971498,NA,2.6523621639252,NA,1.87842516622246e-26
3,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",-19.438745075363,15.9316814468881,2.39655577052051e-27,3.17490845320792,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-21.0524959153687,NA,1.51393896211495e-24,NA,0.221874643179861
3,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.413841685978224,0.0931939274939546,1.26146537690149,1.81772828370759,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.433607409787211,0.198860880884833,1.14938560937796,2.50615041302745,0.000916545317877389
3,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.0812135279057906,0.220142169562622,0.705123294036503,1.67122826036455,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0736210857830444,0.272550118374424,0.662514018308002,1.92834721425754,0.801405558802333
3,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-0.439969013690052,0.194858766298392,0.437079944563204,0.938186208568172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.490446391807117,0.223206376200979,0.401632762160402,0.963421548498868,0.0259206415518632
3,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",0.645144249928228,0.140647090475963,1.45246776378968,2.5208357153478,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.683943210673845,0.302479763986329,1.3417753591505,4.39159514071831,8.31844642194573e-05
3,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.546968195440489,0.087189102838709,1.45828743560398,2.05245730513852,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.577688798875121,0.226776143221824,1.31018164843877,3.18710167211895,3.69570971207181e-06
3,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",0.0449394739926483,0.312660527670879,0.566923122658794,1.93107178280528,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0343536848710145,0.369143586614773,0.528582741658735,2.24669521529902,0.945332087487282
3,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.3007372064575,0.127877561398326,2.87469355553064,4.74559542414851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39346079374843,NA,2.42364856131949,NA,3.32581650587855e-18
3,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",0.00331578319481888,0.200069678893773,0.677725602841388,1.48474930753114,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0106979646071831,0.246545473729941,0.635238656300157,1.66977015316138,0.926512343594356
3,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",0.706904751623617,0.303871525987283,1.13934148063052,3.74943417022682,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.750767217718755,NA,1.07705751978453,NA,0.0285387350923253
3,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.12350695302021,0.0914788244130506,2.57736633350888,3.68901128974646,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20166737336961,NA,2.15768799338889,NA,3.68482014618835e-21
3,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.0715937737654345,0.144573576424261,0.809440206178151,1.42661660747836,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0632044608711563,0.196598339664336,0.757386436074245,1.63684344435541,0.763367821724468
3,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",-18.6189379200684,NA,NA,3.17489930212319,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
3,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.712236129484728,0.0608710846638338,1.81066199613473,2.29860585559932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.756550505369463,0.285782459404345,1.55535332459066,4.76810711020269,2.9635021266371e-13
3,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.33486818029505,0.150920057731715,2.85041781113989,5.15033282774211,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43041350058355,NA,2.44080760453128,NA,4.48116988008934e-15
3,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",0.104820889656605,0.344641264273839,0.566962489586232,2.18913567669536,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0991612092310522,0.409054529113099,0.527426211951722,2.62142479167652,0.816117858880485
3,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.417010486448658,0.0790574107275466,1.30069913936814,1.77322739793251,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.437037694701471,0.190610279300316,1.17208505380043,2.47431310717584,0.000233697985994581
3,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",-0.0421520392841707,0.118234100066504,0.760165168767763,1.2083425337673,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0599044763730992,0.163884975764511,0.706628417906886,1.34335064346134,0.63854672039691
3,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.628093115189388,0.0578101158853893,1.67432220604893,2.10017341613676,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.665480110591015,0.239561265550232,1.44752163377792,3.70215758622413,6.15656687908456e-11
3,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.771219972099833,0.0748496542634825,1.86938272523079,2.50681628615395,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.820391885993034,NA,1.62041755394358,NA,6.34969695656796e-13
3,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",-0.111225635110223,0.336839994934875,0.460508120356071,1.72454582780619,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.134635650579295,0.386705705128923,0.425442728665835,1.93718051192968,0.696954534085112
3,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",0.179389077709312,0.16398051246836,0.868681983224302,1.65204451250135,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.179865303921839,0.224586906190126,0.816330225826497,1.96880779173763,0.38260699874467
3,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.603177953639187,0.118789549044027,1.45161165766272,2.31248083536952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.63852372884267,0.266720923375412,1.32889931505885,3.78058146459454,3.0023665833718e-05
3,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.0832174011176633,0.115031354329846,0.73406460986485,1.15229590728932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.104344228650912,0.158236680983579,0.681454876298405,1.26712575322461,0.43453658626354
3,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",-0.164030001947948,0.330812121697572,0.440766678863074,1.61207161928841,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.191811775901725,0.377740434205041,0.407114383302424,1.78971108200485,0.580842298928534
3,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.26774811553663,0.105966610682869,1.06279799414138,1.61008428502304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.275482842090411,0.184140814106216,0.981936597284732,2.02099545568033,0.0562882857379451
3,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",2.17749195171017,0.128733691165539,6.91368526031823,11.4516017946254,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.34237987300534,NA,4.5995672293045,NA,3.0258568075576e-48
3,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",0.387765531008764,0.299401823227178,0.828568679181493,2.67936019047621,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.405387736901222,0.393843500195025,0.780369606826735,3.65410259579533,0.236204639465381
3,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",0.00876326596341165,0.101714812466846,0.826455877544363,1.23134367325486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00480302741540579,0.153361432789798,0.764935137830717,1.39542849624039,0.909562266370874
3,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",-0.144874015796592,0.137602942541937,0.6599451576477,1.13178392344319,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.171071844397354,0.175748342857813,0.613892990054114,1.22260789405017,0.280264854198469
3,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",0.76913308753786,0.279341560686319,1.27100241807377,3.79925384686334,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.818163822346397,NA,1.20147215104924,NA,0.00970504536004456
3,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",0.789690176971025,0.139462032521571,1.68352553268895,2.90830735744353,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.840382711539756,NA,1.53749892251615,NA,1.05174130162877e-06
3,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",0.384155424435817,0.174568391884223,1.04663020130703,2.07481333996692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.401479831897637,0.260902183532413,0.985534276559421,2.74051646718439,0.0558857784896325
3,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",-0.146493055075376,0.208237522922434,0.57297658292141,1.29610765253918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.172831358017865,0.247059448718384,0.533811211313478,1.40599073487191,0.442086047249933
3,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",-0.267141890974213,1.43174039810511,0.0335545875661784,9.18652323444555,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.303408484576966,NA,0.0354196667075175,NA,0.839645313759063
3,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",0.165123461954243,0.183096407964144,0.825224853758121,1.69151630885434,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.164425296524752,0.241826159979439,0.776534795392379,2.00376377857386,0.470069904276518
3,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",-0.254801347857372,0.194766813531528,0.527469466200405,1.13179807005292,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.290049019814757,0.228670190300942,0.489093093136493,1.19861681947209,0.181233908714638
3,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.33824241702529,0.0816227026411777,3.25686163375106,4.48491327056699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43407243332103,NA,2.57913186785927,NA,1.59355010789182e-33
3,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.120928685590324,0.0840988728935194,0.957259495321993,1.33106683825815,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.116585100959236,0.150179319313752,0.877822007820593,1.5815109438842,0.376790238924528
3,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-0.311096862041362,0.187237974093458,0.505589214318593,1.05330053702089,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.350973504691887,0.218897222645815,0.46782027841622,1.10339332031213,0.0960369415849464
3,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",1.7920952278363,0.267101060159182,3.668482183242,10.4520164211836,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.9252680223116,NA,3.13002895591686,NA,1.61852995763264e-10
3,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.32603961797481,0.104440186549103,3.08152948235016,4.6405090406446,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42086500115906,NA,2.51863206496611,NA,1.0568630338191e-24
3,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",0.197712220189283,0.114715059726934,0.973839498111897,1.52678771535288,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.199698984942273,0.182367346764272,0.904568291810038,1.84886028763463,0.197337621120196
3,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",-0.110285017315569,0.139286476992181,0.681056998109758,1.17572347110312,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.133640889413957,0.179255601502066,0.634289668991087,1.28071627108639,0.395871404851077
3,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.30724588973875,0.0948471859893715,3.07860293078966,4.46500367470102,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40052477963078,NA,2.4973508761032,NA,4.69422905265067e-27
3,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",0.19228378539641,0.302862441369782,0.672144778433828,2.20321451506267,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.193822031944805,0.370631758111448,0.630696135674777,2.69640310754943,0.586513001174021
3,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.855825767695442,0.0829740413483496,2.00319802564765,2.7731869483164,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.911959962635579,NA,1.73255323560608,NA,3.72841471206816e-14
3,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.713725800081216,0.0884661364192833,1.7194734745383,2.43220683305272,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.758167588264872,0.303203468280842,1.52172540389261,4.99471613600289,1.46849902015539e-09
3,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.45098476488672,0.13339348989048,1.2115142177372,2.04370404292458,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.473808793216375,0.236510812600595,1.12631382173398,2.84640144362251,0.00477846444864355
3,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",0.916290731874151,0.60932526098084,0.836284862661211,9.11321131600754,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.977396905899084,NA,0.723944290500707,NA,0.145409585110923
3,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",0.269599845271491,0.210455229415143,0.869734737949521,1.98457012165983,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.277518478120802,0.280265961884952,0.821217572468994,2.46367758590381,0.267627879527653
3,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",0.223143551314209,0.695269901372067,0.330779897890227,5.04857409808125,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.227220559782216,NA,0.2868190062133,NA,0.774560258878479
3,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",1.78120461841885,0.557535725095517,2.27922756045134,20.2739432712304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.9134920229644,NA,1.97064552960726,NA,0.00176304925875017
3,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.663609737898954,0.114987341423567,1.55392403401794,2.4388471845959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.70392787544159,0.290273392139353,1.41227493354441,4.40637616687638,2.38563300313052e-06
3,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.0203957389663,0.186906014621646,1.94284792021743,4.04229666155942,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09006890360322,NA,1.78156603035622,NA,6.4340371112202e-07
3,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.304393177457677,0.152645831274636,1.00742161448856,1.83263509397262,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.315156198207876,0.228535247444675,0.945028456088345,2.31474948694508,0.0955953233680161
3,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.1189824558294,0.0948890107421693,0.935447621616232,1.35693429803567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.114488838970793,0.158012651202752,0.862681296695346,1.60269767737283,0.420635625066332
3,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.169096290973452,0.180389041909629,0.591557204714732,1.19975235147449,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.197292996608472,0.217257841026904,0.551043900694546,1.29135788543599,0.323045211581414
3,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.297424915141547,0.0614723529272274,1.19394661673728,1.51927234514431,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.307609240966174,0.15945113578792,1.06769652408237,1.99479345480196,0.00380984561013133
3,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.131870784805702,0.0679078980099922,0.998928520112389,1.30359002282735,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.128424410670815,0.14054107930891,0.90597995752118,1.57172353852505,0.271930822613988
3,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",0.171419763916887,0.164234936917695,0.861202429309885,1.63945427952095,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.171240237010356,0.224050058989555,0.809341256981184,1.94784857286043,0.407923081973305
3,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.42957728702802,0.129360057776147,3.26247668878862,5.4171439820204,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5329016770483,NA,2.6840353580639,NA,2.23591530073014e-21
3,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.29898500355208,0.0535635652088845,3.30357440885793,4.07540591946086,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39158702544301,NA,2.53413646861142,NA,1.09409774286814e-45
3,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.44952527329864,0.0921225149888233,3.56804398170919,5.11988083537988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55451125968367,NA,2.79474704278251,NA,3.73290087013011e-34
3,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.30386555545699,0.126502762816897,1.0589898337873,1.73880341630964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.314577276118272,0.205623529117335,0.9860206829687,2.20770049742059,0.0538086455035185
3,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",0.676577604156281,0.128285908681673,1.53489180420208,2.53788590647261,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.717962936616208,0.308688969131608,1.40536989993559,4.71306795259272,9.01701578065969e-06
3,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",1.57734959788257,0.253469984453113,3.02681013945661,8.17510358054277,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.69285258172132,NA,2.66396101519459,NA,3.68803537493035e-09
3,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.416125447589593,0.106217925016011,1.23282379392382,1.86950543129296,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.436080036702003,0.208376535095468,1.13258533176727,2.56337290342241,0.0022079565225642
3,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",-0.108445443190373,0.165708315056438,0.647697163671086,1.24015035589209,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.131652442582681,0.205331868925465,0.604354196661016,1.35160300795673,0.467370624372192
3,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.35826211809049,0.116074523291856,3.11328129486284,4.90708961226785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45576309090993,NA,2.56243762156109,NA,1.56745711630369e-22
3,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.308556117382874,0.186142340783551,0.948288805247395,1.96711576573002,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.319659908512576,0.26081883836512,0.894332056656613,2.4860942747322,0.152590524867565
3,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.743421665894325,0.100049225527178,1.73233205503991,2.56421981556687,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.790307076399461,0.348061890446089,1.54453655619048,6.04421394108393,5.27974407302477e-09
3,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",-19.438745075363,15.9316814468881,2.39655577052051e-27,3.17490845320792,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-21.0524959153687,NA,1.51393896211495e-24,NA,0.221874643179861
3,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.757816705935233,0.0803234773411278,1.82538312300578,2.50090368565365,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.805886114936858,NA,1.5941944412472,NA,1.03145277588417e-11
3,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.14119553307201,0.148828535908885,2.35507346231792,4.22056523777252,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22080752210442,NA,2.07837925364785,NA,1.38645797672105e-11
3,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.281005178170248,0.123941220509413,1.04008420942899,1.69069948081338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.289843530265604,0.20033883927353,0.967942923844865,2.12279085282276,0.0720423695067672
3,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",0.860818656303232,0.297130661267259,1.35005030752753,4.32699214616148,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.917366089611507,NA,1.27513887872684,NA,0.00614264766372137
3,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.068865339172414,0.178910016753544,0.754915053667328,1.52221168141937,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.060246856401695,0.229633962662331,0.708612518833516,1.74316455854506,0.811848417351304
3,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",1.34175006576737,0.135490347033569,2.95347180186201,5.02333352051819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43785381944834,NA,2.48941537284811,NA,8.79225757946217e-18
3,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.584029718841162,0.0828972769883763,1.52612203487717,2.11209691953567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.617799620563691,0.235830450053427,1.36141835251763,3.43139004387594,3.35256694783698e-07
3,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",0.668345333575593,0.273842597387666,1.15718054580937,3.38525670378293,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.709053540242966,NA,1.09608322667381,NA,0.022674378983691
3,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.444287840283133,0.164998543150985,1.13269386158468,2.16275127171747,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.466560269223067,0.262902501256583,1.06375416357147,2.98131113745098,0.0193237769311669
3,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.724725617719026,0.165331000880141,1.50175772351646,2.87117643156589,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.770070515776837,NA,1.39569590611796,NA,0.000100427574574267
3,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.437630444817165,0.146745338347835,1.1651062950059,2.07102463865189,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.459365382551777,0.245164783737465,1.08886554279789,2.8467120471548,0.0112350747164068
3,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",0.405465108108165,0.667514968534215,0.428527074234253,5.86621273543384,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.424543845867985,NA,0.37025876372696,NA,0.568855744516042
3,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.46685477385415,0.0766408680220814,3.73940323618191,5.049820602057,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57326734968244,NA,2.85418791840965,NA,9.01377807337792e-43
3,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",0.236839491526811,0.0887293435922053,1.06549834386956,1.50871041156605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.242041537802053,0.167304048482166,0.976281724195519,1.88102292254247,0.0615719255069875
3,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",0.773800208233509,0.145460679282161,1.63795099034771,2.89690072409787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.823185286038053,NA,1.50324642678755,NA,3.78096935025753e-06
3,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.36716186411757,0.0687837635661151,3.43580294344327,4.4991030312954,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46537234890179,NA,2.65453674873122,NA,2.19785524586205e-41
3,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.45815050197629,0.0636304109072185,1.39651378894776,1.79213134610965,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.481558996298172,0.191160044697643,1.23640730022744,2.61573058645248,6.17079726835766e-06
3,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.521585781520743,0.107009482273529,1.36822706465808,2.08128449937332,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.550217754474256,0.232753973050611,1.25006576769754,3.112962897944,0.000112473775452037
3,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",0.885807449128643,0.168534049378555,1.75550901278949,3.39872439928345,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.944412474032483,NA,1.615292292609,NA,2.53042559145745e-06
3,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.35101852652039,0.0748316127297297,3.34140276339919,4.48045784867616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4479002475591,NA,2.61414196647973,NA,2.48832972415801e-37
3,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.34805897020851,0.0563686703314648,3.45120057963092,4.304596012511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44469873047821,NA,2.62929496009904,NA,2.16354127074771e-47
3,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",-0.060552887967314,0.166578535380736,0.678624420975814,1.30380696542763,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0798200653699028,0.208841759217591,0.63424588935572,1.43810473642548,0.645656028797318
3,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",-0.275995974733185,0.242393948060571,0.469245311800396,1.21353455606078,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.312989855879154,0.278181802367623,0.433884038000713,1.29107428833571,0.23726177296299
3,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.706612867367449,0.103643245432741,1.65797130607936,2.48896959309459,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.75046958288793,0.308834417031657,1.48840816482583,4.9943929453467,6.25627289775726e-08
4,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.473514172258554,0.0460175206200281,1.46728923596126,1.75734123936343,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.458655943224102,0.149133607556036,1.20479409113456,2.16171453493387,0.000507963799661464
4,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",0.0330025054738669,0.034327638293831,0.966247695078443,1.10542160473488,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0272006365988203,0.131351219785044,0.807097541937749,1.35063732278615,0.868187048581982
4,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",1.45292302805422,0.168117013801751,3.09615189143262,5.98446293339484,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41787943473713,0.247030741690406,2.62987217232962,6.92596889489218,5.70238704046301e-12
4,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.448411762793496,0.0457670988182586,1.4315093973685,1.71280630767647,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.434065098153529,0.148188022849215,1.17741184911842,2.10476759909924,0.00100273917853683
4,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",0.424067077584696,0.405378043352886,0.695504681181124,3.40735112491007,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.410218118594217,0.423024671392343,0.671068868574851,3.5231050929941,0.330715259496733
4,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",0.797147031213936,0.019489441331498,2.13617364033662,2.30576709288722,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.775622004859007,0.155586430352503,1.63923363185771,3.01655796568194,4.77571653047545e-10
4,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",1.38892866840842,0.0480525526758019,3.6511429621506,4.40791947653931,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35522910419065,0.186029897191452,2.7803802346771,5.7650365316423,6.37252155107475e-25
4,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",1.60238611803971,0.0176145674466901,4.79669409613716,5.13959758865092,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56429914918195,0.190900491653785,3.40698126869462,7.20044491109299,1.33914638939018e-36
4,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",0.044925270786985,0.0956639219806053,0.866658521200854,1.26097526462,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0388692898683265,0.15831373196106,0.77463980226483,1.440832824657,0.831765447431371
4,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",0.490552292482681,0.0977192089514456,1.35051283247311,1.98087101889309,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.475331022781562,0.172114915095955,1.1713557640982,2.29984083936537,0.00249357940238329
4,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.710218914193452,0.0294937551949503,1.92025555915934,2.15560553932935,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.690482184814495,0.153767384261099,1.50930852205535,2.75773222349078,4.92358705660378e-08
4,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",1.44932488567269,0.160766155845449,3.12361198105131,5.86605161327589,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41437812018187,0.242091316111041,2.64584518199693,6.8344163480106,1.57748068594298e-12
4,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",0.03149678006111,0.0353313091937787,0.962892329253173,1.10592546135103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0257255495340555,0.131560928797308,0.805567538170814,1.34918557256313,0.877613714174747
4,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",-0.0752141837945219,0.204961803248301,0.622277954080667,1.38967108632452,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0787922403056386,0.236347546767043,0.590469607121372,1.49127020681463,0.717614585858226
4,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.497186702931289,0.0369945645488573,1.52909209696215,1.76771930394349,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.481832894330968,0.14753012639684,1.23726266986778,2.2060616873657,0.000187912600794889
4,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",0.00971355557382359,0.0594935833437149,0.898519216943903,1.13451287768169,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00436432068267753,0.139079029893425,0.776886848110731,1.34006646482118,0.989429707480351
4,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.0905250528296182,0.040964201041868,1.01017753828886,1.18613819212342,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0835380288670683,0.134971549998876,0.848242936242877,1.439780326733,0.547235744204931
4,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",0.635608756182585,0.185440175089216,1.31991519141722,2.73048599781658,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.61738689296363,0.235166828897989,1.19518756209471,3.00458711373668,0.00522367766696312
4,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.60419796837467,0.0495928073555562,1.66070459474874,2.01706240821041,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.586617889456742,0.154833614600791,1.3559978770828,2.48798772298011,9.98867305371428e-06
4,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",0.905609268764217,0.0469740622013917,2.25656360844991,2.71279120319111,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.881848992775496,0.165395553505961,1.79068023581924,3.42442722387386,1.9285294853419e-11
4,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",0.913438331193144,0.381414020949986,1.19798844631549,5.34285067083774,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.889541764502685,0.408301515518085,1.12175325813396,5.55892865016714,0.0246013525792282
4,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",0.402463837555461,0.186475208711292,1.04021771589169,2.16062907909425,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.389058443325065,0.230570027739282,0.957432625839826,2.36391224040257,0.0813690262867729
4,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",1.61304483161852,0.0156404086328567,4.8668831099658,5.1746049028191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57473895702145,0.191257278679072,3.44100852736776,7.28253751305988,3.24180378558733e-37
4,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.578862292111004,0.0178131071350456,1.72287454799364,1.84747573825581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.561830840457538,0.147034153723473,1.34275305305221,2.38950281026003,6.63283699270852e-06
4,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.210424037224288,0.0825427398134713,1.05023845959447,1.4514729046925,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.200968128281624,0.155687594804089,0.916945930459516,1.68805568662318,0.183450719777238
4,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",0.245502347089764,0.0430125196576218,1.17478477907732,1.390538306315,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.235326504284096,0.140550495666725,0.977869004348533,1.6965016175925,0.0760418671318814
4,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.38130813379686,0.0877397524521259,3.35705352423198,4.73507313234015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34775792161385,0.199327923585347,2.68846861187642,5.87274904257119,2.57599356314268e-19
4,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.322203650141174,0.0643533189663517,0.638445341955418,0.821635152320313,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.320700818706445,0.132058347079667,0.567663300059772,0.952592932946961,0.0173615841054157
4,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",0.730709384006129,0.0560085602390083,1.86070352835498,2.31753513493826,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.710543586534817,0.161512490467887,1.51705560783807,2.85733303601196,1.42291803279703e-07
4,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",0.748567791047901,0.0653020616049343,1.86063694065827,2.40343327902467,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.728039242945485,0.165507692765734,1.53211606401202,2.93124738827385,1.63040409733882e-07
4,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.42775808195779,0.0313551514168333,1.44240761839357,1.63104939723997,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.413833544662755,0.143784977784636,1.16360345056934,2.0444899987173,0.00120401258180946
4,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",0.323242564972742,0.0553792440414635,1.23958781907009,1.54012189826023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.311439629953601,0.147185447694055,1.04233107440194,1.85598578552877,0.0223099323577444
4,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.34742216924528,0.0581557766292695,3.4351844995183,4.31474010122118,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31457599538775,0.18699324152831,2.66281158110552,5.54215041752355,2.69767531342875e-22
4,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",0.0651563141884295,0.107432059950968,0.863537398109391,1.3157513406251,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0586886717876456,0.165964879346927,0.778515814359927,1.49212965540016,0.744588491118686
4,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",0.96639695696438,0.0487864910676118,2.38954895684995,2.89314503552676,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.941388697069063,0.168304596316448,1.89122718076623,3.65818753150317,9.83151347233594e-13
4,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.4890150430404,0.029846856536371,4.18146928625972,4.70045924850141,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45325888284871,0.186936330372228,3.06646063008866,6.38084770180842,9.73642818014881e-31
4,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",1.16468001066845,0.0343559825048775,2.99654731354162,3.42853723157622,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1355992649381,0.173098103486468,2.28140359401915,4.4966063248044,4.75921772300477e-19
4,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",0.87603866145027,0.0171182667792657,2.32225630494787,2.48343238878421,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.852895401672577,0.158463231179421,1.76267423239339,3.28050232339958,6.40608199192085e-12
4,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",0.0686516148728124,0.0504497618954623,0.970156404849957,1.18229971675768,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0621139037794112,0.137372638472129,0.826217507807374,1.41565685837869,0.671090678281429
4,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.464754833513124,0.0404825945932083,1.47016453383689,1.72299348632876,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.450068110033654,0.147274340592007,1.1987823426525,2.13530850267299,0.000544599850665357
4,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.575605967764759,0.0529876575268598,1.60310241716227,1.97318416098104,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.558619236424455,0.154919921419734,1.31788657032297,2.41887922650416,3.12426153531665e-05
4,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.770253557540666,0.0800018770693891,1.84746569600428,2.52796947482302,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.749280900265471,0.172423697321937,1.54436825199047,3.03588628107179,3.02082035298028e-07
4,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.69404530156754,0.0419544132166413,5.01393431475055,5.91019707612271,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.65406798309708,0.199066373575201,3.6742253599963,8.01783286902651,1.82543713475392e-37
4,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.41276091290761,0.0257199977102676,3.90578964938353,4.32010849355319,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37857654179265,0.18275809325867,2.86546222685114,5.86573758251877,3.48164816654961e-28
4,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.707097779162541,0.0303046094007502,1.91123246031802,2.15230677833396,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.687425236896676,0.153801289970725,1.5045468988174,2.74939741871317,5.90415778892194e-08
4,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.186559011750961,0.05301422865983,1.08635426514931,1.33728218876141,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.177613475000555,0.141954838631881,0.920004691559754,1.60492372625274,0.196371015357155
4,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.728144213011045,0.0310609932952928,1.94904221642961,2.20140311632248,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.708038596220788,0.154749673345847,1.53340376884011,2.81256681228186,2.4347866788167e-08
4,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.39871566916143,0.0263028202149064,3.8469778506491,4.26479036279412,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36482027510952,0.182188510467773,2.82880968837927,5.77779346415148,1.31691961414425e-27
4,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",1.18490371763536,0.378567649802174,1.57030444194082,6.92561897862827,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15542538162218,0.410714964632474,1.46209990929994,7.31441291520585,0.00324036856521907
4,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",0.628525739103318,0.17851373072844,1.32562010688612,2.66883306108551,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.610460861452218,0.229732192931937,1.19953029328965,2.95194332109152,0.00460166989415187
4,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",1.92800663046717,0.311952123395172,3.81141706864197,12.9465702502305,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.88321591240637,0.37184897789382,3.31131054800664,14.2244918307406,1.16472871392349e-08
4,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",0.0229706016341962,0.0505028868751789,0.926663402560611,1.12953133103302,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0173727112852362,0.136004141370299,0.791891670803076,1.3495831430704,0.932294580171766
4,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.755152236905213,0.0434278333390285,1.9546484588715,2.31739645854225,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.734470130203563,0.158624605267284,1.56309719976233,2.91091150537767,1.77066610866049e-08
4,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.52050473809139,0.0373665469549294,4.25260573992349,4.92343315480776,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48409886000719,0.189732668797328,3.14693600364696,6.62047869178838,4.37554760008174e-31
4,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",0.127990136364795,0.123539294576969,0.892561366668229,1.44861094246617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.120235045951465,0.177993466363956,0.809082321476447,1.62558370943919,0.507015529555803
4,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",0.341206460705904,0.192478557594803,0.968425372705371,2.05940730986947,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.32906135502435,0.233991849663148,0.895134183196504,2.23994105199187,0.150559265132448
4,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",1.02445559981561,0.0831663220693489,2.36784730375656,3.2804717021816,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.998275704485366,0.183102242254239,1.94620853805759,3.98935969687378,1.38735696163934e-11
4,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",0.9127933395408,0.394212301067371,1.15864334873699,5.43322901054172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.888913932619236,0.419941646284252,1.09579478825607,5.68380520366869,0.0292715139860861
4,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.28283501244124,0.0323854476522243,3.3854071522958,3.8436514088064,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2513227648216,0.177900252446523,2.54185865812906,5.10515974944591,5.59542494610056e-23
4,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",0.13248315416955,0.429511252900606,0.492431960474637,2.65184120756039,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.124633853703298,0.442135182613145,0.484487618162448,2.74141624486719,0.78684057529843
4,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",0.909796721827094,0.0498515320847383,2.25327333438955,2.7395629193839,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.885951246515948,0.166374243035025,1.7946966789176,3.44530031614668,2.22478935050782e-11
4,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",0.142442576571544,0.0668053271344975,1.01165992133969,1.31451074399446,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.13437744782197,0.146144456326819,0.873547366521592,1.5491134772282,0.354694889141443
4,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",0.799512841525024,0.0426378952007441,2.04637132583693,2.41864052957505,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.777922613686136,0.160107718937133,1.62863481466803,3.05064441650627,2.22105262521949e-09
4,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",0.788204780247237,0.0344439448576643,2.05596496441984,2.35316937471496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.766888467013352,0.157747531015169,1.61793257072018,3.00268864463417,1.91105476895254e-09
4,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.437815405788814,0.0330825164912015,1.45208846894686,1.65315225891722,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.423683635979032,0.144513061342865,1.17356455437293,2.06788539321492,0.000949577044750738
4,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",0.145065836209547,0.0577208017919156,1.03248158605043,1.29463214476412,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.136929375763695,0.142426281227017,0.882210137297288,1.54183885049174,0.331074070773125
4,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.4524342810301,0.0696790230797356,3.73047748427018,4.90214560947495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41740046915281,0.195387616705459,2.90811555383405,6.25518474434217,6.15581017216811e-24
4,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.57570376145453,0.0614680290573599,1.57700948506871,2.00667790050893,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.558726199806168,0.157928808007871,1.31027990957832,2.43345081256208,4.92920604799255e-05
4,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",0.624534374363296,0.113636496893354,1.49619064898149,2.33583444912195,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.606559601842591,0.185322199719398,1.30336066566527,2.69499333208913,0.000279052419353902
4,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",0.0740309548221493,0.200700372324323,0.727133735702923,1.59693495687925,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0673828361363397,0.235419134608349,0.685472184354724,1.72491658405032,0.791409487577423
4,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.179267240242079,0.0484348616252696,0.759942035520138,0.918832029253483,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.180706205594401,0.129320788105473,0.657135079122671,1.09096485474211,0.15365600365122
4,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.413780072437881,0.0322853227903552,1.4197920422716,1.61134067775497,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.400143019590399,0.143494234076185,1.14827646966869,2.01526189105011,0.00178655517893005
4,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.55286037177481,0.0975708168792121,3.91108822586172,5.73327102843807,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51578535563919,0.211005006804713,3.11758862974576,7.12909469921532,2.10894895806021e-22
4,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.0846566771614812,0.0661388247880574,0.955577668575848,1.23839996589919,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0777792547875355,0.144134907926566,0.828330353852613,1.45740175553188,0.604392027819394
4,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.435862891964206,0.069245683646218,1.3502944612119,1.77138332367873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.421765460320456,0.156366206897284,1.14441093108389,2.11242019450671,0.00292458092865844
4,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.154716066452515,0.10181581621404,0.957245661801318,1.42677327713585,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.146404457488178,0.164862670124982,0.852373018739512,1.62664361361101,0.373726352247137
4,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",0.0375066135746062,0.0362208880233953,0.967015115034032,1.11454039621388,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0316114478685396,0.131982309697028,0.809694430654888,1.35833922930676,0.841481509263431
4,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.65402594223669,0.0440562126366429,4.79757078768326,5.70194237328747,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6148719796394,0.197542331140361,3.54084638170653,7.68075230206269,1.9689739704794e-35
4,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",1.78756888620849,0.322376679613919,3.26559421590015,11.5551948319089,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.74566963362263,0.376261987171133,2.85242663546207,12.4670600523374,2.77135378699051e-07
4,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",0.0277495995714615,0.0754322619430938,0.886730776843521,1.19181239508639,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0220499019541071,0.146875762460419,0.778868213265432,1.3851784659,0.911438539579942
4,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.47335458908258,0.0383521718249494,4.04905524474345,4.70592019496232,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43791891829618,0.187718208066454,3.01438082535999,6.29173142085955,3.72950718188336e-29
4,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.417598713690198,0.124491362397015,0.514429330405409,0.838031226856637,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.414132755379802,0.16662329339708,0.482861267394148,0.927859842335127,0.0148565699192907
4,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.495921299107686,0.0859700132781529,1.3874381522251,1.94343154902314,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.480592410363426,0.166097580050596,1.19155476171076,2.28496230261489,0.00138055824639442
4,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.322376490865701,0.100638345795213,1.13213299625819,1.67967198475957,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.310615422797319,0.168797344602003,0.99829646320609,1.9347312786383,0.0523654314178239
4,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",0.476665525222327,0.445559958417149,0.669694187519147,3.8406008878435,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.461733820706149,0.461173104356895,0.656073339512242,3.99995316421888,0.314753069700987
4,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.0196408154026888,0.0451425528465162,0.897366742211268,1.07107724088992,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.024362308635837,0.132874616594882,0.763933032568845,1.28606063992084,0.814048039530676
4,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",0.484530757826631,0.0203882549047259,1.55989284349505,1.68967739381072,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.469440747882662,0.143898092245753,1.23057360652007,2.16311770709406,0.000180790342543102
4,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",0.0414643859498746,0.0219651220329667,0.99843588046112,1.08821240237392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0354975875324321,0.12902708954258,0.817602187626356,1.35580790051936,0.813140059528717
4,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.450089814757716,0.0596582190555933,1.39518939450099,1.76276939841208,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.435691040279968,0.152965437405316,1.1683851645971,2.12811389182841,0.00150737224086923
4,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",1.18434429577231,0.0703138136568317,2.85068985671746,3.7553673302955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.154874514127,0.184181986733553,2.27653488511509,4.68625905298933,2.51990566347712e-16
4,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.181305047881134,0.0189364844279104,1.15514890046637,1.24415789158904,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.172461488177971,0.133155992385746,0.931144494524459,1.569286548903,0.178191586632802
4,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.364134343852576,0.0405652582407499,1.32912815246319,1.55820745484561,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.351517863563642,0.143815003135243,1.09256103332684,1.91989205928271,0.00715402110356777
4,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",0.834523998294195,0.0585614584432255,2.05475837745966,2.58497273888419,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.812226924683193,0.166239189332936,1.66601838744841,3.19658236580817,2.29681476322816e-09
4,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.61568229141267,0.0519583590019038,4.54707535986888,5.57424717816157,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57731701835504,0.197562770938308,3.40774735797475,7.39262813438914,1.54677872839095e-32
4,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.47343754306288,0.0271928905033741,4.1382999571528,4.60378705297283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4380029763771,0.185803620853609,3.02592502455744,6.26860378556891,2.15496840520545e-30
4,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",-0.267506066877044,0.108816277028378,0.618750485043958,0.947904790838742,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.267110322363229,0.1589284108519,0.56840403935677,1.05978403471849,0.0917232250064409
4,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.373907220458759,0.0798227435383559,1.24357702815755,1.70044729633698,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.361087650186337,0.159239294234485,1.07033677271664,1.99806638031689,0.0143668056382952
4,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",-0.143677516097128,0.0884082840689094,0.728341314276087,1.03001009488799,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.145847216098031,0.14925145911892,0.654557867898878,1.17499005874243,0.309791129348896
4,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",0.833299440695496,0.10861023006874,1.86256969457674,2.85108997647828,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.811029891020009,0.189065908253276,1.59124677204162,3.33890391537932,6.68926072393795e-07
4,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.658355969112415,0.0376601617367009,1.79415055342419,2.07956097547874,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.639688127972571,0.153542118941477,1.43432900844617,2.61842029841305,6.80384091618034e-07
4,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.38649140853486,0.0623089564406797,3.54916336098192,4.53107185380326,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36540465004001,0.502960862028342,2.11144325159195,15.1642710122182,3.42476741392656e-10
4,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.191395512576192,0.059756194061376,0.735801601047503,0.930014795371938,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.153059647782104,0.233150656210598,0.587633493591588,1.46562524915088,0.491741996083021
4,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",-0.13995757217205,0.099567955928979,0.718868003522004,1.06207197515292,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.103556172291138,0.250937453192289,0.598541549246705,1.6006301687355,0.664524286220663
4,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-0.482376166541659,0.0964143484474345,0.513135877158082,0.74880453309197,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.433079050771018,0.220769799018597,0.447397814957092,1.06299946502894,0.0610203566939792
4,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.411308085741775,0.049443233059298,1.37101434530379,1.66423369802682,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.426948353108115,0.299087647958171,0.974071080970292,3.14599758452749,0.0452101951464538
4,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.0326493673860021,0.0430277189752636,0.950531548137384,1.12516718392546,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0625520136898326,0.252244400796314,0.713989117733707,1.91916908415168,0.756936036962839
4,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.474301168550655,0.0449195417141072,1.47291017993433,1.75649707223241,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.487569000536159,0.307058208357388,1.02695300434288,3.4220583571353,0.0217611779406159
4,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.53981844425056,0.0785095109288815,4.01383560374054,5.460273726422,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51295606328111,0.566667268515678,2.36477552435623,21.8014826020384,1.00808652058066e-11
4,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",-0.0515952172118772,0.0647984851036055,0.838203747266187,1.08059446603866,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0185217232502056,0.248115109437503,0.659386762092633,1.74394246170933,0.945576831020625
4,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",-0.0288945776642583,0.0330034960018101,0.911277880511207,1.03713689052206,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00332681970554638,0.24414561069244,0.680325908946836,1.77154117862781,0.973984321626294
4,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.45426202176368,0.0773691938068791,1.35794260717082,1.8390560657289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.468308325558864,0.310976298254156,0.997329914797207,3.37478302378551,0.0339212486730908
4,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.50890925449549,0.0758207977675388,3.91136179951651,5.26508697800265,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48321111454402,0.55222616125221,2.31125077086589,20.1353225188456,2.11536977932128e-11
4,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.44456089693765,0.0483881186799689,3.86189573247637,4.6684920829858,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42128756213032,0.521723204061507,2.21623652920707,17.1316542824953,3.24893046965442e-11
4,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.319117458882589,0.0950639733984515,0.605703151724131,0.879218940371147,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.275968855775512,0.23331934151747,0.515421161702666,1.28636973173307,0.233740917696472
4,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-0.726291913369776,0.0987602453135008,0.400089345854653,0.589232554229692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.667823624000239,0.204390428596977,0.361254954056844,0.804949635330389,0.00390693689591463
4,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",0.200237724290849,0.0922851520771558,1.02417364077769,1.47055110526256,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.223803046163836,0.28346195257841,0.801380486706851,2.43447470411674,0.317874506362051
4,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.723530979225986,0.0489881906366043,1.87557480459783,2.2726472774422,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.727426267275046,0.346063012698031,1.25521381020584,4.87367370689193,0.000669293243005605
4,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.374992224809201,0.0636768993437803,1.28712950531389,1.65206068387241,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.39199981850111,0.297049013254499,0.94040705065429,3.01309644844827,0.0701186412218352
4,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",0.825780648037608,0.0793491005230502,1.96188276335867,2.67767093930527,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.825804053924258,0.36983383885347,1.34754516206476,5.74314257540967,0.000201395726846594
4,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",0.0361689196743426,0.160862305072466,0.766738756274743,1.44045568089297,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0659307296939894,0.296544329075692,0.657716767293264,2.10318218600195,0.789629685595049
4,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",-0.508207275938322,0.166957639115606,0.439046966537019,0.844773303812074,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.457937266510305,0.256846512171387,0.406286984169527,1.11196010156284,0.0854088762816265
4,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",-0.0677762835994718,0.104788475794216,0.765204938315532,1.15390482339848,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0340933414143777,0.259836854578768,0.63385334698479,1.75523734739562,0.895685187839884
4,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.762111189716657,0.0532538191354745,1.93361609018259,2.38248248934748,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.764568840925707,0.353324727541523,1.29310559883308,5.16577039226269,0.000372121065537939
4,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.50333449657237,0.0526278375059699,4.06284158891261,4.99371419097132,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47784712038575,0.545864796636603,2.31659762118008,19.6848686214421,6.47812147478348e-12
4,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",0.849426241212337,0.197041870249029,1.62595957481293,3.52009538532629,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.848564924318177,0.419670884678024,1.26072387974899,6.53234311723084,0.00257357771855754
4,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.514408266565716,0.0579912510194546,1.49586194848272,1.87765587097215,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.52616508710607,0.315048625512511,1.05647961333391,3.63246027437547,0.0146123365106179
4,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.22262892353444,0.0571569991224572,3.04248633614158,3.80656182794806,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20771441605925,0.452620850097434,1.86112509162198,10.9728311542617,2.28849492344268e-08
4,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.1400917540168,0.0767670346235749,0.99288412233381,1.34148864957166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.165949516938849,0.271846349360763,0.769244073992735,2.23283290386635,0.445639042715561
4,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",0.77567140354244,0.0766574995298748,1.87569807003648,2.53317326206476,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.777577687403753,0.36033139419539,1.29579556034141,5.32066315659773,0.000439936347973716
4,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",0.364057789768676,0.772440856925173,0.432242742141298,8.92757297005076,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.381482380987438,0.843655458482617,0.331740629230959,9.05816694222146,0.618083471107968
4,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.215961114509089,0.103466396737762,1.01917405075314,1.52893798591969,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.238945795087103,0.28916078927573,0.805901883453044,2.50351611278135,0.295996582245569
4,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",1.40474431191226,0.75581728686016,1.2812814373249,24.7942066319173,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3829686908979,NA,0.89952163415723,NA,0.0669899888505167
4,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",0.126617666474582,0.0989257078772095,0.939812118042792,1.38500860283153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.152962768447826,0.277512500408309,0.750146199147509,2.2263018660986,0.496504974125123
4,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.310893326049393,0.12608725787493,1.07531439806379,1.7627340669401,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.330311901164331,0.30916579413106,0.857757271670879,2.88196837383009,0.168059653219917
4,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",0.0549800701207115,0.317943932423286,0.59791877175258,2.07927015653716,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0840231696899245,0.405955749280449,0.543142041158591,2.66694304224935,0.813228887529508
4,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.0564071759052814,0.0455764584877641,0.968692122812429,1.15817789510143,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0854148077696394,0.255272264837484,0.727629176794765,1.97918502724321,0.677743794028796
4,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.0815737094338046,0.0343617785075297,1.01500165736905,1.16135327555494,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.109634411620664,0.256291730847534,0.745546739216378,2.03604188846017,0.593711188416086
4,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",-0.0780661395705241,0.0570507667085744,0.82841743664713,1.03603071903964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0439959888010623,0.243528953872623,0.647290413211682,1.68144868376093,0.852100380400129
4,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.445560287970275,0.0536889731959567,1.40740047736301,1.73707259097967,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.459910307492568,0.304521792375777,1.00029703164357,3.30025744368229,0.0318232635096898
4,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",0.167456917109435,0.188806899950571,0.833179012990897,1.74648062138568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.192279307288914,0.32525289412293,0.714140575202522,2.55561388963723,0.480170409492418
4,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.683171321530403,0.0631400334496768,1.75376798354192,2.24626983602603,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.688600256509153,0.341877564482197,1.20928320430732,4.61893065319338,0.00151891259840919
4,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",0.0425692242451731,0.0812719997593017,0.893058605127116,1.22811111719021,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0721095270844588,0.262568687896187,0.707130863927856,1.97923580031561,0.735175231666502
4,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",-0.00371720399526838,0.0545280633950423,0.896700945615585,1.11039212013829,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0275542662610393,0.250603259882741,0.689653246150367,1.84186819157475,0.88541468971154
4,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",2.43686472501698,0.0896177828568343,9.64468613527367,13.7042000339617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.37621860395388,NA,4.60484560744549,NA,8.83303118945141e-26
4,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",1.65870842678181,0.307507389876117,3.04499900027856,10.1645623455881,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.62736740037643,0.764074550157267,2.18547059896196,43.6825357257143,6.88626510133054e-06
4,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",0.789052014470326,0.186787561443188,1.55823284302131,3.24056005908694,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.790464135287882,0.404192181201469,1.21104146181329,5.90550482807912,0.0040356045876802
4,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",-0.0374332892264452,0.0502928461898689,0.873975383418779,1.06443193796605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00489313783770636,0.246197023604983,0.671634300990981,1.76302893772636,0.995171265898103
4,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",1.11082047672735,0.1858597903235,2.15408066234315,4.46344556576672,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.10011138370378,0.466050436978803,1.57905159609831,9.81300507204875,6.20021558394904e-05
4,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",2.07402490154751,0.194475928355323,5.56364083646709,11.9243717450415,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.0270641567395,NA,3.34941128459857,NA,4.98618613116194e-13
4,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",0.291428248393536,0.777830501942992,0.39584330437492,8.35034368345584,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.311589492634673,0.842373397695271,0.306792650460942,8.33496966551612,0.685145736789033
4,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",0.501152417270947,0.0976149746821728,1.37050008448634,2.0093662379805,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.513396487008191,0.323311752257472,1.02494397478756,3.64004750635184,0.0244207319420924
4,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.40149010976801,0.0957605029438895,3.38520669367579,4.92729048678694,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37983737586886,0.515092284465584,2.11043059176827,15.8951916434742,1.53201755691936e-09
4,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",0.265923791211631,0.199252151492142,0.902742142901127,1.97138385214343,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.287038165106288,0.341650543865827,0.768062309335485,2.93105112776676,0.306335621536609
4,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",0.607037193353402,0.12498059608394,1.44921886137907,2.36538223196084,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.61530311794399,0.348129214491062,1.09795855590154,4.29776036658237,0.0104487311288263
4,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.680745358064131,0.0617241879338908,1.75409574032218,2.23425501773771,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.686263267497769,0.341206318737765,1.20754970095511,4.60018931441513,0.00154660216322013
4,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",-0.0603886846613923,0.0632397970407624,0.833403914409175,1.06786207195617,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0269840563404295,0.246822935660435,0.655045858208948,1.72370853658107,0.914663195822645
4,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.355427153901822,0.0450803155260383,1.30762696007852,1.56037410487208,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.373172388232627,0.290933989998138,0.931772675301989,2.91472034854699,0.0784359532651517
4,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.454254920687734,0.0422769342430486,1.45099317008856,1.71252827820739,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.468277924242721,0.303851308462662,1.0110650565291,3.32702838644959,0.0271370779392667
4,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.707395021919238,0.03214575029111,1.90608559072147,2.16205841067791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.711883622147362,0.341208948232387,1.24410447504101,4.7394944477175,0.000734994977435395
4,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.753482062176276,0.0420590703880132,1.95836586118856,2.30937957812304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.756246058567802,0.350181363610359,1.28820707328695,5.08318029185738,0.000372869557370341
4,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",0.593422113031232,0.0907920395262558,1.52267807678333,2.17356555555,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.602189788022523,0.334604831670363,1.10985303122471,4.12000526185524,0.00764833646843293
4,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.779629549721955,0.0446712070817183,2.00024779082733,2.38304476325195,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.781420709775562,0.355086609676857,1.31464515081229,5.28821476110405,0.000244460949705742
4,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",0.677299254689443,0.157094329050927,1.46742074936812,2.7163925228401,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.682920641732909,0.372163479109853,1.13413235838376,4.87793486784294,0.00790609838451196
4,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.278741244169651,0.0978236315131796,1.09661377622068,1.6091219149624,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.29935742305585,0.294551728492629,0.852518517520149,2.70488990314554,0.187402551316802
4,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.226340149556838,0.0584748882689531,1.12031559973344,1.40892609733364,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.248946665629731,0.277267674666503,0.833728420583871,2.47198568421026,0.244669284326168
4,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",0.817864540409737,0.311042332837856,1.3028071503195,4.40960370623205,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.818193321000889,0.485728083495248,1.07440772722493,7.21230545523041,0.0245300459690621
4,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.40079993305285,0.060940301385364,3.60959367990772,4.58356373581146,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3791742964467,0.507672054841718,2.13581662900673,15.6252306398502,2.12798661417243e-10
4,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",-0.0173409151354551,0.0786160207010282,0.845206823709164,1.15026829892304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0144470701652469,0.25552959060508,0.673493126635939,1.83378126577971,0.935512899835074
4,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",-0.435936266761843,0.107351814503725,0.52678987819335,0.802404733761117,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.38838775315071,0.229174022094738,0.461356864168292,1.13287905906971,0.0996814169426127
4,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.750433302463765,0.0336182419254854,1.98418839984918,2.26367828674755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.753300815870995,0.348661059963949,1.2874883820007,5.05015820494307,0.000359633151303414
4,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.31223112099611,0.0441399212610808,3.41065943423584,4.05492003379697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29394249369575,0.476494568705073,2.00223522744107,12.9628627430262,1.31271824776476e-09
4,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.402704552614219,0.0324119186268251,1.404587084356,1.59487562606915,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.418669872341127,0.295491089488033,0.971779037855049,3.09465663649666,0.0463486663302787
4,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.761163314993698,0.0969152850679129,1.77977745188955,2.6022833366358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.76362202913523,0.363144258561102,1.26788954078744,5.26379934645235,0.00082694511649969
4,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",-0.0643568372039219,0.128332489983552,0.735380125590569,1.21614543925558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.030802690439672,0.27046969330439,0.623109972163234,1.79892535232738,0.910954044840359
4,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.29142483994551,0.123234248366468,2.88346014323737,4.67421104720245,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27393709417242,0.487808554569132,1.90931398177249,12.9218335291447,1.13414492331083e-07
4,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.476461195873349,0.0338433459342425,1.50798063999185,1.72191132546696,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.489648235512939,0.305875593853557,1.03170639179304,3.42199740762874,0.0200822147841528
4,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.41891504774159,0.0316693440828803,3.88632124059209,4.40000008967238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39660868805398,0.510497151971111,2.17947876330311,16.1222098146181,3.86080277865819e-11
4,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",1.95298648734158,0.184485318622511,5.01511262174312,10.3359182575734,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.91056245775529,NA,3.07419973316683,NA,3.22345484132528e-12
4,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.641770417049349,0.0447217211531118,1.74241209038811,2.07627689950572,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.648730521218453,0.332077155472279,1.17654156451224,4.32450545050521,0.00230412090864148
4,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",1.22188636541562,0.0903150745585724,2.85758981357569,4.0714822966768,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20699825472725,0.459020347141373,1.83793553348273,11.1113781979648,9.59858457650511e-08
4,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",0.893608138395572,0.10133325940425,2.01577075100834,2.99882548407711,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.89108212741097,0.38821306946537,1.4076196160081,6.44733799143169,0.000109106833125955
4,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",0.553299427582357,0.312968715367614,0.995274645537511,3.39423453268423,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.563602382586819,0.450724619695349,0.851400599620983,4.98251867783368,0.122199615598687
4,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.569396492632466,0.075728812553779,1.52851582790419,2.05679451021878,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.579052817710771,0.327001626672522,1.09668073489438,3.95156193180533,0.00865972683647484
4,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.44345912194158,0.0414635350883972,3.90798368633459,4.59769748128959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42022766575161,0.520480523356322,2.21749008869375,17.0580481816669,2.52870222314619e-11
4,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",1.30657013988949,0.195861309537862,2.5753736157682,5.54977198100634,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28848975534034,0.521709027486365,1.83423200241105,14.1779462333783,4.58009147253874e-06
4,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",-0.165152385085838,0.162796755424649,0.624303620667487,1.18179337906367,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.127802035527045,0.279732754898522,0.551497908709253,1.65105589151566,0.635073182511202
4,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",-0.143394527252424,0.794287807223549,0.24492680579472,5.5110497711838,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.106878791485754,0.828082776117496,0.197323103332989,5.06884032900599,0.896332521018733
4,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.384821187252688,0.0622935934557571,1.30321759776614,1.66366446926505,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.40145862299777,0.298039888912586,0.948585476321185,3.05112849378146,0.0632267812410107
4,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",0.872790628174969,0.0753124916463204,2.07196365348376,2.78352003089668,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.871045342346524,0.377576450853233,1.40182232445951,6.15857574564478,8.04755699714064e-05
4,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.58707054537318,0.0744736776281805,4.23927832317659,5.67644127254935,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55842851582004,0.589401673478572,2.4554558137697,24.7475010546185,1.78788609677453e-12
4,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.577680840628279,0.0555631626674792,1.6006139492701,1.99011190202601,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.587054623117984,0.323928628041624,1.1132603909852,3.96327176781372,0.00633486264052508
4,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.3044779242754,0.095458936557525,3.07346580242592,4.46825524097103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28647900145206,0.483687572761841,1.95663461888898,13.0298960197718,1.73879979034448e-08
4,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.48067455413073,0.0440766931750415,4.03597318507157,4.79716405240568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45604112778069,0.535333412517596,2.28079682909826,18.5968699605551,8.85292135788582e-12
4,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.296382842829548,0.0560256795689962,1.20705135228248,1.50350209209232,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.316351397628606,0.285347855327516,0.884243740284594,2.70613254101827,0.13940886411373
4,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",-0.0390404539629933,0.0459123785373177,0.8800640490868,1.05359974102856,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00643978182975352,0.245175767564323,0.671843798427336,1.75653293046432,0.989391359210217
4,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.60835294845372,0.0968219589692042,1.52813812355679,2.23353422827302,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.61656220261152,0.338638317658688,1.11965471411216,4.22263001234156,0.0068683145292885
4,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.43617378673704,0.0332229832285488,3.94212439731264,4.49044347475399,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4132172291633,0.516949717090548,2.20816648892591,16.7528464776416,2.37680523098831e-11
4,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",1.5999460550767,0.0899788016067317,4.17277916904805,5.9375269141508,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57081885419437,0.599928365920873,2.46636818893933,25.9046549603222,3.89231901620566e-12
4,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.512525483879422,0.0799749929684686,1.43267374871191,1.96018462368721,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.524324845457103,0.319803608414077,1.04473444157229,3.65965850882255,0.0180798532038413
4,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.23717851662207,0.0547531903502676,3.1007753165527,3.84310542647364,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22171614441149,0.456218270693905,1.88367089286358,11.2634755092447,1.44226524783306e-08
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",-0.21132208244754,0.292663173348415,0.439207968466052,1.38325070562139,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0283129206445423,0.361360441030915,0.524091550062442,2.16066923268197,0.887953892334879
4,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",-0.335242388681897,0.370414798080745,0.363379408158133,1.55222834140888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.15749410492987,0.430830365259944,0.396879590925295,2.14835333284601,0.655695323821298
4,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",-1.10037370850736,NA,NA,60.3011096375841,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",0.326792246464226,0.152845294738368,1.02969713283882,1.87462241223488,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.5327019863886,NA,1.10737582562981,NA,0.00115053603487628
4,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",0.155389390335327,0.347693081684172,0.560031737976104,2.18839853473611,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.354016870370716,NA,0.682041449610453,NA,0.34921941318435
4,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",1.15662349696144,0.3004918128194,1.85088982624847,6.01088968778731,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39783133211184,NA,1.87062155943911,NA,1.00948321543008e-05
4,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",-3.33700491963637,1.21618289244465,0.00585779875177685,0.688918673853097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.28693706609194,1.26886506191218,0.003113461216698,0.450156222637449,0.00921478458048702
4,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",-0.728124806762143,0.571646652722518,0.179021383595165,1.68297604835149,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.567089086704583,0.622467881984922,0.176099139256088,2.02045171791118,0.328969125284271
4,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",0.290718917105147,0.365948336836007,0.659539817821629,2.76842395213687,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.495096741841995,NA,0.754044646219547,NA,0.207953744697084
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",0.963367188876318,0.311610204104058,1.45128462230485,4.92310123944888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19635129850603,NA,1.56018034174745,NA,0.000275390990027435
4,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",-0.289439592594153,0.728238873066544,0.161094905762093,2.79793687663996,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.109747996693902,NA,0.202032355873407,NA,0.86981682001998
4,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",0.638226105905911,0.331575813867513,1.0058018208786,3.68967493908157,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.857356045533851,NA,1.12332486744568,NA,0.0147771690348475
4,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",-0.0274768718431123,0.541458337487575,0.389754196031507,3.25515103681525,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.163363224889413,NA,0.386959677600999,NA,0.792255571094919
4,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",1.76393355690046,0.755063191093166,1.83879437907024,35.4776687512929,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.03097805363788,NA,1.549470022329,NA,0.0104250317377624
4,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",-0.402207850214745,0.553974409357912,0.259504775026289,2.2763188659434,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.227303280070315,0.630428929389549,0.256063888398804,3.03104574775861,0.675209674164277
4,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",0.868875667211725,0.562325180256903,0.833059934327052,7.5505809881712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09784540984947,NA,0.924205187198373,NA,0.0646573181696526
4,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",0.749135951800381,0.272789391169445,1.20811125157962,3.51969013203785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.972992290784233,NA,1.36582449220697,NA,0.000752449421524923
4,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",0.411548719899622,0.227468323924795,0.950453802673769,2.31832217500537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.621067015539841,NA,1.07630250287234,NA,0.010557948761472
4,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",1.53345992876349,0.509726227725323,1.81351312197032,13.3745816269457,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.79069945196881,NA,1.90759886250869,NA,0.000831520820265217
4,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",-0.205392770843005,0.358165856797157,0.425643724171967,1.73296142043558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0221241427709796,0.432713150416429,0.464324186956193,2.53205718508291,0.92147816347774
4,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",0.404473051010516,0.305166811245951,0.864639829134147,2.85990863172628,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.613696293410789,NA,0.940863245356563,NA,0.0597307641357173
4,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",-0.570229837554441,1.48096695553618,0.0477769424955445,15.8643056806059,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.402480806823802,NA,0.0324306881390024,NA,0.787014239789443
4,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",-0.121304042332388,0.389610233999135,0.414058846005053,1.90693430789126,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.065550565763172,0.482794689038824,0.475579709418831,3.15598177006454,0.900356225722097
4,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",1.46084253097361,0.206719616055637,2.8532069950418,6.41583804447301,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.71498842506362,NA,2.61427197781588,NA,3.03217550616568e-15
4,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",1.13976187886948,0.762993641804776,0.963322361223806,19.1731898340182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38026309840128,NA,0.822377916810966,NA,0.0860296043452222
4,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",1.52583717765428,0.75758914846709,1.43912913293608,28.0428319538693,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.78275271475158,NA,1.22307493316083,NA,0.0251831785774656
4,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",0.375781499117857,0.52522625312878,0.484188614787416,3.7945595045558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.583752325734055,NA,0.604308447373701,NA,0.298663898335981
4,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",-0.367117190991844,0.438314188079711,0.26631009931374,1.48448243485871,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.190724854507026,0.502329873389724,0.335371128826826,2.40266708868118,0.653059022862589
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",-0.181528239910319,0.31825751097502,0.469097533420766,1.63329908338029,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00276602752756799,0.392511761172362,0.514173605670524,2.39509648121146,0.971324206253616
4,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",-0.381459698893833,0.406629478835948,0.318805173031076,1.56954090831959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.205677418548649,0.465922971693294,0.352118312547524,2.18714369459327,0.603192669477227
4,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",0.20815297339404,0.309338551446986,0.704832490448777,2.3697624857212,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.409028895888751,NA,0.771655750111618,NA,0.221427922500592
4,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",0.488450154916739,0.147936708166145,1.22318264358307,2.18443546375324,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.701236132165966,NA,1.28231335751607,NA,8.52796999454859e-06
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",-1.04261994052408,NA,NA,8.48460996895846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",0.632077533806418,0.622869393616541,0.607582566650164,6.98200382346493,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.850974748133034,NA,0.647072318731324,NA,0.197796595783021
4,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",-0.676856124335909,0.890252535480501,0.0724328411381595,2.37412829829325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.513614699281672,1.00605119676561,0.0969964841125886,5.00565201560422,0.569192444353465
4,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",0.900637944034013,0.525330220123778,1.02753769615066,8.05603884142488,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13095976712379,NA,1.02266325429025,NA,0.0415304055640956
4,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",2.40650902964003,0.750578059786544,3.54051354150233,67.1201108971991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.70088643111195,NA,2.80104159521577,NA,0.000597346478292289
4,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",0.0365333388615504,0.322377126054354,0.542795235851272,1.92066596940836,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.230104586829519,0.444995734867892,0.635314441584168,3.63538859205227,0.52156852032953
4,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",0.910224687596292,0.271674861697666,1.45227323987681,4.21258287593171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14095138549151,NA,1.57629376162767,NA,6.99400773279887e-05
4,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",0.331021106252579,0.607239267855024,0.40833591334592,4.41350458217433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.537128692677537,NA,0.490522968661985,NA,0.409244103806481
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",-0.195224568538663,0.389848834496376,0.399348374414857,1.84090670711171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.011520895030145,0.469714564131118,0.440777804310405,2.77883807531244,0.948589169181721
4,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",0.0329878726937826,0.373565748837524,0.520847339905302,2.25252663118359,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.226406454240881,0.51042911228307,0.573989634385514,4.24482847286552,0.586707194731006
4,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",0.895881766886819,0.308217706558212,1.34644305232687,4.50711630039667,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.12599634432249,NA,1.47707142353952,NA,0.000543202669528525
4,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",0.182710124726797,0.344479734296695,0.613389721948586,2.36689971566118,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.382499429058517,NA,0.705122384820982,NA,0.305766004075476
4,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",1.98970988320306,0.251471314126844,4.51176307253146,12.090710614707,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.26635864577792,NA,3.63175171195316,NA,8.80026727812608e-18
4,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",-0.552190865066454,0.339641909099215,0.27959743039,1.05862125640993,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.383669752826074,0.381912575696246,0.337661608339164,1.50886655548824,0.260581523932285
4,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",-0.747795639767524,0.392560671643882,0.229206152136461,1.06788077842438,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.587595566991524,0.428747005864896,0.248124694052961,1.33220240911915,0.141118151079529
4,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",1.26733800000474,0.131518167496574,2.76022674491601,4.62212508072875,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51325753996538,NA,2.39768641977212,NA,8.33257227837523e-28
4,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",-1.00379506641366,NA,NA,1537.34939533181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",-1.24129284657214,0.471395025663563,0.101547682619569,0.644427943049088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.10208725234999,0.499685295215185,0.126646680694163,0.897965395122828,0.0230614553373274
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",0.236082461752654,0.344032013042886,0.683076019082713,2.63117782018194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.438140045358527,NA,0.744091877990463,NA,0.237754834764465
4,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",-0.132300695123692,0.170586986709712,0.626051023718564,1.22184901405826,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0540803722470608,0.252666827492154,0.705994511091115,1.90082489604586,0.82469424455346
4,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",1.2460098414313,0.235134331723281,2.19721279175399,5.52287902998783,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49102009044572,NA,2.16972296272411,NA,1.71739775435503e-09
4,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",0.631023452484997,0.352851183114052,0.992729909054573,3.95845807629613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.849903055422559,NA,1.07575769305637,NA,0.0231837116373157
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",-1.76579593774379,NA,NA,2.62858837778696,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",-0.0871917748381942,0.335359484229872,0.465988348548509,1.73497043627916,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.101136667136708,0.427220171609033,0.547275665427129,2.9208353521599,0.804764923013386
4,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",0.711115348984989,0.300987826969717,1.13911567384262,3.70655486718244,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.933379390346068,NA,1.26386391568843,NA,0.00341476140218711
4,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",1.81371006427629,0.478339703617014,2.5885126724334,16.8801881586377,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.08288402430037,NA,2.53794602393689,NA,3.36482345529899e-05
4,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",0.792425077701663,0.576903371600688,0.74401553594525,7.14009655289102,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01814254897853,NA,0.832596826350768,NA,0.0952338927741858
4,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",-1.61511619537224,0.55038945279465,0.0779796594915282,0.674475280824335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.56792041189327,0.759268919813167,0.0684238331669515,1.34211321502115,0.0508583197706538
4,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",2.6967258838619,0.15333336829712,11.0403571479517,20.1380920745972,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.28749130701952,NA,1.70503506423124,NA,0.000308296000013973
4,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",1.98222894303094,0.127608527646562,5.65128813116901,9.31941392937024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.64862661693187,NA,1.1379794501614,NA,0.0086283581321588
4,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",-1.17319981443956,0.535050277382181,0.126092037931134,1.02697272048216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.1727666170049,0.904990400528518,0.0996433844602961,3.46024556986135,0.14131846287996
4,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",-2.47245858927075,0.596103996772524,0.0295967012923475,0.306233426156788,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.33449899731513,0.668573347054477,0.0313741641468714,0.431274215589311,0.0047234052414042
4,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",-1.67941025834869,0.559366836982521,0.071491617640406,0.640505633193872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.62540816578476,0.752175756852044,0.0641212552908377,1.22323062575831,0.0441802252532829
4,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",1.2254789281808,0.158479983457888,2.48510445887487,4.62531656045358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.971981789104404,NA,0.715947877443759,NA,0.122175629295227
4,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",0.555946272387463,0.108851157655805,1.41716062128614,2.17133894953869,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.373323450556668,NA,0.474005595113324,NA,0.536749453428312
4,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",0.129418531224681,0.116518732205753,0.901585283073973,1.42353668413627,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00805479665933882,NA,0.357739608764992,NA,0.989208499287718
4,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",0.044010788354118,0.329008068101271,0.54796790695869,1.99002931644566,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0844217100587097,NA,0.304137033755003,NA,0.92166044728856
4,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",2.37138956018577,0.29391744682161,5.75817806145611,18.2243085274318,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.99659234138936,NA,1.3669897593953,NA,0.00293321633945652
4,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",1.18432725433399,0.251032547810225,2.01577430023516,5.39262831996253,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.935186016821508,NA,0.676453583702848,NA,0.151019945561743
4,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",3.26877781895181,0.0586894761311804,23.4541980001519,29.5211813346725,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.79900060287762,NA,2.35142900091679,NA,6.83961460520469e-06
4,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",0.807951248556978,0.107552743524689,1.82839736892753,2.78720370221078,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.598652116052575,NA,0.557233323407631,NA,0.329569218641002
4,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",-1.14342552265625,0.536903873400893,0.129289781178792,1.06069619667772,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.14615118688887,0.926764846709518,0.101782782138212,3.84947632668005,0.151234208239444
4,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",3.36898097618915,0.141169982142849,22.1944779690828,38.5987417659387,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.88857121555445,NA,2.46084740742698,NA,4.98057816202288e-06
4,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",2.11280631738153,0.332294024369819,4.06271264523228,14.945638674432,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.76537400319355,NA,1.15668308855762,NA,0.00989505537233499
4,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",2.72076904618057,0.253307235824748,8.96676671388654,24.2028712795483,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.30898890661364,NA,1.69033745173073,NA,0.000456798654892669
4,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",0.282744951778013,0.237451019584473,0.838216931033886,2.12614939633016,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.1290639358407,NA,0.378376004437918,NA,0.825035333422739
4,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",0.618061382542935,0.156799897650435,1.36077544508208,2.5160721674002,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.428863038375615,NA,0.487312408841925,NA,0.485881602413465
4,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",-2.16031716166609,0.57316540408445,0.0427582124285711,0.404369222998531,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.05541034753775,0.684432096718928,0.0422338940979983,0.617789383028489,0.011547544619151
4,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",-0.0147123021206381,0.175030353626902,0.699094083847939,1.3883783766553,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.136930779137807,NA,0.318552681323084,NA,0.851565361967092
4,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",-0.151152478075264,0.196926360919982,0.578548405379588,1.25195219384584,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.258930178145412,NA,0.287548495741099,NA,0.708466402455974
4,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.430011231396515,0.130639941003454,1.18437252705032,1.97646971268536,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.260719240928144,NA,0.434473694691764,NA,0.662065191105716
4,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",0.504549511696981,0.28444257479381,0.955640178056037,2.91427357097633,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.327351342985623,NA,0.428185318916014,NA,0.609564483931521
4,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",0.626786652467684,0.194357002118024,1.26565002030552,2.71136253460406,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.436682392957563,NA,0.483883322138634,NA,0.483862625384549
4,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.40650639763863,0.131470030989738,3.16867673027067,5.30509201602064,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13384796143737,NA,0.805451074681292,NA,0.069875637174286
4,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",-0.291873115248382,0.396941256446158,0.333122350658181,1.57891151668016,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.384752594215705,NA,0.226779453766942,NA,0.607934416852391
4,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",4.69560241041654,0.0613125235022585,97.2424574401177,123.661512696937,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",4.07477824904881,NA,4.8182023293099,NA,6.3646789411434e-11
4,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",0.45139867080836,0.329517816495126,0.817857589247915,2.97611587105613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.279834301365149,NA,0.402157128246917,NA,0.667355575371119
4,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",0.384151311297822,0.296396833880891,0.825839862604111,2.63926334934162,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.219698805064789,NA,0.392252730184056,NA,0.727287635499675
4,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",-0.288538527440412,0.469605135082662,0.323441462038206,2.03822874827652,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.381769322639074,NA,0.211989398580467,NA,0.627192548535839
4,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",-1.96622902222005,0.56780471993475,0.0526289191008245,0.487367941301264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.88186063228458,0.707209408587528,0.0500260458110329,0.800113607321854,0.0203727586743449
4,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.744363097542169,0.14845199637613,1.57821702935205,2.82417667620868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.541801125037261,NA,0.529898706766606,NA,0.381179079745491
4,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",0.571594426640035,0.805988664656274,0.483923854688624,11.3997314679697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.38731377788275,NA,0.274453477825636,NA,0.6717026889971
4,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",0.307861273616313,0.232936158949333,0.865493171070161,2.1568248641369,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.151519885975533,NA,0.385649892291212,NA,0.798212375451196
4,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",2.81079162584905,0.256625848065711,10.2992709175184,28.1635319404048,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.38948202351167,NA,1.77620663545287,NA,0.000293874795887191
4,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",0.200205622016207,0.111016855442394,0.988472284000596,1.52742513817101,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0552400018566737,NA,0.375455410555285,NA,0.909423070719309
4,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",0.0100171427678724,0.14644251840001,0.760444476494252,1.35011793052383,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.114819537517641,NA,0.327359000771765,NA,0.877523585993264
4,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",0.333739757551383,0.321797131567496,0.759897015860392,2.68276831853889,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.174628222723966,NA,0.373135465257724,NA,0.780675837088178
4,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",0.87791569270764,0.790811806826323,0.685887505121375,15.2241604383049,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.661210158260114,NA,0.35202504496109,NA,0.47219998439745
4,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.416388209205177,0.157460162906565,1.11588656412543,2.06861998354991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.248538118808661,NA,0.427218284840779,NA,0.678363610727582
4,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",1.67849105852909,0.274743914347738,3.20319669052541,9.403910666835,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37704989253505,NA,0.910843195689336,NA,0.037608437095956
4,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",1.44954718444032,0.262368952823823,2.63268212717322,7.36302271304968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17233193748424,NA,0.794950897118367,NA,0.0743770581030628
4,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",2.1306500626164,0.253419756993602,5.30701517348518,14.3308815299526,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.78132325294165,NA,1.20369531478494,NA,0.00673790771580684
4,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.652402461077916,0.12068729179875,1.51042871449557,2.42414532277283,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.4595690801563,NA,0.503064792773215,NA,0.451858294648241
4,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",1.56302057042561,0.198489499781846,3.21949240940315,7.00965337119304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27379381116343,NA,0.871443529772667,NA,0.0465889967913045
4,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.481690795357127,0.153432474947623,1.20394888801374,2.19690849834857,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.306928078111984,NA,0.446437072073052,NA,0.612405934235269
4,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.210852900039762,0.111269036097557,0.992637828771986,1.53537891528975,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0647602064653133,NA,0.378084166943772,NA,0.897489026811429
4,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",1.31547074649413,0.136813048104895,2.86876606959449,4.90462820134191,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05244889850851,NA,0.760834743029588,NA,0.0925556340000399
4,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",1.10840011172063,0.280562211654151,1.75763113431694,5.27907354082735,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.867295298594462,NA,0.636333244897862,NA,0.188554469780506
4,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",1.45863734710818,0.105542393138676,3.51922215153325,5.32258221470996,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18046069479779,NA,0.835418500782995,NA,0.057726277078596
4,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",0.456879930350383,0.320109272200471,0.799910754716419,2.80541134454289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.284734041269761,NA,0.406066714953374,NA,0.660555434440015
4,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",1.57456991373958,0.0761722876940017,4.15905240018495,5.60622249627553,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28412126932103,NA,0.89972674694757,NA,0.0381484583061367
4,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",0.929552835349673,0.212730185233699,1.68335871627872,3.8755129818177,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.707367927053006,NA,0.584119436508641,NA,0.266848645403155
4,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",0.279552141352942,0.122026398175981,1.04110463718685,1.67970299952088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.126187173429753,NA,0.394541640692387,NA,0.821567255710845
4,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.55904157021194,0.191282771493894,3.2983818655998,6.98138059669848,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27023604889073,NA,0.871147860432938,NA,0.0466072453497051
4,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",0.699507125003401,0.130723598946671,1.56650947270247,2.61503366220671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.501687379261827,NA,0.51727116751305,NA,0.414036791990509
4,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",-0.39544944529565,0.275288138531576,0.392446409712352,1.1546004887365,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.477364605609267,NA,0.231921760297745,NA,0.491963134764281
4,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",0.127017843498868,0.179361899057712,0.793639474294,1.60313284230148,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.010201348006572,NA,0.349849113842611,NA,0.992063127124836
4,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",-0.0319893102695125,0.248915999114799,0.599258254360181,1.58989846484363,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.152377366813685,NA,0.3037413973969,NA,0.837550015893271
4,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",0.0752177602767312,0.150388319878005,0.796373296569691,1.43594639965643,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0565187556001784,NA,0.341542493765252,NA,0.950120439871326
4,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",1.86935102207031,0.422354412384343,3.14648210947034,16.4756562403115,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54768870393163,NA,0.954253441224981,NA,0.0319108885507091
4,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",0.980469492406811,0.208217519698214,1.77718446721652,4.0197834423903,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.752897462629235,NA,0.604392108876838,NA,0.237092577461764
4,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",0.124415066675547,0.240026375205017,0.713818548618852,1.82898216650901,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0125286007564296,NA,0.339602495851117,NA,0.995066098908538
4,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",1.00233413339302,0.136598234771376,2.08505955159774,3.56175235307927,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.772437221729128,NA,0.626133384685034,NA,0.214384057101055
4,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",1.14216270719561,0.132328935895127,2.40154260822194,4.03429345070723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.8974800247272,NA,0.684080694669285,NA,0.149876311484728
4,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.170267895308322,0.175068130090975,0.599331785440528,1.19042992611372,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.276025118886582,NA,0.286590847471908,NA,0.686635416233981
4,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",1.00577066929734,0.170746737086819,1.9440925341894,3.79661627134582,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.775516873487907,NA,0.621797883786159,NA,0.217319926647771
4,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.242347932796835,0.124270684843152,0.614528107352354,1.00023154923381,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.34049277395009,NA,0.27797299711221,NA,0.609192202849465
4,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.515601696662901,0.102873418254985,1.36944333168222,2.04963293192513,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.337249641127436,NA,0.462378113485602,NA,0.574593048233659
4,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",4.34306614754999,0.132322090191096,59.9174843226235,100.651234436961,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.75955827633803,NA,4.04535859488521,NA,2.70452217613814e-09
4,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",-2.02320753559681,0.572489770479001,0.0490935156118322,0.463054901337773,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.93280651011194,0.702468031231475,0.0473918919456513,0.744025449882424,0.0175521265901842
4,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",1.32251898775386,0.772568176868582,1.12610256910506,23.2702151170338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.05874564824593,NA,0.496770132348566,NA,0.24790332547073
4,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",2.24333337465596,0.0672312131365684,8.26728138694002,10.7601256893392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.88207566843294,NA,1.33402036618666,NA,0.00244291776970175
4,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",0.892075783157957,0.274387321230549,1.4676383201327,4.30265837645305,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.673864408353357,NA,0.555322291274469,NA,0.302887134203689
4,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",0.390885556953374,0.136471052663991,1.13665987993306,1.94070387256899,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.225735204896214,NA,0.4228151487854,NA,0.702951123265458
4,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",0.579447486251642,0.113772596758564,1.42984608509061,2.2334493626932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.394336882211878,NA,0.480734885543341,NA,0.515491038929215
4,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",1.34890191835463,0.122339169286193,3.05216089007539,4.93035286087888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.08234127558399,NA,0.778944348750269,NA,0.0826424423804469
4,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",-0.0771703848439574,0.24908803177594,0.570038509270709,1.51339547029731,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.192776086206359,NA,0.294418464891848,NA,0.790228432523895
4,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",0.461155079487046,0.44222438075308,0.732632683291015,4.14696566531769,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.288537138215385,NA,0.372545421897169,NA,0.67941897503746
4,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",-0.439181870416783,0.26611893454663,0.383769643572389,1.08921174151414,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.516468368912094,NA,0.226246043146115,NA,0.453964139888169
4,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",0.820074506213993,0.434011132611368,1.07055322252055,5.86773044545418,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.60949108264537,NA,0.479701031332999,NA,0.39401818973375
4,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",0.682998485030398,0.215363574299282,1.31218814218804,3.05233166754802,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.486896391263909,NA,0.49781852522162,NA,0.440452556595402
4,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",3.05721231879574,0.0736317961567515,18.4251039627594,24.5901367572567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.60981797486457,NA,2.09755288727206,NA,2.81508840635063e-05
4,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",-0.0924379792569764,0.135102531683548,0.698094730420838,1.18553212466776,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.206435786328635,NA,0.306665214943289,NA,0.765090776874511
4,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",0.101672558625805,0.162783980577141,0.807343988012148,1.52820834384121,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0328638716307416,NA,0.346134661538693,NA,0.979749088638296
4,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",-0.0514777574076399,0.375734606578631,0.444620108463859,1.93928149877418,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.169803317026794,NA,0.274422866574126,NA,0.828790813514785
4,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",1.88220998576025,0.369823362974959,2.9494869588749,12.5699894980722,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55918098408707,NA,0.988985114250673,NA,0.0255965616593271
4,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",0.514163014052663,0.22478514570404,1.08489380425641,2.61855774087235,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.335988011984348,NA,0.443937702941204,NA,0.590536349238026
4,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",1.56196954220354,0.763788125154236,1.46663761439013,29.2818209458496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27284827770528,NA,0.593746910327983,NA,0.163252594903441
4,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",1.13212880005324,0.1023428188333,2.54498713589191,3.80114399715988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.888505160425499,NA,0.683847694375403,NA,0.15103252989324
4,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.287758000134,0.0973549137229107,2.99228412340947,4.38268375354385,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02766968077258,NA,0.753529444934225,NA,0.0972541618532656
4,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.16324685671191,0.0897877083558965,2.6875469280449,3.8212981860386,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.916332065246359,NA,0.698593505351003,NA,0.137904666620903
4,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",1.19197551269442,0.266393645755525,2.01635721954619,5.72897384203868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.942024852730023,NA,0.675338555978799,NA,0.151028366560983
4,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",3.58564511761476,0.0676266512719955,31.6411385518455,41.2458181145365,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.08231499489241,NA,2.77539973020114,NA,7.59063388586694e-07
4,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",1.23656215165016,0.293602351086691,1.98553657130391,6.27635412420422,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.981892100956177,NA,0.686184949240949,NA,0.140052607415044
4,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",-0.0429808015773894,0.153761792627873,0.708852345519955,1.29515077893338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0819826137652898,0.288636300520902,0.547774138351966,1.698153142952,0.766615940368784
4,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",-0.262632416499014,0.332971511716952,0.401664572356801,1.48154639814522,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.289862972761623,0.397276032638533,0.358438605237213,1.70113477590011,0.46384273686966
4,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",-0.0692041894276021,0.0920878634696946,0.779106125760379,1.11780817641183,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.106801529535422,0.262440496530999,0.562204946421402,1.57280243775138,0.674101723320626
4,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",-0.056978724778695,0.549899571952134,0.319796509989241,2.76073326601057,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0952004592439246,0.580685280145144,0.305246317396932,2.97310910091718,0.864883871084745
4,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",0.87324377900947,0.102838500957921,1.96059949400303,2.9340091753517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.785163406381214,0.311466023114075,1.27037498239295,4.30697798253061,0.00302650312167738
4,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",0.113278018119363,0.168616907780911,0.806480674982064,1.56188088355455,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0658957533563538,0.302396794302861,0.6199057798513,2.02827539178385,0.828927590806588
4,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",0.188892330035359,0.206071707173273,0.808380968717823,1.81314773137882,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.13746914520738,0.325833443574294,0.63693014073961,2.28450262286955,0.667099776867946
4,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",-0.00527694900440553,0.143389574736441,0.751624110683746,1.31858325912413,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0462983109199855,0.285283286419144,0.571781847629852,1.74943379161637,0.861328509225421
4,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",-0.0352880147893102,0.206427942179087,0.647596098294808,1.45454710202304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0747017959223031,0.31747174055488,0.521569346147442,1.81040995880365,0.805116296109177
4,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.479253199261136,0.0670636471877911,1.4167051986843,1.84267544053067,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.412295247843356,0.281603547292717,0.919419899473168,2.77278788116921,0.105974117449209
4,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",0.438008712123817,0.19240597142335,1.06602616532254,2.26631557826162,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.373240999146313,0.328482292400931,0.80603896360055,2.92122698867773,0.22514040501429
4,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",-0.00830453412541515,0.320691358569149,0.531132975326558,1.86702109085374,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0491442591313239,0.395430488582719,0.459567106214138,2.16536453990264,0.894329073844805
4,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",0.860259438249685,0.265016877151278,1.42245723909978,4.01980299496828,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.772875849930175,0.389074124007265,1.07781265526321,4.95340990415143,0.0281388094598046
4,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.140964551117888,0.0569305961922274,1.02993426474687,1.28744394646415,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0921103899775579,0.262943075128151,0.687801458483537,1.92796078064017,0.721758173957318
4,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",0.855109244838382,0.465606788822175,0.977140906691501,6.06188410756881,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.768003124980943,0.534661719150536,0.806895062642763,6.56185786395039,0.129145375237788
4,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",0.832052390688709,0.209689168298232,1.53663429079062,3.4957954097562,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.746179731640021,0.355405511527923,1.12005787371525,4.51111504779758,0.0184540779051756
4,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",0.0539804872526735,0.0826876324874803,0.897397997207772,1.24094569483888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00980044526654903,0.26510495891552,0.629775794063675,1.78033391217125,0.97796246770164
4,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",1.65366700356238,0.0911541767221683,4.37941243349423,6.26032671482924,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52376197523334,0.354050225929425,2.50123799063404,10.0205420263367,4.9239696726316e-09
4,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",0.665677436377012,0.492732119933162,0.759721049837447,5.24182890665922,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.588721769138897,0.550769909896467,0.650644967918144,5.63607118636866,0.266050041849254
4,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",1.10713545634479,0.377850092662723,1.50257372816889,6.60828789490242,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00652997672186,0.476350845398556,1.15525973792367,7.475165070057,0.0206207630391224
4,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",0.545298878180364,0.187360753627124,1.20096155133968,2.50318316301203,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.474784119014752,0.330511924417236,0.890647454251956,3.25364638682606,0.118817465367155
4,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",1.86459358662829,0.0966607605984669,5.35140136826145,7.81669384807208,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.72340618070275,0.369215969028533,2.98623778269105,12.6963472259226,4.9457958133225e-11
4,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",0.436351272201199,0.495574466334096,0.58999486650401,4.11638260167817,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.371690148007565,0.546599611572531,0.525342410682033,4.47687871016813,0.485711297025515
4,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",0.627939350356051,0.0710732058206593,1.63057024483802,2.15444175683457,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.552976253931831,0.290107153140333,1.04420921091614,3.25586832503072,0.0304960112821597
4,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",0.628170771537862,0.154378073873655,1.38907494187755,2.54413051122038,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.553210119229919,0.318409506275976,0.988170580049251,3.44265296533082,0.053826931394091
4,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",0.820350749493621,0.14590272769002,1.7125728233457,3.03413081962342,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.735104872105338,0.324194130760225,1.17711448458459,4.19495969603306,0.00927092056995086
4,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",0.0287216241896046,0.0791675120775627,0.881103195507726,1.2017158607536,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0141208069467278,0.262970616717899,0.617196745066301,1.73023708643467,0.947797296121599
4,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",0.379383442216641,0.5104378489138,0.54246707617271,4.01184692844173,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.317774472564737,0.557472813678776,0.486729134183169,4.32843381511409,0.560873473697048
4,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",-0.0977540209315202,0.13064594522631,0.702654758296965,1.17261123785794,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.133822741007643,0.275776662963879,0.532864904751801,1.57072501447235,0.619275705593596
4,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",0.0193925888821959,0.151530674427019,0.757247987273599,1.37152717029367,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0229501358938651,0.290109756841378,0.580034873218996,1.80858052801507,0.928149884325542
4,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",0.106777206206579,0.118150154478705,0.883296145974421,1.40360699262945,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.059747050952728,0.279414473555663,0.644370196944625,1.92668851091637,0.832313599484364
4,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",0.406032435574425,0.135977703691204,1.15068083410421,1.96084715288387,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.342977895011078,0.300080165512836,0.826156694531884,2.67867377812363,0.219262903491476
4,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",0.284481519198433,0.12982100588108,1.03176252825355,1.71627719612969,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.227936617577668,0.291988763273729,0.74633370617324,2.34431317137174,0.411599638567195
4,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",1.42519475996493,0.0661147794385766,3.65583254093025,4.73740265163846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30755132172363,0.334367950059514,2.07887561699222,7.71005605673451,2.54446852205367e-07
4,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",1.09071670769489,0.434832249049335,1.29291621188159,7.10935406772904,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.99098802585834,0.518607195474821,1.04688235489873,7.9942250486596,0.0391269731251438
4,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",0.0280256506602799,0.14359380812948,0.777309216019371,1.36473509241017,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.014779496504259,0.286763873475696,0.588724500073435,1.81175643640766,0.950378022038712
4,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.08386731416076,0.104031097901889,2.41573217059753,3.63204854915025,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.984506549394062,0.323323977668063,1.52312488799494,5.40957631695699,0.000203611382732326
4,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",1.20536617790491,0.063048306196048,2.95140126788998,3.77886946852815,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09949809112546,0.320514376315847,1.72376131472225,6.05510660119541,1.39524551409114e-05
4,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",1.37179433873715,0.197606877927161,2.69895600259164,5.85601747163216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25699907477561,0.376353789487707,1.81781344017205,7.9479506694213,4.7748755240571e-05
4,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",1.23556825170277,0.10828750982092,2.78737741120292,4.26132607146771,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1280520418966,0.33320865955671,1.73174556822696,6.39351274644246,2.30372226635735e-05
4,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",0.0990201418989582,0.0721133967077776,0.958837635856633,1.27207038383609,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0524124229894146,0.264353116927411,0.658695526603455,1.85660825105463,0.845120411964041
4,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",0.739948777111511,0.18367780244215,1.47039861788517,3.02084709700611,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.659008451617042,0.337547768761772,1.06075297826625,3.9834248026924,0.0290342575314973
4,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",-0.501772312605595,0.143964516922735,0.456746076532041,0.803083056775821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.5162030315883,0.266154278008655,0.368144632817151,1.04500973837157,0.0644398985931955
4,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",0.70012549550974,0.180789467856384,1.41789872273689,2.8801941195936,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.621317787465124,0.334242368260962,1.02720563981875,3.80778689232797,0.0385950847593133
4,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",0.257199801720533,0.121648325450335,1.02023679163669,1.64359747594955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.202114417755495,0.28750898294688,0.733328769526286,2.26336660235141,0.461715639848674
4,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",1.51326904961204,0.161471510188384,3.32907795219955,6.26922074242734,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39090576834735,0.368216876073614,2.12063496505004,8.98089179913295,1.56017058078597e-06
4,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",0.415762847318449,0.0823766382663552,1.29005240584037,1.78174519492984,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.352162632447273,0.282152061064838,0.863742039455672,2.61048136535357,0.174495599557927
4,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",1.0242774799772,0.171983167766976,1.99544430326837,3.91583411714709,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.928108472673335,0.34593025611995,1.37522506276273,5.33686865109321,0.00166926284461695
4,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",0.77087611943993,0.11703169394976,1.72134503270205,2.72334741616672,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.688279084816525,0.310690603782265,1.15198502009617,3.89374471518519,0.0108559537585927
4,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",0.759524599101116,0.0760590412075971,1.8421712800947,2.4820650183188,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.677526094731703,0.298170917762427,1.16766046056406,3.7577134998149,0.00829482714959442
4,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",0.948292014115487,0.119567193174918,2.04515898480868,3.26797430502179,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.856192950996439,0.320871447756419,1.3414788311749,4.71885211163153,0.00158058193182957
4,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",-0.343899690902741,0.168145354233453,0.508791057430661,0.983536857518754,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.366783394732054,0.284409219177401,0.413422730822175,1.26058891512755,0.206402614680775
4,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",0.515030204915495,0.108070978157124,1.35597754537293,2.07125163646818,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.446133012210425,0.294791271786725,0.927550145099585,2.94571664411117,0.0951985701501607
4,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",0.737135939377462,0.0639088752950923,1.84502787884581,2.37029062830479,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.656327207203527,0.2943493458748,1.15114774190939,3.6494910323734,0.00967391401498173
4,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",0.913362566335156,0.456213797511621,1.05900532346749,6.33224806865509,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.823135483620954,0.529109030313666,0.863173667519807,6.86839129777539,0.0984976006578413
4,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",1.43940330606589,0.0579704782732201,3.76809233611736,4.7294502092492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32099892939893,0.333852952620778,2.11004393008426,7.80986980762725,1.5654712132405e-07
4,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",1.38876949038831,0.109636434548386,3.24030317383244,4.98001958526807,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27305475586715,0.342593846246426,1.97425007478993,7.5619705970775,1.84465886489433e-06
4,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",0.300767650230742,0.134374571010226,1.03961002096655,1.76047613238385,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.243351083502264,0.294600474492,0.754301072504591,2.39372073766047,0.38372635467042
4,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",0.190633423492125,0.142279073887154,0.915863088192921,1.59973074166956,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.139138832090012,0.293112615442381,0.680189056267787,2.14597896849626,0.625835028360276
4,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",1.14790953730312,0.115597308928729,2.51795492452236,3.96133131165989,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04509392270609,0.330492494660488,1.59850692805072,5.8391007101455,0.000103981517166223
4,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",0.898545102237455,0.0478818612260637,2.23644002534344,2.69818351469475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.809098071066749,0.300401092130508,1.33044008889659,4.3191577777381,0.0012257729426484
4,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",-0.509599763371129,0.160679405574136,0.438418121696301,0.823056431796857,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.523608695294134,0.274448392485613,0.35950126176668,1.05419805214529,0.068234711087641
4,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",1.58424179698513,0.0414902726136946,4.4959620519771,5.29000162060333,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45807930461651,0.340798129463636,2.3982075448772,9.12142207777714,4.67060402648753e-09
4,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",0.0106207942094339,0.308469437193314,0.555843389011477,1.86248063818361,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0312706495507541,0.387056229290124,0.47576305156944,2.16928408699326,0.929109212202388
4,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",1.39882227553353,0.428377827125795,1.83080136433404,9.81551209297083,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2825912448055,0.525600974300985,1.39453296634062,10.94494305143,0.00691281981845609
4,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.37779508281001,0.075879639793035,1.25762135934657,1.69327555126312,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.316277766780396,0.278608096997778,0.838411881025038,2.49896807681619,0.219878977397521
4,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",-0.558797196978242,0.205736201853337,0.382465002383017,0.856717515384699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.570171433600115,0.298948623507068,0.326846712659442,1.05505519594057,0.0673913229490711
4,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",1.64558553318525,0.233132230554043,3.30728282742277,8.2481464737074,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.516135093733,0.409461592391966,2.22693853547956,11.0860519433888,4.49347886848018e-06
4,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",0.889663963201874,0.172911236157944,1.74323382097785,3.43336729033079,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.800704654158925,0.339571528280837,1.22173392392215,4.62449432593732,0.00680398016434049
4,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",1.73891165055091,0.187850484940486,3.97189442977771,8.29459034913932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60445631560516,0.392843156837867,2.5207013066076,11.7570614792048,1.2419851322043e-07
4,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",0.448696150137543,0.173193950721924,1.11768661415037,2.20376847383291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.383352565573334,0.319017509940293,0.829628691052142,2.89721120649893,0.196936043498476
4,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",0.732060854119366,0.129796500661695,1.61375832001937,2.68413563398221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.651543502564579,0.313345423663266,1.10370804736111,3.76959268017379,0.0180212592926225
4,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",1.19983092955203,0.0602368048651242,2.95129493380925,3.73731698692486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09425943821602,0.319688152224744,1.71725972183058,6.01276292775501,1.461400807325e-05
4,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",1.62120351310383,0.109714985767748,4.09219466427239,6.29122786177025,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4930478132027,0.35684873912246,2.40977026952459,9.76058924755366,2.20546462645993e-08
4,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",0.563633505924864,0.0515701049284114,1.58837202736171,1.94421968476834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.492138991047918,0.282944718119013,0.995020807990363,3.01660276144852,0.0503485699296096
4,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",2.44907994676481,0.352673381607998,6.04608462718395,24.0916461106754,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.2765882935695,0.52634724008389,3.91349634062764,30.8049209108794,4.02977689389375e-08
4,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",1.41681050967479,0.390005318817896,2.00164954235889,9.2328185395065,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29961607289105,0.497991250825229,1.49783773333957,10.5498578879149,0.00342946591111022
4,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",1.54553130100803,0.160897043664558,3.44055501418352,6.46457726154206,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42143998402703,0.369881792956647,2.18149295360254,9.29911718185081,8.92814962141782e-07
4,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",2.40020039786584,0.372732658889752,5.53972074482966,23.879712927479,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.23033203056184,0.536232936378349,3.65720892924258,29.9250150422294,2.16538643059708e-07
4,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",1.97084832717912,0.147586498212978,5.40071824829076,9.63170629884193,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.8239764441811,0.391496764179268,3.17392359892179,14.7258973257608,1.10369749832702e-10
4,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",0.559083858465729,0.130407312861905,1.35738133704649,2.2631205363758,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.487831236752176,0.305060822838243,0.948680530211404,3.13658075891336,0.0772665214835165
4,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",0.539360761709479,0.0693121977297912,1.49745177519755,1.96494384917106,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.469193129824177,0.285152266303047,0.967728540712143,2.95935896778528,0.0661884665975399
4,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",0.923897850605445,0.267723133953479,1.49995514629196,4.28401479420937,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.83310563214032,0.393536857930727,1.13655446989848,5.3155549967934,0.0185376474974018
4,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",0.635751228911818,0.434353608770039,0.840610950418968,4.61360030718107,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.56040615943365,0.502732908867329,0.694234211309984,4.98149922691126,0.244002345444825
4,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",-0.183927686274475,0.189133250618115,0.575375353527146,1.20762552617396,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.215379724597445,0.301913635845189,0.465982188878399,1.52176651126942,0.472722795923468
4,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",0.567117299531383,0.192996884276443,1.21208450118472,2.58280363791916,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.495434466589345,0.334440547726264,0.902701212145326,3.34885733341312,0.107140198834821
4,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",1.37238840586501,0.371824581282331,1.98045586675552,8.50668759218224,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25757364907256,0.483035448979324,1.47671468888992,9.80883962889029,0.00344014111822206
4,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",0.440922076474778,0.189960883539978,1.07699941808982,2.26780371858604,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.3759980441168,0.32730174095964,0.810179904341952,2.92267793452556,0.219628298193529
4,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",0.83659770426287,0.126597847340295,1.8053908518899,2.96545817815933,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.750481194214758,0.31748460365087,1.2116289869051,4.20587560809339,0.00615860730445514
4,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.370999639889879,0.0726308728643923,1.25703934844131,1.67107481722162,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.309839875157618,0.277480590317311,0.834763471635334,2.47712116440963,0.227940026142451
4,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",0.56107057954631,0.395520227655495,0.837003339965111,3.94513661900012,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.489684473067969,0.469972372308164,0.688496280205105,4.34494231880513,0.276488988292302
4,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",0.0854048760037784,0.449034222606997,0.469100604278853,2.72711366079898,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0395262913977356,0.498856308105414,0.41091053952006,2.90403468602495,0.940131202852266
4,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",0.300392299114614,0.301298361993853,0.753146349655324,2.45363883536052,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.242998583121482,0.391480851930129,0.62383700103305,2.89420534122107,0.522883500142636
4,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",0.349204121077358,0.292010647164939,0.804207655790133,2.52631807969173,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.28920400765043,0.386723557998825,0.660073810308363,3.00574324913768,0.438122689176752
4,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",1.72557914088731,0.149923673552859,4.20314740804215,7.56493404450313,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59184370027773,0.376571593054421,2.56828261533405,11.2387873591367,2.04898530329085e-08
4,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",1.73185546197482,0.131966428624107,4.38065101407541,7.34850022392872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59778195842492,0.370691983804771,2.61404219758284,11.17840322423,6.84274587786839e-09
4,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",0.974824598515115,0.150881952336087,1.97831796152409,3.5740283688707,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.88130461354639,0.334162789011765,1.34119185570049,4.97016344590131,0.00196473551144916
4,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",0.746576151249451,0.180698331190288,1.487376624472,3.02024621396121,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.665280658860193,0.336382289078345,1.07002685316381,3.99993490739036,0.0267028266988542
4,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",1.21730914252087,0.167204739413382,2.44577771133004,4.71049825605842,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11080743419388,0.353969949182512,1.63354721341719,6.54231160133664,0.000147036396073283
4,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",2.38576130648869,0.172875613728691,7.81429824193214,15.3884175141199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.21665906457169,0.429370708986018,4.43994964576246,23.8968173928987,5.97784641600611e-14
4,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",0.62345994700598,0.369778328205364,0.912188692561019,3.88683810457865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.660485069480887,1.30376272439826,0.390568288332849,64.7480456759622,0.436499618697619
4,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",0.760721910664282,0.201017620815648,1.45471452705313,3.1988273008285,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.801176694281683,1.30297727799875,0.484414398520117,80.0588934372726,0.315197712949113
4,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",0.207715100246078,0.249042758086867,0.750767162054392,1.99285834098082,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.234322901929588,1.1135131409216,0.298597442849529,23.4819571950716,0.754696133992692
4,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.633323010748956,0.221615368264556,1.21715936769501,2.90152377061069,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.670587966567993,1.25316536569342,0.432020939669989,58.7350555124636,0.400605554977293
4,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.600195025262202,0.162338939139506,1.31935424205058,2.49303128682361,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.636619883354756,1.22533882663466,0.430893737980277,52.527990044892,0.415706770726052
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",0.897944855891778,0.146837122135725,1.83501079786727,3.26298136908486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.94183476832177,1.35946161025196,0.552969082401855,114.038761189375,0.233166452853214
4,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",-0.974319880158332,0.283675820819754,0.21671440249199,0.658898270661239,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.977252200022889,0.860507883830634,0.106005892344838,3.09215519898204,0.264279366636595
4,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",25.9332861148642,NA,0.117787669950164,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",30.0254835411412,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.53434286379425,0.122722152594183,3.64555787191634,5.89775283778874,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5941642090278,NA,0.930815013741838,NA,0.0449975085380103
4,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",1.55894364717167,0.183502709471659,3.35937276992149,6.89689757852575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.61934124615606,NA,0.932870975635234,NA,0.0448454948321442
4,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",-0.183771921750777,0.460728576078144,0.326067041668502,1.98450708232347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.166934498522427,1.10367432987194,0.180070226907633,13.6251250668721,0.880875125074377
4,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",31.4348307177608,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",32.7979928735099,NA,13.5646779044897,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",30.6229935875497,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",31.9603616875246,NA,0.0701384440094829,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.50686201507002,0.174882906530062,3.21203138958498,6.37530520540432,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56600949129402,NA,0.897288850150231,NA,0.0516819517255667
4,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",0.887748305745304,0.207947205905641,1.61515877824669,3.64943125559226,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.931383462853446,1.36813323174623,0.536114749645,114.385767916729,0.246214493435308
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",1.39559701824269,0.213527634557879,2.67367160835286,6.17473279103273,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45196166006776,NA,0.80876281152705,NA,0.074151890044541
4,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",0.404277110426947,0.178817677548358,1.06483960188472,2.14636689143073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.43584938392093,1.15698471077767,0.364133017381597,33.9558340563202,0.571795498657844
4,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",1.36928418522521,0.310567711113095,2.22281042273525,7.50954898347382,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42495078046945,NA,0.754371100975692,NA,0.0912846873095189
4,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",0.81899844039516,0.172910475458585,1.63187508986193,3.21403232374511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.860911786609579,1.32404950913635,0.513856270502175,92.2375229599567,0.277664584191475
4,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",1.91363068788396,0.298018924415396,3.94547375776525,12.6895872413745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.98292275750676,NA,1.17955536306741,NA,0.0187740465130105
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",-0.85157509355004,0.892569514827846,0.091865031621365,3.03852858097568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.851438230216677,1.29429514861971,0.0545377710353939,8.71183096140273,0.497789113477996
4,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",0.049360911689215,0.503037905902366,0.363281327156779,2.60985487911313,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0720177665578155,1.18591135329791,0.211231775410163,22.0626866767761,0.916398917968333
4,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",0.759368796345335,0.13904284780047,1.6230905484117,2.79930179101772,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.799785197164368,1.2888033960189,0.494878791122276,77.3680624721697,0.308013894659144
4,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",0.513449992842254,0.209191907990623,1.11561879193359,2.53305588197837,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.547709012628135,1.203221216864,0.39345726378091,43.9809980688713,0.486740653822446
4,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",-1.87487914858279,0.323136764237208,0.0812211440576757,0.288255848332465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.90035769547506,0.746364478853481,0.0461485527678386,0.860540428342072,0.0304368577211042
4,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",1.30958181389979,0.391831644184208,1.87830964524374,8.72614829110637,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36376234694061,NA,0.680915560297143,NA,0.119772761684273
4,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",-2.9757084362014,0.485293565081767,0.0186593178990586,0.125043472839107,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.02871574607199,0.737598980217278,0.0137509322561322,0.247755282474983,0.00143422578968738
4,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",30.1036525020597,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",0.11078017251477,0.188757999607981,0.765518994133717,1.60434650323354,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.134989958343435,1.06828858049418,0.283861127302842,18.6966457655039,0.843069087689171
4,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",-2.36690073352011,0.383461752389856,0.0433092056835195,0.194709297281282,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.40466148333664,0.724010699491717,0.0276766306463767,0.472793249833484,0.00761654919445235
4,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",0.676859427471751,0.162891474284974,1.43980290539806,2.72652820186007,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.715208457854814,1.25692460566463,0.458888717063359,63.3139935569145,0.362812725561912
4,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",1.32678046930145,0.151072369140865,2.8289228132783,5.11454690059825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38139613916335,1.77972280291718,0.782074645078434,837.633038845957,0.083456288172716
4,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",-0.44514197475529,0.255633263212797,0.386530009161032,1.05286835642089,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.434844442959427,0.951460818967749,0.170873604438662,7.11942329775164,0.628442341944104
4,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",-14.9157734976015,NA,NA,3627.18286314427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",-2.87513161599068,0.45353492074921,0.0224248507677136,0.132687133057221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.92558567438295,0.722799392169334,0.0158025020769385,0.268671606512915,0.00172410285286
4,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",0.393368980560419,0.170471585389092,1.0667157495245,2.08094240568161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.424663789927514,1.15141108178646,0.36204379069291,33.0313925177792,0.580239556666639
4,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",1.14749465813761,0.316759850245035,1.75496485925162,6.0746515524248,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19760835304932,1.58615507325234,0.626656386655819,314.271329259846,0.155462145891424
4,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",-0.521595687052944,0.661658028890857,0.153598197608355,2.05491938970452,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.513207783731855,1.16377112463363,0.104637372737434,10.0206151084277,0.643317563742525
4,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",2.13098543024194,0.186541485413347,5.88663330521556,12.2302626490098,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.20571373832112,NA,1.46835031658764,NA,0.00657106388202785
4,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",24.9833291906613,NA,0.17869344811912,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",1.72602432068483,0.389137889370379,2.86706882906079,13.1797648874561,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.79062376179297,NA,0.959927288970979,NA,0.0417754002264278
4,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",24.8912310768305,NA,0.396349603494037,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",0.918312724778895,0.347675393072371,1.29031880285697,5.04174281685322,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.962712732293754,1.435397893141,0.508028267588547,141.095668456055,0.257676884284161
4,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",1.85597126065957,0.158895696516296,4.74145144343819,8.83925843308103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.92381983106516,NA,1.19135353795952,NA,0.0167268140314068
4,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",1.47650210774248,0.315311100521912,2.43160441724044,8.36911459194131,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53485404367316,NA,0.820987494344567,NA,0.0698954322570817
4,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",0.463460280573502,0.151141307651247,1.17720919155366,2.12890887768537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.496507709857077,1.1717502425954,0.386385607983011,38.1779118657756,0.519575311302678
4,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.10351036056091,0.123925154417945,2.36281111466034,3.84060435886178,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15254259680314,1.48718676295669,0.657806761507509,223.815246933149,0.144696658546916
4,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",33.0297234845688,NA,9.23206104688142,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",1.17403544305521,1.17647411772715,0.173828399934538,17.4966096052074,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22483115199895,NA,0.230013353578506,NA,0.386570822217476
4,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",32.5134006630232,NA,17.9610292744652,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",32.519284117561,NA,34.8984425422109,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",1.98813809957332,0.387999570875296,3.73684478668239,17.1015992974616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.059273034264,NA,1.1880128225948,NA,0.0193929975583134
4,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",-3.30294118930914,3.28649010809782,5.80854372521285e-05,22.8558915412185,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.36411627783143,3.57538429094919,4.66283372533777e-05,56.9370787323482,0.33522860836008
4,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",0.771537889392826,0.332625986421515,1.16067731362963,4.27538276133873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.812266645040111,1.35253801961775,0.454236190666055,91.1688826532361,0.333646558566552
4,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.0918303057801719,0.170292561238517,0.77974682623894,1.52005813371756,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.115560911034675,1.05861634396643,0.281599722160143,17.8576354647661,0.860880071324718
4,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",-0.580831843463241,0.896945636136586,0.11776482797049,3.96258527463666,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.57392411858641,1.34276135336622,0.0698815254112054,13.4984359059725,0.653946000116418
4,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",1.10648915600133,0.167150117004161,2.20188097632046,4.23985216964113,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1555956489198,1.4984883163837,0.651057429017231,231.553011502706,0.14768484601488
4,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",25.7183936470444,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",0.0854982833840716,0.180562520363631,0.767053228090452,1.55673859952389,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.109070497758305,1.05920266144304,0.278910703146768,17.7278088604454,0.867488737681583
4,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",2.6164570668317,0.386066953034569,7.03783783339399,31.965450389314,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.70332284871281,NA,1.96354247208115,NA,0.00219621999515433
4,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",0.650453514817159,0.25264025461677,1.17006578049723,3.14996571945061,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.688150035596694,1.26953006166469,0.431328835119937,62.5259627845821,0.394111608695395
4,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",0.0952536354245986,0.226418008000154,0.70684263277281,1.71702829297103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.119095934465547,1.07407742341142,0.275064150479809,18.5330421093395,0.859912699685757
4,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",-0.330320745869131,0.242137005939823,0.446297250930281,1.15302572785615,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.317150694783075,0.972154674045986,0.190098718487651,8.58970614374091,0.729550846585888
4,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",-1.05797193819221,NA,NA,36.1646856597015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",0.363883321028154,0.201633447017581,0.966817617613428,2.13111044755187,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.394389628388721,1.14896640562424,0.34866450159286,31.5073362743806,0.609029362474796
4,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",1.0967824510045,0.225233109679053,1.93560425335583,4.68008896593364,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14565003089437,1.50708046796948,0.631304587183087,232.218804642092,0.158382316154429
4,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",0.588008984427027,0.300689820626473,0.987483637642766,3.2094098923118,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.268555898018698,NA,0.619904608384814,NA,0.364748645425418
4,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",0.168697606950016,0.34184284442411,0.579482610373234,2.21306780997556,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00770907800436491,NA,0.491074929609724,NA,0.862865415444258
4,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",2.77510571771009,1.12035844383291,3.51482951883297,283.926505840299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.62919047590722,NA,1.03648311172144,NA,0.026797227977686
4,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",2.45306328202734,1.12463634160543,2.51362920901283,206.483614244051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42884359447396,NA,0.870974120476601,NA,0.0517665257604371
4,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",1.57646800301897,0.228898402673701,3.09273379565572,7.58612312737284,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.883499606863801,NA,1.02219815578961,NA,0.00537356827940996
4,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",-0.213730554409781,0.695083237173989,0.207299032892082,3.16161602573788,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.230220774251161,0.741499707396213,0.301395556401476,5.51401871120402,0.743328090857324
4,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",0.716263130360644,0.281101850409646,1.1729637308541,3.5304758190246,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.348336779645665,NA,0.666271541388421,NA,0.250751427325758
4,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",1.31399378449034,0.492936242388384,1.4186676638959,9.79618211645142,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.720216418187401,NA,0.798685068564496,NA,0.0730392079362048
4,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",-0.0278775068331979,0.3412568777023,0.493552551259373,1.88057285515514,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.114576486684658,0.612369410428183,0.443977139832985,4.89621165570966,0.876547125016025
4,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",1.46492991715529,0.464355662499941,1.76378465693139,10.8884503070303,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.814115450638645,NA,0.875007476508478,NA,0.0386033258941094
4,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",-1.16097588961348,NA,NA,6.15720600192703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",0.608578640514259,0.857604757900943,0.441247714414836,12.7254003848213,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.281370020677976,NA,0.408572165215019,NA,0.58264310851281
4,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",0.686728009503366,0.319172933568914,1.09405407952325,3.82296020342893,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.329976242502664,NA,0.645159204459271,NA,0.289415821367099
4,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",4.09633379223507,0.177341727924045,42.7992599023075,85.7715708754851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.45114745244551,NA,3.02036558123351,NA,1.31862886367393e-14
4,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",1.50392829032828,0.294334137583401,2.60948637360699,8.27237812713303,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.83837384287507,NA,0.966835236206336,NA,0.0121267534331487
4,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",0.119160461888481,0.766343253908898,0.182958730402493,3.68959127529066,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0231272238734019,NA,0.339284656890107,NA,0.952737801583501
4,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",2.20394875105698,0.380128153015079,4.42583828896332,19.6393397194733,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2738682316528,NA,1.29213220473601,NA,0.000584460281290421
4,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",0.690190864880124,0.84375384691904,0.497418700489112,13.5872404713085,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.332141891873039,NA,0.43338057052709,NA,0.522291623840471
4,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",3.035927574536,1.1178761962436,4.59680723982077,367.732639797941,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.7914506652571,NA,1.18894960631623,NA,0.0150111890020464
4,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",0.368251401377163,0.543836625846754,0.481288306449157,4.05727514416072,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.131858626311267,NA,0.473909226399865,NA,0.679489648375956
4,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",1.67504372908876,0.787432285969692,1.53941914364099,33.7197259997171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.944816888524617,NA,0.774966752199779,NA,0.0829974170095171
4,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",-0.195529452417092,0.375631035534345,0.4001191409755,1.74447504827443,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.218874962260733,0.567929661934286,0.397947154371794,3.68697856591132,0.673743112734552
4,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",0.171299873231556,0.343597810624691,0.61989988349648,2.38376548926791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00932823598795248,NA,0.491226775751852,NA,0.859685955462391
4,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",3.01792584775258,0.221041715445539,13.242583806154,31.497408912425,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.78025370301243,NA,1.93563369650395,NA,4.45574442434801e-08
4,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",-0.889873621178038,0.700462942010457,0.107377252574313,1.67256329586682,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.65083156500362,0.604641144017354,0.203646848183838,2.17881643589009,0.264629372578827
4,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",-2.53058493207695,1.35221270348634,0.00361683678904154,0.725003313506687,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.67153811776547,0.900201022783049,0.0357896699613192,1.21972715613562,0.0712596381842141
4,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",28.8598155400172,NA,0.173947669928396,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",-0.256043332679959,0.266859291788255,0.44983360424804,1.28042450662893,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.256521550802165,0.511922464398211,0.411581693616999,3.06164218578647,0.566209318681672
4,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",29.9034032033645,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",3.66149017857026,1.11354124048515,8.70846183154067,684.916292855964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.18060913483704,NA,1.63292891478019,NA,0.00313848212352828
4,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",1.97448760622292,0.421984699317565,3.20374444066768,16.751199854593,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13114035317259,NA,1.14104583807501,NA,0.00323296463368704
4,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",29.5676612816176,NA,0.109246154374704,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",-0.994005181473061,0.639140349737452,0.0940460179378462,1.15190036420729,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.715599644501383,0.557668156393985,0.204130078775999,1.81669906978766,0.189217095394797
4,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",0.694554105641088,0.196727081874629,1.36128736021132,2.94346315183768,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.334856971293992,NA,0.680570626505198,NA,0.235150387196414
4,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",-0.62843391533187,1.17752799091964,0.0981730663463088,9.92246651761995,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.488175234372664,0.980172782062155,0.140557584183336,6.55395497629752,0.586814752915098
4,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",1.73907253064642,1.15126362751395,0.313094222097682,28.5489280389564,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.984650645297045,NA,0.574928849721606,NA,0.181264464786931
4,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",1.85655614817189,0.897648631128938,0.897115273241918,30.2696953975763,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.057742972438,NA,0.776871396107116,NA,0.0801568585906376
4,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",0.700149982580192,1.34216177541954,0.244956330660655,47.2051103081559,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.338337863546614,NA,0.257748824937772,NA,0.656924426162694
4,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",-1.00254573530609,NA,NA,77.0943491613475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",-1.01597509024338,NA,NA,48.2482578494751,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",0.86219442300557,0.488791365807781,0.810967052666169,5.50963894953153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.439141876097807,NA,0.637996452950081,NA,0.250602372842206
4,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",-0.282556040557478,0.396032116618991,0.339221609831188,1.60210069379486,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.273015059681929,0.553335430316261,0.374728838727217,3.27881612020496,0.582064061924602
4,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",1.47548064587045,0.808388418269755,1.19009344772693,28.2998414510749,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.820679251497912,NA,0.685725988863263,NA,0.136213254104553
4,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",30.3018232695606,NA,0.530662110566622,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",-1.53832086132005,0.622674960004875,0.0694527950737232,0.797505160593264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.05423996499378,0.500484069856478,0.151375909470125,1.07666945079713,0.0433725185092188
4,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",2.51166827772588,0.249864757980905,7.49284140690775,19.9534076635976,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46530443576914,NA,1.54740121318838,NA,9.35729983466968e-06
4,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
4,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",-0.0699586563530913,0.244870277211114,0.57000045771764,1.48848039929624,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.140756086085126,0.560730859655003,0.457550487278077,4.1212500776244,0.805854302187538
4,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",-0.00474822530797211,0.242632029884218,0.611051427878941,1.58174066415147,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.100187763790186,0.585822897533465,0.473394797580342,4.70468108939102,0.898619426307058
4,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",1.77095111014002,0.136153452704135,4.53691475791678,7.73657388930575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.82641872296049,0.150318421623847,4.63505316973568,8.35520798738098,3.41833441035508e-35
4,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",-0.0538842621115991,0.0327815335741756,0.88858811963495,1.01043384891346,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0544393250042176,0.0517725018426706,0.856478448605757,1.04918991229719,0.299870165345975
4,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.406609960953966,0.0102042704043147,1.47199779119191,1.53207116826196,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.420171225474998,0.043756289663072,1.39873874026617,1.6604562839211,1.02337931219915e-19
4,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.36083801149507,0.0249201833172339,1.36624286712894,1.50644092183403,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.373007815992555,0.0493509772863915,1.31972568743526,1.60139668824926,7.24717629914638e-13
4,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",-0.0459702131842223,0.0142597744172838,0.928745417960473,0.982138120825427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0462823907492206,0.041936504733268,0.880302953629005,1.03758812841022,0.288477449284742
4,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.627390325811209,0.0357734787831962,1.74586582833692,2.00868457861042,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.647743678724981,0.0575052071198844,1.70964872308187,2.14192336499142,9.19691429396414e-29
4,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.423652164365828,0.12326774869403,1.20301867259261,1.95040034055566,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.437753513352561,0.134025062253041,1.19272159527453,2.0169900799305,0.00126351412189243
4,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.50152853000973,0.0369657917007668,1.5360739395739,1.77559044395888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.518008473201609,0.0575858633413584,1.50133162258635,1.88152929135901,1.83450771307449e-18
4,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",-0.000318998995876786,0.0179710687146534,0.96507008196812,1.0355065615249,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.000770129156188231,0.0437096344274017,0.919531242207134,1.09138481285124,0.953467672474003
4,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.62914273308294,0.0199042243606789,1.80431494650679,1.95073088368605,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.649542614400056,0.0486737275438096,1.74263262684995,2.10895903979555,1.65974564480062e-39
4,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.365897761648932,0.0177481847499807,1.3925713033683,1.49290442723767,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.378245252060991,0.0459746028384327,1.33546750144001,1.59919207794237,7.98684712305574e-15
4,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.47552888592832,0.031529081290142,4.11265647792508,4.65369204300029,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.52191213007427,0.0605485847563479,4.07519148921293,5.16685314755697,1.58114537599733e-166
4,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",-0.0319221988525259,0.013747951169386,0.942825295812617,0.99502909658172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0318032175449481,0.0418438002953514,0.893307554123711,1.05253372753454,0.449705766421022
4,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",-0.0188673165527643,0.0270829102710399,0.930604910696228,1.03483562200368,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0183583875081956,0.0483394318245198,0.893963071472621,1.08047015928645,0.676853773866504
4,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.642343761391183,0.0167951590096504,1.83947359916249,1.96465224838077,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.663156023094522,0.0475112021412373,1.77053303003551,2.13298229359612,3.38302221475523e-43
4,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.679807749554547,0.0127437298388758,1.92487566752821,2.0234740893472,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.701768115417271,0.0464217950068479,1.84422319869325,2.21229016104801,6.44625412745798e-51
4,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",0.82977672136342,0.0582047680015451,2.04671176727216,2.57125212234318,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.85634284098085,0.0754199149991267,2.03372130494622,2.73329517257622,3.93991217625809e-30
4,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",1.30612047753106,0.109277464174637,2.99216407568612,4.59218839493557,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34730802136087,0.123099391609602,3.02715254553593,4.90454914751562,1.38168591239422e-28
4,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",0.11022130205344,0.0402039053241586,1.03197378479435,1.20812512851023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.114718543143056,0.0578431934634983,1.00239818309539,1.25751363254377,0.0680633867549804
4,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",0.0159630509729209,0.0419378397324746,0.935972127766372,1.10320957852911,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0175660510445809,0.0586987375152246,0.908032147397121,1.14295764319109,0.822184824444207
4,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.779189873646255,0.0349958451879288,2.03566251251487,2.33497811209278,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.804202559370528,0.0579067615719775,1.99776114637865,2.50682612510218,3.02659816636244e-44
4,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.122046690936564,0.0299703066100834,1.06539346873639,1.19820622777768,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.126876318820264,0.050890697370749,1.02859251729605,1.25568249774848,0.0230960556677694
4,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.504372400762648,0.0276508324557253,1.56875229079191,1.7483454012354,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.520950032542806,0.0517525812976342,1.52305329952721,1.86560138695078,1.50266126263808e-22
4,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.42703003000248,0.0328526216829985,3.90783638162371,4.44492846889443,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.47192508332779,0.0609370820035318,3.87343362915751,4.91853306462912,1.94695971356951e-151
4,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.33051093266746,0.00870931924455737,3.71901865854798,3.84817779445443,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37246269074122,0.0506260062975855,3.5781091310525,4.36354492518022,1.13503273838699e-198
4,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.478272496575371,0.0582780414955197,1.43967586917261,1.80916194137936,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.494069785553181,0.0738898985742968,1.4196492914985,1.89658128800448,5.58775413309118e-11
4,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",-0.00590492612869906,0.0113476319332838,0.972252223545777,1.01647613974506,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00499422672950764,0.0412384534861101,0.918677840055874,1.07986063835138,0.852511652637877
4,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.717032098009942,0.0364189701649113,1.90804416836706,2.20083858239529,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.740137051064444,0.0584603384055611,1.87170285294418,2.35374799381285,1.42761223459841e-36
4,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.29063731028427,0.010673468949416,3.55995409048813,3.71205962777685,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33137759745752,0.0506731688181958,3.43358358788226,4.18806856779422,1.6738432271115e-183
4,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.35910766571387,0.0110309316713287,3.8095903854749,3.97793217622153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40189533394049,0.0513437838146022,3.67986467710866,4.50028133266983,1.61270180143895e-202
4,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.374488528168646,0.0337294025921023,1.36131462284425,1.5537443009493,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.387077667672639,0.054708118437379,1.32445282112931,1.64123875078421,1.20847559472234e-11
4,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",0.335703694951195,0.0652359863216359,1.23115758443816,1.58990651631865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.347127033444391,0.0792742011280164,1.21270793104445,1.65467559891567,2.07442278963326e-05
4,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.613921411955164,0.0320063017122534,1.73555073472693,1.96754620795804,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.633862024071756,0.0550137750038524,1.69432093205702,2.10208995359141,6.82483905806894e-30
4,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",0.930894401062164,0.14538029315133,1.92195543060276,3.39812360529322,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.960562434793121,0.156923974320288,1.92397094519593,3.55915062116766,9.30691093082219e-10
4,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",1.13053745428492,0.0518259437803163,2.8001069473004,3.43086212662266,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1663342618805,0.071909847199247,2.79235075742626,3.70160025592133,1.20495278527655e-62
4,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.3837438438294,0.0529814459868364,3.59910657440514,4.42986492601923,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42731147908163,0.0742373632616062,3.60899538363622,4.82801091080479,1.24411203873433e-90
4,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.0282541180170343,0.0292517265680228,0.971382618738756,1.0894029772458,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0302188948881814,0.0499212738794936,0.935563465013686,1.13778285299437,0.620967420035215
4,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.373238867155427,0.010351648666624,1.42327930518882,1.48222049239781,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.385775108597396,0.0435563047783799,1.35195743155735,1.60366409257836,8.09334486953747e-17
4,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.64845328968771,0.00991985764775051,1.87578527805611,1.95016213280955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.66944679114036,0.0454498751298449,1.78894846497935,2.13782345470042,6.35465231389767e-48
4,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.32992121557918,0.032152131818189,3.55097523486112,4.02794500097218,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37183531723847,0.0598351423850013,3.51189894809728,4.44023076950382,8.60263087278427e-134
4,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.30991896159884,0.00907441205169506,3.64062829399616,3.77246003034334,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3512398272585,0.050519932539061,3.50366022764782,4.27097738970033,5.4461043006057e-192
4,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.35655631428255,0.0298341071154033,1.3473920813182,1.51455017916544,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.368597600631321,0.0521422971421288,1.30674729580515,1.60309336867816,1.63698289780376e-11
4,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.679314490676058,0.0280252913652686,1.86734333419118,2.08417661276712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.701261844369654,0.0530728348852401,1.81941672364896,2.24018322204346,2.38709320986393e-39
4,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.407578511086578,0.0196150125147564,1.44653924585065,1.56215052377918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.421166283537837,0.0470473748647965,1.39112975900165,1.67286631905414,1.54364039646442e-17
4,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",0.280562583639384,0.154808342584726,0.984222806128488,1.80567516301363,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.290272199533863,0.164911353497944,0.968666006018801,1.84892653893734,0.0835743913693783
4,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",0.00520865742029882,0.0113444873202396,0.983118507088449,1.02782401792537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00644134926378121,0.0413104890055185,0.92913409985081,1.09245989647856,0.950257736019391
4,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.35756177755789,0.0100716057112538,1.40190218999143,1.45835631587108,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.369614577984116,0.0433757212207887,1.33074737658653,1.57738817348747,1.35767173192264e-15
4,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.689037869364221,0.0153163624523474,1.93295644356877,2.05256392018801,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.711283012231126,0.0473075297354922,1.85863276301721,2.23733013896236,1.54496918470359e-50
4,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",0.00322224218853577,0.0370502382915327,0.932913386476659,1.078737471602,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00442099405994186,0.0550273896781565,0.902649036186935,1.11994764480592,0.988718508067175
4,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.37325618993692,0.0137028953318993,3.84377423224561,4.05588583841658,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41649013770196,0.052140110973062,3.72817112665073,4.57361206145894,3.65249321205592e-200
4,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",-0.113024147945038,0.0673009075927971,0.782617535257826,1.01887955391263,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.115394235177289,0.0795021406081296,0.763190859502589,1.04226426988666,0.149146436168962
4,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.366175678731803,0.0168853701524824,1.39531444241484,1.49079454774895,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.378517687139602,0.0456302973093559,1.33673509757965,1.59855104999854,4.98373007431861e-15
4,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.681043680813141,0.0235495366698021,1.88699032975871,2.0694764015294,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.703042714805552,0.0507209446079353,1.83108229928724,2.23385694178659,3.92159412374868e-43
4,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.32814536549688,0.0151763812208692,3.66364679584514,3.88821181728452,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36999765114776,0.0521998316690435,3.55830100208083,4.3662423474588,1.3498407912976e-183
4,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.627384978290844,0.0118116820163701,1.82988710571616,1.91660466473257,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.647734425879738,0.0457723634634246,1.74940280657029,2.09321014899291,4.42946473719574e-44
4,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.3588409708652,0.0251834246056058,3.70458164204258,4.08894726995007,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40163217748109,0.0563965654921119,3.64264297418488,4.54387414654896,1.6617034069291e-161
4,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.36209894081937,0.0109687772354393,3.82147476086766,3.98936961759194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40497826024049,0.0513549085923315,3.69115260469477,4.51428273159644,1.53030107204777e-203
4,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",0.691200391938426,0.149106708435342,1.50090881148782,2.69273755815061,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.713526993251796,0.160058799831139,1.49344606672913,2.7968819633803,9.15765543987305e-06
4,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.27117511562699,0.0284275174653691,3.37260370516644,3.77016542446497,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3112822839634,0.0573634832886979,3.32149916863382,4.15900956409383,1.64343038312325e-132
4,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.0438562089136968,0.0110592163134192,0.93656763585575,0.978062009644085,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0441035438935128,0.0409059981022426,0.883998978774204,1.03774407086879,0.300443130913605
4,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.651451646663675,0.0606895787584105,1.7038964812844,2.16153032221675,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.672548737830301,0.0766616693023238,1.68802551282286,2.27975443209822,3.15000751518913e-18
4,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.693239611866652,0.00979087121825568,1.96219478612016,2.03896667061764,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.715609128053785,0.0457554129774849,1.87238137860609,2.24020864867913,1.30825074670585e-54
4,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.401326314875914,0.0163125909200951,1.44682426572431,1.54236225712126,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.414742400646829,0.0456429856871712,1.38602639065403,1.65757908878983,6.59520545993918e-18
4,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.372147993920098,0.0375247433402442,1.34819477585383,1.5618340214204,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.384668755626013,0.0572551500998938,1.31468621076406,1.64548319790308,1.09580665642878e-10
4,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.30569191701063,0.017815683669985,3.56390107989972,3.8216870091798,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34685956623011,0.0528977077278346,3.47211844485819,4.27216239412427,1.57224235729911e-170
4,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.343498387275816,0.0130777483741429,1.37420465355773,1.44648859609256,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.355131373039842,0.0441217931733952,1.30968890075898,1.5569735108722,4.65523879151504e-14
4,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",-0.0101793962313769,0.0232282274230596,0.945797155967273,1.0359571920392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00939942396534919,0.0462070628308199,0.905780560134468,1.08564051403206,0.797675690552842
4,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",-0.0134278353581121,0.0147349487350385,0.958582023316116,1.01557991297938,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0127412291421966,0.0423177037220174,0.909661303111539,1.0737953271173,0.729017279472695
4,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.351530059424056,0.0126875343509035,1.38634882161344,1.45704114290445,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.363408620973477,0.0440563101139491,1.32074818416482,1.56971793571586,1.01106726506422e-14
4,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.31214803940915,0.0168969684955082,3.59342737856006,3.83949692157085,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35351255893348,0.0526286739577152,3.49715139258542,4.29842793911515,1.02625386331928e-174
4,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.775601293585354,0.11748402002103,1.7307212745377,2.74304094606784,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.800510248883901,0.129300146483264,1.73048610083826,2.87269212511326,6.60848477549482e-10
4,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.388215314091172,0.013582407168432,1.43564867890476,1.51415699608953,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.401222702783619,0.0445925695836908,1.37022629657193,1.63194991527799,1.8633988691349e-17
4,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",0.0371939371586038,0.0214254558196559,0.995218812173529,1.08241384547277,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0394135558756302,0.0455533119685661,0.952335750968018,1.13851874939228,0.471581039853081
4,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",0.119741696992349,0.130647983404394,0.874288537279616,1.45905046927094,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.124515884520554,0.140618305192641,0.860669999626138,1.49357041286127,0.393972989594472
4,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",-0.0320419418555856,0.040846918614011,0.894009600987559,1.0492527185973,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0319477888775548,0.0576520789538059,0.865960417253586,1.08553821831279,0.562656260452539
4,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.35217110431621,0.0116086179906207,3.77899714778404,3.95493282385571,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39474855929214,0.051420348086562,3.65309685437258,4.46888672036209,3.49215586113653e-199
4,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.3879567057602,0.0089242029091361,3.93726273019307,4.0774344359979,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43167939965046,0.0511387415124842,3.79258418895829,4.6344049734307,1.24892762610936e-215
4,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.774094055788451,0.0261086834458004,2.06071360362734,2.28278568948675,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.798950324490933,0.0526539312100329,2.00785677968723,2.46814656904415,1.35552089717238e-52
4,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.43976893045333,0.0236391807975957,4.02939987430013,4.42062609397447,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48504091786772,0.0563169431424456,3.96030115628519,4.93858292370579,1.20063064887945e-186
4,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.414314105890562,0.0270473535944637,1.43532967544888,1.59586871944717,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.428127204840942,0.0508536679636151,1.39043873005766,1.69716980964466,7.12328958297588e-16
4,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",0.00439065634893256,0.0141093016239482,0.977008310488731,1.03256637057337,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00561384264758268,0.042204316428833,0.926732767619143,1.09346094930178,0.965420667760125
4,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.428371090988908,0.038448587514058,1.42360233281076,1.65517411194993,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.442617274542759,0.0582061272027405,1.39055785483727,1.74694548726462,1.89260881306361e-13
4,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.664811357490003,0.0185483050289314,1.87482397661522,2.01621662142198,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.686303659898019,0.0483523153101153,1.80905282331167,2.18658507301906,6.43106604676795e-45
4,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.646300131924119,0.00959079564695768,1.87295028769493,1.94470464033766,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.667226766569851,0.0453588292264862,1.78529822809678,2.13270007794687,9.13151174183206e-48
4,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.611923120237342,0.0122671965142005,1.80020255475187,1.88888312587307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.631798304899217,0.0457863173227959,1.7216865297305,2.06015952026511,8.57110711340753e-42
4,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",-0.0310761796930576,0.0143379465167185,0.942529767592874,0.997020388942775,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.030931230292124,0.0420596197640535,0.893709990953076,1.05389911428292,0.462741775935716
4,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",-0.0286053350550357,0.0184576880770802,0.937284603694796,1.00761333934918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0283845801962782,0.0437508283050381,0.893028869537576,1.06010051131574,0.509832951259305
4,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.674838791956886,0.0121368279866572,1.91760937151819,2.01104559375668,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.696646034383956,0.0462119829548423,1.8355517321926,2.20007786363617,1.46520841314114e-50
4,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.682128863895211,0.0258295438332502,1.88064951608408,2.08103872432141,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.704162169589501,0.0518940111058882,1.82892430186214,2.24150780442728,1.99537194650773e-41
4,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.372564692743514,0.0130273473574835,1.41488331817645,1.4890127706272,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.385090200045975,0.0443073973701074,1.34904391258922,1.60492645778981,2.68883265628172e-16
4,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",0.213841319901713,0.0619901906140817,1.09689248940674,1.39860911612182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.221489244662172,0.0759771518598618,1.07647409504705,1.44993095211317,0.00517195948016738
4,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.38922167473432,0.0232758054546042,3.83346985663666,4.19968634041105,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43293793665104,0.0557571767522615,3.76325999602212,4.68258224072255,4.18016173365581e-175
4,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.34231191353407,0.0145085473084209,3.72074895361223,3.93849015321295,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3845975872055,0.0521146463727555,3.61126425531106,4.42975190976545,2.9318421350414e-189
4,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.643177475264743,0.0162422527084711,1.84299821934809,1.9641550899607,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.664015157944247,0.0473053428321171,1.77279516494717,2.13398479271837,1.16492209185941e-43
4,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.406096155206548,0.0127568377759292,1.46390989822302,1.53897522084307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.419650796090903,0.0444579287578247,1.39608940302146,1.66187573112307,3.7736685455772e-19
4,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.27887929785575,0.0110191409212458,3.51596598407841,3.6711631404637,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31919928761707,0.0506536650946861,3.3923369459452,4.13744218427497,1.54833333207142e-179
4,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.652868180538907,0.0121958590497272,1.87571317585041,1.96756322710806,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.674000755032778,0.0460663964098526,1.79494713020747,2.1501820722141,2.15776768540793e-47
4,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.363138560000602,0.0210265299653678,1.3798228842852,1.4983696681472,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.375368678984768,0.0474011205174618,1.32791160737569,1.59906081489726,6.6626726057273e-14
4,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",-0.0192410335418953,0.0192631680741052,0.944612320323291,1.01870229002761,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0187328521451817,0.0441784338905598,0.900943200556717,1.07128966258644,0.647658101427213
4,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.34375320517113,0.0213595129248873,3.67673331181913,3.99783283507978,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3861163795434,0.0545766831191056,3.59934787010301,4.45795146830891,6.94720272193932e-170
5,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",1.29960486942298,0.508653523196171,1.43324220799521,10.5257467623207,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59365915087683,0.79789002886993,1.0692902010771,24.4020343857558,0.0494414843765545
5,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",0.435023959596112,0.351620763761269,0.829202073845909,3.29049058937951,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.65724552257281,0.678315962115199,0.528864533752585,7.55286341774426,0.355786088633952
5,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",0.326792246464226,0.152845294738368,1.02969713283882,1.87462241223488,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.540009408791766,0.583177510512083,0.566638900526005,5.57326354186075,0.385893264324805
5,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",0.411548719899622,0.227468323924795,0.950453802673769,2.31832217500537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.631828070065793,0.612494246434557,0.586537987514654,6.4715489471099,0.329669428901151
5,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",0.759792098577487,0.232433073305588,1.34327648240767,3.34087473897625,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00902669588096,0.620339049672839,0.842862536523007,9.59011607163962,0.118518520082537
5,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",1.33445177797557,0.345030161180102,2.06906117825952,8.00117452326501,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.63137970277918,0.687859947569945,1.37775590833432,20.4261811855336,0.0200040817654576
5,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",-0.158451781172277,0.531124580902962,0.350925581731121,2.81451232182421,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0144980209635214,0.796720436102417,0.220213049015863,5.00244565776925,0.995777144011962
5,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",-0.0726406816218998,0.181834605189824,0.646285794752681,1.31819725643201,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.107424070280657,0.586275106899462,0.365098120204554,3.63484711176185,0.875378104944776
5,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",0.488450154916739,0.147936708166145,1.22318264358307,2.18443546375324,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.71511154100899,0.584456175555964,0.673604887095933,6.65863526489248,0.247571663173698
5,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",-0.578398091677721,0.21773861574126,0.360972448892216,0.847525838211681,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.440353085867304,0.592440610171833,0.208352530404453,2.12506149676936,0.477232025629345
5,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",-1.08500070309544,0.556963218359472,0.129886463891629,1.15276238116491,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.989020448532705,0.806549813603672,0.079034966432782,1.86591632858869,0.235695436532242
5,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",0.0542017676784633,0.339861769378026,0.512667566228066,1.94275290904435,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.244802938517149,0.665635604211823,0.358624930659017,4.87327124004976,0.735236802288649
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",0.342129507654845,0.153730208856297,1.03889426765954,1.89793848411768,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.556622888386157,0.583710568369691,0.575549112294993,5.67274238626133,0.37138109511457
5,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",-0.21132208244754,0.292663173348415,0.439207968466052,1.38325070562139,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0427772613073932,0.634715481187627,0.285635196255096,3.43837558843367,0.936894531961589
5,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",0.585853134308217,0.269784265825572,1.027950613303,2.95974173716703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.820616264429728,0.635104177829703,0.67796030728301,8.17349084290032,0.217243013942079
5,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",-0.195224568538663,0.389848834496376,0.399348374414857,1.84090670711171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0253425915275318,0.693644656695566,0.258969946140306,3.92746362033464,0.960929758514496
5,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",0.272290726469979,0.276290800310801,0.746399709507077,2.20459984688979,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.481003246243891,0.633483751073216,0.483943639040176,5.7974829341093,0.475579188474916
5,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",1.76393355690046,0.755063191093166,1.83879437907024,35.4776687512929,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.09655919696307,1.00630427873516,1.17649934594468,60.7753124249477,0.0383489284893373
5,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",2.40650902964003,0.750578059786544,3.54051354150233,67.1201108971991,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.79250921404129,1.0094458067636,2.34881150811084,122.837741561551,0.00555779488991952
5,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",-0.557950710838047,0.540146266353739,0.229901799417669,1.91024486724758,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.418198427470622,0.799091583868287,0.14208522399138,3.25780357075795,0.60566135647117
5,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",1.52583717765428,0.75758914846709,1.43912913293608,28.0428319538693,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.83870412534761,1.0059889045565,0.909113953447892,46.9047623162908,0.0701207413067425
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",-1.10037370850736,NA,NA,60.3011096375841,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",1.70515264884154,0.480224902389049,2.31033014098997,15.1778550180266,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.03289395291279,0.78245235894234,1.71162219287199,36.7669174283782,0.00999548383600931
5,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",-3.33700491963637,1.21618289244465,0.00585779875177685,0.688918673853097,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-3.42807654130263,1.40921267985137,0.00210741608056576,0.528199888521624,0.0171560709042132
5,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",0.643956075967674,0.34819520134664,1.02985890370247,4.03223944279459,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.883544637398659,0.679335666924493,0.662131645420193,9.4939618187979,0.211332300280241
5,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",1.36022035234745,0.200808394854654,2.60537294440642,5.72435725468977,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6593001918685,0.617384342576686,1.62667581846676,18.2952362074475,0.00855288762963551
5,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",-1.00379506641366,NA,NA,1537.34939533181,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",0.632077533806418,0.622869393616541,0.607582566650164,6.98200382346493,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.870702232026557,0.880217075539242,0.440930577259861,13.8948698456853,0.336341917743911
5,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",0.0390400133643299,0.357199934481456,0.55108425020789,2.23519938951678,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.228383375237304,0.675998292605243,0.345676035909429,4.89204961232083,0.756580057504291
5,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",-0.568059429403277,1.24599054455156,0.0838058845817497,11.077778142737,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.429132801324237,1.45605664725857,0.0387807134516117,11.679147003703,0.765402927602888
5,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",-0.82508183904837,0.238449295801893,0.269486020156781,0.686235305309334,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.707533904110147,0.59792984304286,0.157713967357976,1.64356834045707,0.263991390703006
5,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",0.428508268336721,0.445121171658186,0.58426406230678,3.34491303102538,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.650202707718612,0.739974848012803,0.465364367378228,8.46308283603805,0.400041377721434
5,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",-0.454363040406714,0.431541212298703,0.24658214952682,1.33850107977267,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.305992141841883,0.718657060045856,0.186137104693159,3.11370132453624,0.67393239662743
5,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",-0.552190865066454,0.339641909099215,0.27959743039,1.05862125640993,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.411980247650671,0.6567509011979,0.188981435808393,2.48012691517556,0.542954208236404
5,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",-0.335242388681897,0.370414798080745,0.363379408158133,1.55222834140888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.17699356301897,0.679045443020917,0.228917657461933,3.27859937008774,0.792713064493652
5,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",-0.205392770843005,0.358165856797157,0.425643724171967,1.73296142043558,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0363555184424371,0.673116017642289,0.266639458758335,3.73111989727141,0.947403418087051
5,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",-0.381459698893833,0.406629478835948,0.318805173031076,1.56954090831959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.227049924674025,0.702354768873891,0.207999990972316,3.26403075662287,0.746886910192418
5,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",0.0329878726937826,0.373565748837524,0.520847339905302,2.25252663118359,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.221840154793267,0.686232634159155,0.336594542559494,4.95851492265383,0.766848846997159
5,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",0.631023452484997,0.352851183114052,0.992729909054573,3.95845807629613,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.869537454084167,0.681963787661322,0.649550049573143,9.41000549859347,0.220548098190246
5,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",0.61092118210509,0.521848287975593,0.775877027504876,6.00052195884567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.847767339603088,0.799014354008809,0.505259519041926,11.5813452018484,0.304528672665837
5,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",1.13976187886948,0.762993641804776,0.963322361223806,19.1731898340182,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42053767058313,1.00672420843118,0.597033648182764,30.892226315922,0.164404579115775
5,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",-1.24129284657214,0.471395025663563,0.101547682619569,0.644427943049088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.15830448684318,0.737762489753458,0.0763337789835834,1.37621378193631,0.133604718265417
5,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",-0.676856124335909,0.890252535480501,0.0724328411381595,2.37412829829325,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.546981672494378,1.10675102212948,0.0683355048227828,5.23338593720566,0.621844211084715
5,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",1.19717566922297,0.521673875020935,1.25053656444537,9.66486093654502,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48272256638911,0.806385879831108,0.940969668204566,22.2008414370222,0.0710150854889496
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",0.331021106252579,0.607239267855024,0.40833591334592,4.41350458217433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.544617457064016,0.863811608607793,0.328419549551918,9.70475441319445,0.544699552211145
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",-1.28537167625473,NA,NA,2.29517340483046,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",0.992409008295117,0.21364508170792,1.79460317497041,4.14646952911886,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26091388529325,0.616218758734615,1.09375224030098,12.2453632409975,0.0478557469851859
5,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",-1.04261994052408,NA,NA,8.48460996895846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",0.153423949891674,0.288982741715645,0.643606440499057,1.9979540359048,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.352261577706876,0.638279528553568,0.421393686269754,5.14395385163518,0.607644348134762
5,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",-0.747795639767524,0.392560671643882,0.229206152136461,1.06788077842438,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.623833876145199,0.68792534239542,0.143776931379885,2.13213861833799,0.382450528537358
5,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",0.236082461752654,0.344032013042886,0.683076019082713,2.63117782018194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.44181450669055,0.670805268317622,0.432478008658629,5.99715105411726,0.535334818613569
5,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",-0.549561348665471,0.54576641354384,0.171571287066543,1.45733379483179,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.4091122764965,0.803664767797079,0.142105163030945,3.31719680455494,0.615163248240154
5,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",0.741202646576465,0.222914313931547,1.36736868101709,3.27623951742347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.988870831029419,0.615926228642455,0.8332247779248,9.31787518977953,0.123769232089233
5,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",-0.132300695123692,0.170586986709712,0.626051023718564,1.22184901405826,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0428083190080563,0.581299512577638,0.345560928631137,3.37388842862219,0.957735188511304
5,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",1.21683268408751,0.206885992393713,2.28043869117768,5.13123320362924,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50399436983775,0.617304083564227,1.39243698673497,15.6558239085101,0.0176408903196978
5,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",1.35482383382883,0.196809726156493,2.63616556385029,5.70193376064786,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.65345457827085,0.615776505280203,1.62227830878566,18.1311430540814,0.00863081821026884
5,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",1.26733800000474,0.131518167496574,2.76022674491601,4.62212508072875,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55873503244445,0.593403044552105,1.54145881286269,15.7813117666564,0.010514460894246
5,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",1.99700661319692,0.459504616425667,3.25992406535714,19.7455648213437,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.34897580029963,0.771820413401164,2.39908449257836,49.4304993163366,0.00240309695668519
5,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",2.02906419241999,0.191244297397697,5.31713398113242,11.2525897609791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.38373814268591,0.625429438109463,3.30948106507281,38.4142984711436,0.000141380433788297
5,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",0.02729110278678,0.0385104999703116,0.953052101205664,1.10835028476164,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0747715927940015,0.333651102286613,0.516727980457712,1.91104381893988,0.824285609764981
5,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.399270349530685,0.0229207333709327,1.42539457446734,1.55939245513374,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.450292146186077,0.307996531080827,0.800060485930207,2.6758210552746,0.17792564601779
5,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.766639051283501,0.0156249409077769,2.08774507132239,2.2196137919669,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.821159805211619,0.285515463782229,1.22319614054581,3.74592009297685,0.0138719565345096
5,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.36545980961623,0.0275707153113366,1.3655272479616,1.52137698260192,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.416159574324728,0.310505403057724,0.76868071181229,2.59627887796103,0.213625658489617
5,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",1.48460765424036,0.106674163493086,3.59838389391111,5.46650713636951,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5459745688027,0.269586198127688,2.64454287747845,7.60842893667568,1.01670752729796e-05
5,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.237721230671717,0.0547881961085021,1.13972443066268,1.4127699601371,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.287225158002323,0.322291823793832,0.657765732806509,2.32670776985191,0.395660096420287
5,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",0.468309789336588,0.0552230397089149,1.43433417535058,1.78099302885475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.519986471256263,0.308049632504243,0.859357085191505,2.87473824719652,0.124003414395031
5,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.11005576711274,0.0269501021171312,2.87913443015902,3.19994033061804,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16786727107987,0.267414642688825,1.80647986226184,5.1532431863045,0.000479342623289555
5,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",1.83876000285523,0.146862187620594,4.7656152515496,8.47495924600031,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.90350684092398,0.274149432873355,3.76960989330194,11.0410213389484,1.80802761606974e-07
5,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",-0.0178773971702213,0.0373442165447312,0.913024635467284,1.05695720955821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0291702152999158,0.336570833839293,0.490139790424732,1.83357714545915,0.931339615287726
5,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.115389291894864,0.0273608209925493,1.06378932109258,1.18422649223797,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.163724892723209,0.326596609060586,0.574293378869014,2.06601221328135,0.625018606599629
5,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.406413456164473,0.0347501331894363,1.40287725862921,1.60760152365014,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.457503512626747,0.308711487906946,0.804880907854148,2.69949803499379,0.172406346423295
5,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",-0.329934761627019,0.013002843133068,0.700874816816803,0.737524642750776,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.285863631326136,0.35678356018553,0.339957074860376,1.37661823421232,0.390909238387292
5,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.685244253699249,0.032774156971466,1.86135053016644,2.11652300506659,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.73899067477163,0.291729621862861,1.11085455280943,3.48576903775667,0.027391391627825
5,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.38680788032948,0.0302352070109872,3.77323950503842,4.24802322521983,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44724059619265,0.253496405034438,2.46831937101238,6.66736780838174,1.53259006523026e-05
5,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.495113632493366,0.0162961828422782,1.58919485182473,1.69402502422367,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.547048248480469,0.301644555588211,0.894752151141164,2.91892793994903,0.101262352293187
5,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",-0.357023537167651,0.0171515394262218,0.676611527055252,0.723666095575535,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.313210190548729,0.358962340548174,0.329030106673228,1.34379875604342,0.347509878023028
5,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",-0.15810650146869,0.0104846133542038,0.836395782214812,0.871486917949851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.112399144019744,0.344302337283291,0.417020561026464,1.60804733957148,0.735416385362579
5,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",0.029689999710384,0.0247665013750337,0.981375905250793,1.08142886991278,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0771951629510741,0.33211488951991,0.519587596568571,1.91008277495314,0.817965491171526
5,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.4356459212101,0.0145532866828889,4.08455261272903,4.32434220850047,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49654356744969,0.249607536081208,2.61527831291002,6.95745734247908,7.26940927333438e-06
5,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.393986283495693,0.0299178581138656,1.39863293858191,1.57266421896712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.444957865047836,0.308952940087306,0.794193444920904,2.66617552245848,0.183861631729506
5,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.114145839049518,0.0153342126856341,1.08775339233193,1.15514221986171,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.162476196673945,0.32585200453252,0.574390032374685,2.06033743305458,0.626871437683066
5,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",-0.370831586772161,0.0220232775063351,0.660986143566873,0.720584391938511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.327149530077514,0.360262186591639,0.323473343048044,1.32785286605107,0.326914330806817
5,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.660423644536907,0.0332550845818214,1.81364374885423,2.06616757602321,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.713933632437239,0.293236723656753,1.07949123409848,3.40742435651984,0.0331086270157473
5,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.730667543660949,0.0119485191869869,2.0284764244794,2.12574497200876,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.784845462151712,0.28741158109889,1.17415726306761,3.62256871049973,0.0186324328067857
5,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.688875250392778,0.0261304200306425,1.89236019113219,2.09646835371062,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.742655940015538,0.290817215214829,1.1170391294937,3.49266161573937,0.0263649930082946
5,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.3674872591919,0.0240999251275606,3.74523407666036,4.11629747977222,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42773579558168,0.253785377128338,2.41839525995568,6.53991783829424,1.93596181991155e-05
5,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",0.0625513728105775,0.0133232222772099,1.03712507900345,1.09272940738493,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.110377658306935,0.329206872885916,0.540767055502242,1.96540937007386,0.741331477988662
5,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",-0.17668779330598,0.0627364227356592,0.741115870932494,0.947739089437347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.131154670982588,0.351421388337384,0.40331701650324,1.5992170156492,0.698419808037967
5,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.433949679219377,0.0144174316644854,1.50039931535668,1.58763672894032,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.485301633598149,0.305302870010656,0.833763872572891,2.75925362124677,0.145922955542308
5,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.132841497176101,0.0266587272343906,1.08401040556786,1.20342034834924,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.181347752478935,0.325381506576024,0.586219017895985,2.09889341307986,0.588140512218672
5,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.13491192111292,0.0503820991285547,2.8209643412932,3.4369106155783,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19295214633049,0.269608596247444,1.84536197428419,5.30962774038831,0.000403187825604693
5,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.525759364446502,0.0253734898571911,1.60990499715075,1.77826366982895,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.577986204230917,0.300439757467942,0.925810281260956,3.00601795133541,0.0838987690159984
5,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.33409766479223,0.0308188100684971,3.57538643612789,4.03449355118315,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39402816019482,0.256223834790347,2.32560723661445,6.349398971812,3.12361140917344e-05
5,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",-0.334499113640986,0.0351794073689391,0.667968778034453,0.766735717774764,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.290470427437652,0.358690441447028,0.337065057564627,1.37514801907596,0.385641027801646
5,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",-0.112224857052856,0.0199205136886125,0.859631475930624,0.929447905451209,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0660799104062126,0.341530577682955,0.439873018428359,1.67783802629684,0.842462401424428
5,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.259101492188992,0.0103300832606438,0.756276202208438,0.787528718986813,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.21435594222202,0.35152481284871,0.369932947799579,1.46743860264188,0.519745271029617
5,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.402321628836669,0.0343959405162464,1.39810267837356,1.59990731106951,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.453372694538743,0.308923497894541,0.801137803378474,2.68917795013869,0.176268136413408
5,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.1640037252329,0.0129507749126536,3.12260860792776,3.28522403688761,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2222947002813,0.263459511439464,1.92459563836262,5.40572293575277,0.00024804364898249
5,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",-0.189649396776737,0.0132919403363606,0.805976670202602,0.849084105516565,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.144242263997764,0.346644864871273,0.401640981661112,1.56302997841728,0.664793582528498
5,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",-0.0491628644396349,0.0300301369164182,0.897640294592447,1.00977761139681,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00241654675109849,0.337941287435964,0.473127796025025,1.77947034211679,0.993590138168094
5,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.210971546355694,0.0576167975529654,1.10349094701471,1.38310702943802,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.260215358269584,0.3245172212282,0.636935139668766,2.27276393147862,0.442269921538328
5,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",1.52366372508678,0.14998846558413,3.45413623866041,6.21842341250845,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58540454686178,0.28854906388462,2.65221263164795,8.21930612862312,1.48725955811301e-05
5,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",0.107609277364787,0.0175467513390347,1.07599427138066,1.15260792881995,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.155874239474424,0.326403646112524,0.569876652908911,2.04857297629554,0.641072866598139
5,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.37689939582411,0.0315265477465121,3.72665699633109,4.21687098567946,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43723772146787,0.254156148020642,2.44013965391806,6.60831738854475,1.76670658777717e-05
5,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.3871280987797,0.0104368316768835,3.92244171388511,4.08624303469443,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44756345358732,0.25182658995304,2.47723178897368,6.64778566119394,1.41930990588229e-05
5,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.52087662330138,0.0226682514159052,4.37830673124548,4.78516243644067,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58258646982484,0.246032879754836,2.87473745181154,7.54128442484206,2.16860014797056e-06
5,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",0.0247026463175396,0.0102657201349124,1.00460189480269,1.04585237410346,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0721615672379094,0.331647248261731,0.517369029136366,1.89844371784957,0.829302261776093
5,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",-0.449747546796564,0.0638741067679711,0.562597042246653,0.722664832885522,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.406816152205558,0.371332350641504,0.29136799813647,1.24910569938094,0.230392605109849
5,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.16137664595081,0.00827650580724793,3.14300030167701,3.24664176941618,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21964732675875,0.26340261163267,1.91960916503256,5.390514688649,0.00025420855325422
5,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",0.034630519776461,0.0373159494500381,0.96232815830053,1.11390968816796,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0821816791506252,0.333014117927454,0.521347603467403,1.92332042506114,0.807059915150508
5,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",2.02298681126315,0.14526732639095,5.7490486524242,10.1601361746949,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.0894822448168,0.266285559890983,4.62345684709605,13.1308296619556,9.56762530146902e-09
5,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",2.67763674517654,0.14181809329925,11.1456196005416,19.4328176870731,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.75037175807211,0.242010144952915,9.46822439180065,24.449352364099,3.3938911283069e-14
5,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.688353322233837,0.0341830622564947,1.86201905780475,2.12900887757651,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.742129423606873,0.291717179930306,1.11445955536799,3.49691068177442,0.0268069121206289
5,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.36382418874918,0.0188692453751094,1.38667012803902,1.49312518721896,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.414508229131057,0.309925617013778,0.768250894421357,2.58893651838762,0.214603161007456
5,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.104272997344,0.0169272485019571,2.91886199712854,3.11910907496791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16203449033994,0.266866999720562,1.79767832332855,5.11713866439673,0.000498486986343246
5,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",-0.0942517484916607,0.0129863929309049,0.887188997662268,0.933521280917758,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0479361002116881,0.339920656698889,0.449628460527292,1.70425967621311,0.885068604976539
5,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.620986463484385,0.116856910315874,1.48514209857351,2.34804044726277,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.674126871879009,0.316965266641291,0.989129910546997,3.42654139703564,0.0566290996912373
5,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.406434940007691,0.00952148748044035,1.47372437399668,1.52976836650622,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.457524684227235,0.306809997509354,0.807909135014422,2.68953255457489,0.170204472152476
5,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.682242202120327,0.00929816598050008,1.94262200824665,2.014733144392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.73595877008164,0.290121054137188,1.11089703463362,3.46399124335246,0.0273300907353246
5,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.13482307024988,0.0101434056268694,3.04952203993636,3.17321823673266,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19282902956449,0.264878733181353,1.8624136207308,5.26025153883256,0.000347556988705897
5,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.573606369854096,0.0174076817971126,1.71525211390569,1.83638126948937,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.626288675075941,0.296963464009117,0.979515795850654,3.13734993263897,0.0606636966074545
5,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.26763058208276,0.0161262411079042,3.44220901791155,3.66682852088572,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32692762449447,0.258230727350638,2.16335461394604,5.9530633128785,7.00032447553752e-05
5,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",0.9910325090229,0.0489243813278822,2.44972423883958,2.96760584039085,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04769453074374,0.276978021072621,1.56814956682418,4.64425139660993,0.00187639227375543
5,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",0.292025256037642,0.122755131211172,1.05556751276579,1.70790901027098,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.342026983320011,0.338106427221037,0.674666030446645,2.53911440384851,0.336444520053206
5,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",0.0987944270124532,0.0167849738047023,1.06814225585442,1.14078522403528,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.146973471098468,0.326948347381471,0.564066435107187,2.03202072640625,0.660237059154611
5,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.110539216822736,0.0315777361323931,1.04994390503255,1.18829462380497,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.15882552564118,0.327317344464267,0.570592473832624,2.05850580681987,0.635805523309133
5,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.246543369744214,0.0096255564767469,1.25569599121053,1.3039804637233,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.296109995246115,0.316951004816722,0.670825450917578,2.32374195970891,0.374881822974605
5,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.0763020519661742,0.0198146005222239,1.03821191255027,1.12206610823787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.124260205291954,0.328628390857968,0.549192073821131,1.99150888151091,0.710378959763353
5,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.52802642739116,0.00922302146647372,1.66524249047423,1.7265485061988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.580274268417053,0.299329415664326,0.930013932421808,3.00655238897503,0.0818964481212013
5,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.21112827694863,0.00850490981982518,3.30185177256576,3.41378650807918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26988692480407,0.260792412589458,2.03089149356075,5.6449555778218,0.000139764163007998
5,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.0419185446306783,0.0122691701409092,1.018043434786,1.06820198500718,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0895442279755715,0.330553961109467,0.527867583792624,1.92868399496074,0.788953620711703
5,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.486410559567677,0.0250441652472348,1.54877512823676,1.70853401643951,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.538262544170455,0.302801120024465,0.884705672947318,2.89926807504855,0.107448351052555
5,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.355129243716604,0.0115221757002552,1.3945508972971,1.45898140555794,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.405730320509101,0.310095131087537,0.761094954606432,2.56652649051179,0.224003224796728
5,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.35827942034433,0.00868580303977103,3.82394120059705,3.95637950607517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41843992489053,0.253216482402154,2.39827721619829,6.47106709513231,2.09839722853743e-05
5,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.114134603434356,0.01164595752732,1.09562316383355,1.14679903714159,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.162467111080633,0.325692238309976,0.574563583630991,2.0596696439243,0.626738419777572
5,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.42248884981587,0.0110068450086316,1.49322779402887,1.55906474839948,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.473731546559537,0.305864559151968,0.823003458879113,2.72964663919106,0.155618752855681
5,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.161937294395664,0.0094074748464855,1.15431824646317,1.1976802137947,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.210683268223583,0.322455797455831,0.607721962382341,2.15107065856661,0.527921500222341
5,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.459753427539281,0.00894330462881415,1.55619257442238,1.61171574313745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.511351004797069,0.303490765806595,0.859427077443826,2.82405173857106,0.125256738202942
5,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",-0.0748473966224603,0.0583449027633268,0.827769557896094,1.04048540635234,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0283441119803837,0.34355636161824,0.455561759656432,1.75153440373291,0.932607549843821
5,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.490491585129662,0.0155768074899207,1.58409136010531,1.68382995168469,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.542382151253072,0.30188698630304,0.890052227691415,2.90635612533815,0.104173231233972
5,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.686943672366875,0.0219660559433938,1.90411909405752,2.07533967872571,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.740705740032616,0.290570999181798,1.1153514810534,3.48402059951745,0.0266240894551624
5,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.32392414559045,0.0204616908147426,3.61099563945317,3.91255999072264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38375757809415,0.255663415065167,2.30392878496811,6.27640901753389,3.41897134611131e-05
5,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",-0.422616187726832,0.0136495609881006,0.638023319451291,0.67309072636615,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.379427679691186,0.36368626856989,0.30431974422982,1.26610801001127,0.254940752258243
5,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.423642208739271,0.0356691684713062,1.42470378311389,1.63850541128804,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.474896428891925,0.307756942192044,0.82093255846449,2.74305078689681,0.156774796848464
5,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.3959723233865,0.0111155985624638,3.95204749324076,4.12805413846676,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45649194453741,0.251411424992484,2.50189694485586,6.70305839202154,1.2576952276327e-05
5,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.930278336361282,0.112285509507051,2.04304861090424,3.17273571937969,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.986371334607379,0.29867277118464,1.41149757387796,4.55136414107566,0.00508800174663289
5,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.443757930026968,0.0124172941747373,1.52112514378657,1.59699731177896,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.495203255366155,0.304604540944545,0.843443654196474,2.78365741606453,0.137773418630558
5,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.10216906627157,0.0104506073223132,2.9495052616591,3.0728426454196,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1599143549879,0.266633878460358,1.79460564824891,5.10372620261875,0.000505120144302301
5,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.657412179512137,0.0112832088757301,1.88764294819708,1.97300606191365,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.710892381709066,0.291654206460723,1.0794610112621,3.38625751648202,0.0330742034521995
5,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.818960988330846,0.024276536939689,2.16313063012201,2.37909179072286,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.873980691713042,0.283156291461516,1.29714312281998,3.93580924916123,0.00892904016412209
5,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.39742345092339,0.0223911174086216,3.87187767289523,4.2270787158239,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45795716763271,0.252117140569643,2.50216724500352,6.72235328962024,1.27599459945798e-05
5,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.22824397631499,0.0105307836315265,3.34559392295577,3.48658987921104,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.28716570933448,0.259975312480521,2.07030998031319,5.73611896802478,0.000113509715710647
5,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.359169831846732,0.0118323453979529,1.39934787741299,1.46578109043657,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.409809404362006,0.309852991087032,0.764657283479896,2.57609288408515,0.219392819362512
5,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.235174855441341,0.0119683247401766,1.23582387481651,1.29518406951304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.284633192236007,0.317769105775764,0.661880980690952,2.30012272166028,0.393801675710495
5,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.737023774965926,0.0240440670014713,1.99382927671707,2.19089045162878,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.791262986079657,0.287831095565173,1.18091164154858,3.64940404767321,0.0179169927948556
5,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.519647720394386,0.011418825572712,1.64425510279686,1.71952558542172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.571815844327911,0.29991663292512,0.920912317453145,2.9839894502689,0.0865180355297998
5,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.288847927476673,0.0182667097896477,1.28800985317576,1.38361890862917,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.338817675231306,0.314635648284719,0.704166017946908,2.41719541360299,0.31041648805755
5,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.763780559932223,0.0149312668082026,2.08460820535199,2.21026057731503,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.818274042525616,0.285641540030078,1.21928565599883,3.73579041969859,0.0142005348118872
5,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.44558597744317,0.0138924281625533,4.13067788520782,4.36186120463995,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50657829129031,0.249073441170971,2.64490256280728,7.02155128767115,6.29842482452986e-06
5,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",32.3665608178094,NA,5.34609999795781,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",0.86219442300557,0.488791365807781,0.810967052666169,5.50963894953153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.468388307468192,NA,0.570279991212266,NA,0.359864827549355
5,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",0.867744036412029,0.206853585468035,1.60279514466907,3.60600396982668,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.471986620284989,NA,0.64871841305389,NA,0.285124741151253
5,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",1.12502396029903,0.199054939571419,2.10913755197846,4.60231825857722,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.63795649840093,NA,0.73651908886347,NA,0.157483027880085
5,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",1.4258447662998,0.191875994377039,2.89460308383693,6.14100294278631,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.831955883558193,NA,0.851926226975294,NA,0.0691168852725328
5,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",1.95835093394932,0.183166153339719,5.02653055758375,10.3060193103753,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17544443259066,NA,1.0947849477963,NA,0.0112750450992344
5,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",1.02756270275901,0.310580546153309,1.5795951342262,5.33677714332152,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.575058299866852,NA,0.677557645758536,NA,0.220868073676297
5,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",1.11231927103997,0.334409907223785,1.6323365052386,6.05494428627364,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.629732034120057,NA,0.699666947700882,NA,0.188362972944776
5,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",0.26721369552804,0.32943458649318,0.652224023332858,2.3726148699149,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0846159336207862,NA,0.458460242181968,NA,0.795693919007047
5,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",3.01792584775258,0.221041715445539,13.242583806154,31.497408912425,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.85887289853707,NA,1.74863368349683,NA,9.77147693539508e-05
5,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",0.363726040447143,0.530594532792755,0.502490882435201,4.02173968191582,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.146874775045206,NA,0.427446549323868,NA,0.736203543785384
5,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",2.45306328202734,1.12463634160543,2.51362920901283,206.483614244051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.49454062157261,NA,0.809248483634545,NA,0.0739238315772727
5,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",29.5676612816176,NA,0.109246154374704,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",2.77510571771009,1.12035844383291,3.51482951883297,283.926505840299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70226353282383,NA,0.96388739918213,NA,0.0420413289415114
5,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",-0.788500097577802,0.323992347718279,0.232158371355098,0.826703775761124,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.596342574998185,0.574431380468821,0.263736686092475,2.50659575554152,0.285458626336462
5,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",0.368251401377163,0.543836625846754,0.481288306449157,4.05727514416072,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.149795449997263,NA,0.424470783228384,NA,0.734648387786029
5,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",-1.53832086132005,0.622674960004875,0.0694527950737232,0.797505160593264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.07996954135461,0.591555121022463,0.135528649815847,1.37751512344438,0.0945671932905182
5,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",2.51166827772588,0.249864757980905,7.49284140690775,19.9534076635976,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.53234232032094,NA,1.38882100397462,NA,0.00141391285998085
5,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",-1.16097588961348,NA,NA,6.15720600192703,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",0.44396899419649,0.77306114862124,0.467068900866519,9.67035988500116,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.198638986655828,NA,0.367521217547285,NA,0.717864361146566
5,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",0.873267338288528,0.348796744281186,1.2439348890751,4.88191600316186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.475538198642168,NA,0.617610165941838,NA,0.313133909498511
5,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",28.8598155400172,NA,0.173947669928396,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",29.9034032033645,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",30.3018232695606,NA,0.530662110566622,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",-0.62843391533187,1.17752799091964,0.0981730663463088,9.92246651761995,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.493098419348065,NA,0.12844146422114,NA,0.618345439053985
5,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",4.09633379223507,0.177341727924045,42.7992599023075,85.7715708754851,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.55447957559843,NA,2.77525208034996,NA,6.69148948653151e-08
5,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",0.36229452798633,0.665376898857442,0.389727464845615,5.2905484835397,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.145958538928735,NA,0.385279029520038,NA,0.75947805154365
5,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",-1.43629769948647,0.300764374269067,0.127388442539108,0.414144813580454,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.01416373589967,0.458535391785228,0.187845442071117,1.13347704140331,0.056796528962199
5,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",0.134387702800701,0.35057164185195,0.588016628633828,2.32382731829161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00102910208324408,NA,0.423529420674396,NA,0.92724786015956
5,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",-0.0760550143335078,0.190529427925678,0.637570488906154,1.34550740705843,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.136786311151474,NA,0.406850905716681,NA,0.855372921300933
5,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",1.72156589460906,0.295636616768973,3.2737721840214,10.4313650310258,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02271299759231,NA,0.952266254551354,NA,0.0341360985339773
5,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",0.0541218580288831,0.874079651467646,0.152507590489654,4.6916689053592,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0528172615043235,NA,0.267734383657038,NA,0.995333922922483
5,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",-1.01597509024338,NA,NA,48.2482578494751,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",1.41872899236911,0.319246676738504,2.29441496976034,8.01970688385006,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.827375201724966,NA,0.817213657670547,NA,0.0868839058996427
5,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",0.119160461888481,0.766343253908898,0.182958730402493,3.68959127529066,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.010873997150283,NA,0.308059896574427,NA,0.955889166769724
5,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",-0.9847476950781,0.252449486705169,0.223676080432843,0.60171429492545,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.722912152018999,0.513025598221766,0.246731571756596,1.84332149389215,0.173807165651731
5,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",-1.68536329923267,1.1516716771691,0.0102025754264026,0.931792545959404,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.17481508939081,0.903307715402698,0.0688572206626218,2.37543598735097,0.199649269258889
5,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",3.035927574536,1.1178761962436,4.59680723982077,367.732639797941,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.87049815989077,NA,1.10665659567653,NA,0.0256179698987928
5,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",0.933473300378191,0.762073641174759,0.785793795779522,15.5835039120022,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.514379044701419,NA,0.485832215882356,NA,0.407048035873883
5,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",3.66149017857026,1.11354124048515,8.70846183154067,684.916292855964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.27398566144426,NA,1.52426596374935,NA,0.0067561189589013
5,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",0.58146272167154,0.326566390139023,0.973511437659663,3.50177863637788,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.287312861141068,NA,0.538765153170049,NA,0.513097866894116
5,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",-0.89864401980668,0.244590429387611,0.248224915009241,0.647495676059736,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.667374837819141,0.527270207548532,0.259346083010322,2.04883092999907,0.21049392029618
5,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",1.61186377001439,0.753360693535791,1.58723780625231,30.4204454522522,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.951952633544291,NA,0.702164740903833,NA,0.138219835490534
5,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",0.722109992617871,0.76614287143645,0.628925449938364,12.6731086472175,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.378044304700828,NA,0.431348285000369,NA,0.530959715562347
5,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",1.99445765677578,0.303197446075051,4.23074257440367,13.8861185570601,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19873270565572,NA,1.07997888089737,NA,0.0139901325623299
5,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",-1.00254573530609,NA,NA,77.0943491613475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",2.01298306612995,1.12323958126094,0.421811575402857,34.4607736708158,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21067965682511,NA,0.637821785497918,NA,0.144395474307
5,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",-0.918818151253916,0.532126539131019,0.120790938739366,0.972586459665377,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.680381984033986,0.635278575147317,0.21084928010392,2.54373771782838,0.27651249413401
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",0.681053286383148,0.123970363817218,1.54464149253247,2.51116486773822,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.728505130708488,1.06903988021426,0.414353099233859,27.3720536890616,0.376190567277344
5,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",1.55894364717167,0.183502709471659,3.35937276992149,6.89689757852575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58177698497941,1.21164339572093,0.836517029553434,96.6451897645558,0.0648954330171009
5,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",29.7857867547214,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.10681704143009,0.108325739555141,2.44354693632771,3.73623994138425,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14233144376712,1.12951926754688,0.589715568775433,49.3787032690919,0.172464000882348
5,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.717341884128269,0.104186749648464,1.6737387588229,2.51799879178968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.763781729821502,1.07191052386202,0.428762135571,28.6444316491283,0.353326197941404
5,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",25.9332861148642,NA,0.117787669950164,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",1.00005263771646,0.0993818316345714,2.24308882809957,3.31157358107751,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.0385624109508,1.112519836021,0.541281590514132,42.4014256652237,0.21273534841756
5,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",29.9103112660727,NA,0.20821495316304,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.5932774287912,0.0925171491513784,4.11784604082093,5.91795400326328,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.61514840223062,1.20595263095571,0.879121444127978,99.3267795842985,0.0556739978203673
5,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.105252623757369,0.153045387269132,0.816209629591001,1.48712218974992,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.168847687720732,0.996544454585489,0.255251413177807,12.6907856968432,0.810635921094498
5,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",30.9114916452109,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",0.400132934134387,0.111001766082002,1.20145605255319,1.85642598508845,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.455459088968192,1.02905467033192,0.329588282189805,18.6139100014471,0.567475689593617
5,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",0.676859427471751,0.162891474284974,1.43980290539806,2.72652820186007,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.724444791479711,1.07399051316696,0.408552095439242,27.5177047578284,0.382031181737437
5,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",1.32678046930145,0.151072369140865,2.8289228132783,5.11454690059825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35612443459447,1.16895611003861,0.698861287936911,68.3007501955333,0.109633282010162
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",30.0608845829091,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",1.72602432068483,0.389137889370379,2.86706882906079,13.1797648874561,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.74416787542863,1.29151436171219,0.868943466449228,137.299690315757,0.0576141498101664
5,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",0.393368980560419,0.170471585389092,1.0667157495245,2.08094240568161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.448884248337573,1.03669302339751,0.322404142755099,18.7616062153964,0.576603921422664
5,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",1.14749465813761,0.316759850245035,1.75496485925162,6.0746515524248,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18186462624938,1.17716933671968,0.563237793333795,56.8471243385446,0.181085624991992
5,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",0.760721910664282,0.201017620815648,1.45471452705313,3.1988273008285,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.805921865314379,1.09258522542911,0.432126465843001,31.3062699441826,0.337484138417413
5,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",-0.183771921750777,0.460728576078144,0.326067041668502,1.98450708232347,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.112074669993703,1.05801697145126,0.16634000745596,10.5236906753208,0.941084943355996
5,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",0.62345994700598,0.369778328205364,0.912188692561019,3.88683810457865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.672517789712735,1.12006300340553,0.352756208656232,28.46252206168,0.444566672442509
5,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",0.846030450881874,0.135561905594301,1.77925980225079,3.02705542980288,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.88884375171841,1.09401391780881,0.473250075626345,34.4781029658818,0.285753592410305
5,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",2.33075388615873,0.146976497500491,7.7976857257191,13.8732742176903,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.33194787130786,1.34656039958353,1.57770687457048,309.324912118256,0.00653197127285994
5,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",31.9603616875246,NA,0.0701384440094829,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",1.47650210774248,0.315311100521912,2.43160441724044,8.36911459194131,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50167154182073,1.22777549977082,0.73912818930854,90.967983180804,0.0913710172626776
5,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",1.98813809957332,0.387999570875296,3.73684478668239,17.1015992974616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.99896157836988,1.33652226267122,1.07817532429331,203.230559674759,0.0299540340816853
5,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",2.6164570668317,0.386066953034569,7.03783783339399,31.965450389314,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.60962072297822,1.4576062754469,1.80031287174586,545.483236601831,0.00475761970604347
5,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",-0.85157509355004,0.892569514827846,0.091865031621365,3.03852858097568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.76115304310014,1.2547463625705,0.0560523022109985,7.66791932913825,0.555272594419659
5,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",-1.05797193819221,NA,NA,36.1646856597015,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",0.404277110426947,0.178817677548358,1.06483960188472,2.14636689143073,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.459486448706336,1.03961821955055,0.324406321126619,19.0958314901539,0.569063532924841
5,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",1.07991154307613,0.162083879512038,2.16214732308611,4.08147724023339,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11617867576377,1.13237214764875,0.569258162898055,48.2017833134458,0.186122766408661
5,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",0.918312724778895,0.347675393072371,1.29031880285697,5.04174281685322,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.95910842635785,1.15321897237168,0.457476835958646,42.0351543676646,0.279614659985701
5,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",-2.9757084362014,0.485293565081767,0.0186593178990586,0.125043472839107,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.82573485579043,0.828110844121578,0.0142654337022965,0.366491103501075,0.00453238580527921
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",-2.87513161599068,0.45353492074921,0.0224248507677136,0.132687133057221,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.72798169446796,0.816981472577687,0.0161507422058396,0.397213742578074,0.00543832798340323
5,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",0.452609135428107,0.134158798666631,1.20289578169152,2.03526214426911,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.506463470364504,1.0389870207391,0.342289803788143,20.0987326504568,0.529773417788204
5,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",-1.87487914858279,0.323136764237208,0.0812211440576757,0.288255848332465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.75577776080868,0.833573826657916,0.0436269599700885,1.1450741395651,0.061109563267586
5,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",32.7979928735099,NA,13.5646779044897,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",-0.961755636447535,1.13000548287895,0.0214200205753531,1.7969860487823,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.868247057256913,1.42937504812767,0.0356434634289137,9.66835060340973,0.552950901333903
5,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",0.0854982833840716,0.180562520363631,0.767053228090452,1.55673859952389,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.149646739303401,0.998865596373995,0.248774220405161,12.4818008243926,0.828683163483575
5,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",-0.368545187602442,0.430204350798555,0.269121383163723,1.45321349029167,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.291667882953062,1.02417258105723,0.145849098422807,8.08087356707918,0.792812153030878
5,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",-0.594452942266011,1.09813154764039,0.064150829877458,4.74968507493994,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.511225753472294,1.43226176936459,0.0522560972181181,14.3358625294328,0.731265666394241
5,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",1.33186276119515,1.08224082267421,0.454179547449463,31.5964063151758,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36106303782314,1.61992526211796,0.298649934211318,170.973258751715,0.302431197678451
5,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",0.81899844039516,0.172910475458585,1.63187508986193,3.21403232374511,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.862569057098606,1.09574529978831,0.457874670411763,33.5851118786922,0.303042767790307
5,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",1.91363068788396,0.298018924415396,3.94547375776525,12.6895872413745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.92651752476344,1.29694341433312,1.06627750645033,172.10390289474,0.0302802473164808
5,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",1.10648915600133,0.167150117004161,2.20188097632046,4.23985216964113,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.14201077094486,1.13718540178235,0.580916258631353,50.1258176038866,0.176927024892654
5,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.58120762888476,0.109462560733173,3.92164697749347,6.02306982027632,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.60341697861504,1.20548595963407,0.867961594141046,97.8866638234819,0.0579695469362373
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",1.30958181389979,0.391831644184208,1.87830964524374,8.72614829110637,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33938156630505,1.22571883164348,0.615161662108432,75.1029132692957,0.142556704518821
5,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",24.9833291906613,NA,0.17869344811912,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",25.7183936470444,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",-1.22927143157079,0.475370946877987,0.102211383390001,0.658828280968865,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.12825920391141,0.959482116308813,0.0667821494683762,2.87134719590534,0.265337766964572
5,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",-1.2383525401249,0.145385986651049,0.218145307146396,0.385701588107699,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.13709393282901,0.843324412769446,0.0828803832343066,2.26011133672282,0.208500339269442
5,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",-0.851140035568446,0.134473589648933,0.328941879878164,0.557246595857025,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.760728918049383,0.882031322977714,0.115324826980613,3.6601228145168,0.407859538945802
5,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",0.771537889392826,0.332625986421515,1.16067731362963,4.27538276133873,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.816446248131484,1.12783201220762,0.408682394549515,33.9946542063382,0.351256007387405
5,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",0.180491812446134,0.172694919063818,0.844503789481725,1.66187351236615,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.241976539996249,1.00942127008359,0.269986375650216,14.1183431901631,0.747393952581391
5,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.591647822815898,0.148507803666936,1.3421713658244,2.40230481948449,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.641603253798546,1.05994614260096,0.382445994737746,24.3795509278275,0.434414815884394
5,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",-2.36690073352011,0.383461752389856,0.0433092056835195,0.194709297281282,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.23399056485204,0.818746653321052,0.0270629975586514,0.670212815535122,0.0193194654861935
5,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",1.67996383278189,0.153841561489644,4.00854753184189,7.32634535231377,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.69940375927234,1.22751819656139,0.931025098889319,114.470124580252,0.046364000217553
5,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",33.0297234845688,NA,9.23206104688142,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",32.5134006630232,NA,17.9610292744652,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",-0.539433347496901,0.127071515449655,0.456278594265584,0.750856656054959,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.457763163655237,0.915433252644431,0.150163886090902,5.43252700147923,0.631126235323735
5,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",32.519284117561,NA,34.8984425422109,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",24.8912310768305,NA,0.396349603494037,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",0.0952536354245986,0.226418008000154,0.70684263277281,1.71702829297103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.159127908826802,1.00978669046304,0.246155168837098,12.8905942366414,0.822263451332281
5,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",1.85597126065957,0.158895696516296,4.74145144343819,8.83925843308103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.87046365765214,1.25890314767573,1.07244861859511,149.120413152799,0.0288299212044303
5,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",0.513449992842254,0.209191907990623,1.11561879193359,2.53305588197837,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.565597962495899,1.06013655328379,0.351097707091534,22.3979222931757,0.49310679767697
5,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",1.36928418522521,0.310567711113095,2.22281042273525,7.50954898347382,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39744280424233,1.20941078369735,0.678495152056094,77.7054356878358,0.114848113819647
5,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",1.39623136922148,0.156924529248148,2.99894854149174,5.54776193957334,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42362761789049,1.18090480121116,0.738401585034816,75.6255591371686,0.0938744032695133
5,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",-0.580831843463241,0.896945636136586,0.11776482797049,3.96258527463666,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.498026276472215,1.28088535908257,0.0709487641040212,10.7529598275565,0.708709623973534
5,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",0.215684337334727,0.116372411613194,0.993119478447208,1.56716329971004,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.276183244545853,1.0054716606055,0.282562793759417,14.548996326235,0.715288253549604
5,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",2.11280631738153,0.332294024369819,4.06271264523228,14.945638674432,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.80247410384758,NA,0.974645634737153,NA,0.0361692742766251
5,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",2.6967258838619,0.15333336829712,11.0403571479517,20.1380920745972,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.34096383921827,NA,1.49318270362469,NA,0.00429188686198155
5,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",0.571594426640035,0.805988664656274,0.483923854688624,11.3997314679697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.381283194879963,NA,0.222437172648491,NA,0.714508742680069
5,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",-1.61511619537224,0.55038945279465,0.0779796594915282,0.674475280824335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.63517286897518,0.908561946163341,0.0531209508216522,1.87070152941883,0.0930777001926601
5,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",-2.47245858927075,0.596103996772524,0.0295967012923475,0.306233426156788,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.42575713564551,0.7989996847917,0.0245849716036891,0.563493927789803,0.0145166990195072
5,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",-0.187269041959155,0.154854017392894,0.614128974006231,1.12689524045534,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.318493141152467,NA,0.215123281581715,NA,0.720463559739721
5,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",-2.16031716166609,0.57316540408445,0.0427582124285711,0.404369222998531,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.13791561259526,0.824789203125313,0.0329480832591484,0.835514208594534,0.0294559385289338
5,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",-1.17319981443956,0.535050277382181,0.126092037931134,1.02697272048216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.22765943199203,1.02117573617173,0.0771952436214054,4.22710725307284,0.205938010171764
5,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",0.434971616461849,0.168504195977238,1.10147432045605,2.13224173592845,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.255304296204861,NA,0.332643348557001,NA,0.738043268674401
5,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",0.152975082170255,0.187444193184135,0.796996148908381,1.66173510975067,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0047409876654382,NA,0.271075833109855,NA,0.983197546971482
5,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",0.279552141352942,0.122026398175981,1.04110463718685,1.67970299952088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.11199401082485,NA,0.302146873342571,NA,0.870408180668768
5,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.41369241258179,0.109107445383368,3.33211691433131,5.11051989025748,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15783551989953,NA,0.657118916601315,NA,0.150860857523244
5,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",-1.62328865859458,0.20508405084016,0.129555288155707,0.289461538277016,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.64270072253008,0.729302791291228,0.0727473052520025,1.26877389189958,0.052865271611887
5,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.15205221828405,0.121936417662725,0.910443657778049,1.46837847216057,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00559203552124804,NA,0.276267763579717,NA,0.98380999880528
5,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",2.37138956018577,0.29391744682161,5.75817806145611,18.2243085274318,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.04095499785794,NA,1.17033416227183,NA,0.0163350417480889
5,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",0.129418531224681,0.116518732205753,0.901585283073973,1.42353668413627,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0264647130191648,NA,0.272255804864976,NA,0.995954634460903
5,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",1.2254789281808,0.158479983457888,2.48510445887487,4.62531656045358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.984256794894092,NA,0.573580189914877,NA,0.22430532218991
5,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",1.57456991373958,0.0761722876940017,4.15905240018495,5.60622249627553,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30618472174972,NA,0.73425837989706,NA,0.104518473110339
5,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",0.807951248556978,0.107552743524689,1.82839736892753,2.78720370221078,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.599241139779671,NA,0.436859916230208,NA,0.449214561819114
5,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",0.0531910332325112,0.148808696502176,0.791244308567629,1.41789144893566,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0967670484160274,NA,0.255795855009649,NA,0.928239307170212
5,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",1.26662071312616,0.130589718057735,2.7694877218076,4.62078522794059,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02221665353676,NA,0.593332755293851,NA,0.205045246619294
5,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",3.26877781895181,0.0586894761311804,23.4541980001519,29.5211813346725,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.86846428429697,NA,2.14688073552897,NA,0.000403627707066511
5,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",0.0431134046638956,0.20098952872035,0.69217043768445,1.52187239968935,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.106055422890934,NA,0.249435971728231,NA,0.920210015124103
5,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",-0.83288345309998,0.148605277221221,0.322706923897244,0.577822389877938,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.91383491985569,0.985606463915208,0.13492727902915,6.42686605294344,0.28087847660425
5,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",0.626786652467684,0.194357002118024,1.26565002030552,2.71136253460406,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.43218131396443,NA,0.377000383440716,NA,0.586159897911203
5,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",-0.09408508116805,0.112670700657827,0.728268379042186,1.13266740293673,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.232564547491914,NA,0.23261293143978,NA,0.798084676578824
5,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",1.00577066929734,0.170746737086819,1.9440925341894,3.79661627134582,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.781655794726395,NA,0.492745357535476,NA,0.33297019230998
5,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",0.758498516410529,0.152513261414514,1.57349215228145,2.86090626112222,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.55363809268501,NA,0.418115147480666,NA,0.486370822815554
5,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",3.36898097618915,0.141169982142849,22.1944779690828,38.5987417659387,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.960859737917,NA,2.26211981879823,NA,0.000302613685966465
5,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",4.34306614754999,0.132322090191096,59.9174843226235,100.651234436961,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.85910803079304,NA,4.01821918215772,NA,2.50074338366436e-06
5,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",1.44954718444032,0.262368952823823,2.63268212717322,7.36302271304968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1908831803618,NA,0.645337707285038,NA,0.153733600230155
5,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",0.456879930350383,0.320109272200471,0.799910754716419,2.80541134454289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.275502053525061,NA,0.316101120030268,NA,0.731275987753839
5,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",1.98222894303094,0.127608527646562,5.65128813116901,9.31941392937024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6820880904898,NA,0.951471956068915,NA,0.0385490585153502
5,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",1.83774946352888,0.227044340985607,4.13332616566205,10.0651595635864,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54885761629175,NA,0.845631174940752,NA,0.0619789863716438
5,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",0.579447486251642,0.113772596758564,1.42984608509061,2.2334493626932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.388532929884313,NA,0.372916806939373,NA,0.617253814010721
5,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",0.431309043289952,0.172261871674002,1.08701496050544,2.13547584472832,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.251926669682244,NA,0.331406065936128,NA,0.741312468836502
5,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",2.72076904618057,0.253307235824748,8.96676671388654,24.2028712795483,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.36312844312215,NA,1.48120408055526,NA,0.00491511748850514
5,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",1.31479202679613,0.127485136521281,2.89610908066234,4.77359978449449,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.06663626720556,NA,0.613160112135924,NA,0.186212203458591
5,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",0.868828906298602,0.145840475561149,1.78501315007499,3.16170026477178,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.655377260047751,NA,0.451721153757655,NA,0.41217366330033
5,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",0.745624391823702,0.135639527291727,1.62643314336209,2.76789343535502,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.541767021626184,NA,0.416161104482176,NA,0.494093809241788
5,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.40884252899554,0.134662741705006,3.16576294945379,5.36696371508763,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15335983974124,NA,0.651962260594968,NA,0.154021356109297
5,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",2.98089561336856,0.219942005530917,13.1683361255964,31.1860845903888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.6029985104239,NA,1.75784590970588,NA,0.0017800548286347
5,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",-0.0361880790345277,0.358660002267655,0.460391351608515,1.87806687050872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.179177278844729,NA,0.216188995768981,NA,0.858484970658339
5,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",1.56302057042561,0.198489499781846,3.21949240940315,7.00965337119304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29552360513229,NA,0.711218499840894,NA,0.114787943624189
5,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",0.460759738380477,0.30307347503238,0.863430772351792,2.83257059229835,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.279079911432893,NA,0.319961470886175,NA,0.726593849510259
5,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",1.27123600379133,0.24576174318036,2.21598735468363,5.80701339636502,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02645818774364,NA,0.575777658216731,NA,0.215237011954684
5,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",-2.02320753559681,0.572489770479001,0.0490935156118322,0.463054901337773,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-2.01148997245176,0.845841286822815,0.0369541104922357,1.01771358164721,0.0405676054307993
5,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",-1.67941025834869,0.559366836982521,0.071491617640406,0.640505633193872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.69446048205431,0.900738091635431,0.0498564085122334,1.70270847410123,0.0830648819579415
5,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",0.0245414115475817,0.165959889237552,0.74150455741173,1.42116483310533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.123189067295981,NA,0.249308519914176,NA,0.903211187440074
5,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",-1.96622902222005,0.56780471993475,0.0526289191008245,0.487367941301264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.95893944544624,0.852082506533688,0.0389741667604984,1.0999291913569,0.0456466154994841
5,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",0.390885556953374,0.136471052663991,1.13665987993306,1.94070387256899,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.214654478766407,NA,0.325467719435547,NA,0.773956910261618
5,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",1.88220998576025,0.369823362974959,2.9494869588749,12.5699894980722,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58985645839755,NA,0.822569339976584,NA,0.0681299336104561
5,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",0.699507125003401,0.130723598946671,1.56650947270247,2.61503366220671,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.499241316249385,NA,0.403629520379752,NA,0.52688070812565
5,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",0.433143792337993,0.464828215427873,0.70305146049086,4.34822594808629,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.25360159258687,NA,0.281622309422305,NA,0.764537167257554
5,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",0.87791569270764,0.790811806826323,0.685887505121375,15.2241604383049,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.663754618745754,NA,0.286427742299219,NA,0.530545219047331
5,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",1.32251898775386,0.772568176868582,1.12610256910506,23.2702151170338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.07374016525747,NA,0.407948376540157,NA,0.311400524786109
5,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",1.40798451546331,0.125164966725614,3.19814216234239,5.22370918165111,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15256995704712,NA,0.652791388579357,NA,0.153662568732863
5,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",0.892075783157957,0.274387321230549,1.4676383201327,4.30265837645305,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.676829040271197,NA,0.438970083281547,NA,0.412831697422425
5,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",-0.0119742921589348,0.146763090267422,0.739222992418328,1.31409088940791,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.156876433863865,NA,0.244381307966189,NA,0.870675108167788
5,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",1.19197551269442,0.266393645755525,2.01635721954619,5.72897384203868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.953361150821468,NA,0.541207024433374,NA,0.251895064703029
5,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",-1.06769537728307,0.163008215039328,0.247486259720423,0.468874679808641,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.13037796734485,0.881649866526676,0.112813226189546,3.57506113748894,0.181379399514752
5,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.658240035931794,0.123616784948848,1.51807257445562,2.46455282144379,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.46118835525449,NA,0.392940379648288,NA,0.557023317426989
5,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.166154685823225,0.155999819576409,0.625887064538552,1.15364064912444,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.299022826290195,NA,0.218320525934507,NA,0.738196002340807
5,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",0.200205622016207,0.111016855442394,0.988472284000596,1.52742513817101,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0388294102483888,NA,0.286489768777758,NA,0.94072234926845
5,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",0.555946272387463,0.108851157655805,1.41716062128614,2.17133894953869,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.366862519960633,NA,0.367265964729385,NA,0.635706416135667
5,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.221170215589132,0.0911573175298269,1.04341595821255,1.49157114553404,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0581648600450278,NA,0.291877503797261,NA,0.921823878008646
5,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",0.391719025359303,0.153655780823001,1.09923408014209,2.00758646994922,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.21542126365954,NA,0.324161911254857,NA,0.773927528802192
5,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",2.24333337465596,0.0672312131365684,8.26728138694002,10.7601256893392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.92283530144898,NA,1.13397116787608,NA,0.0173669372184303
5,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
5,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",-1.14342552265625,0.536903873400893,0.129289781178792,1.06069619667772,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.20020335004016,1.03318202714369,0.0788818940728203,4.52761616663339,0.216884209886897
5,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",1.13212880005324,0.1023428188333,2.54498713589191,3.80114399715988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.898146418845235,NA,0.544850544235366,NA,0.262092686459191
5,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",0.957787575827443,0.4616260287032,1.19781434669821,7.31582126467709,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.737405556206364,NA,0.411958078531645,NA,0.408821378690879
5,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",2.1306500626164,0.253419756993602,5.30701517348518,14.3308815299526,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.81897498787461,NA,1.01550151339849,NA,0.0299416560359652
5,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",0.212180677242784,0.146066973350603,0.933417049030156,1.6547812652397,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0498660114867498,NA,0.28642256822207,NA,0.930428078760698
5,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",1.45863734710818,0.105542393138676,3.51922215153325,5.32258221470996,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19927980908124,NA,0.677419168419528,NA,0.136839373624623
5,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",0.70794958968481,0.14601142240774,1.53319806492913,2.71749377937521,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.507025703131665,NA,0.404498598907279,NA,0.521830254306432
5,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",2.0677514228428,0.224929811839026,5.22572818312392,12.6202518563988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.76095030851988,NA,0.983412906302181,NA,0.0340382216952791
5,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",3.05721231879574,0.0736317961567515,18.4251039627594,24.5901367572567,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.67337461546423,NA,1.88536130368356,NA,0.000984914906079643
5,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",1.36491904967234,0.459972466796091,1.80735708249659,10.9673704341094,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1128407251755,NA,0.549120939825421,NA,0.216794764391341
5,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",0.12640535209938,0.337633980226697,0.569669135241085,2.13999037471062,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0292420354655949,NA,0.246763768081212,NA,0.993647978301647
5,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",-0.209567236392603,0.143603007159643,0.605591662530098,1.06328598610888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.339055003959392,NA,0.21245568059164,NA,0.70136369622994
5,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.516578759284915,0.139939370695017,1.28233666999696,2.21939844908911,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.330558372515275,NA,0.354912599570962,NA,0.669057597272631
5,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",4.69560241041654,0.0613125235022585,97.2424574401177,123.661512696937,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",4.18417105041796,NA,4.93462934278047,NA,2.64887188063748e-07
5,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.424260262495529,0.130467512282395,1.18400733382025,1.97452523280035,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.245430565510138,NA,0.333621628839637,NA,0.745307311385041
5,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.569378166632164,0.0840856970825921,1.49974395504582,2.0852823644901,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.379250634132642,NA,0.372279045439584,NA,0.62394560216239
5,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",2.29851388364322,0.223548060285488,6.60213158822577,15.8581705362465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.97374411088664,NA,1.14192214596208,NA,0.0176233895378345
5,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.402302206445894,0.10951707512314,1.20013441588216,1.84362291195868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.225185257212893,NA,0.330084349217844,NA,0.763251132865884
5,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.154976488709446,0.100895512578348,0.701947257871584,1.04248379759491,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.288714477609872,NA,0.223327243491302,NA,0.745441174349125
5,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",-0.0924379792569764,0.135102531683548,0.698094730420838,1.18553212466776,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.231045818404719,NA,0.231565005104917,NA,0.800194818096749
5,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",0.0100171427678724,0.14644251840001,0.760444476494252,1.35011793052383,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.136590626354723,NA,0.248252262419843,NA,0.890024960221284
5,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",-0.614559201098265,0.169699388416009,0.387941557901532,0.754506643471932,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.712512636647189,1.16808894579178,0.157099811137578,15.3014958727729,0.405761886824259
5,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",3.58564511761476,0.0676266512719955,31.6411385518455,41.2458181145365,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.16063261350417,NA,2.59560082253838,NA,9.92198921937789e-05
5,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",2.12835170445446,0.458309733183613,3.89395818001712,23.4757343989532,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.81682573494269,NA,0.924851748101687,NA,0.0452178991078459
5,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",1.14216270719561,0.132328935895127,2.40154260822194,4.03429345070723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.907409416624651,NA,0.545503124304035,NA,0.259432128579581
5,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",1.34890191835463,0.122339169286193,3.05216089007539,4.93035286087888,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.09808999917722,NA,0.627907975409972,NA,0.173466987574979
5,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.06936320919504,0.0837037102177371,2.46718439268568,3.42530354218729,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.84029706308016,NA,0.523722088092593,NA,0.292226647995869
5,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.21939684019648,0.0752630791739606,2.92505701793494,3.92882273664082,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.978647032620354,NA,0.579936603726581,NA,0.221245731630558
5,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",1.56196954220354,0.763788125154236,1.46663761439013,29.2818209458496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29454701801898,NA,0.490851942739892,NA,0.221625643939157
5,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.42814879189496,0.0634763257794395,3.69231436304884,4.735446807455,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2694281303552,0.679359369269772,0.814806686994787,11.6841754994857,0.0906252686055662
5,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",-0.191886326024466,0.103531037615266,0.67804751455537,1.01744674406936,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.441476231789167,0.789684438875946,0.113052398693629,2.49827940318374,0.552997612482051
5,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",1.83732138295097,0.197573747615395,4.36948738568231,9.47939559481267,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70153875621257,0.685024661458096,1.25371903911128,18.3818119601844,0.0281705303640552
5,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.88341555339971,0.0814544251534739,5.62896434920726,7.74634370786053,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.75020021020666,0.65485619274929,1.39806573295324,18.2119644902192,0.0198373154868855
5,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.556727350974876,0.058536232284581,1.55906678822985,1.96117786392253,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.349158195734288,0.733509581178568,0.285008337696239,5.05343332582746,0.644836061639508
5,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",-0.754516700727682,0.161302322256985,0.347591297652583,0.654139637751958,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.03563406396728,0.840803925255069,0.0553166438106826,1.49362997267895,0.172977025481493
5,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.865809312964786,0.0453674329184645,2.17746077244624,2.6012614067376,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.675550225700643,0.71249380528155,0.415339941734639,6.78196198065659,0.368537063830805
5,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",-0.0792613320348505,0.158138621275394,0.687629666569554,1.27811603139541,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.322484544813027,0.792290127813737,0.127161897123144,2.83892655682385,0.667798296912722
5,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",2.05708465284996,0.197466758913879,5.44453749056805,11.8067131646731,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.93362776087328,0.672958219667472,1.62731559975382,22.7571534472933,0.012587176770216
5,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.0847889617807309,0.0427921849986557,1.00202465140408,1.18502620396591,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.149259243108852,0.763925553428127,0.160745324890861,3.21105371623482,0.836245968382985
5,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",-0.213994363161986,0.0570081299562997,0.723374282545548,0.904511058777148,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.464809321219311,0.785786200949211,0.111210159320642,2.42030064585443,0.52937848095559
5,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.744943738006732,0.0425721286309324,1.93993758667401,2.29225369170825,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.547896642654568,0.720029944625943,0.358970692149439,6.03726435036378,0.466454622448138
5,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.42383554908677,0.0323449844625785,3.90051631644623,4.42778271280302,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26487630888346,0.677109684656422,0.814608415889146,11.578772195644,0.090825773544037
5,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.36773968041698,0.126918098190329,3.09295374031978,5.08673586122644,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.2056246612643,0.693023389508439,0.743068810239611,11.2417569054768,0.11235246482464
5,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.599220690184367,0.0455722602371016,1.66713609726429,1.99321162549009,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.394041713189864,0.729678004504295,0.300718799121795,5.25250730867191,0.601853239799986
5,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",0.581003045477778,0.156452764696652,1.3353154057963,2.46563921706429,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.374782300367403,0.748236346549237,0.284279713485726,5.34005505816802,0.627556785911785
5,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.446419320523535,0.0994491031615398,1.29368987367869,1.91043664042309,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.232652278183808,0.745765164589331,0.246825170936469,4.59179366347575,0.761873273718806
5,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",1.36111423180941,0.749254840872707,1.24927184129846,23.5608364547005,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.19862472297827,1.0505754879154,0.365498077159214,22.4588776736055,0.271812764191108
5,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",0.248172225321069,0.0546633773450239,1.15356806775112,1.42923067269988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0232847102434245,0.753690540431339,0.195908694897117,3.75957552528055,0.980322066697761
5,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",1.56803678246928,0.215164860887812,3.23904663863023,7.52860522315477,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41715120746128,0.706026963361997,0.899471379778022,14.3195651805731,0.0695617364019439
5,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",1.84464484703811,0.32062895498552,3.59813429142117,12.644949255244,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70928526800813,0.735796714592647,1.14378441502728,20.4628807122002,0.0371279655952274
5,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.720735099495279,0.0325592218455906,1.93019954002932,2.19296210773706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.522330517461699,0.720992243977752,0.349007163224741,5.8918782257957,0.487370093668707
5,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",0.139695937367959,0.0630666828212684,1.01867521708123,1.30436956258246,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0912738100311428,0.761785286426608,0.171361636874045,3.39452666682933,0.897627407236281
5,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",2.45877616633152,0.214615937822259,7.9030991575851,18.3299071844612,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.35785723561384,0.657802622937888,2.58473414543239,34.0612902898402,0.0024931719394016
5,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",0.352790164087753,0.756130559774386,0.447051234052773,8.66156356204485,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.133767874971415,1.10014815289276,0.111096118682002,8.29076294064813,0.906005316353682
5,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",1.11933941140752,0.0791057469199436,2.63313534203657,3.59040177498683,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.943294780486102,0.700016654290185,0.560173101238251,8.71029298708395,0.210229836338245
5,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",2.61652871301096,0.19723206168753,9.53271379323248,20.6530893868911,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.52442923729342,0.643456066402063,3.15063646024778,39.2482130131286,0.00111467064543694
5,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.83764316048165,0.0789096335133337,5.40259403563109,7.36102577500678,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70185749764471,0.657132301105567,1.32473645141008,17.4113940356394,0.0234627513673309
5,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",0.64817304656692,0.0978574894648517,1.58778058641333,2.33014732094208,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.445731238390758,0.732392849803959,0.315446833455495,5.56870254145568,0.557435136013718
5,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",-0.587861675740379,0.104819198199867,0.45508485816696,0.686336210028721,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.8596203848478,0.818164160062766,0.0693929481165666,1.71459096113441,0.250622928312441
5,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.63468834766978,0.0496061056817591,1.71414495283654,2.082078654079,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.431501593956912,0.727670538697399,0.313754883879152,5.43724704246623,0.5675008449723
5,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.923446891815672,0.097572683221095,2.09193875706243,3.06659909505818,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.736405311365474,0.71483383626832,0.440083677745944,7.2522136592842,0.330269070610725
5,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.920805451707399,0.0494138984556899,2.28296840018544,2.77090906512317,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.733629774798168,0.70931437543506,0.443612313072956,7.15389520585101,0.328711693851013
5,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",1.24815521432913,0.215518449692412,2.35048575040997,5.47087631750855,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.07933309316118,0.724528151595249,0.61373966626083,10.5056554742768,0.167441301173519
5,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",0.0665025990060442,0.0999777396248034,0.883690273719334,1.30768302887956,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.168570693531761,0.771290845703334,0.155313188735653,3.193421556349,0.817536737467415
5,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.61701347232192,0.0491007979064218,4.58291121835689,5.55559775747012,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46884311320864,0.66672166262238,1.0244095920643,13.9798545387369,0.049742277291076
5,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.512334920141864,0.062698360792977,1.47940965157139,1.89158704339304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.302271803620899,0.73682770118872,0.269840328955913,4.84712935975919,0.690647365788771
5,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",0.723854186385938,0.127489352218152,1.62238630457489,2.67419171063535,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.525653978739789,0.732769934914765,0.342185925669579,6.04967357137586,0.491143854697514
5,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.23946065216366,0.0581487355447173,3.08791254403565,3.87844447737807,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.07015175248266,0.690260626712014,0.65030371333298,9.73235753828315,0.153755952648301
5,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.816479610322207,0.0793411468907108,1.94413884836341,2.65337047269933,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.623437234284338,0.719017333908224,0.388696677278011,6.51130676472726,0.4088780265796
5,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.841109707258553,0.0932806267611301,0.36083533758279,0.520128066773311,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.1270695847414,0.835282631938697,0.0508658907690497,1.34404678068133,0.131644405517768
5,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",-0.183093176381711,0.0912916759666111,0.699530525988772,1.00051107841965,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.432184638734311,0.787329983167924,0.114670946846321,2.51076688434501,0.560364464210957
5,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.625270210191889,0.0543880384194133,1.68281872035761,2.08270470966129,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.421552904598499,0.72867335007398,0.309952806031749,5.39251463686881,0.576756950021556
5,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.470440584147447,0.0426172675267346,1.47408492927495,1.74210478593816,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.258027172563691,0.73792876606958,0.257274223252339,4.64139451405414,0.734243488419913
5,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.59184615506383,0.0972420723707658,4.08494384751489,5.98041462866802,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44230985408645,0.674210356196133,0.982399547228724,13.8059388332492,0.055735602705244
5,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.910733206704663,0.078567167492005,2.13941898153642,2.91104442439611,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.722988345355412,0.712952828869901,0.435670896165188,7.12675198497069,0.337619630625453
5,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",1.55058925738844,0.197747519282033,3.278464593762,7.11731987699819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39872603837801,0.701199394522901,0.891054608527322,13.9196506016451,0.0713793076233997
5,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.486278888931445,0.0638909088371111,1.43845279539273,1.84783715330712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.274752488893379,0.738658029161739,0.261370503133962,4.72879277219959,0.718026268177409
5,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",1.20400991755451,0.0782997115254968,2.87032567285314,3.90147515845018,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.0327127813721,0.694701535652002,0.62039069209363,9.44772648440653,0.1699101635188
5,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.91893753774883,0.0782032110686606,5.86761155592426,7.9725039504853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.78772039515527,0.652370360817196,1.45981448188309,18.8319366020177,0.0172794988841689
5,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.102817861004677,0.102934150164193,0.91140394641794,1.3644144798256,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.130219374784191,0.769263916940354,0.162219429362107,3.30902566686754,0.857472405201285
5,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.431589072885811,0.0327002225540154,1.44500355233007,1.64262290553003,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.216994687350665,0.739922600864077,0.245678888798357,4.46698360564172,0.775892924545442
5,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.887672363701364,0.0542614688739756,2.18787506455034,2.70643381297318,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.698639062755232,0.711817584390614,0.42586567832845,6.9354252162475,0.352708562299465
5,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",0.788129462039309,0.10207073342388,1.81180598392362,2.70319404040502,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.593484774968602,0.724087435777306,0.373192198460718,6.37707084603394,0.433805691428004
5,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.55870544382805,0.0539961971579138,4.28328236966675,5.29297689640965,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40731849110351,0.670605825103338,0.954548564866111,13.2263330823437,0.0602863835764961
5,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",3.23215661752673,0.0973656095894982,21.0616760643023,30.8495222804553,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",3.17457216314481,0.585121997598322,6.84869810383881,67.8768246289183,2.45908526711729e-05
5,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",0.0171816664387432,0.032772884076453,0.954659835291153,1.08552870014918,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.2206570045258,0.768017312504761,0.148144283127437,3.00718357063699,0.762136511222724
5,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",0.226868333278401,0.0498371019755357,1.13964762973584,1.38552200539806,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.000815485749132165,0.754746802256173,0.191025228514853,3.68106946903195,0.995632158623709
5,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.483759908848071,0.0789439328906694,1.39479380397561,1.90065986663141,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.272090402568835,0.74048967357968,0.259719716799203,4.73278555076036,0.721261461425936
5,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",0.672057366356233,0.753067562456386,0.620524845625672,11.8791049102281,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.470925924895105,1.08308681150376,0.162507196710137,11.342869341104,0.668742844808085
5,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",0.272561771583287,0.0983018446725705,1.08945283333067,1.60161377894173,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.049041859590912,0.757126305872661,0.199818731829342,3.88660458154807,0.953130885548127
5,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-1.07762695847828,0.0943765666853827,0.284179293305729,0.411395359261299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.37686090899573,0.85335438509008,0.0378871644149131,1.07459605439052,0.0657744515684904
5,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.232255933279014,0.0456731508269698,1.15492739281699,1.38136610407269,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00647595817171918,0.754079215026174,0.192400163183674,3.69787493692057,0.998283154752494
5,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.180200781822496,0.0342408448900513,1.12057963240069,1.28154672320343,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0484981499637588,0.756902940918705,0.1808087968396,3.51377103908462,0.942905837617144
5,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.191376446413593,0.0566387177022214,1.08588073893616,1.35582631132083,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0366958268153673,0.757687521590723,0.182737875861975,3.56219875635911,0.955607539495901
5,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",0.109921217536401,0.0643648464415346,0.986454529598798,1.26955635739681,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.122717864864217,0.763942582258026,0.165196893573448,3.30019868045184,0.864452708429719
5,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.17549396898977,0.0560032001710845,2.908361312422,3.62233306161178,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00259791328659,0.69398760288327,0.602380134023975,9.147812993815,0.181462852666374
5,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",2.37458821046691,0.09750723155214,8.92978410437344,13.086923719105,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.26892648858288,0.629971316402508,2.49314074921473,29.4585869132652,0.00258576270465584
5,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.75872327307673,0.0637899212842889,1.88923255970023,2.42594851987247,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.562441926731623,0.720936729851954,0.363726032995816,6.13902355845758,0.45561391114544
5,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.134172571327063,0.0592070218948768,0.780241281085105,0.984063539534979,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.380499957892453,0.780359252934149,0.122619079887103,2.61242633837533,0.605898983080456
5,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",0.491367041475112,0.0822479673985263,1.39684861454353,1.92827306528118,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.280124211412712,0.740402373597747,0.261919072276405,4.77123062964671,0.713391280894916
5,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.5330662383816,0.0451786020565737,4.24434520412488,5.06667316921678,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3802409340308,0.671388137886839,0.927037732897066,12.8845913686784,0.0651779463555675
5,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",2.57965010010331,0.0974312660740321,10.9661417087103,16.0664949471935,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.48549640216489,0.618902244360105,3.1775248221885,35.9509228317564,0.000962114616175799
5,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.263942711564506,0.0587816668370937,1.1628196544478,1.46413949160849,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0399395706371478,0.752982925525937,0.199574477287271,3.81931481002257,0.962551277444943
5,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",1.82874670704515,0.214957039411173,4.20574241514887,9.76756247468285,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.69248117566995,0.691437152883008,1.22662827517195,18.4424117764491,0.0301037198910311
5,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",0.643147830097916,0.32306062226416,1.07587165071707,3.81715560723475,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.440418399429909,0.803430320454724,0.272868345718262,6.36378377817232,0.594772111914126
5,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.790825556639047,0.0625838213523311,1.95522217381602,2.49884319455429,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.596349234739058,0.718761192490169,0.378225095158781,6.3295321962142,0.428610177394021
5,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.45479979801145,0.0622507129459721,3.80075583815896,4.85116199331727,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29757557820203,0.677631030795191,0.841478217846626,11.9851655361186,0.0836237829258601
5,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.583479915160598,0.0462466316492708,1.63903142512137,1.96479701121799,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.377416241346039,0.730753978890172,0.295000133058557,5.17440050901117,0.617484272949008
5,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-1.47218980847863,0.0966796645643898,0.190624087151192,0.278461742419126,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.79352585971065,0.884534105205413,0.0231082947258269,0.740630322439863,0.0166752004983552
5,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",0.381924190147297,0.0798196784214821,1.25753633107882,1.71951436325936,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.164539176115448,0.747321537281551,0.229420333735712,4.29412219606412,0.831208759449381
5,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",0.148073647170472,0.0465396343832702,1.05982553691746,1.27193113112383,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0824264578977632,0.759845708969848,0.173591358679038,3.41265025935499,0.906835081934649
5,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",0.959917375377656,0.322082402577788,1.48036392383997,5.23217870773414,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.774910905536309,0.784567740355306,0.399226787784751,8.64709473663148,0.346704522064745
5,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",2.75333291905468,0.0973149162547286,13.0479573382688,19.107846414755,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.66892960505349,0.609684350549707,3.90055623821915,42.5652378046881,0.000391770693863522
5,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",0.0114473260048518,0.760458921155503,0.313946134558476,6.18675267370004,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.226708956159036,1.11993408244327,0.0737032769183567,5.94382529675922,0.832498687543416
5,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",1.19748607447431,0.321582203451095,1.87939952008005,6.62951331670625,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02582306830953,0.770949470603086,0.530361148279039,10.890265316033,0.212062121674077
5,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",0.091042605720568,0.12859904057451,0.859619359993438,1.42309401283975,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.142666814840352,0.774486973045817,0.1585185110451,3.30041838501659,0.84540388245095
5,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.478398320283388,0.0564647653075158,1.44732960009905,1.80589807440045,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.266430267152848,0.738483835981201,0.259232030515519,4.68690146537581,0.726132436634522
5,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.804039398408169,0.0340658532846655,2.09170096109131,2.39052565965311,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.610317112462124,0.715716267458719,0.385985487130565,6.38276064282829,0.416512330163854
5,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.456526068439713,0.127796940739633,1.24115458713606,2.04827273033748,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.24332428836448,0.750044292145238,0.247459157953387,4.68145926397217,0.752592065909383
5,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.41756241134136,0.0421676520941372,3.80404424590896,4.48778353392777,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25824975594443,0.678103959437206,0.807522501226738,11.5228764687175,0.0927763002813561
5,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.59907699640004,0.0459574427984962,4.52842349196372,5.42231978945491,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44989963945818,0.66752740704954,1.0031599715374,13.7331736795097,0.0527006444274841
5,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.897517057792829,0.0818692309679058,2.09843049069227,2.89247104074021,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.709027445553974,0.714210402985325,0.428414622739345,7.04268526306979,0.347346882577081
5,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.893301144981155,0.0461526087543431,2.23439618998081,2.67750645022692,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.704583410811626,0.710805319043226,0.429324586178922,6.9640668114194,0.348205408085864
5,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",1.19826906896181,0.0816325983596802,2.83619444332289,3.90577830911216,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02665001531714,0.695492076277199,0.615590550790806,9.40372244190424,0.172670086073261
5,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.46125992514663,0.0339151524226972,4.03700546785406,4.61101566653384,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.30440263242628,0.674945303119241,0.85185917994711,12.0059567652849,0.0811731226231967
5,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",-0.321355090734783,0.159045330674392,0.538711921918297,1.00488380853189,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.578164578782371,0.809261903202634,0.0944634233502741,2.25399860061716,0.444793147500033
5,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.40636321615497,0.0986131382191016,3.38454028727341,4.98171638352743,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.24641655177441,0.685428558486193,0.786406755235951,11.5484295393793,0.0985437106881613
5,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.542733544207868,0.034096697549825,1.61063087868094,1.84095148749719,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.334382575255281,0.732658753611979,0.281181796560642,4.96898544813293,0.658371592136929
5,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.743041556471084,0.0990343428745195,1.74200179823364,2.56829537657552,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.545926777180586,0.726475807508003,0.353719376098347,6.10117535401877,0.471637909539898
5,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.87588532370989,0.0867558392932675,5.52043400890389,7.75651490338533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.73718478983564,0.293125572230167,3.11328628107189,9.82283698530105,4.68190800012921e-07
5,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",0.772749220742616,0.38460616055349,1.0276431735323,4.64084492308165,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.595034593395481,0.505302086583336,0.651384717286116,4.72134130625744,0.261777776889317
5,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",1.10578668965222,0.173981077182424,2.16204534942276,4.27612824794397,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.939876021168735,0.35014459351574,1.24905006135127,4.92795895288511,0.0138316392594016
5,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.54133434038137,0.0647106524744789,4.11858183478099,5.30776045169819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3908068661406,0.295613508332856,2.18729481588397,6.9688428737683,4.33856934797983e-05
5,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.690359272538828,0.0424788582194781,1.83518069951069,2.16767901094853,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.509729235818321,0.315042224308472,0.868099343069933,2.9846834853942,0.136880179177141
5,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",1.00962317631464,0.366533092421299,1.35770852235383,5.71207119592573,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.84031064764504,0.486267635493717,0.865342024325334,5.82118388936113,0.100623220744236
5,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",0.124647349915593,0.0318264001962774,1.06417493002705,1.20557542202149,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0759612753388962,0.33070101007841,0.466902141150096,1.7069165363418,0.784143452179457
5,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",1.7957920760031,0.161263336080676,4.42717464073941,8.3303232709706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.65425720435669,0.327130180328632,2.67964046063482,9.66015189715393,9.20519833965458e-06
5,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",2.02522091377344,0.0172465143635314,7.32663616628506,7.83908086901046,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.89178356333588,0.27563992760498,3.76328694900859,11.0870906356131,1.32392418983811e-08
5,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.586105844291094,0.0423031154687114,1.65415017570007,1.95250380878207,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.401836492096972,0.318070850331251,0.774147164726216,2.69344632194432,0.244757218403625
5,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.132789328969542,0.0368476560531806,1.06232065814102,1.22739737559649,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0675314556521398,0.331010783658036,0.47059437820352,1.72250509213693,0.804078256251583
5,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",0.820991875831785,0.331440673331506,1.19916872596674,4.39669074203312,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.645022813267895,0.461946591541512,0.745729160305194,4.56037366302309,0.185488970709224
5,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.290371904297643,0.059816268827271,0.664940132743386,0.840647540018396,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.50567735192802,0.347811510414811,0.292899771600649,1.14507628897011,0.120885866996616
5,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",0.135016925610196,0.0308773210822684,1.07727494960144,1.21588417990913,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0652252476507807,0.330283490213632,0.472364161766113,1.72406078425261,0.809089193037749
5,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",0.0289290196032874,0.039252286442441,0.953004844044773,1.11152266222239,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.175062293289195,0.334525600004329,0.41939757482204,1.55640754961204,0.567689263927777
5,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",0.151239059174122,0.0862733728453832,0.981775976827851,1.37684311534872,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0484468403280775,0.340243108299875,0.471129201410485,1.78801410764546,0.853121968658849
5,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",0.667571089565647,0.340340435557816,1.00769960039721,3.82584784717088,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.486138878337287,0.47185421473667,0.623373581684444,3.96309483226653,0.328777660745008
5,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",0.0287609084086296,0.0552404796585773,0.92366916166254,1.146985710175,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.175236177442667,0.336972279777971,0.417327357386499,1.56364983884862,0.570148514090276
5,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",1.12988802752822,0.0943552638643361,2.57771131399567,3.73134125753923,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.964831333515025,0.314896208633224,1.37242603560982,4.71595036712892,0.00574676626948718
5,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.85449490578646,0.0160944599626523,2.27734693123167,2.42565177756389,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.679681253652462,0.307603231815447,1.04509240938999,3.48995144433003,0.044073751119184
5,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",1.33160875136794,0.0443138902902232,3.47331535120474,4.1322284115272,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17366279619738,0.29721336109712,1.75285132041679,5.61981505457383,0.000500915137133125
5,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",1.00239243983537,0.0398248030103197,2.52056456323927,2.94642705543537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.83280598203511,0.305702443541743,1.22367706280289,4.05597811415102,0.0138512302976927
5,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",0.42682327413699,0.112473402166551,1.22982563939208,1.9112548916848,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.236895899268885,0.340463596153653,0.627605469586185,2.38392724318275,0.525474046217532
5,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",1.4930345576435,0.148711289180097,3.34351281728793,5.98921012470545,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34079469224251,0.327830460403428,1.95278301628894,7.05916896194009,0.000269380649716935
5,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",1.11311306237415,0.0158266244984232,2.9510258571468,3.13990356013029,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.947439157290538,0.300197958692365,1.38807077949836,4.50266403415235,0.00473743910724242
5,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",1.76971940403309,0.0148932149813011,5.70078318294449,6.04350351463377,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.62725232080892,0.28218219708758,2.84815710182087,8.60898169081856,1.0404546476213e-06
5,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.65926050224798,0.0353035286688986,4.90561916873673,5.63371231948089,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51287709067936,0.287053093236886,2.51476596619931,7.74778652445195,6.33909786151845e-06
5,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",0.93220223700178,0.180369736560205,1.79274991602499,3.63564698241554,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.760147021654719,0.357830699511422,1.0269138486462,4.17547702064363,0.0492378052558593
5,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.290770291622063,0.036680153372323,1.24464204002273,1.43710623061466,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0960357235614617,0.326163991776833,0.560120444716587,2.01161104377245,0.806755538170909
5,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",1.03484399922921,0.0314767301868842,2.64665913213549,2.99422266853877,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.866404312336677,0.303716069820047,1.27064513391919,4.17899115823765,0.0101810099690924
5,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.504699886614076,0.028215399804505,1.5674010242609,1.75070958687658,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.317551176496216,0.318801398142447,0.710178079415112,2.47796830567878,0.360585669199778
5,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.940191121279323,0.0448065906469462,2.34597879361885,2.79642361019622,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.76840640414197,0.308206292719098,1.14130294380712,3.82025437225011,0.0236534736326426
5,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.767820826489622,0.0268384157627004,2.04475546541944,2.27159644064581,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.589944083476617,0.310919821375366,0.948685295140674,3.2094678713575,0.0822636707265239
5,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.840017175227545,0.0563283837297287,2.07509222072273,2.58780183566277,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.664679523067819,0.313078229810108,1.01845496140836,3.47477887791526,0.052330921337066
5,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",1.18675665082195,0.0431228464402136,3.01269945219888,3.56753526962948,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02368651521582,0.301018995560328,1.49625508120239,4.86924139426995,0.00243430870800768
5,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",1.07189792298652,0.0541261783881189,2.62771656008932,3.24880085798053,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.904768075973527,0.306115337208437,1.31445878901214,4.36393898183712,0.00780646304905941
5,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.86193773057612,0.0396174562904863,5.95841768815256,6.95946450354697,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.72273002167979,0.282331297336309,3.13407061827562,9.47873648876734,2.76094927507688e-07
5,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.526694155074595,0.0333312524744525,1.58625578937593,1.80765874800647,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.340322953268982,0.31867915747037,0.726814502098641,2.53480155829384,0.326337296297349
5,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.765543953091676,0.0275640016448858,2.03720861483706,2.26965865007684,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.587586746295174,0.311054442917324,0.94618821425557,3.2027097199421,0.0835868170961511
5,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.48511134759854,0.0275909093963671,4.18324471142379,4.66105384516019,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33261276853562,0.290828461598898,2.08243851477244,6.51147620900405,6.86908158688388e-05
5,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.44656793551336,0.0244782495336234,4.05003249211344,4.45790033738673,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29270313908021,0.291577241906397,1.99761699624768,6.26461261964354,0.000111870351803025
5,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",0.770695654915894,0.168238335348978,1.55856420755057,3.01393692872624,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.592933361354404,0.35547817925119,0.871935809829894,3.51278576130136,0.121146640687818
5,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",0.980764799935618,0.162504677563336,1.94626266415039,3.68001777297236,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.810441318879276,0.347259657395403,1.10280338490497,4.3020356303787,0.0316439331991809
5,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",1.91323747003041,0.28230545308675,3.99028858832125,12.0670741335215,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.775842974594,0.403870865153176,2.60499752062732,12.686981939845,6.43736238673576e-05
5,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",0.895595699692978,0.0603773586129441,2.17642007005253,2.75758763982259,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.722223124547567,0.312315003273267,1.08076365483344,3.67634920378386,0.0350774793690157
5,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.51825346133993,0.0542894417167352,4.10633412772394,5.08015306365823,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36691352582071,0.293964395973936,2.14231214836314,6.78154496289657,5.31220977505047e-05
5,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.419039902483501,0.0767068121067481,1.30883594017698,1.76795467060679,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.228839946218889,0.329797521758049,0.635704000412913,2.31581180445664,0.528119881610189
5,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.493922910863862,0.0290754346053775,1.54798472981004,1.7348613904517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.306391044571145,0.319206409993219,0.701690918758708,2.4522448635233,0.378676826181413
5,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.593994600211124,0.074123701309292,1.5673190259301,2.09578063653816,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.409985827902232,0.32406583693261,0.771413441923652,2.74775421793692,0.243219513755798
5,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.901363368171029,0.0971946299429423,2.03922688349367,2.98490137382393,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.728219746517638,0.322014708271636,1.06679247591027,3.76945685865065,0.0385531212026959
5,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.1635871133194,0.0300980890491028,3.01847477549657,3.39646098807403,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.999697334232239,0.29995571492563,1.46365819090951,4.74335033875152,0.00294844620946132
5,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",0.371561469230575,0.0512606378562575,1.31152413443584,1.60340249447012,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.179685035085175,0.3258489334382,0.609698589696401,2.18696292410971,0.621650647667977
5,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",1.02311848464471,0.0454766138075244,2.54558211259268,3.04233222993714,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.854264587529977,0.305966341871207,1.24972623831597,4.14660753742987,0.0117429890383479
5,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.80499205486538,0.0413618072541878,5.60936975996907,6.59672739014193,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66377177827849,0.284085643082283,2.94362294417597,8.96417765596586,7.11231091158437e-07
5,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.536291648221197,0.0167291473345172,1.6545796367647,1.76671878639792,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.350212847875271,0.316982980289502,0.736563685807465,2.55177928386162,0.30981651621265
5,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",-0.161535679518377,0.101350067234982,0.696309847768054,1.03595574846154,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.372245389418221,0.354096389853819,0.330915470825576,1.32596438306608,0.263367956241531
5,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.402129963334421,0.0444789206131963,0.612807197262109,0.729532945124501,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.62132672169377,0.348922243593034,0.260103755280979,1.02129904743007,0.056070341903943
5,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.648884898443878,0.118606955636905,0.412674099523862,0.65693750941356,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.876831264341023,0.374866394789225,0.191095206776971,0.830660389357743,0.0112855651825496
5,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",0.927975374830848,0.0769436388457143,2.17673528130578,2.94303010595885,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.75578934418045,0.315313997118475,1.1112756823293,3.82484053086987,0.0289747325590342
5,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.612936487771108,0.0474769778460219,1.68215519793951,2.02624061129759,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.429614742185703,0.31807039921756,0.796092333500356,2.76979400504523,0.213543355865644
5,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.568112584280233,0.0780830049962655,1.51468897359598,2.05708488272956,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.383186452033346,0.325809053620807,0.748316078876101,2.68375839139085,0.278015785568622
5,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",0.195707054161909,0.0463371083296535,1.11049150718103,1.33167938810892,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00238996402778327,0.330365248268955,0.503128420816577,1.83693449149719,0.958797595195452
5,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.87079448598524,0.0731356368197365,2.07081607770124,2.75834041048506,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.69658738341903,0.315936951970697,1.04575182844636,3.60811752200991,0.0439354470513593
5,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.46528548471008,0.0237966278024717,4.1320483209323,4.53603967192406,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31208559246665,0.291006323970147,2.03919660679891,6.38071231090425,8.76313044570752e-05
5,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",0.474631584516629,0.180080526776722,1.13028174041987,2.28958281256652,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.286395068823708,0.369231213993549,0.623491894645036,2.65100880602662,0.473488082801203
5,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",0.553174362747596,0.102681781488969,1.4233636667316,2.1287352777121,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.367714784029934,0.333511187660247,0.725745444206229,2.68259304018552,0.308486555778367
5,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",0.79545555266465,0.0313414658689421,2.08360378893818,2.35597645945354,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.618555501085941,0.310572198392098,0.977055026800228,3.30094351281573,0.0684830791359382
5,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.70561239605219,0.0917844394996155,4.61023849422196,6.60659228303564,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5608869524581,0.299051959874838,2.57765004551886,8.32397820772336,6.64867939467988e-06
5,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.611708656997537,0.0302927053266904,1.73737525854317,1.95642871120517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.428298727836962,0.315832621262229,0.79857021778498,2.75414967638609,0.21198140007894
5,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.888077505573762,0.0285530284280176,2.29838082770548,2.57057780838392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.714450843367653,0.307609048652985,1.08227940934762,3.61421504815111,0.0346082242748314
5,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",0.116065621390043,0.389677919698287,0.517841387191082,2.3855342189029,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0848456996964777,0.521851942807398,0.318103392925575,2.46020138956112,0.848307671300884
5,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.61393380858687,0.0254119923786294,4.77929352909389,5.27989345213471,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.46595308860286,0.287137609010659,2.39850543839905,7.39204597520766,1.15367434919259e-05
5,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.22975588866474,0.0419072058801968,0.731841520332731,0.862501783456821,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.442889566804323,0.343033263575983,0.31495175022175,1.20843950070143,0.168814014296791
5,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",1.03712833740005,0.0194732608418417,2.71564301244553,2.93105533907837,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.868769167694212,0.302565436691632,1.27655903688459,4.17954723390651,0.00975254739702039
5,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.630698328730633,0.0634864782299178,1.65949100999264,2.12840602933196,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.447994507589747,0.320553157858573,0.80702269901851,2.83528314115267,0.19772902189374
5,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",0.327653295404065,0.0466377677429092,1.26630582551344,1.52031956527912,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.134223293352302,0.326420423958967,0.581776038874085,2.09148602760169,0.720193818788383
5,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",1.32560202293742,0.0187860912694725,3.6286256292898,3.90592287368963,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16744804598783,0.294445158022942,1.75140645525091,5.55458084144834,0.000485079018864543
5,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.905384452638084,0.0400976366977355,2.28642407228991,2.67558729074205,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.732369560095323,0.308499187690609,1.10004052995011,3.6863677320582,0.0308749150171839
5,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",2.01486090269297,0.313642469009081,4.18964373617279,14.3259358414451,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.88105805546453,0.426323187562908,2.77080937946236,14.7360321179237,5.52567102306416e-05
5,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.5681239910677,0.0359444109947394,4.47278586248735,5.14955834085625,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41850407809772,0.289573407853529,2.27594632710222,7.0816209866469,2.34269782806932e-05
5,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",1.37559386246536,0.0664579066009743,3.47759748583153,4.51250253117053,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21920111174751,0.300459602946863,1.82333962440776,5.92067095368549,0.000350373181875745
5,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",0.447408895825539,0.409856985722223,0.699146644221719,3.48586107609392,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.258207396697341,0.532067425390876,0.440404185517653,3.54523203480405,0.650650306117632
5,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.825439861723025,0.0483796436387867,2.07686633488321,2.5105576660172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.649597573635133,0.312059612741665,1.00511450023206,3.41559828043593,0.0570509370334946
5,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",0.227417821175415,0.0333232468006676,1.1759217770246,1.3400099754263,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0304422488102433,0.327710976772965,0.522740648198172,1.88878467505414,0.962443217850902
5,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",1.1284181356439,0.0458380885720866,2.82614578197873,3.38243503393289,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.963285726985815,0.303057643775929,1.40249066989388,4.60072472496649,0.00441923140381622
5,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",0.459373292282896,0.0605987123272174,1.40599474145105,1.78298270813028,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.270603538026999,0.32496664429665,0.669275246062043,2.39237348621094,0.446137969280763
5,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",0.614319921939997,0.190221673164639,1.27711824575234,2.69193812364153,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.431021207310744,0.371128620312469,0.718487178020864,3.0777230059076,0.278597528364915
5,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.104562979257557,0.0951691936250541,0.920468738436196,1.33667360511583,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.096725488445383,0.344182826307563,0.445300714461428,1.71629247258813,0.745801975148986
5,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.0304376860079255,0.0601109225823393,0.915899156256666,1.15925954135875,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.17350010164757,0.33781858008633,0.417363810060166,1.56898279671315,0.574702038519677
5,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",0.469375395320822,0.0521319750242294,1.44375858341407,1.77110461370836,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.280962380397562,0.323081574763241,0.678794967526228,2.40853900522989,0.425834971991634
5,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",0.865092320616997,0.104825663891532,1.936779043644,2.9210272672254,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.690662459515377,0.325573596915638,1.0201037144685,3.65512156118245,0.051590671522462
5,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.73818205303525,0.0490974927123967,5.16919779068895,6.26623781572257,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59458067338264,0.287153781324819,2.72947096500586,8.41259462918859,2.19865718738283e-06
5,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",0.274053258223999,0.0686529178729412,1.14956292724715,1.50455368559592,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0787262260458331,0.332187471777817,0.544000245795832,2.00039644077454,0.849778860253433
5,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.402608774255771,0.0542977090522208,1.34456714655755,1.66348574225401,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.211830886839798,0.325451696538619,0.630237915504819,2.25711922417092,0.555971000047819
5,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",0.655290852148264,0.0209084087420245,1.84844782725254,2.00632708751864,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.473437066094561,0.313724568628539,0.839123444763859,2.87019583038526,0.165258722378192
5,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",0.64851139465442,0.0511889871187591,1.73019459570201,2.11465362323133,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.46644818174704,0.317652332944003,0.826826942093654,2.87201650671192,0.176388780589609
5,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.491943165830418,0.0345965940894828,1.52827795798351,1.75024843493931,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.30433791170652,0.319858898458505,0.699349890262632,2.45032272055246,0.382854097010103
5,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.185919047430664,0.0373394443826997,1.11922907849123,1.295644244976,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0125240605235402,0.329435419448868,0.498934006148657,1.81499310809985,0.934352301530621
5,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",1.03824839397925,0.100090605969077,2.32505363579223,3.44213209245876,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.869945239079196,0.31925586240553,1.23690576657154,4.3235330161968,0.0133765385352682
5,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",0.0992271993300094,0.0817509549078564,0.940808909826972,1.29620740939535,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.102294547051922,0.340602144841414,0.44595152207737,1.69484424563424,0.73088882758022
5,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",1.91473814117544,0.162672441384764,4.99783886156599,9.45619274766834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.57594925553457,0.523028734479495,1.70375141108869,13.237682496672,0.00409713394893226
5,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",-0.303018246510077,0.408834822702802,0.332000189399157,1.64869376475238,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.899826629116042,0.688048398494621,0.10349489491227,1.5355170570871,0.185410421449593
5,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",0.565916354147862,0.125513583896726,1.38158040358151,2.25970047633943,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0701846909638011,0.524170801743198,0.376717845102146,2.94012763333507,0.910993508759143
5,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",1.34828903547524,0.0858532338163635,3.26318085861496,4.56875589884561,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.943616213058638,0.505721565267907,0.936104003210029,6.79619851619515,0.0744576863323069
5,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",2.23306037739977,0.0806177838878774,7.99180540052844,10.9619764427969,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.93133480156785,0.495327586797748,2.5670540801181,17.892961629266,0.000233643709417549
5,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",0.278577629544937,0.0593142906453062,1.17679383962576,1.48483165516863,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.250564920199081,0.512548318009654,0.279579195402041,2.08482059804731,0.614377521316088
5,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",1.30871537494999,0.0827720418748872,3.15493324098929,4.36416893393616,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.899436530108171,0.505501366119536,0.896005612128272,6.49946808820559,0.0888792322202699
5,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",2.04685962642499,0.0784582698344738,6.66132519703206,9.06000081147649,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.7234595093336,0.496842928849618,2.07875513341894,14.5757285028916,0.00102375299531819
5,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.407605172741519,0.0519763431114376,1.35823579647497,1.66517491216052,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.106574449539208,0.510152180391404,0.324443389013074,2.39675463370185,0.820875281063153
5,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",1.32555298578033,0.11361788547912,3.02779359687314,4.72660929972712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.918226368974459,0.512743804685779,0.900144384034361,6.71751758397173,0.0865694720460126
5,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",1.12712902144671,0.123821193246051,2.43462669458015,3.9557238073022,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.69670630479749,0.517754647384039,0.714122043537421,5.43500000491077,0.197540739658291
5,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",1.35388155389915,0.120994612637412,3.07248674307353,4.93709654227039,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.949850487936904,0.514548761802072,0.925805714495366,6.95807743047543,0.0772762050369453
5,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.46050612417397,0.0818783432479903,3.67972509190337,5.07230451542587,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.0688650369921,0.503709104033224,1.06529846303734,7.67338932920763,0.0427252706486954
5,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",0.426754240428959,0.0975545849250962,1.26763737303375,1.85811359652077,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0851473019362517,0.518194975730376,0.326281436915118,2.48753438277304,0.855395990047713
5,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",0.521533728381059,0.0900945250626525,1.41424111005901,2.01326366237627,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0206378174614608,0.515491766425022,0.364639500909309,2.75066997927351,0.984731405304821
5,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",1.83455216769,0.0493296283746315,5.69184934415234,6.90609117969833,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48644276759729,0.494400883206722,1.64768740210598,11.4431189047322,0.00431798093795379
5,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",1.06961072553552,0.101086947154991,2.39894940600814,3.56542922193861,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.632496544268057,0.512169060518764,0.677049914719098,5.04125745352741,0.237466380501372
5,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",1.23825089753466,0.046050458314135,3.15503383511211,3.77920511224846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.820777173309104,0.500405832879847,0.836466946884209,5.94759268702792,0.11693051149397
5,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",1.35649817347689,0.145960942262263,2.94178843348091,5.21309686518341,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.952766492851419,0.52253429698109,0.914087156521372,7.08845532936662,0.0806848230246662
5,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",1.23630163470444,0.0444217764959685,3.15779430975829,3.75843987623553,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.818601270839331,0.500243174704833,0.834913670352314,5.93276432405491,0.117790511601981
5,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",0.604956897533049,0.0907333369786793,1.53555867346387,2.19144779021846,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.113768112123443,0.514724737101639,0.400865660097804,3.01486475958029,0.843951318235917
5,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",1.04397495370896,0.0885167397834574,2.39427453217468,3.38738934389666,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.60387853280536,0.509532502381353,0.66134371867908,4.87367918319412,0.257186194293112
5,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",0.605094682226235,0.153898887667592,1.36161038463469,2.48914843939852,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.113921702568203,0.533116598406958,0.386733223610472,3.12601333098538,0.848864649611509
5,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.932849356597011,0.0538299188497109,2.28933645906369,2.82715646597988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.479821760718691,0.504655570839912,0.589741868402144,4.26372477204414,0.364744507939534
5,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",1.16426676631363,0.0522221669389081,2.89473527503586,3.55231959625145,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.738178410318501,0.50194287378252,0.767813201613355,5.4924317948826,0.159734313540927
5,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",1.59877847488418,0.166226518299362,3.61574905546183,6.93717769786061,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22323872944125,0.527589231627568,1.18641033153703,9.38435560406396,0.0265331502241132
5,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",1.00714325496571,0.0893768940852332,2.30357711383862,3.27007908149664,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.562759826646138,0.510113046948718,0.633960832643701,4.6825287514487,0.291805114119911
5,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",0.456464740063508,0.103095716901679,1.29229054846631,1.93584523869245,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0519798124798446,0.519211774085661,0.336621698162078,2.57661679481537,0.905406753564981
5,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",0.721382010875389,0.157159785050917,1.52197999276654,2.81811198265561,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.243757899668692,0.533100183294025,0.440402383792168,3.55959885543182,0.667843822193542
5,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",0.658700039835434,0.0553253605112686,1.73497987738865,2.15516490647074,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.173765452877077,0.507834877032226,0.431458833074174,3.15848651182854,0.752727499504283
5,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",0.756151243798688,0.0979991460305359,1.76245642774163,2.58792947895045,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.282556522197162,0.514762706659234,0.474596600117571,3.56991802230096,0.604938843553455
5,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",1.44100418970031,0.0906658370310197,3.54854510928517,5.06290911259675,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.04709385861753,0.505788752663228,1.03810007132726,7.53868426354878,0.0479447627961708
5,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",0.895212899874347,0.033925491586885,2.29110252564347,2.61697386608669,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.437805652251574,0.502902107753581,0.567405808229079,4.07413933316998,0.407346947625282
5,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",1.12961800898504,0.0327120798474434,2.90341412149154,3.30063978700659,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.699498552909804,0.500255098797909,0.741108100190843,5.26644295374132,0.18142512369788
5,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.631289955611488,0.0354496892788291,1.75432797119657,2.0158603756257,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.143165771901538,0.505914520156771,0.420024740184217,3.05172441643081,0.797149499010592
5,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",0.285774536349257,0.359528593322147,0.671353738894274,2.7479827289461,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.242553495954244,0.647650215579159,0.216265417041637,2.73872737601562,0.697924892144488
5,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",1.71433804416912,0.0310648595275384,5.22727106802869,5.90418469183834,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35223723887769,0.493829976755574,1.44223139183615,9.99384526237311,0.00923176186797611
5,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",0.90070530309358,0.127600356882204,1.92595590443688,3.17594944687816,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.44393160285285,0.521269393206184,0.550708690314264,4.2494483372163,0.416705412854302
5,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",0.433848055136609,0.219608902933871,1.01239928003456,2.39449923043253,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0772507072545575,0.562785769082517,0.301348207680087,2.73625673191047,0.877418011776349
5,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",0.234771257082622,0.201930533628058,0.85669428286554,1.89057117631777,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.299491165379583,0.55647788921122,0.244257302616353,2.16370093579723,0.580706798184728
5,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",0.569486923588751,0.21455623956688,1.17245375997951,2.71867271249248,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0741713921432912,0.559000532478504,0.353265874743568,3.16042813026998,0.910781635225229
5,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",1.13623519023202,0.197886273706976,2.14364994952488,4.65624765289074,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.706863138761619,0.54560788014094,0.683090005138564,5.79859090452954,0.21344671745634
5,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",0.0785340260237854,0.23631129880998,0.683779470217447,1.72668510187279,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.473877712174251,0.574642007807185,0.19796082837571,1.88300550701213,0.401800757183195
5,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",0.149864262401676,0.09721614387123,0.960955065540845,1.4067086041046,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.394267214538446,0.521112042144473,0.238099898058978,1.83612379315948,0.441017290631197
5,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",2.18455577173312,0.160416655515647,6.57670651366106,12.333952493031,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.87716145067975,0.519461785611629,2.31925501832413,17.7697718602516,0.000607595570291395
5,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",0.0918695416750166,0.0537352057050028,0.986816035956618,1.21819041566747,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.459007564562788,0.513836915770221,0.226367498732517,1.69656937577858,0.364293337844401
5,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",2.74675337870544,0.157272897241235,11.6180494588615,21.5216263285172,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.50477414663315,0.512683914171325,4.40425447434325,32.8599639062025,4.42073462818586e-06
5,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",1.1041854409842,0.149753707164918,2.26695122858839,4.07740029547611,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.671089844215909,0.526465133168524,0.684264119687409,5.38864576736006,0.221866417432801
5,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",2.08117086229191,0.138835547144674,6.16399129700903,10.6222392941047,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.76175510564789,0.512695573879387,2.09387733520911,15.6230478658501,0.0011110033503492
5,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",0.0761540192085446,0.055932286941765,0.967267905583571,1.20438704627299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.476552658426189,0.514302651544455,0.222224592708211,1.66856273595461,0.346920791299665
5,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",1.92838540185409,0.358786994539518,3.62511806478901,14.7952477644516,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.59118446214531,0.633215303652689,1.39389642007556,16.6808504978241,0.0153063557064614
5,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",0.946639648782797,0.0530482314097399,2.32470535794267,2.86205113901946,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.495217290238236,0.504402910626904,0.599194901731215,4.32778005763743,0.349128048598766
5,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",1.03446867372243,0.136818325900286,2.16482258925411,3.70119742458019,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.593260942184544,0.522782382637527,0.637579549468184,4.94903722265068,0.277368719281751
5,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",1.60790010055014,0.0838946158268099,4.2484709137251,5.90275968177003,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23341060026498,0.502563413929377,1.25880562216092,9.0265996493893,0.0193005162523586
5,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",0.095492301161544,0.372784903544162,0.538189117814915,2.3204118915162,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.454975987545259,0.658559845910399,0.171151665611538,2.26211898304357,0.481527127961678
5,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",1.92196127816709,0.359419421153919,3.59642016871992,14.7145558060204,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58401285929474,0.633716057553813,1.38256969146832,16.5778117773886,0.0158462277583293
5,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",1.29029302631396,0.112986035077335,2.92646792622702,4.55713131936781,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.878862484393195,0.51293951260938,0.865043115485648,6.46052131285844,0.101010749568806
5,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",1.01294133233934,0.0855688818949569,2.33407569118342,3.26428195477584,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.569233156807849,0.509235938917414,0.63917886176313,4.70486577709354,0.285454876336484
5,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",0.784453775702206,0.332286952206022,1.17786515797791,4.33293234818922,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.314131219844636,0.624817639714482,0.394798821978546,4.57159055133201,0.632114299847894
5,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",0.586051585291777,0.190254972998123,1.24862109558518,2.63221476770366,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0926643801616265,0.547755316351505,0.367879441171442,3.14924072713619,0.882744677233934
5,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",0.837175872773932,0.183306550178449,1.62930001084525,3.34243289781105,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.373036569055297,0.542222108841948,0.492334570137596,4.12421144601092,0.512563097652895
5,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",1.41294773691256,0.0802798147429269,3.51925278319339,4.82079947618896,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01577282622514,0.503899679727702,1.00981211085589,7.27915462748209,0.0541213741325957
5,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",1.25293856114189,0.361196380584532,1.80775437850678,7.44802722066066,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.837145446087792,0.640543987996778,0.64608479044137,7.95707734496079,0.205898626405229
5,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",1.00449944812263,0.117630811026837,2.17797738863499,3.45388936736023,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.559805590267325,0.517241499669499,0.623319522385934,4.73439244396242,0.300726512871813
5,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",1.8974878276868,0.115779543930524,5.3504943654382,8.42359278578589,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.55669777239643,0.507400338680621,1.72322684979472,12.5933813690002,0.00354338624304357
5,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",1.59536537866456,0.0495656195373206,4.47869071971283,5.43915877509111,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21941776035217,0.496979999748552,1.25496027587239,8.80420739664229,0.0194152505869037
5,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",-0.293445707288583,0.115811941460317,0.593804348244705,0.934979265895024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.889168758202251,0.530624170281013,0.142418090265952,1.1399908960643,0.089674061482125
5,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",2.16462924777711,0.12487148832704,6.87569948352299,11.2175623941618,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.85492848263811,0.507345472953168,2.32273424369529,16.9709448347094,0.000536295430680051
5,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",1.52240260295556,0.171051551948208,3.31969692075935,6.49078353147549,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13796794352992,0.530275582298116,1.08365166083756,8.66228540774556,0.0398425087976936
5,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",0.704514292941811,0.0893764825633352,1.70094144774559,2.41459425912371,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.224910694607868,0.513356716473284,0.449228878092099,3.3605296002011,0.682431446049009
5,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",0.00195758958566472,0.139669640000847,0.762797367456443,1.3188129765746,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.559390790172483,0.5345832097274,0.196573865919469,1.59809239574805,0.288746369015411
5,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",0.618003716938214,0.050105087796884,1.6826286156213,2.04779899999293,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.128333340309315,0.507602696043932,0.412469150076605,3.01672601311452,0.819950389864579
5,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",1.589265758304,0.129407745143179,3.83105579447809,6.3624242057985,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21260716480901,0.514660378203552,1.20398316404139,9.05273547555487,0.0244128263867772
5,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",0.386482954030671,0.12858558805777,1.14704642948662,1.89882744117245,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.130113246674614,0.527000008867981,0.306587498152674,2.41947357456443,0.792061277580822
5,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",1.32177416208391,0.132533651131974,2.91197317190379,4.89568048793544,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.914003699444144,0.518414951774353,0.886440686562722,6.76395789339458,0.0913276847297003
5,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",0.657420121146284,0.122401433897278,1.52377050563201,2.4620458810203,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.172335924055249,0.522281894050313,0.418813504995692,3.24455384465296,0.761143346366402
5,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",2.87956671113638,0.345854755157373,9.67864661842631,37.5490398264236,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.65304099989516,0.616305818134143,4.16969512256851,46.698747073553,3.96445725534979e-05
5,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",0.384778281751252,0.0942307163278662,1.2234741611117,1.77016383655559,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.132008723779642,0.517880889852648,0.311524930766824,2.37211004973096,0.785785449006216
5,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",1.28180106889954,0.0987446221214303,2.98057507576528,4.38938034829423,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.869385264945861,0.509350105706398,0.862927252600763,6.35467547988869,0.102458267042704
5,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",1.59600891817741,0.366824140379196,2.55044408858065,10.7423266962044,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22014731598782,0.641661250552422,0.945767374753927,11.6990452800687,0.0657568631122631
5,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",2.60975134273792,0.34852755011902,7.34271208450098,28.7866333579115,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.35180752317146,0.620380953155047,3.06009062242496,34.8235255681729,0.00028237600231553
5,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",1.59029505533584,0.349060075053319,2.60815314044466,10.2464644351669,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.21377052931537,0.629230641805196,0.96292810527847,11.3448314892007,0.0621960532305051
5,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",0.546596490082304,0.057042380873506,1.54568113583293,1.93298743901445,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0486168581309054,0.509293815558039,0.37958221501928,2.7946615466529,0.941523666146808
5,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",2.00968433900788,0.10783555083294,6.07460768766458,9.27038583629924,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.68195281308341,0.504049821119494,1.96621089620306,14.1816273647177,0.0015512501427394
5,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",0.738256640908763,0.0869973064942734,1.76784375363206,2.48627041081188,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.26257975028249,0.512483621019325,0.467285592014933,3.48366262082225,0.630143410013713
5,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",0.671302937842907,0.10702459489911,1.59110271434213,2.42045613951001,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.187834353375364,0.517904397456504,0.429025096500285,3.26711741324121,0.737075995909108
5,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",1.36988895525116,0.375736576599003,1.99082631562228,8.68337347315254,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.967703633734473,0.649924139701544,0.722846809386377,9.23589803817764,0.149204299617145
5,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",2.16377023784569,0.354274358528859,4.63704790444905,18.5934227575175,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.85395747251858,0.628083866070486,1.8314887141357,21.4810822976386,0.00448791376948079
5,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",1.88642619790709,0.133784080729749,5.11868401713564,8.64794169230358,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.54434749202519,0.513004853188351,1.68346324375789,12.5760624117115,0.00417665651660658
5,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",0.94667558294765,0.146015906091198,1.94872895677232,3.45405594663091,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.495250561891054,0.52678501855514,0.573495753764151,4.52200093857649,0.368929665866553
5,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",1.21822544898338,0.141230385478844,2.58261472802912,4.49252670643064,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.798402329228133,0.522338049133286,0.783551104570258,6.07151726303816,0.142972757784187
5,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",1.72460400301917,0.364371619648712,2.91732877944527,12.1700607532128,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36366752673496,0.638853213733383,1.09791504287739,13.4324248144047,0.0390347832763101
5,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",0.62660453081694,0.0483889650063076,1.70280439789111,2.05845930963046,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.13793502902966,0.507301072485685,0.416697855742003,3.04405277248046,0.805473266420498
5,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",-0.00650496621370753,0.102247088798488,0.813653601582757,1.21480147539439,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.568836148715627,0.524007988228842,0.198802687972193,1.55058317982242,0.271257500229337
5,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",0.036546737874064,0.112139271032239,0.833401625916579,1.29348258088355,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.520774716571718,0.526060378674128,0.207760970436909,1.63354377682442,0.315307007731679
5,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",2.08364972989914,0.337480564244593,4.39116090354132,16.4856966894166,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.76451449708709,0.617116494291582,1.71107037290335,19.2242274496502,0.005931809569251
5,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",1.9917258186201,0.0935001692038373,6.1283463132491,8.84134374522492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66190603514311,0.500653538234698,1.94003128970761,13.8077483468603,0.00164774218240226
5,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",0.0777232751291482,0.104990798681293,0.880433961844783,1.328719921387,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.474805387752248,0.523770888709961,0.218520500615267,1.70279107147795,0.35732728852209
5,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.37177533193119,0.0505277530016226,1.3140928066483,1.60193407943481,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.146575761210155,0.510363870442452,0.311582721969739,2.30366007312182,0.761260540315999
5,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",1.52213684817998,0.351166500298296,2.42401487716075,9.60201134808537,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13767281207154,0.631261232681462,0.888778119211398,10.5549073399088,0.0813141185684579
6,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,10003,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.48477455134036,1.41826230841481,1.37798824832474,1.27031140305094,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1311276,10070,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046928084503,2.23872695699956,1.09702103475281,1.06068158707479,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1110942,1,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42196022547426,1.17720215875844,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1336926,10064,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99298321299323,1.90972342469496,1.06058597964411,1.08569026622695,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1350310,10011,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,3.99358477468947,3.49379790519136,1.23307939908773,1.27860332148996,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10055,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,2.00080454470905,1.96754377476108,1.19175693666726,1.06457187993963,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10056,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,4.00915607155796,3.50921589827522,1.19168591797809,1.06454875413501,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,757352,10023,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=4","Exposure control",4,1,3.97153981480365,3.39901436763903,1.07676169143701,1.1121734322306,"Acute pancreatitis",2.05513052627512,0.699750239383469,2.48959146447995,38.6709689135886,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,1,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis","Exposure control",1,1,1,1,1.12709367663571,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,795113,10007,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=2","Exposure control",2,1,2.00153000242616,2.62571891680818,1.15467042417531,1.05141588448132,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,795113,10008,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=4","Exposure control",4,1,4.00478551776244,5.63180711473874,1.15463113442068,1.05140350842209,"Acute pancreatitis",1.75830357678069,0.355795077101138,2.89230693637956,11.6667802159063,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,1,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis","Exposure control",1,1,1,1,1.21164092594579,1.10200164890323,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1140088,1,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis","Exposure control",1,1,1,1,1.42017272112346,1.42196022547426,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10054,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50101095957034,1.3342024613166,1.19176869918078,1.06457591810822,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915855,1,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.05512718203205,1.21768142039078,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",36110310,"Arthropod infestation","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915855,10037,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,2.00907498117601,1.93191209240506,1.05510043370213,1.21757273057503,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915855,10038,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,3.99183352580171,4.27326308714532,1.05505071877875,1.2173696586054,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1110942,NA,1105775,"omalizumab","Aminophylline",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915855,10036,943634,"olopatadine","epinastine",35607032,"Conjunctivitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50005553521086,1.54551178381315,1.0551145585596,1.21763059003723,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,NA,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517070,10013,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,2.00054242801727,2.12528584688023,1.34424614651857,1.08575232087297,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,1,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27034047423826,1.27993331072414,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,757352,10021,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50067774236388,1.46082266908325,1.07701587442723,1.11254321750112,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,757352,10022,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99143153807119,1.86818145685751,1.07696524712545,1.11247113573456,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,1,965748,"ramelteon","Scopolamine",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.19178541559461,1.06458139546306,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,NA,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,1,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis","Exposure control",1,1,1,1,1.1166311728855,1.08701152572305,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10051,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50012512275864,1.42566041176383,1.11661016895231,1.08699945724335,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10052,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=2","Exposure control",2,1,2.00046306407333,1.76616032188019,1.11659405958226,1.08698966871603,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10053,732893,"Prilocaine","Bupivacaine",438112,"Neoplastic disease","Acute pancreatitis, RR=4","Exposure control",4,1,3.98994153596329,3.38487900290884,1.11652168108872,1.08694836297831,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,1,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis","Exposure control",1,1,1,1,1.37803251432971,1.27034047423826,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,795113,1,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis","Exposure control",1,1,1,1,1.1546896190039,1.05142191590801,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,795113,10006,704943,"Chlorzoxazone","Methocarbamol",36516951,"Back pain","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.50022297246367,1.62532567339237,1.15468041125015,1.05141899045195,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,10004,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=2","Exposure control",2,1,2.00231661088788,1.91928024079234,1.37793272955004,1.27028114479421,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,1,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.21374254765432,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,10005,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Acute pancreatitis, RR=4","Exposure control",4,1,4.01608645034893,3.35600553774457,1.37774937397447,1.27018146899586,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,757352,1,704599,"Eszopiclone","Triazolam",436962,"Insomnia","Acute pancreatitis","Exposure control",1,1,1,1,1.0770665204338,1.11261686195808,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,1,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.25028008208769,1.13516931197556,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,NA,732893,"ropivacaine","Bupivacaine",37522270,"Surgery","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,NA,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1140088,NA,1110942,"Dyphylline","omalizumab",37203741,"Bronchospasm and obstruction","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,1,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","Acute pancreatitis","Exposure control",1,1,1,1,1.32546112829674,1.43120263080319,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1311276,1,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis","Exposure control",1,1,1,1,1.0971124819301,1.06073740399916,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1311276,10069,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49453137567654,1.14287707000562,1.09707225788059,1.06071245262786,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1311276,10071,1336926,"vardenafil","tadalafil",36919202,"Sexual dysfunction","Acute pancreatitis, RR=4","Exposure control",4,1,3.99158859028212,3.95571199915396,1.09686379305767,1.06058485931998,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1336926,1,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.06073740399916,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1336926,10063,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49826526484469,1.57597478575261,1.06066539240612,1.08572462455994,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,987366,NA,19025115,"lubiprostone","picosulfate sodium",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=2","Exposure control",2,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,1,932815,"brinzolamide","Levobunolol",35606985,"Glaucoma","Acute pancreatitis","Exposure control",1,1,1,1,1.27993331072414,1.58467984716998,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1336926,10065,918906,"tadalafil","oxybutynin",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,4.01055153951876,3.97289088115071,1.06027344876648,1.08555179726508,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,1,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis","Exposure control",1,1,1,1,1.13131572448215,1.14180841381342,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,1,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis","Exposure control",1,1,1,1,1.1245778360816,1.13516931197556,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,10066,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49675588328611,1.33927412589936,1.12446021842562,1.13502148760684,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,1,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","Acute pancreatitis","Exposure control",1,1,1,1,1.21768142039078,1.08587718410193,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,10067,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=2","Exposure control",2,1,1.99380345211933,1.67908285545212,1.12437058738976,1.13491124707213,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,10068,989482,"Terazosin","Dutasteride",37119607,"Benign prostatic hyperplasia","Acute pancreatitis, RR=4","Exposure control",4,1,3.98003933142264,3.77798435062876,1.12399192287351,1.13444388834338,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517070,1,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.34453591401689,1.08575580747547,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,924939,"picosulfate sodium","Bisacodyl",35702117,"Gastrointestinal motility and defaecation conditions","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,NA,NA,NA,NA,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517070,10012,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.4816508949383,1.87521483126603,1.34441374457021,1.08575415589418,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,40163718,1,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.19651407738241,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,1,1517070,"fesoterodine","desmopressin",36718449,"Urinary incontinence","Acute pancreatitis","Exposure control",1,1,1,1,1.32024111460917,1.34453591401689,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,40163718,10048,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49428525263692,1.62075446415764,1.19645179208118,1.27885426416875,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517070,10014,918906,"desmopressin","oxybutynin",36718449,"Urinary incontinence","Acute pancreatitis, RR=4","Exposure control",4,1,4.00268145400823,4.00275766960335,1.34373236714739,1.08574528870796,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,40163718,10049,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00174825465837,2.20196336818594,1.19638911508429,1.2787785039797,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,40163718,10050,1315865,"prasugrel","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=4","Exposure control",4,1,4.02394471194369,4.2523953063101,1.196097274961,1.27849832096402,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1350310,1,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis","Exposure control",1,1,1,1,1.23341495565509,1.27891066683316,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1350310,10009,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=1.5","Exposure control",1.5,1,1.49133196784494,1.32016562462626,1.23335063269324,1.27885568325926,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1350310,10010,1315865,"cilostazol","fondaparinux",37622411,"Phlebosclerosis","Acute pancreatitis, RR=2","Exposure control",2,1,2.00205690566487,1.80194889680898,1.2333138814292,1.27881324995605,"Acute pancreatitis",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,10179,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,3.99051857569138,3.08181994691538,1.07304186391745,1.07926287050732,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,10177,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49692420543078,1.32911220650407,1.07312871025416,1.07935970204414,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,10178,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00729964374402,1.75054629901118,1.07311133359993,1.07934049596568,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,3,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07314639333961,1.07937932871022,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1778162,3,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.04098869408813,1.44863810109965,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1774470,NA,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1778162,10172,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=2","Exposure control",2,3,2.00902925688916,1.84723687017733,1.04097537845368,1.44851888148472,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1781733,3,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke","Exposure control",1,3,1,1,1.0983089737813,1.23466513555885,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1781733,NA,1702559,"Atovaquone","Tinidazole",36110538,"Arthropod-borne disease","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1782521,3,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke","Exposure control",1,3,1,1,1.3079605205872,1.6130979241678,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1778162,10173,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=4","Exposure control",4,3,3.98308197671623,3.40038809599669,1.04094810646583,1.44830262257093,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1776684,NA,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1776684,3,1715117,"Ceftazidime","Aztreonam",36102971,"Lower respiratory tract and lung infections","Stroke","Exposure control",1,3,1,1,1.44863810109965,2.22041071393251,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,NA,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1778162,10171,1776684,"Cefuroxime","Ceftazidime",36102971,"Lower respiratory tract and lung infections","Stroke, RR=1.5","Exposure control",1.5,3,1.49564967655301,1.41186064213749,1.04098153238219,1.44857932007311,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796435,3,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke","Exposure control",1,3,1,1,1.21414794931696,1.08090033696478,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796458,3,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.03751391954947,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796458,10159,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,1.50001061636383,1.32955033210961,1.03749308820384,1.04098416755021,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1749008,3,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke","Exposure control",1,3,1,1,1.17793322938425,1.14990615689869,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1790868,NA,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1711246,3,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke","Exposure control",1,3,1,1,1.61011657045399,1.09376551546049,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796435,NA,1769535,"Cefixime","Cefadroxil",35708603,"Pharyngitis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796458,10160,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,2.00002333067905,1.59092441155451,1.03747518966493,1.04097894783864,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1796458,10161,1778162,"cefdinir","Cefuroxime",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,4.00015944139736,3.19329296985586,1.03739523186042,1.04096096935557,"Stroke",0.906101315509349,0.267978777732066,1.47227362458975,4.20916964912348,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,3,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke","Exposure control",1,3,1,1,1.07937932871022,1.19331274488609,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10195,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=1.5","Exposure control",1.5,3,1.49462667002102,1.35561893463942,1.07936855647282,1.19328680335808,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10196,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=2","Exposure control",2,3,2.00040274281174,1.97837796113244,1.07935626621434,1.19325841907328,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10197,943634,"levocetirizine","epinastine",36009773,"Rhinitis allergic","Stroke, RR=4","Exposure control",4,3,4.00194911451515,3.86835781562251,1.07930871935599,1.19314134034069,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,3,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke","Exposure control",1,3,1,1,1.31164308418311,1.2149620682031,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1782521,NA,1749301,"isoniazid","Ethambutol",36110782,"Tuberculosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,954819,NA,945286,"cevimeline","Pilocarpine",35606954,"Sjogren's syndrome","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1784444,3,922868,"Ivermectin","Permethrin",4085103,"Arthropod dermatosis","Stroke","Exposure control",1,3,1,1,1.19352203866776,1.09984974664134,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,3,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke","Exposure control",1,3,1,1,1.05794120765381,1.17206625281286,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10207,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=1.5","Exposure control",1.5,3,1.5001157064155,1.38990694028744,1.05793182226891,1.17203893900586,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,3,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke","Exposure control",1,3,1,1,1.10532541111389,1.15123039726084,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1790868,3,902722,"Amikacin","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,1.73149402058985,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10208,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=2","Exposure control",2,3,2.00053605726806,1.98326350830409,1.05792339086269,1.17201299692534,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10209,781182,"Scopolamine","ramelteon",436962,"Insomnia","Stroke, RR=4","Exposure control",4,3,4.01336809448996,3.67961467146374,1.05788577297891,1.17190286066462,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19025115,NA,987366,"picosulfate sodium","lubiprostone",35702117,"Gastrointestinal motility and defaecation conditions","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,3,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke","Exposure control",1,3,1,1,1.25926808791232,1.10495826523241,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1711246,NA,1703603,"entecavir","famciclovir",36102154,"Viral infectious disorders","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1715117,3,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke","Exposure control",1,3,1,1,2.22041071393251,1.03794600196624,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1715117,NA,902722,"Aztreonam","Tobramycin",35306246,"Cystic fibrosis","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19027958,NA,916005,"fesoterodine","Solifenacin",36718449,"Urinary incontinence","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19033354,3,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke","Exposure control",1,3,1,1,1.61712601544201,1.07376262658572,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1749008,NA,1768849,"cefpodoxime","Cefaclor",35406429,"Otitis media","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1763779,3,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke","Exposure control",1,3,1,1,1.21172765183072,1.05455074493011,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19033354,NA,966956,"Petrolatum","Silver Sulfadiazine",37320089,"Skin dystrophy","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,3,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke","Exposure control",1,3,1,1,1.45049544431846,2.99936179629212,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1763779,NA,1741309,"Griseofulvin","terbinafine",36102955,"Tinea infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1768849,3,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke","Exposure control",1,3,1,1,1.14990615689869,1.21414794931696,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=1.5","Exposure control",1.5,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10192,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=1.5","Exposure control",1.5,3,1.4903544157293,1.34351380217603,1.45046630936424,2.99888900038717,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1768849,NA,1796435,"Cefaclor","Cefixime",372328,"Otitis media","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10193,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=2","Exposure control",2,3,2.00556888095036,1.71577689224239,1.45043332824625,2.99811328937978,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1769535,3,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.08090033696478,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10194,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","Stroke, RR=4","Exposure control",4,3,4.00822316215671,3.13097450973546,1.45030707418474,2.99606433454577,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=2","Exposure control",2,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1769535,NA,1778162,"Cefadroxil","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke, RR=4","Exposure control",4,3,NA,NA,NA,NA,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1771162,3,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke","Exposure control",1,3,1,1,1.03669010992366,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517740,3,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke","Exposure control",1,3,1,1,1.27371911621761,1.32021219694007,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1771162,10156,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=1.5","Exposure control",1.5,3,1.49657628706593,1.39875344256195,1.03668331634942,1.0409805134146,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517740,10198,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=1.5","Exposure control",1.5,3,1.50267863574692,1.55403054547512,1.27367363746901,1.32015857439243,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1771162,10157,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=2","Exposure control",2,3,2.01018650997732,1.73604579304545,1.03667563564807,1.04097155105413,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517740,10199,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=2","Exposure control",2,3,1.99497381267166,2.31937092735218,1.27363076425166,1.32010819077752,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1771162,10158,1778162,"Cefazolin","Cefuroxime",37203741,"Bronchospasm and obstruction","Stroke, RR=4","Exposure control",4,3,3.99545831817827,3.29153302451507,1.03664885029288,1.04093934679765,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1517740,10200,1512446,"paricalcitol","Doxercalciferol",35506745,"Hyperparathyroidism","Stroke, RR=4","Exposure control",4,3,3.97792310604696,4.87670166731441,1.27349462048106,1.31994797120433,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1774470,3,1778162,"Cefotaxime","Cefuroxime",36102976,"Upper respiratory tract infections","Stroke","Exposure control",1,3,1,1,1.20620279375398,1.04098869408813,"Stroke",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,739138,10534,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.5025007971631,1.43500779588191,1.00916307090723,1.01267702703075,"Sertraline",0.454504471758459,0.0510420047533969,1.42587420118312,1.74170772343194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.429695646140546,0.0529803393159581,1.38710344695267,1.70727210361442,9.3849710203126e-20
6,739138,137053,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis","Outcome control",1,137053,1,1,1.01131918396351,1.01542474100614,"Sertraline",-0.0458597483045756,0.0629545774504172,0.844077361350676,1.08032970905829,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0441141291803598,0.0615226096375351,0.848704888859047,1.08017217166074,0.566420804178065
6,739138,198678,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease","Outcome control",1,198678,1,1,1.01244352066242,1.01778672825925,"Sertraline",0.120454015796377,0.053264733272696,1.01617253809701,1.25211869615676,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.113375637096835,0.0532477567873725,1.00990286033526,1.24431044801293,0.0144944971396397
6,739138,10542,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=4","Outcome control",4,260134,3.97380083506091,3.30168407813862,1.03645647176158,1.09359844258643,"Sertraline",1.49120046428792,0.223836906475099,2.91748432742464,7.01567031453194,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41136815159406,0.217823313479438,2.69371091618321,6.32665376030023,2.00545767096581e-11
6,739138,141932,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00669419626439,1.00832794827749,"Sertraline",0.0637893458050028,0.0355117250114846,0.994141596071884,1.14262445772948,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0597279992573991,0.0373898148791189,0.987298675523282,1.14314439334965,0.0383311437483655
6,739138,10552,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=1.5","Outcome control",1.5,439727,1.5046235405612,1.39418585979903,1.03335211129908,1.04655898722857,"Sertraline",0.440905178125094,0.214059975067596,1.02577319547097,2.37392890547785,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.416819999925603,0.204028758260784,1.018503602313,2.26621837804545,0.0352608674951019
6,739138,10544,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00239793615081,2.00831790519331,1.00979963780238,1.01234727538118,"Sertraline",0.735219393718759,0.0369986333492066,1.94041551061642,2.24326884642819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.69551147796524,0.0439282565844772,1.84310351518077,2.18944140569994,3.60793065570251e-90
6,739138,321596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.01405256792298,1.01761752228642,"Sertraline",0.0534793026680897,0.0709208492507196,0.917820612134347,1.21197504983858,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0499318535599031,0.0691123845987553,0.91874590373477,1.20462688791888,0.372514934860677
6,739138,433811,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis","Outcome control",1,433811,1,1,1.01505505721407,1.02021447281632,"Sertraline",0.152452960121076,0.072336083203932,1.01054606970772,1.34184171372525,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.143704134321712,0.0706961578762089,1.00601370025633,1.32726380906445,0.0249243947941941
6,739138,260134,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup","Outcome control",1,260134,1,1,1.03675782450739,1.09611080399204,"Sertraline",-0.226600480457587,0.313448131584564,0.427015451241954,1.45901130362256,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.215258936241101,0.297235645125959,0.450572010048353,1.44470471146403,0.489080755611967
6,739138,10560,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=4","Outcome control",4,433811,3.97437230910304,3.88276182796189,1.01480554592459,1.01985225536045,"Sertraline",1.57222263993155,0.0561236076721672,4.32071078326736,5.38393985558065,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.48808917669794,0.0721315548402458,3.87123176468472,5.13624999950643,8.30374258657596e-175
6,739138,4324765,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint","Outcome control",1,4324765,1,1,1.00480562557927,1.00630943879151,"Sertraline",-0.0135076707824861,0.0253290175934814,0.938750815219707,1.03674159909876,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0134827482958865,0.0285219744277391,0.933620982116716,1.04406250822667,0.88256025007832
6,739138,10583,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,1.99137460260296,1.85444212834807,1.0264144198734,1.03347404148115,"Sertraline",1.0393345836397,0.129261890470901,2.20448132283764,3.6589987824547,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.983484290051865,0.127037700273552,2.0911629841089,3.44078277844043,4.81462283866835e-16
6,739138,10564,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.5043862873718,1.48963323349554,1.01071302658179,1.01472317459676,"Sertraline",0.479485388262944,0.048785569466668,1.46836061074985,1.77781034876409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.453350758385757,0.0512031009773166,1.42533318855962,1.74214666884218,1.14114808223675e-23
6,739138,10540,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=1.5","Outcome control",1.5,260134,1.50307429376651,1.38458483226733,1.0367068341751,1.09568689667727,"Sertraline",0.271099654051727,0.276746866326975,0.764868334262831,2.26319200779908,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.256054770786763,0.262955136634964,0.772432129034529,2.16528948056409,0.310161742307384
6,739138,10595,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99431273588341,1.91941319967006,1.00665192507108,1.00960190340913,"Sertraline",0.697183824221838,0.0298590821958482,1.89426381535095,2.12947554530608,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.659512794318694,0.0382440592800228,1.79763817866143,2.08837789527554,6.34222976573548e-124
6,739138,10580,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.99478246109138,2.01385015656317,1.0139791972189,1.01753015315241,"Sertraline",0.732737127077049,0.0599962767205556,1.85093292791175,2.34168529222787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.69317301756004,0.0627144672942755,1.77232061389045,2.26624882265861,3.53272595709483e-35
6,739138,139099,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail","Outcome control",1,139099,1,1,1.01074143011528,1.01476418451235,"Sertraline",0.0520657362001862,0.0539482491725117,0.947647123597931,1.17081509927762,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0486171603372721,0.053609670958488,0.945826696365195,1.16701607244885,0.251741504467993
6,739138,10591,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50485076373324,1.58537159312899,1.00667630343344,1.00830702152782,"Sertraline",0.52972045975957,0.0316162872069173,1.59659724304712,1.80725335618517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.500942122509896,0.0376549367518135,1.53518886835224,1.77936766087482,2.77149228391508e-65
6,739138,4084966,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region","Outcome control",1,4084966,1,1,1.00918671995619,1.01271515940524,"Sertraline",0.0126378465719121,0.0572137654569028,0.905189557336661,1.1327665759595,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.01128177006206,0.0564407108686776,0.906081137747323,1.1304514884104,0.695368119131303
6,739138,133141,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis","Outcome control",1,133141,1,1,1.01409366626481,1.01909499273984,"Sertraline",-0.0258249674416055,0.0768045826984246,0.838194043008607,1.13265312785784,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.025140235827987,0.0743633601383616,0.843499038645246,1.12896637142464,0.834378574874494
6,739138,10581,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97213299076692,4.06048338053399,1.01383896768418,1.01736371473031,"Sertraline",1.40118541154708,0.0537945425110949,3.65731608625454,4.51588102361531,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32613051872051,0.0666898729509831,3.32268516499124,4.31541173266536,1.25683546616317e-151
6,739138,138102,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00364868632671,1.00476781105766,"Sertraline",-0.0248702568307854,0.0196928754725096,0.938451567978345,1.0137644935299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0242167507212363,0.0241214018705776,0.931619427409949,1.02400690572547,0.443085711682724
6,739138,10582,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.49543480010633,1.43581006510764,1.0264878767511,1.03356564443394,"Sertraline",0.844352286897388,0.131228925453997,1.80517429928309,3.0194209876521,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.798852178671946,0.127732893492462,1.73487386777,2.86233708532496,7.58480526130144e-11
6,739138,10584,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.00223906245731,3.61956239213121,1.02613227424201,1.03312518365357,"Sertraline",1.65612877791,0.111771690327312,4.23066024496174,6.55674992696072,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.56754172771704,0.118288005197812,3.83266545153462,6.09361170820547,3.08376387475384e-50
6,739138,10585,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=1.5","Outcome control",1.5,75650,1.50302136338127,1.44730512741294,1.01470042907707,1.02013306513095,"Sertraline",0.428206740388304,0.0692827543366361,1.34041667606305,1.75868069776129,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.404814457614394,0.0690024755026747,1.3111245932023,1.71835935234691,2.58993972247993e-10
6,739138,10586,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=2","Outcome control",2,75650,2.00723886035154,1.88575854537112,1.01466235017114,1.02007389557354,"Sertraline",0.681283083753368,0.0649273275158892,1.74109625681649,2.24571823061527,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.644448073828635,0.0666084169883214,1.67495884594103,2.17469579875248,1.87125722428107e-26
6,739138,135777,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00502822963063,1.00659475553342,"Sertraline",-0.025470014128112,0.0254635498286939,0.927348899021789,1.02468973713163,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0248252721373058,0.0285581642476878,0.923028775909338,1.03236375250693,0.537414886914308
6,739138,201061,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00986474116177,1.01242601938582,"Sertraline",0.0175467383306411,0.0436246006739778,0.934178851573695,1.10840043132024,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0159351226506944,0.0442434018661831,0.932329880342918,1.10889316630238,0.53125943544157
6,739138,10587,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria, RR=4","Outcome control",4,75650,4.00795887996993,3.63384049316562,1.01451752428745,1.01984838100658,"Sertraline",1.41891624086411,0.0588173458229544,3.68745609710201,4.64363086704578,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34291973407124,0.0707610944132865,3.35255662931425,4.42425375283814,2.49134439687553e-130
6,739138,201093,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue","Outcome control",1,201093,1,1,1.00532852301647,1.00757972466888,"Sertraline",-0.0443517231614816,0.0268476496117237,0.9075346337789,1.00825115769152,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0426763512307205,0.0295680194210493,0.904862575515199,1.01605990521795,0.197668322621429
6,739138,10588,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=1.5","Outcome control",1.5,137053,1.49631783131427,1.50251807173667,1.01129160770054,1.01538317608217,"Sertraline",0.42044613672756,0.0554114009611965,1.36629797250975,1.69776651554712,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.397444892540391,0.0565885991235917,1.33353132262091,1.6647147473287,8.23158370806081e-15
6,739138,257007,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis","Outcome control",1,257007,1,1,1.00369294634958,1.00509468005473,"Sertraline",-0.0392574917695703,0.0218110077527062,0.921243144950744,1.00347231736192,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0378591968676465,0.0256176817424463,0.916320603484971,1.01311576228418,0.176330643957801
6,739138,10589,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=2","Outcome control",2,137053,2.0044774944336,2.02802013385055,1.01126368341738,1.01534165278584,"Sertraline",0.790836109806483,0.0519460544278687,1.9928187121155,2.44287314842373,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.748194550183223,0.056440153650777,1.8960154377513,2.3655152974053,1.3555702606646e-53
6,739138,257012,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis","Outcome control",1,257012,1,1,1.0051892926653,1.00698440955142,"Sertraline",7.41170846415664e-05,0.025779863311342,0.950758455692982,1.05185994016629,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.000615345069771609,0.028963467740518,0.94490044114445,1.0585065472239,0.702686873180577
6,739138,10590,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic dermatitis, RR=4","Outcome control",4,137053,4.02051460567171,4.05505353032494,1.0111572423124,1.01518253068022,"Sertraline",1.51773398983017,0.046508124063345,4.16800088635101,5.0015357406941,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43649304550207,0.064246336966346,3.73184883728885,4.80061863006205,1.4001762406857e-236
6,739138,260139,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis","Outcome control",1,260139,1,1,1.00393580282379,1.00531222240347,"Sertraline",-0.00917201075505817,0.0199618188947057,0.952841930661775,1.03039542684062,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00937679327488014,0.0244288816924477,0.945016080296818,1.03998482443096,0.97626322852283
6,739138,10592,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00502173799598,2.15162656009218,1.00665954466381,1.00828752477695,"Sertraline",0.854455233403971,0.0297351712959127,2.21738803408518,2.49151179194528,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.808423109840652,0.0403138427589349,2.07887330647615,2.43477275354079,1.02596715333274e-185
6,739138,10593,743670,"Sertraline","Venlafaxine",36918942,"Depression","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02513577010928,4.48744487555428,1.00659671804966,1.00821443681682,"Sertraline",1.60843434541368,0.0269470848271949,4.73940656981545,5.26742992391592,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.5223699161902,0.0559895825959882,4.13648477073997,5.15167275513009,0
6,739138,374919,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis","Outcome control",1,374919,1,1,1.02276841251746,1.02909487570889,"Sertraline",-0.0648520611332062,0.126899559223907,0.72994826791817,1.20040082067214,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0620958317459201,0.121139129948658,0.741656495805257,1.1924232450499,0.664221509266459
6,739138,10594,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49649180960652,1.4684885281554,1.00666612922402,1.00962668980715,"Sertraline",0.41532965410315,0.0314837429507831,1.42433764953291,1.61142825859935,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.3925695703627,0.0364716500090049,1.3804389089767,1.59259974310193,1.52052947002366e-41
6,739138,436659,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia","Outcome control",1,436659,1,1,1.00833456853007,1.01081645041352,"Sertraline",0.009466737272571,0.0429227835101427,0.928103951872561,1.09816728331292,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00828511745178084,0.0435915396624959,0.92639655054961,1.09902431503565,0.654097976460544
6,739138,10596,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97127993225734,3.7234185380377,1.00659924624898,1.00950988831052,"Sertraline",1.41396640411107,0.0268323830575081,3.90266149396666,4.33551222492504,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33822626291798,0.0501602784605783,3.47412264083138,4.22900460819358,0
6,739138,439727,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection","Outcome control",1,439727,1,1,1.03338132409139,1.0466018984063,"Sertraline",0.207782045972832,0.222353035504039,0.794602507903958,1.89969738694706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.196068181484264,0.211485478123577,0.804596297323894,1.84336594684001,0.327881440312212
6,739138,73008,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy","Outcome control",1,73008,1,1,1.00543536799189,1.00694295115409,"Sertraline",-0.00693472828473086,0.026655205700324,0.942480734787981,1.04628593209856,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00725379195118373,0.0296249434278406,0.93742708694898,1.05286113224156,0.915410464700653
6,739138,441788,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00631555629865,1.0090942476926,"Sertraline",-0.0496273590157684,0.0337159702447343,0.890643611062037,1.01648770201862,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0476502671672687,0.0353039357842088,0.890295206594798,1.02243466220429,0.237098361143631
6,739138,75650,743670,"Sertraline","Venlafaxine",36918942,"Depression","Proteinuria","Outcome control",1,75650,1,1,1.0147386447271,1.02019256588055,"Sertraline",-0.0151219722767524,0.0775785389998536,0.845700190312198,1.14626853854113,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0150050219766369,0.0751047417743038,0.850862931746588,1.14213686091058,0.944957836409694
6,739138,140641,743670,"Sertraline","Venlafaxine",36918942,"Depression","Verruca vulgaris","Outcome control",1,140641,1,1,1.00668068124674,1.00965223041729,"Sertraline",-0.0206484395317622,0.0351884040176174,0.914226712975007,1.04944275696338,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0202431446457134,0.036700534235665,0.912583955409295,1.05378480432171,0.757121221341426
6,739138,4311499,743670,"Sertraline","Venlafaxine",36918942,"Depression","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.0265601037473,1.03365495595265,"Sertraline",0.370336325369332,0.154615657753481,1.06978155253338,1.96116113256029,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.349994694519791,0.1479467805462,1.06318046264771,1.89876860846565,0.0139569839673233
6,739138,10522,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.50367923034952,1.48518537857028,1.00392785451458,1.00530045569429,"Sertraline",0.438967490999567,0.0179335657596038,1.49757047020591,1.60663574679349,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.414981776635759,0.0272887821655021,1.43738454315978,1.5996666009308,3.52522293189205e-138
6,739138,10523,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=2","Outcome control",2,260139,2.00842347523063,1.95974121450668,1.00392055431733,1.00528966782976,"Sertraline",0.752311285573925,0.0169239467366547,2.05277716981605,2.19357853719199,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.711695273769867,0.031201513889979,1.92057837040537,2.17044900791655,0
6,739138,10524,743670,"Sertraline","Venlafaxine",36918942,"Depression","Acute bronchitis, RR=4","Outcome control",4,260139,4.02254604609746,3.89027564265248,1.00389661632727,1.00525476253569,"Sertraline",1.46183540263283,0.015641645778093,4.18375811649687,4.44830906385496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38354204496212,0.0471270779900003,3.65827652988472,4.4005383871208,0
6,739138,10525,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=1.5","Outcome control",1.5,257007,1.50262906380938,1.4453455321763,1.00368657537387,1.00508485625603,"Sertraline",0.435733894626146,0.0195476049246933,1.4880520074455,1.60655653491765,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.411920743722384,0.0282288846090067,1.43034449618971,1.59770866107255,5.6960760776112e-115
6,739138,10526,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=2","Outcome control",2,257007,2.00840932645591,1.90074310956516,1.00368068911507,1.00507583437855,"Sertraline",0.745057420368024,0.0182450353354909,2.03271290495896,2.18341580063657,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.704826667386287,0.0317469135957772,1.90535289887859,2.15785107697848,0
6,739138,10527,743670,"Sertraline","Venlafaxine",36918942,"Depression","Allergic rhinitis, RR=4","Outcome control",4,257007,4.02538904861419,3.69229144598741,1.00366114415544,1.00504622980968,"Sertraline",1.442388531348,0.0164223776321816,4.09718695775596,4.36961615019391,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36513159366318,0.0467739806200615,3.59344668625135,4.31657583215472,0
6,739138,10528,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=1.5","Outcome control",1.5,4324765,1.5022204180183,1.52771420174798,1.00479569305255,1.00629615443668,"Sertraline",0.416986204452602,0.0227656650449918,1.4512277112271,1.58668932943254,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.394181819841429,0.0301167164801044,1.39994348256122,1.57536536865758,2.10981777817913e-78
6,739138,10529,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=2","Outcome control",2,4324765,2.00927405200162,2.06225054734338,1.00478633901129,1.00628381397509,"Sertraline",0.715561866985832,0.0214872078125446,1.96115350044449,2.133494248098,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.676896782774681,0.0330782932525806,1.84788598838703,2.10371915312479,8.65499435118667e-250
6,739138,10530,743670,"Sertraline","Venlafaxine",36918942,"Depression","Arthropathy of knee joint, RR=4","Outcome control",4,4324765,4.02982152984303,4.16674759115476,1.00475339791496,1.00624030050641,"Sertraline",1.43190129430044,0.0196458553651705,4.02904460399883,4.35158268607305,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35521094967318,0.0475769717675924,3.55208703688571,4.28034507255885,0
6,739138,10531,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50233789923163,1.51635843483665,1.00364244956245,1.00475965102479,"Sertraline",0.399930597829216,0.0177463710221209,1.44076820485448,1.5445628773753,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.378016847565093,0.0267157457815691,1.38667777948542,1.53977237757096,6.37052271009905e-118
6,739138,10532,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.00551128223189,2.03019365814783,1.00363674012704,1.00475221741148,"Sertraline",0.706097943909254,0.0164457399245028,1.9618854063338,2.09252625141528,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.667934617274215,0.0302151578180563,1.84165471024633,2.07322571080088,0
6,739138,10533,743670,"Sertraline","Venlafaxine",36918942,"Depression","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02958335213766,4.10021113172847,1.00361765655257,1.00472768342145,"Sertraline",1.40766120829654,0.0161215973835224,3.95927676612716,4.2175604744161,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33224619310093,0.0456407728553467,3.48395793084407,4.16650487966053,0
6,739138,10535,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00747515534506,1.89408893778798,1.00913985257847,1.0126395199889,"Sertraline",0.782437928112099,0.0480740679098682,1.99136411032412,2.40431915985269,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.74019481020901,0.0531729627984436,1.89305437708726,2.33176567550348,5.20929619163241e-61
6,739138,10536,743670,"Sertraline","Venlafaxine",36918942,"Depression","Candida infection of genital region, RR=4","Outcome control",4,4084966,4.02679972425744,3.64620153521154,1.00905179369217,1.01249840341481,"Sertraline",1.49601398566134,0.0437515200830979,4.09959330364556,4.86657586415076,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41589922107963,0.0619191326404412,3.67188036977478,4.68058186836628,1.4221724612814e-259
6,739138,10537,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.5040833363545,1.53195777857632,1.00517735738477,1.00696842973172,"Sertraline",0.457054841851899,0.0231818850615108,1.50966686368196,1.65327856586815,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.432121012183192,0.0308302823885518,1.45215806096074,1.63870001564717,3.4775201709196e-90
6,739138,10538,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00629044074675,2.05265836808033,1.00516608030691,1.0069533202553,"Sertraline",0.737740665014611,0.0217564248115266,2.00409741284133,2.18251396943662,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.697898408671909,0.0335672327556379,1.88541868241028,2.15056595728278,1.07112161358074e-258
6,739138,10539,743670,"Sertraline","Venlafaxine",36918942,"Depression","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02981789396084,4.23100163832591,1.00512650166449,1.00690091931739,"Sertraline",1.44705367339331,0.0201135293916124,4.08681941522334,4.42208190691306,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.3695597558246,0.0481965424988503,3.5995139880471,4.34804277897929,0
6,739138,10541,743670,"Sertraline","Venlafaxine",36918942,"Depression","Croup, RR=2","Outcome control",2,260134,2.00511426395553,1.7005131920587,1.03665319832821,1.09520625098465,"Sertraline",0.738314191575,0.248240545769397,1.30145717006126,3.44377962077603,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.698430890848443,0.236936263776078,1.26650301511238,3.20602758518295,0.00258228148542074
6,739138,10543,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50275387308071,1.51188388197879,1.00983164143847,1.01238583697419,"Sertraline",0.436868378874021,0.0391522571945403,1.43368018355113,1.67149547764992,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.412999451941445,0.0427970472003019,1.39158608724071,1.64576530805283,3.83042150057926e-30
6,739138,10545,743670,"Sertraline","Venlafaxine",36918942,"Depression","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.01972057429423,4.07647412988626,1.00967901722318,1.01220168033029,"Sertraline",1.43004637410331,0.0333827278350054,3.91574978467138,4.46319427801027,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35345851793554,0.0540128362043138,3.50137904218401,4.32703837646066,0
6,739138,10546,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=1.5","Outcome control",1.5,73008,1.50239755818785,1.54195897188634,1.00542253514333,1.00692748972022,"Sertraline",0.403326434143597,0.0239338364101199,1.42834598452742,1.56883928246867,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.381241284082277,0.0307847361121872,1.38011196584805,1.55712096149749,9.4501217429347e-67
6,739138,10547,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=2","Outcome control",2,73008,2.00741600832166,2.09059745701628,1.00541015209466,1.00691255400084,"Sertraline",0.703474004860364,0.022496405766813,1.93367014472061,2.1119340027685,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.665450385070633,0.033503136834907,1.82526582667188,2.08143075038759,1.3422078461192e-220
6,739138,10548,743670,"Sertraline","Venlafaxine",36918942,"Depression","Enthesopathy, RR=4","Outcome control",4,73008,4.02851823606049,4.28461227044424,1.00536648658389,1.00686034327341,"Sertraline",1.42040917276472,0.0205384026289698,3.97605399474579,4.30940105359284,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.34433016369191,0.0475792660437091,3.51334224082723,4.23369479372018,0
6,739138,10549,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.4958328117684,1.47265306672729,1.0140608568949,1.019044685845,"Sertraline",0.453800920715286,0.0674636296803556,1.3796617000493,1.79730962335987,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.429052538117684,0.0674903971479432,1.34734445747481,1.75539355934682,6.35928383636024e-12
6,739138,10550,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=2","Outcome control",2,133141,2.00073095598339,1.93422591808405,1.01402851744561,1.01899573509453,"Sertraline",0.716298747464053,0.0641744039712182,1.80627827660851,2.32292593200848,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.677603656145066,0.0662063589889648,1.73295871130448,2.24645707938844,1.11960561495906e-29
6,739138,10551,743670,"Sertraline","Venlafaxine",36918942,"Depression","Tinea pedis, RR=4","Outcome control",4,133141,4.02780894704861,3.82300456551488,1.01390145002018,1.01880260505709,"Sertraline",1.51380299415509,0.0578074083195744,4.06335934139943,5.09679001206017,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43277021688255,0.0719905034473553,3.66187521970539,4.85579559355211,4.3871224516449e-153
6,739138,10553,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=2","Outcome control",2,439727,1.99898191420677,1.79748729648755,1.03332532085459,1.04651806711693,"Sertraline",0.681440526997582,0.189348617697196,1.37330822302082,2.88479988249922,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.644606327886964,0.18135690544603,1.33791928107203,2.72378276855867,0.000261787628194588
6,739138,10554,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human immunodeficiency virus infection, RR=4","Outcome control",4,439727,4.01322680285131,3.23533952700714,1.03320601381104,1.04633816486159,"Sertraline",1.08155894442396,0.179249686504332,2.09946322731831,4.23900073429812,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02347909998747,0.173538792489698,1.9874150927825,3.92393278527648,1.14119751031424e-09
6,739138,10555,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.5042297116174,1.4679208021645,1.00630202793426,1.00907075785695,"Sertraline",0.373590826907027,0.0301969480883105,1.36953233822958,1.54162828227035,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.353063987572149,0.0351333864029586,1.33031078919293,1.52673723933777,6.28576298596333e-37
6,739138,10556,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00933365981247,1.93060947072834,1.0062888061184,1.00904773573976,"Sertraline",0.681723168187475,0.0284132634240274,1.8704287467569,2.09079761452262,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.644884494977932,0.0370407381649405,1.77563010268367,2.05310313474366,7.99103621646793e-131
6,739138,10557,743670,"Sertraline","Venlafaxine",36918942,"Depression","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02493927974191,3.78116386015118,1.00624029614036,1.00896381746586,"Sertraline",1.40214133422266,0.0255898240894465,3.86597017057079,4.27388364276139,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32702497488353,0.0492453240051737,3.44126679213103,4.17401240256841,0
6,739138,10558,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=1.5","Outcome control",1.5,433811,1.49517074730438,1.49302540355984,1.01501223272145,1.02015263555783,"Sertraline",0.55521133761294,0.0656114948074124,1.53289410268601,1.9824825106263,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.52507640231152,0.0663915573182874,1.48665265448131,1.92856687355402,7.24578316317159e-18
6,739138,10559,743670,"Sertraline","Venlafaxine",36918942,"Depression","Hydronephrosis, RR=2","Outcome control",2,433811,1.99725743020617,1.94359998698941,1.01496815221933,1.02008796185148,"Sertraline",0.83685530257206,0.06189970797763,2.04685818416654,2.60895151182952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.791756141010356,0.0652421455138465,1.94692421340354,2.5143022050385,1.38738798671158e-42
6,739138,10561,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=1.5","Outcome control",1.5,201093,1.50354955552695,1.4665806589192,1.00531582426583,1.00755800083301,"Sertraline",0.403606250235897,0.0238678938260155,1.42884669655416,1.56898362566492,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.38150649614703,0.0307416306146425,1.38059529337779,1.55740310182771,3.37185646199794e-67
6,739138,10562,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=2","Outcome control",2,201093,2.00736643598839,1.92298877230282,1.00530364073289,1.00753714746474,"Sertraline",0.709912772336419,0.0224493972248367,1.94645165662219,2.12550213179369,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.671547399206251,0.0335661210233452,1.83624118742654,2.09446348162024,1.70865140167043e-225
6,739138,10563,743670,"Sertraline","Venlafaxine",36918942,"Depression","Infection of skin AND/OR subcutaneous tissue, RR=4","Outcome control",4,201093,4.01148555975981,3.74986507391689,1.00526099532739,1.00746504194188,"Sertraline",1.43615061042931,0.020450834478822,4.03990044695759,4.3770975630301,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35923591002122,0.0480028176592904,3.56359144348043,4.30138238668641,0
6,739138,10565,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=2","Outcome control",2,139099,2.00601061479253,1.95625764260341,1.01068514112253,1.01468251725167,"Sertraline",0.74960768486949,0.0458764482538591,1.93503844060188,2.31627331605379,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.709132257872621,0.0510577372452475,1.8425649652974,2.25083499451419,1.53385299116026e-61
6,739138,10566,743670,"Sertraline","Venlafaxine",36918942,"Depression","Ingrowing nail, RR=4","Outcome control",4,139099,4.02292473688128,3.92582617552391,1.01057793960325,1.01452861751735,"Sertraline",1.44802395055234,0.0421011476847823,3.92035283763586,4.62379189843066,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37047881788003,0.0596876275377652,3.52269306600505,4.45130349385026,1.03031488928433e-262
6,739138,10567,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=1.5","Outcome control",1.5,198678,1.49868762450132,1.41300436450766,1.01239962517029,1.01770915480102,"Sertraline",0.527145728436045,0.048276979537839,1.54153367301889,1.86268704817316,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.498481400772195,0.0511082727769516,1.49155958600895,1.82241587092273,9.86178405095288e-29
6,739138,10568,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=2","Outcome control",2,198678,1.9907058806484,1.82343778288426,1.01235706809276,1.01763451391352,"Sertraline",0.778696461696514,0.0460158075377478,1.99121614989626,2.3848213924163,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.736662941991005,0.0514684422214078,1.89265961712741,2.31575468187858,8.19169831917027e-66
6,739138,10569,743670,"Sertraline","Venlafaxine",36918942,"Depression","Intestinal infectious disease, RR=4","Outcome control",4,198678,3.97603361058761,3.48834195413423,1.01219381617603,1.01734935723478,"Sertraline",1.50469374762794,0.0419254042028605,4.1505836323463,4.89196235806231,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42414389885078,0.0609833300727987,3.7092850657454,4.7109491915769,9.97863905125329e-286
6,739138,10570,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=1.5","Outcome control",1.5,436659,1.5047280967243,1.46866640938739,1.00831167325053,1.01078676382965,"Sertraline",0.483187168949985,0.0378221876369994,1.50562496037497,1.74624596206355,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.456860068364349,0.0420846121883134,1.45614472977835,1.71731323276089,7.89692435927972e-39
6,739138,10571,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=2","Outcome control",2,436659,2.001438652701,1.93980153339564,1.0082894548882,1.01075799298478,"Sertraline",0.802613741001091,0.0354720812157993,2.08206089941758,2.39266121002356,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.759328514493945,0.0436074306334353,1.96619083204669,2.33272256942389,4.4435041376332e-116
6,739138,10572,743670,"Sertraline","Venlafaxine",36918942,"Depression","Iron deficiency anemia, RR=4","Outcome control",4,436659,4.02277937999165,3.79639672998479,1.0082065319919,1.01065129886758,"Sertraline",1.49536511605919,0.0322366569218348,4.18956023821472,4.75388009377282,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41530990299743,0.0551409842580094,3.71861343023812,4.61586624053033,0
6,739138,10573,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=1.5","Outcome control",1.5,374919,1.50454891271731,1.39247086329304,1.02272466165641,1.02903905163278,"Sertraline",0.270924026149286,0.116045863390033,1.04426806239448,1.64576882663269,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.255859463025105,0.111589074979581,1.03894870771756,1.60902833791556,0.0155724468302379
6,739138,10574,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=2","Outcome control",2,374919,2.00038827563926,1.82472881625812,1.02268309267817,1.02898746784693,"Sertraline",0.556505792026361,0.106907057587772,1.41679694095625,2.15430165599055,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.526283423860852,0.103983370794038,1.38275136343614,2.07857503459883,1.17810804922364e-07
6,739138,10575,743670,"Sertraline","Venlafaxine",36918942,"Depression","Multiple sclerosis, RR=4","Outcome control",4,374919,4.02898099708666,3.53643412536441,1.02251289314089,1.0287738396114,"Sertraline",1.16445288615091,0.0958530731763258,2.6637224951045,3.87855135270886,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.10196537508341,0.0979107182653577,2.49397221501866,3.66079255651504,1.67592737314361e-34
6,739138,10576,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50291279657255,1.51472132959526,1.00501693284658,1.00657950432164,"Sertraline",0.42940115070307,0.0229908707128509,1.4687028742808,1.60721387890976,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.405936347417654,0.0304017952645155,1.41573925119443,1.59492175920832,2.43933948874018e-81
6,739138,10577,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00514429183955,2.02649830502611,1.00500618408796,1.00656499491017,"Sertraline",0.715319917569583,0.0214938272842,1.96065504324124,2.13300733409454,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.676667675280701,0.0330785732063034,1.84746038619647,2.10323693593029,1.79834902683223e-249
6,739138,10578,743670,"Sertraline","Venlafaxine",36918942,"Depression","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02833329969509,4.10128425605055,1.00496822414352,1.00651428996903,"Sertraline",1.45925407813107,0.0195312591545913,4.14169408566994,4.47124115147428,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38111158944396,0.0483465328026948,3.64061550313078,4.40027785485834,0
6,739138,10579,743670,"Sertraline","Venlafaxine",36918942,"Depression","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.50006865885539,1.52003455581871,1.01401499567823,1.01757281619937,"Sertraline",0.480923591147879,0.0627246782049265,1.43087587975216,1.82972005645807,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.454686509393108,0.0634138919060913,1.39353287150458,1.78678880545431,5.16158903448746e-15
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,10095,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.98149881485395,3.53210283009005,1.04891345988985,1.05273740327369,"GI bleeding",1.93189142730798,0.224751009759026,4.47089498482034,10.7897475047096,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33679321762213,NA,2.36611311454659,NA,1.30546030134478e-16
6,1103006,10093,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49617676426044,1.41586972205837,1.04899234638876,1.05282310175735,"GI bleeding",0.847541299275547,0.289735168163161,1.31981421760544,4.10921483178766,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.491211047151484,0.273287230113894,1.02460336109086,2.99089247601767,0.00747365043804092
6,1111706,10146,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,4.00440448512359,5.51559720223523,1.17055121699518,1.24833216194799,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1111706,10144,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50154670667693,2.25409486017401,1.17060028456165,1.24840199997411,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,2,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.04900818728296,1.05284030313926,"GI bleeding",-0.149578005021439,0.396922203461727,0.386796522465186,1.83317592525201,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.286357218221397,0.318715928397765,0.408149115788038,1.42364543603943,0.575804747720855
6,1111706,10145,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,2.00270525258605,3.00328876768768,1.17059156458371,1.2483889879672,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1111706,2,1110942,"zafirlukast","omalizumab",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.17061122963423,1.2484173992489,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,NA,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,751347,10123,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49757535092703,1.3365344417952,1.14193820458178,1.29332639109409,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103006,10094,1136422,"desloratadine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,2.00831220549289,1.86815205477728,1.04897465606379,1.05280372685819,"GI bleeding",1.0890560820527,0.271101532182526,1.74683588641158,5.05564057224964,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.67954563616248,0.28533160051115,1.2559591303667,3.84348247175295,0.000177052725466872
6,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,2,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.03924293581155,1.115870298702,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,10079,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=2","Exposure control",2,2,2.00079261997684,1.97482036705139,1.10776772453863,1.0612538400786,"GI bleeding",1.6707764106456,0.266051083911583,3.18106098537319,9.02605928268261,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.13317863712857,NA,1.90830802205038,NA,1.88557086622038e-09
6,781182,10126,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49715946201759,1.57795559736854,1.11586043136199,3.59522476737487,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10127,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99400286277292,2.0489598402597,1.11584891260583,3.59490355901379,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,937439,10082,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=2","Exposure control",2,2,1.99876278211994,1.82534577787009,1.22280224714923,1.25301137334576,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,937439,10083,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=4","Exposure control",4,2,4.00793375108662,3.90345138822465,1.22274565162942,1.25294839881011,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,2,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding","Exposure control",1,2,1,1,1.10785281808305,1.06130272106832,"GI bleeding",0.443237634177501,0.353467067791938,0.769467235308761,3.07562625098806,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.175928476379727,0.299084935835502,0.688193330006814,2.22266277986139,0.294254260075233
6,938044,10084,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50067820022277,1.57219962258548,1.14837965262882,1.04309518106704,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,10078,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50023169130367,1.45478249950925,1.1078166950047,1.06128234880879,"GI bleeding",1.09051764419751,0.300389491037896,1.65220196590327,5.36348575186739,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.680684823066595,0.307439248774682,1.2091809421365,4.03530921963229,0.000701578004018858
6,938044,10085,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00086720498512,2.14382175220788,1.14837285604219,1.04309341267969,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,10080,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","GI bleeding, RR=4","Exposure control",4,2,4.0108919371918,3.30166027689129,1.10760343639579,1.06115960903665,"GI bleeding",1.97903883636403,0.245115121543862,4.53830104489054,11.8625495791482,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37356225280834,NA,2.39330504567674,NA,7.36224604305036e-15
6,781182,10128,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,3.99995273337894,4.09552231177805,1.11580964668417,3.59386139388557,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,751347,2,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding","Exposure control",1,2,1,1,1.14196022970408,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,751347,10124,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=2","Exposure control",2,2,1.99604583446775,1.76721420343696,1.14191684228822,1.29328639305176,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,751347,10125,19087394,"Primidone","lacosamide",36702242,"Encephalopathies","GI bleeding, RR=4","Exposure control",4,2,4.010275750201,3.38033165969101,1.14182340858475,1.29312256288573,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,732893,2,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.05154992739763,1.07474362532504,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,2,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14858573631929,1.14838785564568,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,732893,NA,1136487,"Bupivacaine","ropivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,10117,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50148762620268,1.50125239654437,1.14857420705772,1.14837692364732,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,734275,2,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.07939775013571,1.29336720833065,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,10118,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=2","Exposure control",2,2,2.00324273559452,1.78440050789956,1.14856457484001,1.14836966798843,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,734275,10114,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50231929392456,1.24191943851938,1.07937188631014,1.29327752206189,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,945286,10119,938044,"Pilocarpine","brinzolamide",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.03281887530364,3.20420397730588,1.14852105036591,1.14832492852789,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,734275,10115,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99805428059134,1.54827459707391,1.07934677812715,1.29318735893358,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,734275,10116,19087394,"Phenobarbital","lacosamide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,4.0040818947025,2.57977101310061,1.07924716031434,1.29283255479598,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,2,731188,"ramelteon","quazepam",436962,"Insomnia","GI bleeding","Exposure control",1,2,1,1,1.115870298702,3.59548318558058,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,2,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.06899578510353,1.05154992739763,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,2,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.05284030313926,2.05652386838457,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10105,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50352117464502,1.45560990521685,1.05282721094459,2.05610629865186,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,2,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.32970441940445,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10106,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=2","Exposure control",2,2,1.99547812458371,1.83950629503492,1.05281524355941,2.05562000175666,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10120,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50113778147291,1.49299654367722,1.06897911919457,1.05153975649183,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136422,10107,1105889,"levocetirizine","Triprolidine",36009773,"Rhinitis allergic","GI bleeding, RR=4","Exposure control",4,2,3.9932648345129,3.82235740506125,1.05276298105285,2.05371828703834,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10121,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,1.99637257610011,1.93115587773,1.06896388057551,1.05152939409811,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,951279,10122,732893,"Prilocaine","Bupivacaine",37522270,"Surgery","GI bleeding, RR=4","Exposure control",4,2,3.99293574697153,3.63875935013644,1.0688960524209,1.05148695866017,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1588712,NA,1536743,"Follicle Stimulating Hormone","ganirelix",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,2,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding","Exposure control",1,2,1,1,1.07474362532504,1.62453722259015,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,2,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.25091800671738,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,2,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding","Exposure control",1,2,1,1,1.13039893274989,1.06981541045489,"GI bleeding",-0.066083222201808,0.405022874572926,0.410196962114242,2.00680249102544,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.221238132696543,0.326297533235241,0.430136949349732,1.5455984670031,0.732212378800464
6,19012925,10135,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49604324665121,1.48312402253125,1.13037562953168,1.06980246370173,"GI bleeding",0.569507750927213,0.328601173438306,0.916578563732706,3.32339029983402,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.274396201614443,0.285313347552633,0.78597042310869,2.4050523106947,0.13041497151496
6,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,10136,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=2","Exposure control",2,2,2.00444270420209,2.00495373573236,1.13035863118942,1.06979337488325,"GI bleeding",0.630342209481102,0.315771524711364,1.0081828049263,3.47623961398575,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.321836225831438,0.278578115897089,0.838582541288166,2.49918301568029,0.0772999743168192
6,1136487,NA,1036884,"ropivacaine","Tetracaine",73553,"Arthropathy","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19012925,10137,989482,"silodosin","Dutasteride",37119607,"Benign prostatic hyperplasia","GI bleeding, RR=4","Exposure control",4,2,3.99140199716925,3.92989498996412,1.13026815718957,1.06974287729485,"GI bleeding",1.30582684337274,0.263261892274508,2.218390115552,6.22609552216986,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.8485663919923,0.322928651751815,1.48350488609089,5.26070216027101,2.80293856326698e-06
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1589795,NA,1563600,"Luteinizing Hormone","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10132,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49681430538996,1.36145650905154,1.03922752440457,1.11582384658137,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,2,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding","Exposure control",1,2,1,1,1.13964291564967,1.16317329418227,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10133,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=2","Exposure control",2,2,1.99250350989318,1.74037031126327,1.03921026865187,1.1157743405968,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10134,781182,"Scopolamine","ramelteon",436962,"Insomnia","GI bleeding, RR=4","Exposure control",4,2,4.0136151716305,3.37124243831855,1.03914688993224,1.1155890128118,"GI bleeding",2.73358709606657,0.445657371606372,6.90794009919872,39.6311840594101,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.96198648995375,NA,3.17047698299258,NA,2.35616416652279e-09
6,1236744,2,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding","Exposure control",1,2,1,1,1.22244193041019,1.86966499934379,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1236744,NA,1143374,"Terbutaline","Ephedrine",36009700,"Asthma","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,NA,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1317967,2,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding","Exposure control",1,2,1,1,1.11110475022084,1.22394414215615,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1317967,10072,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=1.5","Exposure control",1.5,2,1.4950416867779,1.48799384162304,1.11108307995452,1.22389789573333,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1317967,10073,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=2","Exposure control",2,2,2.00911464594972,2.02341917669635,1.11105910515966,1.2238427293306,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,937439,2,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding","Exposure control",1,2,1,1,1.22282833213478,1.2530397393856,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1317967,10074,1309799,"aliskiren","eplerenone",37622411,"Phlebosclerosis","GI bleeding, RR=4","Exposure control",4,2,4.00300731946257,4.17007341685093,1.11096976191317,1.22365625274607,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,937439,10081,759740,"Bethanechol","Pyridostigmine",35702117,"Gastrointestinal motility and defaecation conditions","GI bleeding, RR=1.5","Exposure control",1.5,2,1.49827099273229,1.44563440283362,1.22281457205662,1.25302456699838,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,2,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding","Exposure control",1,2,1,1,1.14838785564568,1.04309710057575,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,938044,10086,717136,"brinzolamide","Neostigmine",35606985,"Glaucoma","GI bleeding, RR=4","Exposure control",4,2,4.00824175406885,4.37018784872652,1.14833524953339,1.04308549539244,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,2,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding","Exposure control",1,2,1,1,1.29336720833065,1.95591734442258,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10102,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=1.5","Exposure control",1.5,2,1.50212811734704,1.40202747837896,1.29335253647721,1.95575611091984,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,993979,2,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding","Exposure control",1,2,1,1,1.35385504660219,1.06388769078117,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10103,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=2","Exposure control",2,2,1.99484619337071,1.95380991026734,1.29333507151764,1.95573408908807,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,19087394,10104,750119,"lacosamide","Ethosuximide",36718530,"Epilepsy","GI bleeding, RR=4","Exposure control",4,2,3.99729130026543,3.66834228048311,1.29327440880609,1.95539961774018,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,943634,2,1136422,"epinastine","levocetirizine",36009773,"Rhinitis allergic","GI bleeding","Exposure control",1,2,1,1,1.12911124315135,1.05284030313926,"GI bleeding",-1.60108145409458,1.53215971544086,0.00526341684541029,2.1360981040628,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-1.41825738975501,1.20174424631591,0.0232831355749666,2.58758473859945,0.274697662060877
6,993979,NA,922868,"Malathion","Permethrin",36110310,"Arthropod infestation","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1036884,2,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding","Exposure control",1,2,1,1,1.62453722259015,1.08453946842925,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,43013884,2,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding","Exposure control",1,2,1,1,1.38547673433273,1.14393369322471,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1036884,NA,702774,"Tetracaine","Mepivacaine",37522270,"Surgery","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=1.5","Exposure control",1.5,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=2","Exposure control",2,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,43013884,NA,1502826,"alogliptin","nateglinide",35506622,"Type 2 diabetes mellitus","GI bleeding, RR=4","Exposure control",4,2,NA,NA,NA,NA,"GI bleeding",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1102527,10258,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4973450198463,1.20452594748251,1.0327952721171,1.03731516257344,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1114122,10263,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.0135657689888,1.39285915950764,1.10435803393573,1.01950774223332,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103640,10292,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99150428604329,2.01876607615654,1.10890422097653,1.03895521349703,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1102527,10260,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98151395950303,2.22887048480213,1.03263186274091,1.03711971081534,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103640,10293,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01027806632592,3.83068621140788,1.10885486327305,1.03893877966989,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103640,10291,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50212231618126,1.55577568324212,1.10891672248944,1.03895934478827,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1103640,4,780442,"Methadone","varenicline",36919128,"Drug dependence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10892888010875,1.03896341905018,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1114122,10262,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9982719469601,1.09754918626055,1.10437652158026,1.01951079699765,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,10222,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4958840734222,1.49189256958124,1.08783821138474,1.05174838992224,"Inflammatory Bowel Disease",0.667367627087535,0.38880370210237,0.903444551201706,4.14765023067414,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.727131296472994,0.393570425693958,0.96297482785899,4.5043325057617,0.0509453214886028
6,989482,4,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09039619537178,1.08181059132784,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,4,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08785386878862,1.05175845012798,"Inflammatory Bowel Disease",0.218388508807547,0.438777300740356,0.517715313031116,2.89112481812264,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.303344215137587,0.436326584027493,0.57940304066677,3.20467869661075,0.479953283305455
6,753626,10264,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50116404096219,1.38207961569627,1.03592553382879,1.01663395961993,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1102527,10259,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00559680303008,1.42242076503798,1.03275785788768,1.03726970945107,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1114122,10261,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49574773479101,1.13495934610731,1.104381225677,1.01951153212417,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1363053,10239,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99244378495437,3.4931428839037,1.0716647756513,1.0581782600049,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1114122,4,989878,"Nalbuphine","Lidocaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10438609600888,1.01951224907064,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1386957,10253,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0019641210561,1.93920921898259,1.07929657726566,1.10413015788465,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1386957,4,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07931869850917,1.1041606521898,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1386957,10254,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01865885015862,3.67254688289012,1.07924646379034,1.10407066928547,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1363053,10238,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00654555333107,1.94018160919195,1.07182801811267,1.05821952231092,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,902427,10283,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99736514971062,1.62950883650071,1.06313860049949,1.04104072129303,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1386957,10252,1313200,"Labetalol","Nadolol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49822136873825,1.50720369144404,1.07930695687718,1.10414608457414,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915542,4,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07371615870545,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,4,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03736145782142,1.0646937753461,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915542,10229,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99481486035793,1.60490558804338,1.07368560379013,1.04104860672341,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,4,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.1104529492256,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915542,10230,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01839182289112,3.62965909776753,1.07363088465086,1.04102895720102,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,916005,4,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.07412828439747,1.05823884471389,"Inflammatory Bowel Disease",-0.43397238199566,0.300655057394607,0.35147655039917,1.14217448168004,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.312403965188537,0.312154129351047,0.39902080530828,1.35646219401486,0.254741829661814
6,916005,10274,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.0023963195357,2.09101390784301,1.07407844161325,1.05819958300505,"Inflammatory Bowel Disease",0.390095793736412,0.262132495774636,0.893213933978818,2.49580505057634,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.465415773145007,0.283704349883108,0.91906715062901,2.79464343494307,0.0661467122130887
6,916005,10275,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02373921671079,4.33685704307607,1.07398204513871,1.05812337974727,"Inflammatory Bowel Disease",1.12842206404216,0.197203383266817,2.12157651026545,4.59598229127366,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.16227771536107,0.237266212435543,2.02241032746796,5.12615822053254,6.15612487598767e-10
6,981709,4,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10073311999978,1.07371615870545,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,924566,10277,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00548282431079,1.80218101660234,1.03031397662063,1.07402011239028,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,924566,10278,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02198634224946,3.4152369870516,1.02996843669315,1.07380286618211,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,902427,4,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06318803004197,1.04105852228168,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,742185,10223,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00068142984377,1.98377386083092,1.0878202680947,1.05173717706709,"Inflammatory Bowel Disease",1.12212572974804,0.304859251528754,1.70614329109622,5.63649120242522,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15636331744791,0.323239178799024,1.69866075372094,6.0310097211965,6.8593080339507e-05
6,742185,10224,705944,"atomoxetine","Methylphenidate",36918919,"Atypical attention deficit syndrome","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.03087460986253,3.57971503717562,1.08774878772612,1.0516918527361,"Inflammatory Bowel Disease",1.66823963874114,0.316835742468046,2.90949371846254,10.073944868359,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.67182480495557,0.336308317340882,2.77411646172806,10.3670932968741,2.78764673009562e-08
6,1513103,10268,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00063654814814,1.88790252656535,1.06584434542899,1.09268499820857,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,708298,4,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01665490410001,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,708298,10288,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49539120926857,1.32481820568359,1.01656853240038,1.03717832048161,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,753626,4,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03597174756629,1.01665490410001,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,753626,10265,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00336807995799,1.78284985858017,1.03588003392575,1.01661356961113,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1524674,4,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.10543911488518,1.06672510626041,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1363053,4,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0719059791895,1.05823884471389,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1363053,10237,913782,"Doxazosin","tolterodine",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49693984189691,1.45931501402843,1.07186658099147,1.058228551802,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1550023,10246,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50141104159528,1.42607163360944,1.0549809367473,1.03912055039265,"Inflammatory Bowel Disease",0.522255456669766,0.480975819549373,0.62379583001628,4.11014541172176,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.590161510354156,0.475331248572724,0.715269075588362,4.60972304533437,0.201893588374661
6,1550023,10247,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00879189175664,2.01166629170527,1.05495767810866,1.03910287754848,"Inflammatory Bowel Disease",1.19685240240225,0.39529370094761,1.48940987296335,7.01396258545562,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.226893667746,0.401525127795437,1.5636575645784,7.54569535045652,0.00111662157573199
6,1550023,10248,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99806523957325,3.68243803468325,1.05486749541671,1.03903458428095,"Inflammatory Bowel Disease",1.7257258305823,0.346265006272351,2.82515658586962,10.9780483511892,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.72608458005698,0.361566092915125,2.78754032883723,11.5014445982011,1.53565001502848e-07
6,781182,10294,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.4931877942217,1.57587971681765,1.11044791538743,1.03735970864929,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10295,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00253234457708,1.97699801984155,1.11044282586066,1.03735813385045,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,781182,10296,965748,"ramelteon","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01528457129492,4.16540925203993,1.11042141931814,1.03735087971812,"Inflammatory Bowel Disease",1.36793119208374,0.459976103196463,1.60171059707496,9.71960882519203,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38837062087904,0.459541952467391,1.64049306319788,9.93802389301137,0.00150894153043735
6,708298,10289,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99678411807644,1.63317032939317,1.01648558813123,1.03700164432834,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,708298,10290,965748,"Midazolam","Scopolamine",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.97280437690973,2.94404609597639,1.01619009517647,1.03637180125174,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,753626,10266,708298,"Propofol","Midazolam",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99674661634178,3.30088852084551,1.03572021200066,1.01654109867549,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,902427,10282,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50211510789173,1.38601386939405,1.06316303051667,1.04104947153916,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,902427,10284,717136,"Timolol","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01660914100521,3.03292180162069,1.06304359142642,1.04100571783431,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,915542,10228,717136,"brimonidine","Neostigmine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50034905135329,1.37536792605685,1.07370137819071,1.04105367795551,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1524674,NA,1512480,"zoledronic acid","Ibandronate",36416551,"Osteoporosis","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,NA,NA,NA,NA,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1550023,4,1502905,"Insulin Lispro","Insulin Glargine",35506622,"Type 2 diabetes mellitus","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.05500330709637,1.03913740624147,"Inflammatory Bowel Disease",0.525020613215776,0.483077835520286,0.622498536870423,4.13553340461064,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.592773074678274,0.477237732798663,0.714465906611388,4.63908680461317,0.201833153214163
6,1598819,4,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.09268713568635,1.10692813436648,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,10231,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50016422640616,1.41196581079975,1.0926802914762,1.10691955019682,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,10232,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00066035847036,2.29529620192498,1.09267776778852,1.1069172237965,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1598819,10233,1563600,"Clomiphene","Chorionic Gonadotropin",37119655,"Infertility female","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00297345013136,3.88502041584906,1.09265968246829,1.10689523531794,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10270,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50363834363081,1.33791638933271,1.03734566118705,1.06466709354081,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,916005,10273,913782,"Solifenacin","tolterodine",36718449,"Urinary incontinence","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49892527895342,1.54073921693193,1.07410388804064,1.0582196467548,"Inflammatory Bowel Disease",0.0430398018805415,0.267309665624888,0.614637089104188,1.75261919226455,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.137840601652792,0.286163214809943,0.658935695812752,2.02305725898543,0.614603918337943
6,965748,10271,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99792862678582,1.68129084250476,1.03733107293476,1.06464257083213,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,965748,10272,704599,"Scopolamine","Triazolam",436962,"Insomnia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02433389651367,3.21532255994574,1.03727168386145,1.064542125054,"Inflammatory Bowel Disease",2.3094229413008,0.389193717385675,5.03924149069756,23.1701986281312,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.27702318400874,0.401543940379514,4.47498589540488,21.5963975905393,6.8678042764607e-10
6,924566,4,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03049573649283,1.07412828439747,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,981709,10234,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50043449198713,1.33372357084456,1.10071881985105,1.07370652649238,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,924566,10276,916005,"tamsulosin","Solifenacin",4025202,"Elimination pattern","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50240722168954,1.40637049624326,1.03040676733938,1.07407597304021,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,981709,10235,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99055618934371,2.00080313816562,1.10070763694167,1.07369887823799,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,981709,10236,915542,"dorzolamide","brimonidine",35606985,"Glaucoma","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99534246406214,4.21560663957224,1.10064740131046,1.07365899812915,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989482,10240,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50101331537445,1.42019891312674,1.09034023483053,1.08176824503736,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1338005,4,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0641519794828,1.07931869850917,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989482,10241,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00790731711754,1.96996292871645,1.09027425837041,1.08171884433592,"Inflammatory Bowel Disease",1.1383513845926,0.36274284718169,1.57378817323426,6.52350230171915,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17167637901093,0.372834973959938,1.56512500402942,6.74938870025573,0.000697473429468119
6,1338005,10225,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50123253508363,1.51620559687242,1.06412509650114,1.07929703541346,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989482,10242,1341238,"Dutasteride","Terazosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02056133488988,4.00623843887978,1.09002620264242,1.08153342546166,"Inflammatory Bowel Disease",1.43875866567106,0.318679775073032,2.30264198724212,8.03059736854619,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.45522354337707,0.336593418537788,2.23200904634543,8.3505220099264,1.57059173747973e-06
6,1338005,10226,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00772750914151,2.09963890282552,1.06409774567066,1.0792750800815,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989878,4,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.01951224907064,1.05149945019831,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1338005,10227,1386957,"Bisoprolol","Labetalol",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.02107051453185,4.09785363451978,1.06399600573037,1.0791904574611,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989878,10255,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50292389860161,1.31940199154064,1.01948397613455,1.05141956339209,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,989878,10256,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,2.00847043222719,1.66009353748072,1.01945682668532,1.05134290979018,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,4,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.08181059132784,1.03049573649283,"Inflammatory Bowel Disease",0.179397633987375,0.242927271303131,0.730611020824801,1.89341736333018,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.266546143758993,0.266825898142536,0.778493020065586,2.21564386976369,0.264695867048987
6,989878,10257,732893,"Lidocaine","Bupivacaine",37522270,"Surgery","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.01403105015709,2.91724317003044,1.01934946238357,1.05104079254958,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1513103,4,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.06598350981321,1.09268713568635,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1513103,10267,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.49978829331587,1.42870540303039,1.06591142730485,1.0926862621334,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,10279,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50108772561118,1.50810672059294,1.08176598206195,1.03048173578679,"Inflammatory Bowel Disease",0.595107804459501,0.2071310942342,1.19587803446047,2.69344122542449,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.658921903086641,0.241042876263698,1.21278994598488,3.11987881077002,0.000916086204203198
6,1513103,10269,1598819,"Raloxifene","Clomiphene",35506596,"Polycystic ovaries","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,4.00663362119523,3.7837420559712,1.06555848019931,1.09268018446909,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1341238,10280,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.9977367050796,1.94770563635237,1.08171578165123,1.03046617190515,"Inflammatory Bowel Disease",0.803942020027625,0.191311943555737,1.52462037395965,3.2273923278324,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.856034533818811,0.230568158934812,1.50803769185782,3.72333524879879,2.85740075633783e-06
6,996416,4,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0679498714281,1.09039619537178,"Inflammatory Bowel Disease",-0.425029925088055,0.278439248519599,0.373141957683858,1.11144997851321,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.303963359174838,0.293244476353627,0.417599904889327,1.31819813452577,0.231049112431065
6,1341238,10281,924566,"Terazosin","tamsulosin",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99254090849348,3.8391077115291,1.08154506990721,1.03041275406678,"Inflammatory Bowel Disease",1.38230769976803,0.157756812289632,2.91661208359954,5.41307886973875,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40191724379574,0.211427833034345,2.70433504026796,6.19435214220444,9.39900616886059e-21
6,996416,10243,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50070529360061,1.4623981215208,1.06790133610226,1.09032046822146,"Inflammatory Bowel Disease",-0.21209526406338,0.246832465154897,0.494659738820901,1.30171201767186,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.103006708058743,0.26790448507853,0.536658147371308,1.5338367863205,0.625300421739026
6,1347384,4,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.0523749171736,1.04728513511495,"Inflammatory Bowel Disease",-0.125576808352849,0.212756107414972,0.5801952811811,1.33589045318091,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0213185082294145,0.240936614623367,0.613977878471771,1.57878852153328,0.872948571811666
6,996416,10244,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99144899836991,1.91773279981021,1.06784733556511,1.09023680421873,"Inflammatory Bowel Disease",0.157036662758657,0.235033088076902,0.73749938219261,1.8530311303562,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.245441633988811,0.260316680320812,0.772004253047094,2.14182317264256,0.290199851559562
6,1347384,10249,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=1.5","Exposure control",1.5,4,1.50184349201495,1.44792784651999,1.05234364291758,1.04725613964148,"Inflammatory Bowel Disease",0.26667110897465,0.186511378892471,0.905777566403156,1.88165113726123,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.348931535493921,0.223267698435108,0.920762723283337,2.20922194029582,0.054774649312669
6,996416,10245,989482,"Finasteride","Dutasteride",37119607,"Benign prostatic hyperplasia","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.99097387255798,4.19324983301036,1.06764799435492,1.08993156185913,"Inflammatory Bowel Disease",0.979298791786924,0.193505166988298,1.83804982234301,3.92447053513963,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.02154936552309,0.233446509198433,1.7697916928641,4.41918527733078,3.13060553802837e-08
6,1347384,10250,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=2","Exposure control",2,4,1.99171282466792,2.05648431002521,1.05231428339765,1.04722896395086,"Inflammatory Bowel Disease",0.555424760756965,0.176362993216536,1.23515556778474,2.46582677708718,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.621468713876542,0.217854720735493,1.2224595947286,2.87151482317758,0.000244028777861602
6,1347384,10251,1334456,"irbesartan","Ramipril",37622529,"Hypertension","Inflammatory Bowel Disease, RR=4","Exposure control",4,4,3.98696891569079,3.93154734450591,1.05219619368667,1.04712017021396,"Inflammatory Bowel Disease",1.27313695393183,0.152991746215964,2.65802062674377,4.84185710028455,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.29889651548933,0.20734295572352,2.45884507462646,5.54258616807738,4.66207537289373e-19
6,1102527,4,965748,"Meperidine","Scopolamine",36803580,"Delivery","Inflammatory Bowel Disease","Exposure control",1,4,1,1,1.03283424723125,1.03736145782142,"Inflammatory Bowel Disease",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10297,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=1.5","Outcome control",1.5,440083,1.50435172445698,1.45514507849569,1.01389603240868,1.01960401021158,"Diclofenac",0.598994200480236,0.116729161489032,1.45149022425322,2.29368724762035,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.455531826414441,0.149457402736473,1.22051521085444,2.19270365211908,3.60433826759871e-06
6,1124300,10304,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=2","Outcome control",2,433753,2.00987579629235,1.80273020839109,1.01407654747753,1.02004353867617,"Diclofenac",0.848641143418004,0.124443481890213,1.8365354728484,2.9912470881544,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.65886382882259,0.170173983656122,1.45716165908684,2.83930763679316,3.56016798792035e-10
6,1124300,10315,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=1.5","Outcome control",1.5,381581,1.49554936167974,1.47379538631881,1.01656086048898,1.02272827307258,"Diclofenac",0.714118290882498,0.145782065305549,1.53854313056313,2.72451694560533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.549301058113328,0.17303086916127,1.28809113524232,2.53813593029586,5.36332602016168e-06
6,1124300,10305,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=4","Outcome control",4,433753,4.02240222380715,3.4292709138066,1.01402655361368,1.01995843566229,"Diclofenac",1.54202211472745,0.109013475228294,3.7891580606963,5.80935074863291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22360826261165,0.245789688889812,2.41885504896794,6.33932429023158,2.18930372084491e-38
6,1124300,10310,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=2","Outcome control",2,4084966,2.00983904109147,1.94471961673668,1.01040908518247,1.01548957665757,"Diclofenac",0.927915499461231,0.115015930650292,2.02611448722338,3.1802953717303,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.723431210991967,0.171678030887079,1.55856450177856,3.0548507020875,1.71400428529152e-13
6,1124300,10312,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50084577544203,1.53284719834127,1.02055448882404,1.02686346467169,"Diclofenac",0.645453212162703,0.249714657479856,1.17591705714036,3.1296206135937,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.493372643314306,0.239897698703444,1.0662619963885,2.73065298607772,0.0139119904493582
6,1124300,10324,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.49466385059974,1.44448466358407,1.08867242360752,1.13664701822583,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10300,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=1.5","Outcome control",1.5,436677,1.50317156007078,1.47293485619585,1.00654402986992,1.0095189714656,"Diclofenac",0.519624413158579,0.0592265216749973,1.49750972446507,1.88884823456542,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.390905809728401,0.118171572700032,1.21167024226102,1.92557346305655,1.21661705051427e-11
6,1124300,10316,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=2","Outcome control",2,381581,2.00281616002402,1.91928612344833,1.01654460173283,1.02270348411382,"Diclofenac",0.990811261914961,0.150863873073289,2.01005953204505,3.63111533225625,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.774658295490744,0.195812231873166,1.57381522102479,3.3908227565455,6.7705708822155e-10
6,1124300,10326,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97907025772392,4.30607718096681,1.08802990388705,1.13526459542426,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10301,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=2","Outcome control",2,436677,2.00141854068372,1.94586399910245,1.00653869419801,1.00951008972751,"Diclofenac",0.861405700170843,0.0533121890936337,2.13275155046375,2.62844625726252,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.669257192378734,0.142136610261952,1.5558187562339,2.7160190194051,2.62648012360711e-34
6,1124300,10309,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=1.5","Outcome control",1.5,4084966,1.49880635536879,1.44569708518464,1.0104219826026,1.0155143668701,"Diclofenac",0.652632847476687,0.118320740461175,1.52557157957624,2.42584016934868,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.499219328232819,0.153554219292867,1.2682211573215,2.31529413141511,5.62297920770772e-07
6,1124300,10325,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder, RR=2","Outcome control",2,436373,2.00006250367208,2.0833888805643,1.08855294758695,1.13638075325122,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10329,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=4","Outcome control",4,443767,4.00160164323652,3.72121509055954,1.0118014207057,1.01524394918334,"Diclofenac",2.28033708021554,0.12570021874997,7.69381581830389,12.5931456371657,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.82494810884699,NA,3.90350927965845,NA,1.09148410243821e-64
6,1124300,10332,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=4","Outcome control",4,72715,4.02291045628812,2.87453424947615,1.00824264245744,1.01098696523634,"Diclofenac",2.06684473922815,0.0315380617453857,7.42864966299756,8.40621263053768,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.6510647579925,NA,3.52787014378571,NA,0
6,1124300,10331,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=2","Outcome control",2,72715,2.00859238066925,1.62903636506727,1.00839270060524,1.01119448349772,"Diclofenac",1.20226465998982,0.0349186323978211,3.10807132478407,3.56399071644782,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.946881477750102,0.174172504041702,1.98949754630348,3.93781415985442,9.90053604999269e-100
6,1124300,10334,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00050280890469,1.94903423125752,1.00820516670487,1.01122597724117,"Diclofenac",0.592549640772198,0.0876193281880751,1.52397213954638,2.14852515247202,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.450282335322167,0.13436571313719,1.2499100181664,2.1165247616906,5.37006956641964e-09
6,1124300,10335,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97430362060361,3.78291902272505,1.00817902209207,1.01118688428276,"Diclofenac",1.35869058954476,0.076923559235197,3.35182043805642,4.53143390130693,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.07430420650081,0.204825248962178,2.17578324836204,4.85635878583848,9.29246087794856e-52
6,1124300,10337,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.9971772529911,1.86725722440274,1.00652352851706,1.00937577973227,"Diclofenac",0.781507430016691,0.0491259027566263,1.98481067686427,2.40630778405398,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.604179046239713,0.13421299819481,1.47290672070226,2.49264175747023,4.64292324907971e-31
6,1124300,10317,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion, RR=4","Outcome control",4,381581,4.0232069498288,3.88760124303185,1.01647934122995,1.02260423462077,"Diclofenac",1.79824080451653,0.131619631568557,4.69856871929695,7.87109673860158,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43226389982709,0.318509966225623,2.83460389374077,9.8792671354597,1.31695104743032e-37
6,1124300,10338,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.99924789136634,3.59342945502899,1.00649902601834,1.00933312978547,"Diclofenac",1.55826732459238,0.0435052150416581,4.36501787143796,5.17665757795826,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.23683953266895,0.231232678457839,2.52662565490632,6.25449323430178,4.82278974049221e-138
6,1124300,10318,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=1.5","Outcome control",1.5,198075,1.50236724888598,1.41411551486412,1.02230478470344,1.03397093940307,"Diclofenac",0.622234707219997,0.210590180527573,1.24254433738232,2.83675133422768,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.474465456711344,0.210635867636698,1.10588335662147,2.52520402691877,0.00524964123425676
6,1124300,10298,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=2","Outcome control",2,440083,1.99250851628532,1.85444749510961,1.0138781398519,1.01957444749062,"Diclofenac",0.933141087234187,0.1031438216735,2.08215714622217,3.11964994138627,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.727687203489234,0.16658233868521,1.5813360277092,3.03818666435074,3.86834577757525e-16
6,1124300,10339,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.49838048126044,1.44677277948562,1.01025182601443,1.01405261470767,"Diclofenac",0.610273043582598,0.0698914713243735,1.60555345691502,2.11158333824704,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.46470806262343,0.128063481325397,1.28479160851132,2.12250321748515,8.59803292757686e-13
6,1124300,10299,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder, RR=4","Outcome control",4,440083,4.02500077856933,3.68404698833721,1.01380618270599,1.0194571103321,"Diclofenac",1.89331891849531,0.097701676522444,5.50524574546858,8.07429003609446,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50972158247119,0.345550178931719,3.08406130494519,11.9505720198944,1.29149369584065e-68
6,1124300,10333,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49578330230883,1.47210180595841,1.0082119978069,1.01123618592043,"Diclofenac",0.314414692759208,0.0960161084297529,1.1344114172419,1.6528319833816,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.223746959776702,0.123240998027758,1.00752291352952,1.63328053863894,0.0055238785840122
6,1124300,10340,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=2","Outcome control",2,139099,2.00834391379905,1.90367665464703,1.01023240878175,1.01402254476482,"Diclofenac",1.00611453691735,0.0656561211230875,2.40615819268704,3.11241399776615,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.787122128454413,0.159177956533208,1.7122172686761,3.19553749208839,6.89143096359224e-36
6,1124300,10314,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,4.01550595016521,4.1513698271922,1.02046173420513,1.02673744304405,"Diclofenac",1.88736802684633,0.214744630476736,4.4056532285969,10.2233265315667,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.50488414584838,0.40699301987719,2.80522233060004,13.8303592284029,1.67705915058399e-17
6,1124300,10341,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail, RR=4","Outcome control",4,139099,4.02044017197362,3.7312092281037,1.01015943739101,1.01391039840669,"Diclofenac",1.74700097445823,0.0577333899239055,5.1280942231785,6.43045195079457,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39055875857954,0.278850731404896,2.85067172907453,8.50478921729268,3.92501891001524e-126
6,1124300,10321,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=1.5","Outcome control",1.5,260134,1.50002871187052,1.57503375207054,1.06984822375643,1.11883801957443,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10342,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=1.5","Outcome control",1.5,141216,1.50011036957641,1.33521172591319,1.03646727923875,1.06019635455073,"Diclofenac",0.414179011587138,0.762814745662706,0.398508904297255,7.92603903973096,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.305004358785968,0.647775275764824,0.400461941173814,5.07382959106319,0.607822255970398
6,1124300,10322,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=2","Outcome control",2,260134,2.00008937320302,1.92504207048664,1.06979246499316,1.11868559888873,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10302,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder, RR=4","Outcome control",4,436677,4.01203719944666,3.87138351196915,1.00651791999056,1.00947553137235,"Diclofenac",1.5954544651953,0.0476845936126827,4.49412277616857,5.41780453261503,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26712763419295,0.239545319860416,2.58683826444963,6.6156415822022,1.2882530233497e-131
6,1124300,10303,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49623813832008,1.4133692504466,1.01408998468534,1.02006669537418,"Diclofenac",0.502068096538701,0.130655629812505,1.28102868958079,2.13790008059312,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.376600394876938,0.152155992413464,1.11718534189686,2.02841148076774,0.000489072609951608
6,1124300,10345,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.50240811066305,1.44422312937577,1.010085951239,1.01363283149462,"Diclofenac",0.549816195114767,0.0822012558197822,1.47587340940868,2.0369894505137,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.415476111580042,0.129243166754097,1.21691361444558,2.01968535267846,1.35952248051463e-08
6,1124300,10346,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.9968543873519,1.88165716293559,1.01007354174282,1.01361478670383,"Diclofenac",0.830979858027049,0.077308195109186,1.97448254163515,2.67339424011505,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.644474946141325,0.147314087824903,1.49959566929422,2.67154279418447,7.12039611078425e-20
6,1124300,10313,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,1.99661880722243,1.99516504605961,1.02053542508593,1.02683722485109,"Diclofenac",0.915359626019478,0.269768399920708,1.49180816339158,4.29504319626282,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.713188378793882,0.268968848356159,1.27844966685907,3.66924771055657,0.00107809759423954
6,1124300,10327,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=1.5","Outcome control",1.5,443767,1.49719553876945,1.45237202134343,1.01186205971822,1.01532274659164,"Diclofenac",0.950450615794723,0.155529481013585,1.91208764101832,3.51788519988568,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.741786241179547,0.195204404553563,1.51971457771509,3.26646952110089,8.9348857571918e-09
6,1124300,10307,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=2","Outcome control",2,261880,2.00036256928993,1.94644890048408,1.01038612083686,1.01352567924427,"Diclofenac",0.645898155696969,0.0653542372597595,1.67875800585204,2.16893907032304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.493714411949191,0.128851298009619,1.32286851719523,2.19216645740054,1.81014378187572e-15
6,1124300,10328,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy, RR=2","Outcome control",2,443767,1.99387088703874,1.9249889431132,1.01184968245508,1.01530656783815,"Diclofenac",1.39356405744619,0.139007615299617,3.08344292026982,5.31719890492572,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.10268505334206,0.234073162253489,2.13020635563489,5.33222602198123,4.56996000433088e-21
6,1124300,10308,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=4","Outcome control",4,261880,3.97289727463812,3.7820208805227,1.01032553257225,1.01344448770997,"Diclofenac",1.4062465738367,0.0564234364353906,3.65626169188738,4.56134272020907,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.11302158467018,0.206782252914837,2.27018233133733,5.1060784713147,2.84222674039999e-84
6,1124300,10349,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=2","Outcome control",2,195501,2.0027492230197,1.72318653537957,1.01933949860188,1.03308051386783,"Diclofenac",0.669818526429676,0.270132937322929,1.16073055252805,3.34662123374762,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.513217207226924,0.25614357235794,1.05546993540127,2.88074936803263,0.0179070333787823
6,1124300,10350,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=4","Outcome control",4,195501,4.00508608205465,3.31482148741767,1.0192685850917,1.03287469103003,"Diclofenac",1.47843726022324,0.198364063899013,3.01595754078089,6.56327826858517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.17181780544527,0.278619379147608,2.13390569096124,6.3605945481733,7.36601211347329e-13
6,1124300,10330,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis, RR=1.5","Outcome control",1.5,72715,1.50225491847122,1.31753977390197,1.00843631284451,1.01125550370606,"Diclofenac",0.822104750594781,0.0374482828067994,2.11434961274682,2.44866217567464,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.637231740617812,0.134972835648109,1.52397633909238,2.58676154633141,2.60418818953331e-44
6,1124300,10311,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region, RR=4","Outcome control",4,4084966,3.9907319116547,3.74482579932298,1.01036006606153,1.01539449665355,"Diclofenac",1.9023847141887,0.100409865256234,5.52696844890519,8.19266222862706,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.51710686331869,0.351499252797008,3.09808207954234,12.2881451436781,3.06330134474043e-66
6,1124300,10353,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=4","Outcome control",4,373478,3.97765989688864,3.97155187940306,1.00910322782302,1.01182018807177,"Diclofenac",1.5961816700191,0.0635756147675029,4.36180788035428,5.59625964111447,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26772562207432,0.24286031893668,2.57317311187542,6.66676522139079,5.44567756433671e-93
6,1124300,10336,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49648964867094,1.43475623299507,1.00652993223102,1.00938699279552,"Diclofenac",0.525745090718573,0.0521076540884628,1.52772398047088,1.87392897716185,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.395867873889569,0.11621439503406,1.22267435506431,1.92821096412821,1.08766144888648e-13
6,1124300,10319,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=2","Outcome control",2,198075,1.9949792386268,1.83779488480867,1.02228405447683,1.03392899620113,"Diclofenac",1.01196995790671,0.200664945956842,1.88014635453822,4.12861399426969,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.791891891829788,0.22783831377558,1.50846671838031,3.68475300127229,1.42306483106708e-06
6,1124300,10320,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum, RR=4","Outcome control",4,198075,4.01928272816482,3.4329283855668,1.02219450979081,1.03374530687468,"Diclofenac",1.71891736589056,0.179814386979466,3.97052517050672,8.03460481858409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36768410104865,0.317781197426437,2.57944680600108,8.96433891342289,4.57347166148799e-20
6,1124300,10361,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99325162071653,1.85112878791437,1.00681761010951,1.00975328841044,"Diclofenac",0.7939427264478,0.0509717300745657,2.00230183239111,2.44514137981641,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.614308559128292,0.135726707859847,1.48466191462307,2.52748818596845,8.89042734284695e-31
6,1124300,10323,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup, RR=4","Outcome control",4,260134,4.00049785219355,4.60057299817686,1.06955380267751,1.11799849027001,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,10344,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=4","Outcome control",4,141216,4.02108785408364,3.07666943019633,1.03631354080329,1.05979353659419,"Diclofenac",2.44471424157184,0.537709914018244,4.53408810647651,37.3154748333893,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.9588307595009,NA,2.82855832115434,NA,7.09281192376174e-06
6,1124300,10365,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=4","Outcome control",4,436070,4.02412382443618,3.65055250222373,1.00468760626423,1.00631135901498,"Diclofenac",2.14832009246883,0.0396684397632273,7.93570193910394,9.27079593913096,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.71742434469809,NA,3.70874314922371,NA,1.2779617575474e-286
6,1124300,10306,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis, RR=1.5","Outcome control",1.5,261880,1.49690169237647,1.46852806208408,1.01040245378015,1.01354771677662,"Diclofenac",0.32607210956129,0.0707204130765524,1.20615787915688,1.59147128738291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.233238058657912,0.111430619206506,1.04123220592351,1.61156350042633,0.000247825515372377
6,1124300,10347,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98735230582593,3.6614076451928,1.01002527769148,1.01354497102237,"Diclofenac",1.58925557604401,0.0672006458812464,4.30171115469454,5.59814099709196,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26209188069882,0.242252802734153,2.5573101573134,6.60990659779747,1.68705831235873e-85
6,1124300,10348,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries, RR=1.5","Outcome control",1.5,195501,1.50044977397466,1.36164595155891,1.01935833864942,1.03313667512304,"Diclofenac",0.384535691640828,0.335170511358424,0.747888462743607,2.78248061052743,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.280860407470071,0.295907763144122,0.764556377493236,2.43873047056297,0.283512475557794
6,1124300,10369,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=1.5","Outcome control",1.5,433527,1.4981223883951,1.40493553647077,1.01371855666586,1.02049408519336,"Diclofenac",0.586718414122826,0.156054291174268,1.32701426319878,2.44648691778845,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.445533854188162,0.172176484668561,1.15554981370431,2.26935506265862,0.000490066991718547
6,1124300,10371,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=4","Outcome control",4,433527,4.02131833513017,3.4936018316888,1.01364740755107,1.02036110194013,"Diclofenac",1.66827780128905,0.129274281017263,4.14040214365977,6.87257455365921,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32641162057072,0.280423999192054,2.59943209486461,7.80320755176672,1.465667240679e-33
6,1124300,10351,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50195926106378,1.48736347586227,1.00915525496335,1.01189063894183,"Diclofenac",0.542837248465758,0.0816537089431738,1.46727684994315,2.02078259015847,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.409791811549682,0.128568843109358,1.2112392522025,2.00496101149184,1.77463990167213e-08
6,1124300,72715,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Exostosis","Outcome control",1,72715,1,1,1.0084821456931,1.01131945348291,"Diclofenac",0.0976408070637817,0.044092371590935,1.01118088970805,1.2019650585048,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.047193369633251,0.0896326742384954,0.896385218957228,1.27375419651207,0.22177931026019
6,1124300,10352,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia, RR=2","Outcome control",2,373478,2.00917721706592,2.03874995795757,1.00914446177867,1.0118760662474,"Diclofenac",0.864414488518389,0.0708658452401098,2.06810380786935,2.73032639709165,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.671710690230947,0.147793081221034,1.54297321704641,2.75398636201701,3.7133468865637e-24
6,1124300,78804,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00821884551256,1.011246446532,"Diclofenac",-0.18386650263253,0.108089127149007,0.672456387974348,1.0272481958205,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.182118606188366,0.112330570898656,0.677935380917066,1.05298021382178,0.0769986195540332
6,1124300,133141,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis","Outcome control",1,133141,1,1,1.01281470251533,1.01769281883779,"Diclofenac",0.0834558482883741,0.100809656304746,0.891669857888163,1.32380115595999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0356426630336655,0.116277557919918,0.840842728304163,1.32637414074067,0.575981406082447
6,1124300,10355,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=2","Outcome control",2,440690,1.99043151275221,1.87370274576594,1.04179426982221,1.06672830973266,"Diclofenac",0.807794208379462,0.286990180766935,1.30237987392537,4.0115355553164,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.62559490452774,0.275505241616568,1.14753222876437,3.37898189920547,0.00678857989413307
6,1124300,134898,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.01009851817955,1.01365103979063,"Diclofenac",0.0227100028010898,0.0934033307512164,0.851450881939621,1.22791899665828,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0138602669821528,0.109735982616135,0.809424677666916,1.24448972853749,0.995136856262027
6,1124300,10356,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=4","Outcome control",4,440690,3.99190230710621,3.33249027690758,1.04161404400648,1.06629766344085,"Diclofenac",1.2013387617472,0.236890722356898,2.12281284379287,5.37273231731103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.94612927917349,0.268362979651814,1.66194338800265,4.75858893982314,9.74574567548015e-07
6,1124300,139099,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Ingrowing nail","Outcome control",1,139099,1,1,1.01027105043267,1.01408222877727,"Diclofenac",0.107444068595119,0.0793061543566604,0.952576887416662,1.29990340653437,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0551671369545471,0.10528908042585,0.876515641850119,1.32435411766707,0.344960292406065
6,1124300,10357,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=1.5","Outcome control",1.5,133141,1.50034824115756,1.38452993166795,1.01279038616144,1.01765482508537,"Diclofenac",0.634910810919244,0.0884032437715128,1.58786036565788,2.24548554415655,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.484784577640672,0.137463969633492,1.28861064781415,2.20872070207707,4.85190818109145e-10
6,1124300,140641,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris","Outcome control",1,140641,1,1,1.00683144427652,1.00977710309367,"Diclofenac",0.0552442258037957,0.0604409788600252,0.938525944549399,1.18943630887118,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0126466592295725,0.0940593567968021,0.857635944814093,1.24002349520107,0.655737496601369
6,1124300,141216,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection","Outcome control",1,141216,1,1,1.03649781295198,1.06027656222211,"Diclofenac",-0.00191654770528219,0.736894518090837,0.257486663064538,4.62643261494135,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0338966446212311,0.615078863605616,0.297645915910739,3.31750880075411,0.974064247572185
6,1124300,10359,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=4","Outcome control",4,133141,4.00163892925041,3.26348711889177,1.01267390256996,1.01747367263439,"Diclofenac",1.8020444061675,0.0740170454035777,5.25460438419732,7.02339138227229,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.43541721840306,0.299989876653175,2.93728459930754,9.52027996843608,1.23716717202235e-95
6,1124300,195501,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Polycystic ovaries","Outcome control",1,195501,1,1,1.01937614644596,1.033188800114,"Diclofenac",-0.185727606690288,0.320971640935663,0.431556426191186,1.51866051030069,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.183606579087562,0.27294712145775,0.494692002821773,1.44211837867805,0.521125256075919
6,1124300,198075,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Condyloma acuminatum","Outcome control",1,198075,1,1,1.02232684698548,1.03401619111564,"Diclofenac",0.174733462989179,0.240623770678818,0.741247661654366,1.9037152382406,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.109986953218136,0.216977355005873,0.745982612206971,1.74627092696178,0.532403563043609
6,1124300,260134,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Croup","Outcome control",1,260134,1,1,1.06990660088232,1.11900404701374,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,261880,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Atelectasis","Outcome control",1,261880,1,1,1.01041853535633,1.0135693371037,"Diclofenac",-0.169399505823981,0.0811587413699969,0.719401228210733,0.988862862050246,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.170304401809042,0.0962037214654544,0.708124995401043,1.03249376263942,0.0374375331431706
6,1124300,10363,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=1.5","Outcome control",1.5,436070,1.50271155371245,1.44667868903877,1.00471480310564,1.00634993198199,"Diclofenac",0.821385286542293,0.0455723897403229,2.08056957630357,2.48750991544093,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.636656338300075,0.136684627812294,1.5179713295177,2.59391595937952,5.44370209854365e-37
6,1124300,10343,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Molluscum contagiosum infection, RR=2","Outcome control",2,141216,2.00992683772584,1.70291932881447,1.03643611323062,1.06011256291456,"Diclofenac",0.882862556935529,0.508970810698669,0.966362088836215,7.10580627081076,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.686737426171031,0.455859788850843,0.871772628654237,5.20547470827034,0.0919667836418082
6,1124300,373478,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Presbyopia","Outcome control",1,373478,1,1,1.00916634789989,1.01190576083148,"Diclofenac",0.0767963624961227,0.0924587999700645,0.900621190669242,1.29402988918535,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0302139419228445,0.111198962645052,0.844480130017509,1.30585480861751,0.592115819171386
6,1124300,10364,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency, RR=2","Outcome control",2,436070,2.00782668831481,1.88350324453709,1.00470889832021,1.00634154203669,"Diclofenac",1.16891911204315,0.0430861365166171,2.96045339197671,3.50516284852189,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.919722215939326,0.171467566969207,1.93909169339108,3.79756539433977,1.56741929612726e-78
6,1124300,381581,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Chalazion","Outcome control",1,381581,1,1,1.01657719223798,1.02275317305295,"Diclofenac",0.30563743898246,0.170099635205759,0.972739750020173,1.89484987409774,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.216599498965885,0.169339476164512,0.914125844355318,1.77537473183324,0.106238119997968
6,1124300,433527,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis","Outcome control",1,433527,1,1,1.01373299519777,1.0205211046453,"Diclofenac",-0.0595408277734216,0.183453964551412,0.65730163164142,1.34920302369775,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0808301008358642,0.168428546804098,0.673829878015642,1.30401786683895,0.665019198613716
6,1124300,433753,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Alcohol abuse","Outcome control",1,433753,1,1,1.0141025049371,1.02008805048048,"Diclofenac",-0.0392688819123665,0.153584044801844,0.710626014005852,1.29748711486149,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0643189598812462,0.147236822760291,0.714289677227543,1.2721279520567,0.700655716673913
6,1124300,436070,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Vitamin D deficiency","Outcome control",1,436070,1,1,1.00472098244939,1.0063587685732,"Diclofenac",-0.0691729467503185,0.0590082419844838,0.830973411388152,1.04723208877968,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0886754001858028,0.088317029694454,0.781715516143992,1.10509576914499,0.21269195190379
6,1124300,440083,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Acute stress disorder","Outcome control",1,440083,1,1,1.01391417575098,1.01963359918807,"Diclofenac",0.0927375725400915,0.130001818596291,0.850074688631111,1.41505259549653,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0432069544249448,0.134914560369388,0.817112059603245,1.38662997505418,0.606154065724068
6,1124300,440638,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease","Outcome control",1,440638,1,1,1.02426385861014,1.0334173600814,"Diclofenac",-0.249889001768211,0.171158197142291,0.554244672718323,1.08413101893398,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.235860247793071,0.155366849029433,0.58997509980542,1.08475256499138,0.12347672478211
6,1124300,440690,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia","Outcome control",1,440690,1,1,1.04188334308322,1.06694126103655,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,441788,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00653640080233,1.00939833056157,"Diclofenac",0.043529436699711,0.0588378761847535,0.930505123748864,1.17188380064224,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00310124555962221,0.0928555064802082,0.851275238619233,1.22503219326639,0.769189769873937
6,1124300,443767,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Diabetic oculopathy","Outcome control",1,443767,1,1,1.01187448793879,1.01533887433785,"Diclofenac",0.0764019221398488,0.190785997124319,0.741489382814412,1.56638893720064,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0299112821590118,0.17712061729143,0.742275893471786,1.48626428554743,0.781293083162406
6,1124300,4084966,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Candida infection of genital region","Outcome control",1,4084966,1,1,1.01043474307625,1.01553918665776,"Diclofenac",0.0551124079202547,0.135834879789527,0.809383607489179,1.37847890024327,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.012554790637954,0.137605515951471,0.787607512072896,1.35073422684702,0.81681229571482
6,1124300,10354,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49684426782667,1.37961094018387,1.04183906806884,1.06683718501917,"Diclofenac",0.214909055389754,0.339216627250171,0.636033824331055,2.40416153960195,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.142703259064491,0.29472836141337,0.663494751887461,2.10660914010196,0.572850082560284
6,1124300,10358,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Tinea pedis, RR=2","Outcome control",2,133141,2.00861300871272,1.76312766735123,1.01276580151807,1.01761621542855,"Diclofenac",1.09676800312829,0.0879713524491787,2.52497493882365,3.56467363397354,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.860957320581698,0.175982629468451,1.79935217402066,3.58681968451789,6.11494115555372e-28
6,1124300,10360,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49599455880216,1.43092779603839,1.0068244294205,1.00976500625955,"Diclofenac",0.490083845827292,0.0538272615649902,1.46923003940482,1.81436849214173,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.366823628815278,0.11445727677206,1.19001304510156,1.86382075436297,1.28036305219418e-11
6,1124300,10362,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Verruca vulgaris, RR=4","Outcome control",4,140641,3.98051475433887,3.57675637142014,1.00679106408995,1.00970764407703,"Diclofenac",1.54703461740154,0.0450939076718908,4.30287756881796,5.13484095853168,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.22769067494597,0.229279686280247,2.50652295217684,6.15741083217122,3.06916803137766e-131
6,1124300,10366,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=1.5","Outcome control",1.5,440638,1.50048079419154,1.33752265217776,1.02421876326128,1.03334736793094,"Diclofenac",0.230033778545147,0.145356390043183,0.947046385938603,1.67427355685464,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.155022726407863,0.149794959986172,0.890851031737278,1.60256808487797,0.170396198460583
6,1124300,10367,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=2","Outcome control",2,440638,2.00128004681694,1.66241323916563,1.02417453608813,1.03328027132416,"Diclofenac",0.401388937737761,0.137982526045522,1.14122299621776,1.96007365997021,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.294593451310698,0.151872223624601,1.02580344503638,1.86042383764763,0.00872868029637624
6,1124300,10368,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Lyme disease, RR=4","Outcome control",4,440638,4.01277251898658,3.16172331713275,1.02400134796068,1.0330150769355,"Diclofenac",1.31273893226034,0.119621428404832,2.95393859676351,4.72112340271301,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.03683323605139,0.21413137245489,2.04565076271303,4.73553882419407,3.53664692990689e-24
6,1124300,10370,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Endometriosis, RR=2","Outcome control",2,433527,2.00787966768444,1.84600473701678,1.01370415518599,1.02046694729118,"Diclofenac",0.851499295503856,0.147891840445527,1.76172826606496,3.14565035321465,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.661193671809945,0.18335110635278,1.42412545555962,2.92203718721285,7.37788345078493e-08
6,1124300,81250,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.02057269089756,1.02688785755685,"Diclofenac",-0.262297923407403,0.290336041377463,0.43015848362822,1.34244797914014,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.245971330112727,0.247514956412818,0.487768715434696,1.28701665715298,0.332673835740758
6,1124300,436373,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Developmental speech disorder","Outcome control",1,436373,1,1,1.08880464320312,1.13692317478941,"Diclofenac",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1124300,436677,1118084,"Diclofenac","Celecoxib",36516812,"Arthralgia","Adjustment disorder","Outcome control",1,436677,1,1,1.00654955445599,1.00952819392579,"Diclofenac",0.04883626333166,0.0647775808683057,0.924471319020687,1.19171113056665,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.00743499181943331,0.0957326924342364,0.850270663293444,1.23746471985637,0.731436994612859
6,1797513,10388,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00534230399077,1.93526810080367,1.00499090953997,1.00382105589748,"Ciprofloxacin",1.26542568780373,0.266713218325683,2.12498296902708,6.04517475102453,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.714340896084431,0.247170524932831,1.27515829652368,3.36006721707393,9.8899624196206e-06
6,1797513,10384,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=1.5","Outcome control",1.5,72715,1.49970446594549,1.50991252325003,1.0052974980394,1.00405899513384,"Ciprofloxacin",0.766606896847147,0.243238541245993,1.33434927303985,3.46225911036621,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.406807651705517,0.233414682348012,0.962419532869477,2.40287016088001,0.00337555194117773
6,1797513,10394,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=2","Outcome control",2,381549,2.00922280193992,2.00371178886907,1.00742536956958,1.00536249039499,"Ciprofloxacin",1.18976023511194,0.280271190478566,1.90078424121272,5.70252716022787,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.667718749899799,0.252191995784622,1.20497317403896,3.23824579647097,6.51304503963797e-05
6,1797513,10392,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=4","Outcome control",4,441788,3.98018875150485,3.75143908613818,1.00357435585827,1.00241243436994,"Ciprofloxacin",2.17092636171072,0.117002269524292,6.98702994906959,11.0529353443989,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27261531859835,0.208020985257515,2.41006047305692,5.44707691004495,1.17579557744331e-38
6,1797513,10395,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=4","Outcome control",4,381549,4.02320841733364,4.07848731212821,1.00739924156363,1.00534476373184,"Ciprofloxacin",2.21795829099432,0.252689073610591,5.69236681521831,15.3275074892997,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.301626074805,0.250244111076027,2.28413817253548,6.09170296675394,1.13572588872605e-15
6,1797513,10396,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50444942521476,1.4844168030368,1.00279051515655,1.00208342035048,"Ciprofloxacin",0.651006493074967,0.113668181504453,1.53447546798564,2.39590179379342,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.335538251684513,0.190786094487947,0.974142892744368,2.05786794549007,4.39924660312761e-05
6,1797513,10398,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02945084939404,3.90328275648866,1.00278238054813,1.00207733301135,"Ciprofloxacin",2.05545975033524,0.0885754964739781,6.5798738554853,9.31126670206711,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.20145025670092,0.201242489089183,2.27397396289712,5.00473771549472,2.30077794778614e-43
6,1797513,10399,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=1.5","Outcome control",1.5,134898,1.49779017147192,1.48282801062738,1.00615777353475,1.00470610193928,"Ciprofloxacin",0.316487017377681,0.260714916297114,0.820424538868602,2.27971480582268,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.129304653219458,0.236825001209261,0.723855234211964,1.83156920168747,0.226756039312024
6,1797513,10400,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=2","Outcome control",2,134898,1.99770287393548,2.04198002179135,1.00615302524153,1.00470223610241,"Ciprofloxacin",0.750394832243638,0.239846451213434,1.32454002878761,3.39141101524701,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.396810610077755,0.231921115569267,0.955640825489157,2.3720176580016,0.00368401342774673
6,1797513,10402,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=1.5","Outcome control",1.5,433736,1.50307258190651,1.45011154425065,1.00272467007403,1.0020098207631,"Ciprofloxacin",1.34883820436362,0.107745212679594,3.12273322805613,4.76387839656723,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.765783044313777,0.196899265161362,1.48168231743856,3.20595199244142,2.61764687650523e-17
6,1797513,10401,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter, RR=4","Outcome control",4,134898,3.98667116554864,4.04125031605791,1.00613400139016,1.00468690315922,"Ciprofloxacin",1.97286713840769,0.190604249837463,4.97872735249448,10.5100215638544,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.1504972327464,0.225772225823274,2.05934994238029,4.9898269694243,8.95709948548704e-19
6,1797513,10404,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=4","Outcome control",4,433736,4.02589544682144,3.71358526058612,1.00270918480019,1.00199871248004,"Ciprofloxacin",2.76379645948114,0.0805450572195561,13.575575394871,18.6156583595168,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.63813899317418,0.208453250855379,3.47455705137178,7.86630723563822,4.6013292395255e-81
6,1797513,10405,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.49804179767945,1.46082449745793,1.01391050536321,1.00930728788757,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10385,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=2","Outcome control",2,72715,2.00267967925348,2.02744319815407,1.00529329124409,1.00405558828722,"Ciprofloxacin",1.3823931628481,0.20568369035704,2.67809760176701,5.99767529302606,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.786472113527412,0.224963122021691,1.43175881588791,3.45818146835125,3.48522297786045e-09
6,1797513,10406,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,2.0014907235821,1.95106512066126,1.01390173420982,1.0093024630443,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10386,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis, RR=4","Outcome control",4,72715,4.02311543885556,4.08888021144464,1.00527633923701,1.00404195231439,"Ciprofloxacin",2.34736054869809,0.172738971453219,7.51798621209712,14.7969730574106,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38140744887166,0.224229213695649,2.60385968591925,6.27113403482943,2.75788047855248e-29
6,1797513,10393,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura, RR=1.5","Outcome control",1.5,381549,1.49980075600509,1.50424415909964,1.00743192606562,1.00536694103563,"Ciprofloxacin",0.812484233587554,0.320775101230075,1.20336527989712,4.23141868270653,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.43513302038229,0.267067754025192,0.926917188823072,2.64057133572351,0.0139497075837538
6,1797513,10407,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,3.97283945825626,3.85353089096637,1.01386893658391,1.00928428349528,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10387,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.49540243108765,1.46395748015495,1.00499406640083,1.0038235605109,"Ciprofloxacin",1.19909588010006,0.274812073169818,1.95450978460208,5.73956224961207,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.673463838053992,0.249969702595107,1.2172348750116,3.24282550458412,4.30030325160397e-05
6,1797513,10408,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=1.5","Outcome control",1.5,321596,1.49898804000987,1.45114019162455,1.00763439256406,1.00592525607733,"Ciprofloxacin",1.50494019515075,0.348078780480251,2.34459917550072,9.17569561159623,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.862027431226857,0.28493982361389,1.37318671160383,4.19577341856479,3.12295570192738e-05
6,1797513,10409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=2","Outcome control",2,321596,1.9902529103807,1.90691057169606,1.00762483615268,1.0059173502259,"Ciprofloxacin",2.02184195407162,0.320245447405361,4.09581547463479,14.3723313299859,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.18071512414503,0.276493840777596,1.92183014511293,5.68092386817726,2.10830024687153e-09
6,1797513,10403,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity, RR=2","Outcome control",2,433736,2.00871678141824,1.903563380405,1.00272151674968,1.00200755185501,"Ciprofloxacin",1.92961285674378,0.0953574144393422,5.72319732640012,8.31716805004844,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.12386577236546,0.200969872063031,2.10485501886449,4.6275798115995,1.36150043764447e-36
6,1797513,10410,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency, RR=4","Outcome control",4,321596,3.97969207819174,3.76762370784153,1.00758630304266,1.0058854723396,"Ciprofloxacin",3.01957995556195,0.281628967979893,12.1699680372058,36.70586491071,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.7958541045912,0.26936679558712,3.61214673761497,10.3833202416142,2.92235754052049e-23
6,1797513,10411,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=1.5","Outcome control",1.5,373478,1.50333153247416,1.51614825958701,1.00584919989506,1.00460455569553,"Ciprofloxacin",0.574223321817671,0.293884212687857,0.998136138228538,3.15863301578405,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.288207822735957,0.253152368740952,0.822113438710062,2.21768123329008,0.0570281693089136
6,1797513,10391,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=2","Outcome control",2,441788,1.99007785574838,1.90979093860836,1.00358415234953,1.00241805083734,"Ciprofloxacin",1.12200019239168,0.130789630874055,2.37809900187643,3.97087852815005,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.625929757701004,0.199750003918782,1.28062282636502,2.80205245941264,1.20827009386129e-10
6,1797513,10412,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=2","Outcome control",2,373478,1.99807515619899,2.02255144950593,1.00584611255527,1.00460196592476,"Ciprofloxacin",0.92409619561322,0.269504789765856,1.48406768835298,4.26834480672922,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.503918016798216,0.245445531899172,1.03609555493526,2.71173372010267,0.00124371792108517
6,1797513,10414,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=1.5","Outcome control",1.5,372409,1.50013569749037,1.54442880512353,1.00429241581707,1.00324847541509,"Ciprofloxacin",1.50096426565038,0.215213666138841,2.95578475650976,6.87152632375562,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.859575675914912,0.229462053854705,1.52713346086123,3.75416971352529,6.04315892850276e-10
6,1797513,10415,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=2","Outcome control",2,372409,1.99881739884126,2.07757802522115,1.0042890014755,1.00324576466101,"Ciprofloxacin",2.17467904157757,0.19309846348137,6.07450281727194,12.9491767265618,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27492806822723,0.228663764875167,2.31988340667273,5.68517788027977,4.98266784343516e-22
6,1797513,10416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica, RR=4","Outcome control",4,372409,3.97232626669781,4.17600756839872,1.00427559944391,1.00323515970362,"Ciprofloxacin",2.86596281621979,0.173367042175202,12.6455486713102,24.9504432381615,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.70114461930978,0.230153572924271,3.54703315869702,8.74338095494395,2.00446911726783e-42
6,1797513,10417,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50162964920773,1.5613102092256,1.00355443741597,1.00279364593553,"Ciprofloxacin",0.857138022942054,0.186682562968167,1.63700842847427,3.40298384091819,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.462628699924693,0.213490828487976,1.05834408101096,2.4438487878815,6.86841025516445e-05
6,1797513,10397,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00578443901543,1.96320927027287,1.00278890383177,1.00208220617634,"Ciprofloxacin",1.09678852457739,0.103886342722883,2.44573380959983,3.67507001788279,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.610382025488771,0.193371846898855,1.27668959306659,2.72447073474778,2.12393535019251e-12
6,1797513,10418,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.00471341034532,2.09737153633331,1.00355263591398,1.00279205079906,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10419,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02838156054672,4.28177145161632,1.00354544722848,1.00278568840335,"Ciprofloxacin",2.39532795371568,0.14246057460057,8.35763415563766,14.6086027140307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41097830704558,0.216505525941942,2.7231575734812,6.36286117338494,3.56971698851724e-38
6,1797513,10420,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=1.5","Outcome control",1.5,313459,1.49556106270353,1.48428240885638,1.00357057556068,1.00267216520805,"Ciprofloxacin",1.08749639938745,0.144965879902756,2.23417313790106,3.9437301189291,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.604657622809531,0.203093266110279,1.24541742172752,2.76096905883055,3.69973201944014e-09
6,1797513,10421,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=2","Outcome control",2,313459,1.99053578783069,1.97325441361277,1.00356777264959,1.00267002366975,"Ciprofloxacin",1.45588072007936,0.132918797565748,3.30913936867182,5.57181168291535,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.83177994184771,0.203804376576762,1.56174453351638,3.4718998909128,1.87398949105148e-16
6,1797513,10422,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea, RR=4","Outcome control",4,313459,3.97236536180231,3.92947069140624,1.00355686497653,1.00266164707512,"Ciprofloxacin",2.30836426465641,0.110382760321467,8.12789362466391,12.5283524611162,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35734981261235,0.208226272373946,2.62279443738663,5.93265785515718,1.03245830611268e-45
6,1797513,10423,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=1.5","Outcome control",1.5,440690,1.49352537995245,1.43478993576185,1.02182554154271,1.01407116208877,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=2","Outcome control",2,440690,1.99137543278733,1.88408685767917,1.02181584857065,1.01406634736499,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10425,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia, RR=4","Outcome control",4,440690,4.00023513006215,3.60159628689115,1.02177465678098,1.01404628897504,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10426,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.49735260708344,1.45567912899711,1.00375923905759,1.00251961399339,"Ciprofloxacin",0.782339294042154,0.14943528840442,1.63189677960299,2.93151271075156,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.416517141224125,0.201260544070433,1.035049135702,2.27817739578663,2.52056524005306e-05
6,1797513,10427,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=2","Outcome control",2,140641,1.99161997011874,1.91766263852713,1.00375665177387,1.00251815711041,"Ciprofloxacin",1.20685310748328,0.1350293067807,2.56987930805795,4.36301831640514,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.678245104759884,0.201706618761595,1.34442546984636,2.96430373909547,1.09350553076094e-11
6,1797513,10428,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris, RR=4","Outcome control",4,140641,3.97598690632373,3.7319726193374,1.00374627787327,1.00251230892576,"Ciprofloxacin",2.16091289278329,0.11493494319381,6.94877218725472,10.9036945213185,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.26644012216173,0.207466361734176,2.39778755934997,5.40756909248955,6.07362237569288e-39
6,1797513,10429,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=1.5","Outcome control",1.5,378424,1.49805537264634,1.46927327255866,1.00654638475344,1.00472291713202,"Ciprofloxacin",1.1300734491401,0.260513363892293,1.8595897818341,5.16316383255564,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.630905949341122,0.243474387427917,1.18135000561645,3.06810441996024,5.44384355422466e-05
6,1797513,10432,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=1.5","Outcome control",1.5,136661,1.49520854397856,1.48743438430948,1.00534183524083,1.00408253961107,"Ciprofloxacin",0.10706051551545,0.237809808411801,0.694300828922026,1.76358272295215,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.000215734414325841,0.225735589591721,0.649954864164429,1.57462144814839,0.603942290227537
6,1797513,10372,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.49962569404273,1.43174295899323,1.00835939939039,1.00590661328785,"Ciprofloxacin",0.695757026247311,0.360226115609929,0.991522259130922,4.06960744707891,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.363160852785181,0.284783241221947,0.832978263514521,2.543604223916,0.0558838616539361
6,1797513,10433,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=2","Outcome control",2,136661,1.99629127627744,1.97302260452136,1.00533782744534,1.00407932799907,"Ciprofloxacin",0.757961875506735,0.204997592499257,1.43023969283885,3.19445931180747,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.401485795654051,0.21889046549506,0.984943695805295,2.32301069281208,0.000943965156083439
6,1797513,10413,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia, RR=4","Outcome control",4,373478,3.97418630030476,4.1324573868657,1.00583349460089,1.00459157900341,"Ciprofloxacin",1.71409767902394,0.230437108925344,3.56321338826831,8.79303247155003,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.990973403917777,0.237033185029716,1.71656815196055,4.3469743386256,2.23724365192452e-11
6,1797513,10373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=2","Outcome control",2,433753,2.00100152800304,1.85280460847001,1.00835201214091,1.0059017051478,"Ciprofloxacin",1.45297384456321,0.264752256269959,2.5534335003308,7.20841215176651,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.82998748881184,0.248004818228025,1.42959229981857,3.77934351791089,3.59087251534179e-07
6,1797513,10434,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter, RR=4","Outcome control",4,136661,3.99899493618824,3.88294230076535,1.00532218322477,1.00406684084167,"Ciprofloxacin",1.78693170365419,0.1606919867296,4.38465038380971,8.2318510619957,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.03588089688083,0.214745910964878,1.87579907125316,4.35281709095198,2.24363864506405e-19
6,1797513,10374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse, RR=4","Outcome control",4,433753,4.00328329022492,3.56847367763857,1.00832205689284,1.00588227015395,"Ciprofloxacin",2.45284650387142,0.250492701095851,7.23345269418269,19.3101297998945,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.44644319871925,0.251679676427011,2.63381546105203,7.06391721108079,5.0876913498926e-19
6,1797513,10435,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=1.5","Outcome control",1.5,437409,1.49770150318745,1.46608787059259,1.00785981580787,1.00500061731255,"Ciprofloxacin",0.267864632712274,0.333840183033211,0.672025928424082,2.48723366615467,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0993270334181953,0.269202723222451,0.659244123055713,1.89381614123908,0.39955093941889
6,1797513,10375,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=1.5","Outcome control",1.5,81250,1.50058398018099,1.3992981938766,1.01301786329939,1.01028539820565,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10436,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=2","Outcome control",2,437409,1.99784519791065,1.97625645981853,1.00785466251117,1.00499814848669,"Ciprofloxacin",1.26329190029021,0.272414100731476,2.07733182495326,6.04316539334864,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.713042819663147,0.249512671978959,1.26764589708137,3.37108030261234,1.45346339367793e-05
6,1797513,10376,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=2","Outcome control",2,81250,2.00339699185288,1.85592162916624,1.01300785795286,1.0102767973785,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10377,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast, RR=4","Outcome control",4,81250,3.99984810442086,3.45340803863672,1.01296829972044,1.01024290304727,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10378,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=1.5","Outcome control",1.5,436373,1.4992375251148,1.43762623979163,1.01709665763749,1.00918997638251,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10439,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=2","Outcome control",2,73302,1.99102966536795,1.96709613661221,1.00656803719657,1.00450012366149,"Ciprofloxacin",1.26871315980866,0.199841596552075,2.41041793749362,5.27598195278473,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.716383852119016,0.221851933084906,1.34275216511624,3.20388763941809,2.89023197557456e-08
6,1797513,10440,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=4","Outcome control",4,73302,3.9929081196959,3.95610894528489,1.00654139796927,1.00448464920645,"Ciprofloxacin",2.13464152029463,0.168566614242113,6.11556727767326,11.8414551001708,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25025805163422,0.220714583700958,2.29868877338433,5.4604113823531,2.5727450412906e-25
6,1797513,10380,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=4","Outcome control",4,436373,3.97222328713556,3.89316637277512,1.01703404897776,1.00915937885436,"Ciprofloxacin",2.27504372693406,0.498014702070847,3.86050532228133,27.1935509313378,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33683040245043,0.364843274335122,1.89023672921893,7.89998949859232,6.86505539930804e-06
6,1797513,10441,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=1.5","Outcome control",1.5,4242416,1.50399493084709,1.53074505482386,1.01239053945219,1.00998269366279,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10381,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=1.5","Outcome control",1.5,192367,1.50018863176125,1.46816038876128,1.00672902441493,1.00486663027099,"Ciprofloxacin",1.46744463641973,0.893391205025193,0.790248370705845,26.222588145012,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.83889571835032,0.582305404683162,0.749165504617885,7.34338486748817,0.096414789778958
6,1797513,10382,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=2","Outcome control",2,192367,1.9936958254546,1.91316452790268,1.00672510277736,1.00486401163672,"Ciprofloxacin",1.86331967716644,0.809290384456646,1.51898233348647,36.2485944344683,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.08298135406022,0.535063962078839,1.04974582778338,8.5502477256398,0.0206010651659425
6,1797513,10443,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=4","Outcome control",4,4242416,3.99419868491239,4.26804211468817,1.01234451404777,1.00993904156913,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10383,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix, RR=4","Outcome control",4,192367,3.99776066547747,3.65635765314038,1.00670962856033,1.00485350563159,"Ciprofloxacin",2.67006006976893,0.389296827539341,7.05415511467463,32.447790248828,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.58037181498616,0.313517084227378,2.66868761995865,9.12074245867067,3.58885738811576e-11
6,1797513,10444,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=1.5","Outcome control",1.5,375519,1.50002547490984,1.47442895673679,1.01974358964841,1.01468571124381,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10445,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=2","Outcome control",2,375519,2.00637738651258,1.83964280849559,1.01972831332268,1.01467425640797,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10446,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome, RR=4","Outcome control",4,375519,3.97953976718972,3.52589105432318,1.01966652122413,1.01462759148366,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,72715,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Exostosis","Outcome control",1,72715,1,1,1.0053017074269,1.00406240430923,"Ciprofloxacin",-0.126483519771279,0.305654810049744,0.479568576796046,1.58927265393533,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.143801968553082,0.253286653945111,0.53304478837165,1.4386650159929,0.773474919848406
6,1797513,73302,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine","Outcome control",1,73302,1,1,1.00658143786028,1.00450790131862,"Ciprofloxacin",-0.0734380459624935,0.280921535059645,0.528783185809061,1.59044745449913,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.111097711627884,0.242522527939926,0.56255141809561,1.45557076386079,0.891680825135112
6,1797513,78804,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00499704556788,1.00382596791042,"Ciprofloxacin",0.403604084004219,0.335553500700532,0.769316765362646,2.86650373622093,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.183015114252986,0.270963316698636,0.71445976046143,2.06664822935866,0.222986399350394
6,1797513,10389,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,3.97513676952442,3.80197253263383,1.00497914568723,1.0038115635776,"Ciprofloxacin",2.3169415053471,0.229406968020683,6.55486865228156,16.1104296961838,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.36265093475739,0.242527757186074,2.46532134784899,6.37901375727918,1.69951519523809e-19
6,1797513,81250,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Carcinoma in situ of breast","Outcome control",1,81250,1,1,1.01302805028391,1.01029408939647,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10430,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=2","Outcome control",2,378424,1.99523604488383,1.94038779918784,1.00654163203175,1.00471967859597,"Ciprofloxacin",1.56369640866267,0.22652477703438,3.0809137252587,7.48714107866496,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.89825232746916,0.234165112151134,1.57296206710264,3.93877941153801,5.82199009981642e-10
6,1797513,10390,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.49597993202193,1.43836164193086,1.00358665796486,1.00241947596991,"Ciprofloxacin",0.794117809425912,0.141646298429756,1.67574862874403,2.9197654709689,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.423778425193302,0.199222115346276,1.0467827193989,2.28566663440024,1.0341717057926e-05
6,1797513,134898,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic uninodular goiter","Outcome control",1,134898,1,1,1.0061626038954,1.00470999301374,"Ciprofloxacin",-0.843410741823636,0.384367458236375,0.194549230914607,0.877764203135907,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.585805500138115,0.287043753142519,0.320370256364208,0.986998198651388,0.044210201349258
6,1797513,10431,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism, RR=4","Outcome control",4,378424,3.97630659543198,3.7988819783483,1.00652286193277,1.00470687436537,"Ciprofloxacin",2.33376322551231,0.202748291053475,7.007226341783,15.5133454133001,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.37301647092871,0.233471148377297,2.5357095242922,6.33230034400823,1.75545767093885e-23
6,1797513,135777,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00279216068663,1.00208465219603,"Ciprofloxacin",-0.177561929719941,0.144878769262394,0.628572602984088,1.10916846062261,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.175294071754495,0.190739577738446,0.583826640582836,1.23310356755331,0.442014112892372
6,1797513,136661,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Non-toxic nodular goiter","Outcome control",1,136661,1,1,1.00534576960355,1.00408567330122,"Ciprofloxacin",-0.617612670276938,0.301778263008435,0.29246715548913,0.95460861100467,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.446588521112449,0.248108847453329,0.397535752365922,1.05137455141477,0.072023537658753
6,1797513,140641,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Verruca vulgaris","Outcome control",1,140641,1,1,1.00376187972384,1.00252110101216,"Ciprofloxacin",-0.109592451500311,0.19282022884642,0.610283390735289,1.29953895730637,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.133388579272261,0.206855872328229,0.5899400976732,1.32727217909286,0.733134445595047
6,1797513,141932,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00355622673455,1.00279523504766,"Ciprofloxacin",0.162581926476008,0.235502160113747,0.737702701814298,1.85695328445327,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0344456771249206,0.225267054845151,0.673259687414213,1.62808824463974,0.464229110227833
6,1797513,192367,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Dysplasia of cervix","Outcome control",1,192367,1,1,1.00673287895459,1.0048692722493,"Ciprofloxacin",0.378658719286564,1.37695658490781,0.096834097140199,21.3876686760077,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.167635412709291,0.867675653314581,0.218498096455232,6.55513089116798,0.766581499722912
6,1797513,313459,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sleep apnea","Outcome control",1,313459,1,1,1.00357335443521,1.00267430256935,"Ciprofloxacin",0.0521503536517937,0.195744615979917,0.712741484085451,1.53521171367585,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0336683711365302,0.209300634472059,0.648834257057802,1.47383144346285,0.716497185690695
6,1797513,10437,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury, RR=4","Outcome control",4,437409,3.97781368206273,3.86554850040962,1.00783357118827,1.00498821909801,"Ciprofloxacin",1.74229509355341,0.232105836855728,3.65443716349518,9.07733141313989,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.00835908715139,0.237921885320604,1.74371147263244,4.43112066797717,1.384783870701e-11
6,1797513,321596,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Peripheral venous insufficiency","Outcome control",1,321596,1,1,1.00764421809833,1.00593342194069,"Ciprofloxacin",-0.0133708218662797,0.901834541627444,0.154028937402586,5.28309264358955,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0740664506052579,0.582089268930779,0.300102442514897,2.93913881454279,0.983928500723871
6,1797513,10438,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Curvature of spine, RR=1.5","Outcome control",1.5,73302,1.49692389550554,1.5030051580875,1.00657469129323,1.00450398819577,"Ciprofloxacin",0.648529477081669,0.225928275881622,1.22710682268571,2.97511231024307,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.334018569723844,0.225647320073061,0.908419116334822,2.2000318028307,0.00812480112548588
6,1797513,372409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Sciatica","Outcome control",1,372409,1,1,1.00429584380416,1.00325119096259,"Ciprofloxacin",0.458031292243482,0.276809128368565,0.914531117068834,2.70669425713862,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.216575514290399,0.244786163681598,0.777788537139102,2.03042175903891,0.105687409610438
6,1797513,10379,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder, RR=2","Outcome control",2,436373,1.99360461472921,1.94102576229949,1.01708404669136,1.00918387864476,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,373478,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Presbyopia","Outcome control",1,373478,1,1,1.00585249335435,1.00460725214412,"Ciprofloxacin",-0.217825436366322,0.368189154826795,0.380910412321428,1.61298080058447,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.200117428612315,0.282643448882215,0.475629223897323,1.44026235919104,0.631472110063909
6,1797513,375519,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol withdrawal syndrome","Outcome control",1,375519,1,1,1.01975952756603,1.0146976540943,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,378424,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Astigmatism","Outcome control",1,378424,1,1,1.00655108511487,1.00472615347135,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,10442,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa, RR=2","Outcome control",2,4242416,1.99756834970052,2.07414966736666,1.01238120147014,1.00997386654356,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,381549,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Migraine with aura","Outcome control",1,381549,1,1,1.00743839560267,1.00537136546402,"Ciprofloxacin",-0.0824343594240868,0.42398117681717,0.389743922155975,2.05383814395805,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.116644484904839,0.311779629940284,0.488423510981316,1.65794899367039,0.908484280222785
6,1797513,433736,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obesity","Outcome control",1,433736,1,1,1.00272790035586,1.00201212608095,"Ciprofloxacin",0.275293581067968,0.146254532341339,0.987210064718478,1.75143386041994,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.103904049478908,0.195408545621358,0.765324078876132,1.64630193499941,0.107569256241253
6,1797513,433753,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Alcohol abuse","Outcome control",1,433753,1,1,1.00836690248196,1.00591151090354,"Ciprofloxacin",0.0980580773697775,0.444617621582678,0.456930451837245,2.61076939840823,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.00536477103815931,0.323563317351622,0.533585536277782,1.89687729809381,0.778427803024476
6,1797513,436373,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Developmental speech disorder","Outcome control",1,436373,1,1,1.01710950360188,1.00919619849488,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,437409,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Intracranial injury","Outcome control",1,437409,1,1,1.00786532321935,1.00500317347937,"Ciprofloxacin",-0.511871947775114,0.486747832471617,0.222820801248447,1.50174689924081,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.381407222310807,0.342749235579696,0.352532026010612,1.35112625553278,0.338742141517545
6,1797513,440374,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.01391885686643,1.00931190787506,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,440690,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Social phobia","Outcome control",1,440690,1,1,1.02183565624025,1.01407620340068,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1797513,441788,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00358913726296,1.00242089961781,"Ciprofloxacin",-0.108072108924998,0.181450885133203,0.625024616048181,1.2729157756687,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.132451332708152,0.202911745867794,0.595074641791378,1.31828413723493,0.727218352721085
6,1797513,4242416,1734104,"Ciprofloxacin","Azithromycin",35406429,"Otitis media","Cutis laxa","Outcome control",1,4242416,1,1,1.01239975862144,1.00999158553888,"Ciprofloxacin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10493,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=2","Outcome control",2,135777,2.00728272366264,1.937538912818,1.00399334434591,1.00901091358321,"Metformin",0.8718813395983,0.084757619176079,2.02934200910627,2.8290907465739,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.850621169526912,NA,1.89707484761893,NA,1.4005646338359e-16
6,1503297,10501,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=1.5","Outcome control",1.5,372328,1.50111039367303,1.52586560413874,1.00498165030379,1.01185709735432,"Metformin",0.431282990592073,0.10636284728178,1.24879026701345,1.89479375509197,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.392943452476992,0.120114973266289,1.1850974957903,1.89774642355746,0.00104246681575523
6,1503297,10447,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=1.5","Outcome control",1.5,260139,1.5047291831338,1.52419067733833,1.00340297528373,1.00783867753067,"Metformin",0.340537823860965,0.0654689238062833,1.23697615788037,1.59887984087988,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.298680514726877,0.0772979578128706,1.16816674481738,1.58160169088886,0.000406363952810997
6,1503297,10448,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=2","Outcome control",2,260139,2.00895738765375,2.04890211499952,1.00338695804416,1.00779702487684,"Metformin",0.683288846968617,0.0617165623646871,1.7564146839623,2.23714186696772,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.654716947568431,0.0959062748715922,1.64489956920316,2.39557915374411,5.06305058398202e-15
6,1503297,10449,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis, RR=4","Outcome control",4,260139,4.01896476714712,4.13332748501804,1.00333647675847,1.00766652820644,"Metformin",1.38607126990707,0.0578348349129369,3.57575904501062,4.48566098226731,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.38474769861886,NA,2.99487314209058,NA,1.59393715433777e-64
6,1503297,10450,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=1.5","Outcome control",1.5,256439,1.50388821541915,1.53500781018917,1.0065404004499,1.01536370445032,"Metformin",0.436790033004565,0.152497112002614,1.15121509400001,2.09299422148611,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.398661085732952,0.167261106489776,1.08840637454743,2.09670292283351,0.0141573791733627
6,1503297,10451,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=2","Outcome control",2,256439,2.00963363157114,2.08494262384687,1.00651661955809,1.01530331480126,"Metformin",0.648485521893424,0.140983586288698,1.45654466258459,2.53124800656676,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.618564668743471,0.16666094911087,1.38146733527939,2.65500127916353,5.59050924975548e-05
6,1503297,10452,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen, RR=4","Outcome control",4,256439,4.02796357783768,4.22094172681499,1.00642906691946,1.01508154167435,"Metformin",1.27842902613454,0.129759226181797,2.80139415071724,4.65882851168666,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27292646635517,NA,2.56227800548774,NA,1.3069069912796e-18
6,1503297,10513,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=1.5","Outcome control",1.5,433753,1.50161781999032,1.47048974091786,1.01223174368358,1.02753281207824,"Metformin",0.401014577133798,0.475401362847023,0.612106986345803,3.94595459642075,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.361497756054102,0.521520202008288,0.545254482065104,4.21150039498424,0.450068578403165
6,1503297,10453,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=1.5","Outcome control",1.5,133834,1.50152535324131,1.48605422711321,1.01016185873672,1.02393897814102,"Metformin",0.227013488421726,0.219990215317724,0.822315803715898,1.94782824161116,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.180774867454961,0.232809948150174,0.765014055668053,1.90548611657773,0.408228487291419
6,1503297,10457,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=2","Outcome control",2,438409,1.99942607609706,1.91174679565245,1.01060529839758,1.02705685823726,"Metformin",1.02919423417126,0.358458987114757,1.4456558524241,5.89259516013299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.01403351407696,NA,1.32486822778715,NA,0.00634392529317527
6,1503297,10458,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=4","Outcome control",4,438409,4.00525404075601,3.71451984544699,1.01045276918616,1.02652437607597,"Metformin",1.86917980897915,0.286303760064719,3.85821070152731,11.8519646123136,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.88656307568752,NA,3.38598908130609,NA,3.42750274992009e-10
6,1503297,10519,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=1.5","Outcome control",1.5,260134,1.5032964902579,1.38952117030273,1.07672296438517,1.21815251584984,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10459,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=1.5","Outcome control",1.5,138102,1.50445885435426,1.45423458908844,1.00288613229733,1.00649636203434,"Metformin",0.506238043447012,0.0671179500308013,1.4557372845401,1.89384665251472,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.470805874323586,0.0860239906292815,1.37385744511905,1.92481581677415,6.59281930659239e-08
6,1503297,10460,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=2","Outcome control",2,138102,2.0098439409952,1.9083637659985,1.00287717709896,1.00647483150377,"Metformin",0.763116605104426,0.0638727387778227,1.89451685759997,2.43352393242555,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.737626872704976,0.108072212239426,1.76745254078088,2.69979151894216,6.41442119769522e-18
6,1503297,10521,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=4","Outcome control",4,260134,4.00721557863619,3.85351428856004,1.07484658269129,1.20951912297912,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,133834,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis","Outcome control",1,133834,1,1,1.01022169882702,1.02410390890933,"Metformin",-0.188286589424234,0.267643720700762,0.48727707636873,1.39127658779848,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.250652656360321,0.279090545452249,0.451283178440234,1.34763956081419,0.40404814672877
6,1503297,10463,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=2","Outcome control",2,436665,2.00612672815534,1.96042990081189,1.01162482532026,1.02792278116848,"Metformin",0.422332969518316,0.277936542775478,0.895360343146312,2.66169251413218,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.383646757309531,0.299330088543295,0.832779987175634,2.6922212418142,0.17656105288143
6,1503297,10465,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=1.5","Outcome control",1.5,257012,1.50449140955198,1.56059457049292,1.00456288815483,1.01059691713295,"Metformin",0.614462669131034,0.0884448506252506,1.55703559964973,2.20225360184395,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.583209283962443,0.112490705617816,1.47257112285102,2.2886574959298,3.08054382883918e-08
6,1503297,10467,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=4","Outcome control",4,257012,4.02082713287059,4.32669825044056,1.00448497929343,1.01040530765529,"Metformin",1.33894652687835,0.0830571960370502,3.25002622298544,4.50073758309332,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33577134879521,NA,2.83678276247196,NA,3.84649214972539e-39
6,1503297,10468,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=1.5","Outcome control",1.5,134438,1.50440380451339,1.48968658458812,1.00418420504987,1.00967577020453,"Metformin",0.435792999100741,0.0831106421411844,1.31521316379099,1.82172979202965,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.397624631131109,0.0974893454178099,1.24435271676177,1.82351635509429,6.63515944100946e-05
6,1503297,141932,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis","Outcome control",1,141932,1,1,1.00478039972121,1.01050725926765,"Metformin",0.117190341969719,0.148901480084932,0.842523856538915,1.5103324250427,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0666698742817398,0.157427576884844,0.78846481250964,1.46146193825909,0.624522197596245
6,1503297,10469,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=2","Outcome control",2,134438,2.00652124792833,1.97305208573633,1.00416468327424,1.00962440121426,"Metformin",0.803904236103783,0.0787394166443585,1.91786281843118,2.61134206999174,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.780009686674597,NA,1.79653107577741,NA,1.38230111986275e-15
6,1503297,10470,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis, RR=4","Outcome control",4,134438,4.02165521118701,3.91312478937159,1.0040979504135,1.00944992136329,"Metformin",1.41687405453062,0.0728141722305316,3.583814129612,4.76765201125232,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.41675499955849,NA,3.03415760577746,NA,7.03563963156173e-52
6,1503297,197610,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary","Outcome control",1,197610,1,1,1.00731358183271,1.02010432366761,"Metformin",0.209592046881387,0.289828461967495,0.704374968482187,2.19385935487994,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.162656307823748,0.305972425374461,0.651982540950586,2.16333794307183,0.564304325876924
6,1503297,10464,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=4","Outcome control",4,436665,4.02237675390533,3.82913494951502,1.01142735049926,1.02734690859079,"Metformin",1.35278871867721,0.251024901164939,2.42658410455922,6.49143802146017,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.35017977590351,NA,2.25704071960462,NA,3.17577179978109e-07
6,1503297,10471,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=1.5","Outcome control",1.5,201606,1.49556212166068,1.48507045287561,1.01841306639546,1.04254293813012,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10472,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=2","Outcome control",2,201606,1.99763113871373,1.94166683753812,1.01834672140735,1.0423683797373,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,201606,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease","Outcome control",1,201606,1,1,1.01847752543134,1.04271056686753,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10473,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Crohn's disease, RR=4","Outcome control",4,201606,3.98863374793884,3.76718539011918,1.01809703261654,1.04171841158964,"Metformin",0.788481367933469,0.308096927046768,1.22729030081893,4.10631689134403,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.763987741838011,NA,1.14416813586223,NA,0.0166811366521182
6,1503297,10454,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=2","Outcome control",2,133834,2.00422547250782,1.98424773250739,1.01010344563194,1.02377862047544,"Metformin",0.614874151528714,0.190662190214955,1.2856076995801,2.71451575018329,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.583636356552725,0.216184564475601,1.21104974498374,2.82615028458482,0.00371356908848451
6,1503297,260139,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Acute bronchitis","Outcome control",1,260139,1,1,1.00342087800862,1.00788546844936,"Metformin",-0.0390266996910343,0.0724471831405517,0.834223029233225,1.10819575647928,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0955765721267214,0.0775233959111395,0.782353954943684,1.06017937430851,0.385394087934402
6,1503297,10477,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=1.5","Outcome control",1.5,194696,1.50330272309304,1.38360057139625,1.01170252806964,1.03597386944665,"Metformin",0.187846869099894,0.826332099212071,0.246561138577483,6.29035191753292,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.140065557425585,NA,0.213884258405569,NA,0.857926872404672
6,1503297,10478,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=2","Outcome control",2,194696,2.00776623277533,1.75935503470843,1.01165404675686,1.03572140380494,"Metformin",0.574030268254094,0.61037104654559,0.603621531774791,6.60483962217433,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.541221480708408,NA,0.49582843078053,NA,0.383140342766799
6,1503297,379805,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia","Outcome control",1,379805,1,1,1.00829266999222,1.01936352274224,"Metformin",0.0742317140833797,0.155349788742519,0.794510139864427,1.46072144103395,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0220453202546345,0.163718996575542,0.744404743085252,1.41424566668761,0.833358650964909
6,1503297,10479,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea, RR=4","Outcome control",4,194696,4.01004894675673,3.24031694093189,1.01147330884689,1.03480282447062,"Metformin",1.32414505536189,0.632895981240104,1.24267661824949,14.8525902070051,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32042043339702,NA,1.03165659994995,NA,0.0431581296914773
6,1503297,10480,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=1.5","Outcome control",1.5,78804,1.50356416963172,1.45001005390666,1.00796742195747,1.01917583043859,"Metformin",-0.138412877741242,0.491984080792145,0.31327031716653,2.15513492240548,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.198844272016934,0.514400926634942,0.301036858411479,2.26119178119122,0.719116090096616
6,1503297,433753,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse","Outcome control",1,433753,1,1,1.01229097137764,1.02768125878431,"Metformin",0.175805082639191,0.413115156960586,0.530033392048783,2.67665100386334,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.127556647840813,0.436470848918236,0.489872263458961,2.71101656199847,0.743760450531445
6,1503297,10481,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=2","Outcome control",2,78804,2.00788213256668,1.88751569714917,1.00794006518105,1.01910375375647,"Metformin",0.333278231621556,0.268410058334132,0.829766636947661,2.37628255959438,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.291140614308798,0.286089189028307,0.774180300661958,2.37619038770323,0.283565007268442
6,1503297,10461,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin, RR=4","Outcome control",4,138102,4.02580984087254,3.72520311184039,1.0028480246975,1.00640507829351,"Metformin",1.42359715081486,0.0603452613526686,3.69453776806078,4.6804980619104,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42372840750565,NA,3.07357458272886,NA,4.33872828525094e-65
6,1503297,10482,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast, RR=4","Outcome control",4,78804,4.02422961568523,3.70425518433029,1.00783687634301,1.01883206153274,"Metformin",1.13352233712709,0.197153049549837,2.13432495475268,4.62268714607986,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.12243498383711,NA,2.01280714891322,NA,8.85199868872594e-08
6,1503297,10462,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder, RR=1.5","Outcome control",1.5,436665,1.50181180978202,1.48230455378157,1.01167778318074,1.02807922735411,"Metformin",0.387961713954967,0.468025819840153,0.600967222388926,3.76373801714495,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.347938821378739,0.510774637299638,0.546048488218501,4.04366834320212,0.459698621176523
6,1503297,438409,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder","Outcome control",1,438409,1,1,1.01068508047986,1.02733925434636,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10483,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=1.5","Outcome control",1.5,441788,1.50288269355257,1.47114024969987,1.00599257058497,1.01407986978377,"Metformin",0.28914438997353,0.124964994184295,1.04665058422367,1.70821492473099,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.245298945603903,0.13518319406246,0.987937093645759,1.67828448144033,0.067094801462335
6,1503297,10484,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=2","Outcome control",2,441788,2.00294843251024,1.93516796926562,1.00596380370946,1.01400067096844,"Metformin",0.666965087932279,0.115512754311898,1.55768580941938,2.44979155357643,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.63776847320877,0.1426447775442,1.47680735443714,2.5832280986852,8.93185216226441e-07
6,1503297,441788,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection","Outcome control",1,441788,1,1,1.00602229082482,1.01416181635587,"Metformin",-0.140688284611047,0.147929389432185,0.650756705133982,1.1621283629989,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.201215557095745,0.154761715767758,0.604789663183931,1.10935662772612,0.252659033360547
6,1503297,10485,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Human papilloma virus infection, RR=4","Outcome control",4,441788,4.02548401836812,3.83055179654812,1.00585787379918,1.01371151009005,"Metformin",1.32747002593074,0.105311204503903,3.08115257912346,4.6558108144969,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.32387426816761,NA,2.75010466770302,NA,1.67417694220318e-27
6,1503297,10486,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=1.5","Outcome control",1.5,139099,1.50351826074728,1.49051503281077,1.00909567324352,1.02064110767303,"Metformin",0.512902533914131,0.110898163267824,1.34663767800289,2.07990805571063,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.477726991150329,0.127974288406909,1.276149327809,2.10748901509441,0.000127123199267734
6,1503297,10466,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis, RR=2","Outcome control",2,257012,2.00790524679768,2.11658552402446,1.00454523457151,1.01055333941493,"Metformin",0.77993036547899,0.0869720428675918,1.84303564840412,2.59176254731434,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.755079805183909,NA,1.7336814487957,NA,5.29438636900972e-13
6,1503297,10489,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=1.5","Outcome control",1.5,379805,1.50467872248169,1.53112920628202,1.00823677907876,1.01922448092767,"Metformin",0.46521949591938,0.141034983615158,1.21218705923961,2.10701697640845,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.428194108946634,0.156457434660243,1.14636630891995,2.11678638526503,0.00486633176364964
6,1503297,10490,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=2","Outcome control",2,379805,2.00718437800468,2.06839857107455,1.00818385199126,1.01909310982392,"Metformin",0.705221719776823,0.138535234575848,1.54971922788328,2.66744720468168,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.677500371588935,0.169454481636872,1.46954181740004,2.85536598394645,7.73243411337032e-06
6,1503297,10491,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Myopia, RR=4","Outcome control",4,379805,4.02719188275201,4.19782029213026,1.00799341414196,1.01862237992456,"Metformin",1.26445865905324,0.133078601027584,2.74630222232071,4.6270239713027,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.25841647937873,NA,2.52012443050986,NA,1.59410170894892e-17
6,1503297,10492,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=1.5","Outcome control",1.5,135777,1.50365627467665,1.4669100186434,1.00400999510811,1.00905148538651,"Metformin",0.551364272460071,0.0889488588623318,1.46000170944532,2.06909378468436,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.517659206260874,0.108702355926428,1.38203051434588,2.11627868761913,9.16603457559661e-07
6,1503297,10494,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin, RR=4","Outcome control",4,135777,4.02358036897814,3.82088437550851,1.00393543130831,1.00887042329374,"Metformin",1.48387907240156,0.0791774692885727,3.78609847126874,5.16397193458999,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.4863591022987,NA,3.17273609673152,NA,4.2564777114114e-51
6,1503297,10497,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=4","Outcome control",4,440374,4.01571228610587,3.62375002462934,1.02385027524998,1.05841384942295,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10498,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=1.5","Outcome control",1.5,380733,1.5045399169549,1.58343391452192,1.00748409339191,1.01773258007364,"Metformin",0.324199079186162,0.168457032554525,1.00038319213307,1.93619082810409,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.281704175174377,0.180789329212171,0.938774656433142,1.9069428106868,0.107892456226767
6,1503297,10499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=2","Outcome control",2,380733,2.00563966796368,2.15958058017547,1.00744669674561,1.01763481860979,"Metformin",0.796959484254409,0.140257224433627,1.69352477168457,2.93471468584626,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.772794275839009,NA,1.60524455420239,NA,4.78845718423253e-07
6,1503297,10500,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia, RR=4","Outcome control",4,380733,4.02220102637377,4.48421718116382,1.00730890107906,1.01727596843788,"Metformin",1.42620952485469,0.158113637830336,3.08655211132194,5.73649684094299,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.42643881161273,NA,2.79716724713598,NA,1.10510485446271e-16
6,1503297,10502,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=2","Outcome control",2,372328,2.00982834056865,2.06311816851584,1.00495642463166,1.01178774787073,"Metformin",0.735233973402737,0.0920924926071235,1.74473618432138,2.50327355659997,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.708702609855238,0.127749170827622,1.64671773174486,2.7170632267976,7.8065403271738e-11
6,1503297,10503,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media, RR=4","Outcome control",4,372328,4.02941293301064,4.18419323507229,1.00486936797007,1.01155000110462,"Metformin",1.33429607703143,0.087886226716091,3.20631359587664,4.52505414539218,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.33094731128358,NA,2.81424053434293,NA,5.29530757656507e-36
6,1503297,10505,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=2","Outcome control",2,4311499,2.00994789245918,1.77850772143443,1.01711040557929,1.03695107125413,"Metformin",-0.0396093375044215,0.243648930648952,0.590872481677988,1.53561538961978,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0962101874014681,0.254808374196867,0.552952667956957,1.5013243224778,0.751017804202519
6,1503297,10506,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=4","Outcome control",4,4311499,4.01956384811136,3.30346494393905,1.01676889126895,1.03621542696225,"Metformin",0.31669939984026,0.203912618143702,0.923961645691483,2.05492234295112,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.273897029207803,0.21763113346254,0.867243025631814,2.035338882185,0.189178614786901
6,1503297,10507,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=1.5","Outcome control",1.5,141932,1.50449496402517,1.47809871187787,1.00475777528166,1.01045632402873,"Metformin",0.66917579974263,0.133350230732359,1.50983057029326,2.54650221855278,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.640057874865669,0.160646705719635,1.43131543555844,2.68671006604244,1.23300756391136e-05
6,1503297,10508,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=2","Outcome control",2,141932,2.0093451708453,1.95545905413049,1.00473604222967,1.01040724621999,"Metformin",0.985656824758952,0.123797264377652,2.11469125112053,3.43557800365517,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.968808440911412,NA,1.98428816584323,NA,2.62084248939217e-12
6,1503297,10509,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Seborrheic keratosis, RR=4","Outcome control",4,141932,4.02612368015094,3.87630315817771,1.00465869232873,1.01023339283736,"Metformin",1.66001126226102,0.109824837942346,4.26879211847815,6.56555054549631,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.66929008431874,NA,3.51672970418063,NA,6.52118389998241e-40
6,1503297,10510,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=1.5","Outcome control",1.5,140641,1.5046812749317,1.47257290227051,1.00622892895542,1.01447709594614,"Metformin",0.337326898157402,0.139582543055632,1.07151737610249,1.85193171933304,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.295343218339179,0.151203933977771,1.00828335838148,1.82386480617789,0.0468713680748175
6,1503297,10514,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=2","Outcome control",2,433753,2.0028144532299,1.97871844470989,1.01217312617255,1.02738517079516,"Metformin",0.792268928277275,0.345524444980492,1.14648598019758,4.44212351285741,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.767921817717049,NA,1.06505522415413,NA,0.031409641977688
6,1503297,10515,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Alcohol abuse, RR=4","Outcome control",4,433753,4.01352513874068,3.92974216792605,1.01194817182978,1.02682298508875,"Metformin",1.78231264126494,0.366905163135424,3.06458248203558,12.9119488474122,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.79635083370836,NA,2.75993744308602,NA,2.62166792714054e-06
6,1503297,10455,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Atopic dermatitis, RR=4","Outcome control",4,133834,4.01729909316343,3.90495431325175,1.0098835782743,1.02317884966314,"Metformin",1.39674241263527,0.182016124059391,2.87384320412891,5.86580850442766,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.39582906561618,NA,2.63615325939278,NA,9.05745995278084e-13
6,1503297,10516,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=1.5","Outcome control",1.5,201061,1.50458311198084,1.51486876442265,1.00736699209782,1.01640052667835,"Metformin",0.285820230576028,0.123909912410428,1.04555444375385,1.69938300033653,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.24184678795315,0.134037736967213,0.986641450687827,1.668574545985,0.0688268065194067
6,1503297,10456,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Attention deficit hyperactivity disorder, RR=1.5","Outcome control",1.5,438409,1.50085717476643,1.43244760688815,1.01064481878832,1.02719666862123,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10517,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=2","Outcome control",2,201061,2.00892813789243,2.02834153306343,1.0073135687247,1.01627561663897,"Metformin",0.580639254058499,0.116837938465109,1.42499112845554,2.25277297537832,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.548100110170447,0.137532581341341,1.3510551253101,2.31637548653527,2.6903555752355e-05
6,1503297,10518,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia, RR=4","Outcome control",4,201061,4.02819411132239,4.05830798076538,1.00712009598137,1.01582289203049,"Metformin",1.16930794642415,0.098194290954619,2.66553154342819,3.91696860148085,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.15959431122265,NA,2.43042541313107,NA,7.93089735485377e-24
6,1503297,10520,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup, RR=2","Outcome control",2,260134,2.00011969560439,1.94752640156771,1.07634618255783,1.21635762288974,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,78804,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Fibrocystic disease of breast","Outcome control",1,78804,1,1,1.00799558429979,1.01925033674604,"Metformin",-0.281306909356057,0.387134484335016,0.356616566486685,1.62652392298809,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.347278869387991,0.403351052859571,0.3212632419593,1.56144652298491,0.411717464585436
6,1503297,134438,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Contact dermatitis","Outcome control",1,134438,1,1,1.00420507812541,1.00973088458822,"Metformin",0.110362291296884,0.0903381557616339,0.935927395168021,1.33362618711019,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0595809719726916,0.0971591643425372,0.880579139988333,1.28876120580877,0.502172223865836
6,1503297,10504,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract, RR=1.5","Outcome control",1.5,4311499,1.50022068477631,1.38045202592765,1.01719990592478,1.03714406486525,"Metformin",-0.174604966916201,0.274080890211584,0.48999474524888,1.43478747243987,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.236440393187324,0.285851705797135,0.451783637463165,1.38536854904134,0.443317573939699
6,1503297,135777,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Neoplasm of uncertain behavior of skin","Outcome control",1,135777,1,1,1.00402764818983,1.00909450798642,"Metformin",0.0963096523690437,0.107520756735206,0.890695560614176,1.3576035215301,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.0449792572242843,0.114557382731032,0.838663843970827,1.31404658611961,0.6378980441316
6,1503297,138102,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Benign neoplasm of skin","Outcome control",1,138102,1,1,1.00289592897211,1.00651995684632,"Metformin",0.157482664002609,0.0720921750027697,1.01654786412115,1.34852118470745,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.108523837920366,0.0794491780566274,0.957977752829609,1.30800664250207,0.191757199057921
6,1503297,139099,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail","Outcome control",1,139099,1,1,1.00920735566613,1.02092227578185,"Metformin",0.193227926564428,0.119108642047175,0.960894163137354,1.53266230096245,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.145655017770897,0.127598767399986,0.905556684854333,1.49327631355949,0.240677874154478
6,1503297,140641,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris","Outcome control",1,140641,1,1,1.00626070578559,1.01456196129906,"Metformin",-0.0794221711516266,0.158091581234571,0.677005175258501,1.25813598580178,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.137569398015989,0.165570092272395,0.631309859547661,1.20811870408936,0.47650236603286
6,1503297,194696,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Dysmenorrhea","Outcome control",1,194696,1,1,1.01175172437391,1.03623177440251,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10511,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=2","Outcome control",2,140641,2.00668053975024,1.94366904934746,1.00619880018724,1.01439720216127,"Metformin",0.6140338681135,0.119728351641102,1.46513100923481,2.34262285265652,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.582784828928779,0.142609286918438,1.3895846907648,2.43032028044032,1.25206386298598e-05
6,1503297,201061,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Diaphragmatic hernia","Outcome control",1,201061,1,1,1.00742332173704,1.01653306452773,"Metformin",-0.18946802481777,0.144378680636481,0.621690873896901,1.09487667491764,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.251891203590087,0.150901726374251,0.579109207965703,1.04629954171162,0.137606223397662
6,1503297,10512,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Verruca vulgaris, RR=4","Outcome control",4,140641,4.02682968665522,3.83247337785435,1.00608612774665,1.01409885007388,"Metformin",1.40324455171954,0.107649289918454,3.30968994525982,5.04719162772683,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.40257971432544,NA,2.91425330521636,NA,1.21624474381958e-29
6,1503297,256439,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Allergic rhinitis due to pollen","Outcome control",1,256439,1,1,1.00656492072174,1.01542604795956,"Metformin",-0.154709086546888,0.176078249109346,0.605100803812091,1.20665713319483,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.215776602139493,0.18393080334714,0.562941448049305,1.1576775015035,0.291696053841528
6,1503297,10474,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=1.5","Outcome control",1.5,197610,1.50471185850788,1.28392330922401,1.00724453224965,1.01983247835842,"Metformin",0.943986511708144,0.283971176839313,1.49621252865574,4.55435306223931,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.925521564993532,NA,1.40898544698273,NA,0.00176037547899381
6,1503297,257012,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Chronic sinusitis","Outcome control",1,257012,1,1,1.00458190505324,1.01064391988238,"Metformin",0.216602842194117,0.0976854014929742,1.025903688697,1.50454963739103,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.169939302362974,0.106102992177281,0.967977248421717,1.46721990775081,0.113384198226999
6,1503297,10475,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=2","Outcome control",2,197610,2.00977521882633,1.56870618555695,1.00718064838344,1.01958405787708,"Metformin",1.2767476404792,0.203846543065095,2.4396570364261,5.42447562704296,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.27118447111886,NA,2.2810581538924,NA,4.52036541452439e-09
6,1503297,260134,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Croup","Outcome control",1,260134,1,1,1.07713563973704,1.2201040678876,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10476,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Cyst of ovary, RR=4","Outcome control",4,197610,4.02783685213262,2.68738187419712,1.00696675457878,1.01877465901818,"Metformin",2.19061645519365,0.20643302598797,6.1069842728523,13.7169963209335,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",2.22046046823977,NA,4.61094085245302,NA,7.04247917516204e-24
6,1503297,372328,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otitis media","Outcome control",1,372328,1,1,1.00500826548887,1.01193073767627,"Metformin",-0.0155788291119833,0.107401187944621,0.796652826853788,1.21369402907278,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.0712518545630968,0.113490583101921,0.747300377476795,1.16600904828249,0.646683295004466
6,1503297,380733,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Otalgia","Outcome control",1,380733,1,1,1.00752336667241,1.01783562313973,"Metformin",-0.108863604088919,0.184984616695486,0.622439344381173,1.28533229300831,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.1681516007699,0.193369456752775,0.579781178594309,1.23724831997211,0.44129912892895
6,1503297,436665,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Bipolar disorder","Outcome control",1,436665,1,1,1.01173072989428,1.02823556737381,"Metformin",-0.269449009170536,0.449644745431631,0.305028611230701,1.77753098495952,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.334961026349617,0.468756987882476,0.286379318217864,1.79868450664213,0.495017302818851
6,1503297,440374,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder","Outcome control",1,440374,1,1,1.02451948814368,1.06051799106313,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,4311499,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Primary malignant neoplasm of respiratory tract","Outcome control",1,4311499,1,1,1.01729064360035,1.03733929866971,"Metformin",-0.43055263320926,0.336856998960111,0.329353291304372,1.23346946410476,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",-0.502311878373555,0.350493878936915,0.304780288560317,1.20411713661018,0.168243137276827
6,1503297,10487,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=2","Outcome control",2,139099,2.00739052410506,1.96597058060055,1.0089906819737,1.02037778743643,"Metformin",0.712191207696979,0.106169254008535,1.65914518312315,2.51551699755652,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",0.684746338111602,0.138122419047179,1.57099680257775,2.69969892510723,1.71579654619327e-08
6,1503297,10488,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Ingrowing nail, RR=4","Outcome control",4,139099,4.02697698375311,3.9051389856537,1.00862278757448,1.01946383625741,"Metformin",1.31495147224529,0.0958433185599135,3.09723943793536,4.50960747761016,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",1.31087269247956,NA,2.74983648056424,NA,5.61761127392623e-31
6,1503297,10495,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=1.5","Outcome control",1.5,440374,1.50442532190753,1.43269139670627,1.02440549235915,1.06015638655852,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
6,1503297,10496,1560171,"Metformin","Glipizide",35506622,"Type 2 diabetes mellitus","Obsessive-compulsive disorder, RR=2","Outcome control",2,440374,1.99334145865672,1.82255709957225,1.02429290938869,1.0597985699676,"Metformin",NA,NA,NA,NA,"CohortMethod",TRUE,FALSE,TRUE,"CCAE",NA,NA,NA,NA,NA
